id	sid	tid	token	lemma	pos
ajpf-815	1	1	1	1	NUM
ajpf-815	1	2	in	in	ADP
ajpf-815	1	3	ternationa	ternationa	NOUN
ajpf-815	1	4	l	l	NOUN
ajpf-815	1	5	scholars	scholar	NOUN
ajpf-815	1	6	journa	journa	VERB
ajpf-815	1	7	ls	ls	PROPN
ajpf-815	1	8	african	african	ADJ
ajpf-815	1	9	journal	journal	PROPN
ajpf-815	1	10	of	of	ADP
ajpf-815	1	11	pig	pig	PROPN
ajpf-815	1	12	farming	farming	PROPN
ajpf-815	1	13	issn	issn	PROPN
ajpf-815	1	14	:	:	PUNCT
ajpf-815	1	15	2375	2375	NUM
ajpf-815	1	16	-	-	SYM
ajpf-815	1	17	0731	0731	NUM
ajpf-815	1	18	vol	vol	NOUN
ajpf-815	1	19	.	.	PROPN
ajpf-815	1	20	11	11	NUM
ajpf-815	1	21	(	(	PUNCT
ajpf-815	1	22	3	3	NUM
ajpf-815	1	23	)	)	PUNCT
ajpf-815	1	24	,	,	PUNCT
ajpf-815	1	25	pp	pp	PROPN
ajpf-815	1	26	.	.	PUNCT
ajpf-815	2	1	001	001	NUM
ajpf-815	2	2	-	-	PUNCT
ajpf-815	2	3	010	010	NUM
ajpf-815	2	4	,	,	PUNCT
ajpf-815	2	5	march	march	PROPN
ajpf-815	2	6	,	,	PUNCT
ajpf-815	2	7	2023	2023	NUM
ajpf-815	2	8	.	.	PUNCT
ajpf-815	3	1	available	available	ADJ
ajpf-815	3	2	online	online	ADV
ajpf-815	3	3	at	at	ADP
ajpf-815	3	4	www.internationalscholarsjournals.org	www.internationalscholarsjournals.org	PROPN
ajpf-815	3	5	©	©	PROPN
ajpf-815	3	6	international	international	ADJ
ajpf-815	3	7	scholars	scholar	NOUN
ajpf-815	3	8	journals	journal	NOUN
ajpf-815	3	9	author(s	author(s	PROPN
ajpf-815	3	10	)	)	PUNCT
ajpf-815	3	11	retain	retain	VERB
ajpf-815	3	12	the	the	DET
ajpf-815	3	13	copyright	copyright	NOUN
ajpf-815	3	14	of	of	ADP
ajpf-815	3	15	this	this	DET
ajpf-815	3	16	article	article	NOUN
ajpf-815	3	17	.	.	PUNCT
ajpf-815	4	1	full	full	ADJ
ajpf-815	4	2	length	length	NOUN
ajpf-815	4	3	research	research	NOUN
ajpf-815	4	4	paper	paper	NOUN
ajpf-815	4	5	in	in	ADP
ajpf-815	4	6	vitro	vitro	X
ajpf-815	4	7	antiviral	antiviral	ADJ
ajpf-815	4	8	activity	activity	NOUN
ajpf-815	4	9	of	of	ADP
ajpf-815	4	10	brazilian	brazilian	ADJ
ajpf-815	4	11	cerrado	cerrado	NOUN
ajpf-815	4	12	plant	plant	NOUN
ajpf-815	4	13	extracts	extract	NOUN
ajpf-815	4	14	against	against	ADP
ajpf-815	4	15	animal	animal	NOUN
ajpf-815	4	16	and	and	CCONJ
ajpf-815	4	17	human	human	PROPN
ajpf-815	4	18	herpesviruses	herpesviruse	NOUN
ajpf-815	4	19	marina	marina	PROPN
ajpf-815	4	20	a.	a.	PROPN
ajpf-815	4	21	padilla1,2	padilla1,2	PROPN
ajpf-815	4	22	,	,	PUNCT
ajpf-815	4	23	isabela	isabela	PROPN
ajpf-815	4	24	c.	c.	PROPN
ajpf-815	4	25	simoni1	simoni1	PROPN
ajpf-815	4	26	*	*	PROPN
ajpf-815	4	27	,	,	PUNCT
ajpf-815	4	28	verônica	verônica	PROPN
ajpf-815	4	29	moreira	moreira	PROPN
ajpf-815	4	30	h.	h.	PROPN
ajpf-815	4	31	hoe1	hoe1	PROPN
ajpf-815	4	32	,	,	PUNCT
ajpf-815	4	33	maria	maria	PROPN
ajpf-815	4	34	judite	judite	PROPN
ajpf-815	4	35	b.	b.	PROPN
ajpf-815	4	36	fernandes1	fernandes1	PROPN
ajpf-815	4	37	,	,	PUNCT
ajpf-815	4	38	clarice	clarice	PROPN
ajpf-815	4	39	w.	w.	PROPN
ajpf-815	4	40	arns2	arns2	PROPN
ajpf-815	4	41	,	,	PUNCT
ajpf-815	4	42	juliana	juliana	PROPN
ajpf-815	4	43	r.	r.	PROPN
ajpf-815	4	44	brito3	brito3	PROPN
ajpf-815	4	45	and	and	CCONJ
ajpf-815	4	46	joão	joão	PROPN
ajpf-815	4	47	henrique	henrique	PROPN
ajpf-815	4	48	g.	g.	PROPN
ajpf-815	4	49	lago4	lago4	PROPN
ajpf-815	4	50	1	1	NUM
ajpf-815	4	51	centro	centro	X
ajpf-815	4	52	de	de	X
ajpf-815	4	53	pesquisa	pesquisa	X
ajpf-815	4	54	e	e	PROPN
ajpf-815	4	55	desenvolvimento	desenvolvimento	PROPN
ajpf-815	4	56	de	de	X
ajpf-815	4	57	sanidade	sanidade	PROPN
ajpf-815	4	58	animal	animal	PROPN
ajpf-815	4	59	,	,	PUNCT
ajpf-815	4	60	instituto	instituto	PROPN
ajpf-815	4	61	biológico	biológico	PROPN
ajpf-815	4	62	,	,	PUNCT
ajpf-815	4	63	av	av	PROPN
ajpf-815	4	64	.	.	PUNCT
ajpf-815	4	65	cons	con	NOUN
ajpf-815	4	66	.	.	PUNCT
ajpf-815	5	1	rodrigues	rodrigues	PROPN
ajpf-815	5	2	alves	alves	PROPN
ajpf-815	5	3	,	,	PUNCT
ajpf-815	5	4	1252	1252	NUM
ajpf-815	5	5	,	,	PUNCT
ajpf-815	5	6	cep	cep	NOUN
ajpf-815	5	7	04014	04014	NUM
ajpf-815	5	8	-	-	SYM
ajpf-815	5	9	900	900	NUM
ajpf-815	5	10	,	,	PUNCT
ajpf-815	5	11	são	são	NOUN
ajpf-815	5	12	paulo	paulo	PROPN
ajpf-815	5	13	,	,	PUNCT
ajpf-815	5	14	sp	sp	NOUN
ajpf-815	5	15	,	,	PUNCT
ajpf-815	5	16	brasil	brasil	PROPN
ajpf-815	5	17	.	.	PUNCT
ajpf-815	6	1	2	2	NUM
ajpf-815	6	2	laboratório	laboratório	PROPN
ajpf-815	6	3	de	de	X
ajpf-815	6	4	virologia	virologia	PROPN
ajpf-815	6	5	animal	animal	NOUN
ajpf-815	6	6	,	,	PUNCT
ajpf-815	6	7	universidade	universidade	PROPN
ajpf-815	6	8	estadual	estadual	PROPN
ajpf-815	6	9	de	de	PROPN
ajpf-815	6	10	campinas	campinas	PROPN
ajpf-815	6	11	,	,	PUNCT
ajpf-815	6	12	campinas	campinas	PROPN
ajpf-815	6	13	,	,	PUNCT
ajpf-815	6	14	sp	sp	PROPN
ajpf-815	6	15	,	,	PUNCT
ajpf-815	6	16	brasil	brasil	PROPN
ajpf-815	6	17	.	.	PUNCT
ajpf-815	7	1	3	3	NUM
ajpf-815	7	2	instituto	instituto	PROPN
ajpf-815	7	3	de	de	PROPN
ajpf-815	7	4	ciências	ciências	PROPN
ajpf-815	7	5	ambientais	ambientais	PROPN
ajpf-815	7	6	,	,	PUNCT
ajpf-815	7	7	químicas	química	NOUN
ajpf-815	7	8	e	e	NOUN
ajpf-815	7	9	farmacêuticas	farmacêutica	NOUN
ajpf-815	7	10	,	,	PUNCT
ajpf-815	7	11	universidade	universidade	PROPN
ajpf-815	7	12	federal	federal	PROPN
ajpf-815	7	13	de	de	PROPN
ajpf-815	7	14	são	são	PROPN
ajpf-815	7	15	paulo	paulo	PROPN
ajpf-815	7	16	,	,	PUNCT
ajpf-815	7	17	são	são	PROPN
ajpf-815	7	18	paulo	paulo	PROPN
ajpf-815	7	19	,	,	PUNCT
ajpf-815	7	20	brazil	brazil	PROPN
ajpf-815	7	21	.	.	PUNCT
ajpf-815	7	22	4	4	NUM
ajpf-815	7	23	centro	centro	X
ajpf-815	7	24	de	de	PROPN
ajpf-815	7	25	ciências	ciências	PROPN
ajpf-815	7	26	naturais	naturais	PROPN
ajpf-815	7	27	e	e	PROPN
ajpf-815	7	28	humanas	humanas	PROPN
ajpf-815	7	29	,	,	PUNCT
ajpf-815	7	30	universidade	universidade	PROPN
ajpf-815	7	31	federal	federal	PROPN
ajpf-815	7	32	do	do	AUX
ajpf-815	7	33	abc	abc	PROPN
ajpf-815	7	34	,	,	PUNCT
ajpf-815	7	35	são	são	PROPN
ajpf-815	7	36	paulo	paulo	PROPN
ajpf-815	7	37	,	,	PUNCT
ajpf-815	7	38	brazil	brazil	PROPN
ajpf-815	7	39	.	.	PUNCT
ajpf-815	7	40	accepted	accept	VERB
ajpf-815	7	41	16	16	NUM
ajpf-815	7	42	january	january	PROPN
ajpf-815	7	43	,	,	PUNCT
ajpf-815	7	44	2023	2023	NUM
ajpf-815	7	45	the	the	DET
ajpf-815	7	46	brazilian	brazilian	ADJ
ajpf-815	7	47	savanna	savanna	NOUN
ajpf-815	7	48	known	know	VERB
ajpf-815	7	49	as	as	ADP
ajpf-815	7	50	“	"	PUNCT
ajpf-815	7	51	cerrado	cerrado	NOUN
ajpf-815	7	52	”	"	PUNCT
ajpf-815	7	53	is	be	AUX
ajpf-815	7	54	very	very	ADV
ajpf-815	7	55	rich	rich	ADJ
ajpf-815	7	56	in	in	ADP
ajpf-815	7	57	medicinal	medicinal	ADJ
ajpf-815	7	58	plants	plant	NOUN
ajpf-815	7	59	that	that	PRON
ajpf-815	7	60	are	be	AUX
ajpf-815	7	61	used	use	VERB
ajpf-815	7	62	by	by	ADP
ajpf-815	7	63	the	the	DET
ajpf-815	7	64	local	local	ADJ
ajpf-815	7	65	population	population	NOUN
ajpf-815	7	66	for	for	ADP
ajpf-815	7	67	treatment	treatment	NOUN
ajpf-815	7	68	of	of	ADP
ajpf-815	7	69	several	several	ADJ
ajpf-815	7	70	illnesses	illness	NOUN
ajpf-815	7	71	.	.	PUNCT
ajpf-815	8	1	the	the	DET
ajpf-815	8	2	herpesvirus	herpesvirus	NOUN
ajpf-815	8	3	is	be	AUX
ajpf-815	8	4	a	a	DET
ajpf-815	8	5	serious	serious	ADJ
ajpf-815	8	6	problem	problem	NOUN
ajpf-815	8	7	worldwide	worldwide	ADV
ajpf-815	8	8	,	,	PUNCT
ajpf-815	8	9	and	and	CCONJ
ajpf-815	8	10	affects	affect	VERB
ajpf-815	8	11	both	both	PRON
ajpf-815	8	12	animal	animal	NOUN
ajpf-815	8	13	and	and	CCONJ
ajpf-815	8	14	human	human	ADJ
ajpf-815	8	15	health	health	NOUN
ajpf-815	8	16	.	.	PUNCT
ajpf-815	9	1	this	this	DET
ajpf-815	9	2	work	work	NOUN
ajpf-815	9	3	aimed	aim	VERB
ajpf-815	9	4	to	to	PART
ajpf-815	9	5	study	study	VERB
ajpf-815	9	6	the	the	DET
ajpf-815	9	7	antiviral	antiviral	ADJ
ajpf-815	9	8	activity	activity	NOUN
ajpf-815	9	9	of	of	ADP
ajpf-815	9	10	eight	eight	NUM
ajpf-815	9	11	extracts	extract	NOUN
ajpf-815	9	12	from	from	ADP
ajpf-815	9	13	plants	plant	NOUN
ajpf-815	9	14	natives	native	NOUN
ajpf-815	9	15	of	of	ADP
ajpf-815	9	16	“	"	PUNCT
ajpf-815	9	17	cerrado	cerrado	NOUN
ajpf-815	9	18	”	"	PUNCT
ajpf-815	9	19	region	region	NOUN
ajpf-815	9	20	against	against	ADP
ajpf-815	9	21	human	human	NOUN
ajpf-815	9	22	(	(	PUNCT
ajpf-815	9	23	hsv-1	hsv-1	NOUN
ajpf-815	9	24	)	)	PUNCT
ajpf-815	9	25	,	,	PUNCT
ajpf-815	9	26	equine	equine	NOUN
ajpf-815	9	27	(	(	PUNCT
ajpf-815	9	28	eqhv-1	eqhv-1	NUM
ajpf-815	9	29	)	)	PUNCT
ajpf-815	9	30	and	and	CCONJ
ajpf-815	9	31	swine	swine	ADJ
ajpf-815	9	32	herpesviruses	herpesviruse	NOUN
ajpf-815	9	33	(	(	PUNCT
ajpf-815	9	34	suhv-1	suhv-1	NOUN
ajpf-815	9	35	)	)	PUNCT
ajpf-815	9	36	.	.	PUNCT
ajpf-815	10	1	the	the	DET
ajpf-815	10	2	results	result	NOUN
ajpf-815	10	3	showed	show	VERB
ajpf-815	10	4	that	that	SCONJ
ajpf-815	10	5	all	all	DET
ajpf-815	10	6	plant	plant	NOUN
ajpf-815	10	7	extracts	extract	NOUN
ajpf-815	10	8	:	:	PUNCT
ajpf-815	10	9	banisteriopsis	banisteriopsis	NOUN
ajpf-815	10	10	variabilis	variabilis	PROPN
ajpf-815	10	11	,	,	PUNCT
ajpf-815	10	12	byrsonima	byrsonima	PROPN
ajpf-815	10	13	intermedia	intermedia	PROPN
ajpf-815	10	14	,	,	PUNCT
ajpf-815	10	15	campomanesia	campomanesia	PROPN
ajpf-815	10	16	xanthocarpa	xanthocarpa	PROPN
ajpf-815	10	17	,	,	PUNCT
ajpf-815	10	18	erythroxilum	erythroxilum	NOUN
ajpf-815	10	19	deciduum	deciduum	PROPN
ajpf-815	10	20	,	,	PUNCT
ajpf-815	10	21	lacistema	lacistema	NOUN
ajpf-815	10	22	hasslerianum	hasslerianum	NOUN
ajpf-815	10	23	,	,	PUNCT
ajpf-815	10	24	ocotea	ocotea	NOUN
ajpf-815	10	25	pulchella	pulchella	NOUN
ajpf-815	10	26	,	,	PUNCT
ajpf-815	10	27	stryphodendron	stryphodendron	PROPN
ajpf-815	10	28	adstringens	adstringens	PROPN
ajpf-815	10	29	and	and	CCONJ
ajpf-815	10	30	xylopia	xylopia	PROPN
ajpf-815	10	31	aromatica	aromatica	PROPN
ajpf-815	10	32	presented	present	VERB
ajpf-815	10	33	antiviral	antiviral	ADJ
ajpf-815	10	34	activity	activity	NOUN
ajpf-815	10	35	against	against	ADP
ajpf-815	10	36	at	at	ADV
ajpf-815	10	37	least	least	ADV
ajpf-815	10	38	one	one	NUM
ajpf-815	10	39	herpesvirus	herpesvirus	NOUN
ajpf-815	10	40	.	.	PUNCT
ajpf-815	11	1	furthermore	furthermore	ADV
ajpf-815	11	2	,	,	PUNCT
ajpf-815	11	3	it	it	PRON
ajpf-815	11	4	was	be	AUX
ajpf-815	11	5	observed	observe	VERB
ajpf-815	11	6	a	a	DET
ajpf-815	11	7	direct	direct	ADJ
ajpf-815	11	8	anti	anti	ADJ
ajpf-815	11	9	-	-	ADJ
ajpf-815	11	10	herpes	herpes	ADJ
ajpf-815	11	11	effect	effect	NOUN
ajpf-815	11	12	of	of	ADP
ajpf-815	11	13	extracts	extract	NOUN
ajpf-815	11	14	from	from	ADP
ajpf-815	11	15	b.	b.	PROPN
ajpf-815	11	16	variabilis	variabilis	PROPN
ajpf-815	11	17	and	and	CCONJ
ajpf-815	11	18	b.	b.	PROPN
ajpf-815	11	19	intermedia	intermedia	PROPN
ajpf-815	11	20	in	in	ADP
ajpf-815	11	21	non	non	ADJ
ajpf-815	11	22	-	-	ADJ
ajpf-815	11	23	toxic	toxic	ADJ
ajpf-815	11	24	concentrations	concentration	NOUN
ajpf-815	11	25	against	against	ADP
ajpf-815	11	26	all	all	DET
ajpf-815	11	27	herpesviruses	herpesviruse	NOUN
ajpf-815	11	28	.	.	PUNCT
ajpf-815	12	1	b.	b.	PROPN
ajpf-815	12	2	intermedia	intermedia	PROPN
ajpf-815	12	3	crude	crude	PROPN
ajpf-815	12	4	aqueous	aqueous	ADJ
ajpf-815	12	5	extract	extract	NOUN
ajpf-815	12	6	showed	show	VERB
ajpf-815	12	7	the	the	DET
ajpf-815	12	8	most	most	ADV
ajpf-815	12	9	promising	promising	ADJ
ajpf-815	12	10	results	result	NOUN
ajpf-815	12	11	with	with	ADP
ajpf-815	12	12	selective	selective	ADJ
ajpf-815	12	13	index	index	NOUN
ajpf-815	12	14	values	value	NOUN
ajpf-815	12	15	of	of	ADP
ajpf-815	12	16	the	the	DET
ajpf-815	12	17	41.76	41.76	NUM
ajpf-815	12	18	±	±	NUM
ajpf-815	12	19	0.04	0.04	NUM
ajpf-815	12	20	;	;	PUNCT
ajpf-815	12	21	4.12	4.12	NUM
ajpf-815	12	22	±	±	NUM
ajpf-815	12	23	0.1	0.1	NUM
ajpf-815	12	24	and	and	CCONJ
ajpf-815	12	25	193.97	193.97	NUM
ajpf-815	12	26	±	±	NUM
ajpf-815	12	27	0.09	0.09	NUM
ajpf-815	12	28	respectively	respectively	ADV
ajpf-815	12	29	against	against	ADP
ajpf-815	12	30	hsv-1	hsv-1	PRON
ajpf-815	12	31	,	,	PUNCT
ajpf-815	12	32	eqhv-1	eqhv-1	NUM
ajpf-815	12	33	and	and	CCONJ
ajpf-815	12	34	suhv-1	suhv-1	NUM
ajpf-815	12	35	.	.	PROPN
ajpf-815	12	36	due	due	ADP
ajpf-815	12	37	to	to	ADP
ajpf-815	12	38	this	this	PRON
ajpf-815	12	39	,	,	PUNCT
ajpf-815	12	40	b.	b.	PROPN
ajpf-815	12	41	intermedia	intermedia	PROPN
ajpf-815	12	42	extract	extract	PROPN
ajpf-815	12	43	was	be	AUX
ajpf-815	12	44	also	also	ADV
ajpf-815	12	45	analyzed	analyze	VERB
ajpf-815	12	46	by	by	ADP
ajpf-815	12	47	hplc	hplc	PROPN
ajpf-815	12	48	/	/	SYM
ajpf-815	12	49	ms	ms	NOUN
ajpf-815	12	50	allowing	allow	VERB
ajpf-815	12	51	for	for	ADP
ajpf-815	12	52	the	the	DET
ajpf-815	12	53	identification	identification	NOUN
ajpf-815	12	54	of	of	ADP
ajpf-815	12	55	gallic	gallic	ADJ
ajpf-815	12	56	acid	acid	NOUN
ajpf-815	12	57	and	and	CCONJ
ajpf-815	12	58	quercetin	quercetin	NOUN
ajpf-815	12	59	as	as	ADP
ajpf-815	12	60	main	main	ADJ
ajpf-815	12	61	compounds	compound	NOUN
ajpf-815	12	62	.	.	PUNCT
ajpf-815	13	1	key	key	ADJ
ajpf-815	13	2	words	word	NOUN
ajpf-815	13	3	:	:	PUNCT
ajpf-815	13	4	brazilian	brazilian	ADJ
ajpf-815	13	5	savanna	savanna	NOUN
ajpf-815	13	6	,	,	PUNCT
ajpf-815	13	7	cerrado	cerrado	PROPN
ajpf-815	13	8	,	,	PUNCT
ajpf-815	13	9	byrsonima	byrsonima	NOUN
ajpf-815	13	10	intermedia	intermedia	PROPN
ajpf-815	13	11	,	,	PUNCT
ajpf-815	13	12	antiviral	antiviral	NOUN
ajpf-815	13	13	,	,	PUNCT
ajpf-815	13	14	herpesvirus	herpesvirus	NOUN
ajpf-815	13	15	,	,	PUNCT
ajpf-815	13	16	gallic	gallic	NOUN
ajpf-815	13	17	acid	acid	NOUN
ajpf-815	13	18	,	,	PUNCT
ajpf-815	13	19	quercetin	quercetin	NOUN
ajpf-815	13	20	.	.	PUNCT
ajpf-815	14	1	introduction	introduction	NOUN
ajpf-815	14	2	the	the	DET
ajpf-815	14	3	herpes	herpe	NOUN
ajpf-815	14	4	viruses	virus	NOUN
ajpf-815	14	5	are	be	AUX
ajpf-815	14	6	a	a	DET
ajpf-815	14	7	serious	serious	ADJ
ajpf-815	14	8	worldwide	worldwide	ADJ
ajpf-815	14	9	problem	problem	NOUN
ajpf-815	14	10	that	that	PRON
ajpf-815	14	11	can	can	AUX
ajpf-815	14	12	affect	affect	VERB
ajpf-815	14	13	the	the	DET
ajpf-815	14	14	health	health	NOUN
ajpf-815	14	15	of	of	ADP
ajpf-815	14	16	both	both	DET
ajpf-815	14	17	animals	animal	NOUN
ajpf-815	14	18	and	and	CCONJ
ajpf-815	14	19	human	human	ADJ
ajpf-815	14	20	beings	being	NOUN
ajpf-815	14	21	.	.	PUNCT
ajpf-815	15	1	the	the	DET
ajpf-815	15	2	herpes	herpe	NOUN
ajpf-815	15	3	simplex	simplex	NOUN
ajpf-815	15	4	virus	virus	NOUN
ajpf-815	15	5	(	(	PUNCT
ajpf-815	15	6	hsv-1	hsv-1	X
ajpf-815	15	7	)	)	PUNCT
ajpf-815	15	8	is	be	AUX
ajpf-815	15	9	pathogenic	pathogenic	ADJ
ajpf-815	15	10	to	to	ADP
ajpf-815	15	11	humans	human	NOUN
ajpf-815	15	12	(	(	PUNCT
ajpf-815	15	13	wyler	wyler	X
ajpf-815	15	14	et	et	PROPN
ajpf-815	15	15	al	al	PROPN
ajpf-815	15	16	.	.	PROPN
ajpf-815	15	17	,	,	PUNCT
ajpf-815	15	18	2017	2017	NUM
ajpf-815	15	19	)	)	PUNCT
ajpf-815	15	20	,	,	PUNCT
ajpf-815	15	21	whereas	whereas	SCONJ
ajpf-815	15	22	equine	equine	NOUN
ajpf-815	15	23	(	(	PUNCT
ajpf-815	15	24	eqhv-1	eqhv-1	NUM
ajpf-815	15	25	)	)	PUNCT
ajpf-815	15	26	and	and	CCONJ
ajpf-815	15	27	swine	swine	ADJ
ajpf-815	15	28	herpesviruses	herpesviruse	NOUN
ajpf-815	15	29	(	(	PUNCT
ajpf-815	15	30	suhv-1	suhv-1	NOUN
ajpf-815	15	31	)	)	PUNCT
ajpf-815	15	32	,	,	PUNCT
ajpf-815	15	33	are	be	AUX
ajpf-815	15	34	responsible	responsible	ADJ
ajpf-815	15	35	for	for	ADP
ajpf-815	15	36	causing	cause	VERB
ajpf-815	15	37	serious	serious	ADJ
ajpf-815	15	38	diseases	disease	NOUN
ajpf-815	15	39	in	in	ADP
ajpf-815	15	40	horses	horse	NOUN
ajpf-815	15	41	and	and	CCONJ
ajpf-815	15	42	pigs	pig	NOUN
ajpf-815	15	43	respectively	respectively	ADV
ajpf-815	15	44	,	,	PUNCT
ajpf-815	15	45	resulting	result	VERB
ajpf-815	15	46	in	in	ADP
ajpf-815	15	47	large	large	ADJ
ajpf-815	15	48	economic	economic	ADJ
ajpf-815	15	49	losses	loss	NOUN
ajpf-815	15	50	(	(	PUNCT
ajpf-815	15	51	wernike	wernike	INTJ
ajpf-815	15	52	et	et	PROPN
ajpf-815	15	53	al	al	PROPN
ajpf-815	15	54	.	.	PROPN
ajpf-815	15	55	,	,	PUNCT
ajpf-815	15	56	2013	2013	NUM
ajpf-815	15	57	;	;	PUNCT
ajpf-815	15	58	gulati	gulati	PROPN
ajpf-815	15	59	et	et	PROPN
ajpf-815	15	60	al	al	PROPN
ajpf-815	15	61	.	.	PROPN
ajpf-815	15	62	,	,	PUNCT
ajpf-815	15	63	2016	2016	NUM
ajpf-815	15	64	)	)	PUNCT
ajpf-815	15	65	.	.	PUNCT
ajpf-815	16	1	these	these	DET
ajpf-815	16	2	viruses	virus	NOUN
ajpf-815	16	3	belong	belong	VERB
ajpf-815	16	4	to	to	ADP
ajpf-815	16	5	the	the	DET
ajpf-815	16	6	subfamily	subfamily	ADV
ajpf-815	16	7	alphaherpesvirinae	alphaherpesvirinae	NOUN
ajpf-815	16	8	,	,	PUNCT
ajpf-815	16	9	characterized	characterize	VERB
ajpf-815	16	10	by	by	ADP
ajpf-815	16	11	a	a	DET
ajpf-815	16	12	rapid	rapid	ADJ
ajpf-815	16	13	lytic	lytic	ADJ
ajpf-815	16	14	viral	viral	ADJ
ajpf-815	16	15	cycle	cycle	NOUN
ajpf-815	16	16	and	and	CCONJ
ajpf-815	16	17	the	the	DET
ajpf-815	16	18	establishment	establishment	NOUN
ajpf-815	16	19	of	of	ADP
ajpf-815	16	20	neuronal	neuronal	ADJ
ajpf-815	16	21	latency	latency	NOUN
ajpf-815	16	22	,	,	PUNCT
ajpf-815	16	23	which	which	PRON
ajpf-815	16	24	can	can	AUX
ajpf-815	16	25	be	be	AUX
ajpf-815	16	26	reactivated	reactivate	VERB
ajpf-815	16	27	(	(	PUNCT
ajpf-815	16	28	riaz	riaz	PROPN
ajpf-815	16	29	et	et	PROPN
ajpf-815	16	30	al	al	PROPN
ajpf-815	16	31	.	.	PROPN
ajpf-815	16	32	,	,	PUNCT
ajpf-815	16	33	2017	2017	NUM
ajpf-815	16	34	)	)	PUNCT
ajpf-815	16	35	.	.	PUNCT
ajpf-815	17	1	the	the	DET
ajpf-815	17	2	emerging	emerge	VERB
ajpf-815	17	3	of	of	ADP
ajpf-815	17	4	resistant	resistant	ADJ
ajpf-815	17	5	virus	virus	NOUN
ajpf-815	17	6	strains	strain	VERB
ajpf-815	17	7	to	to	PART
ajpf-815	17	8	available	available	VERB
ajpf-815	17	9	drugs	drug	NOUN
ajpf-815	17	10	against	against	ADP
ajpf-815	17	11	human	human	NOUN
ajpf-815	17	12	*	*	PUNCT
ajpf-815	17	13	corresponding	correspond	VERB
ajpf-815	17	14	author	author	NOUN
ajpf-815	17	15	.	.	PUNCT
ajpf-815	18	1	e	e	X
ajpf-815	18	2	-	-	NOUN
ajpf-815	18	3	mail	mail	NOUN
ajpf-815	18	4	:	:	PUNCT
ajpf-815	18	5	isabelasimoni@gmail.com	isabelasimoni@gmail.com	ADJ
ajpf-815	18	6	,	,	PUNCT
ajpf-815	18	7	simoni@biologico.sp.gov.br	simoni@biologico.sp.gov.br	ADJ
ajpf-815	18	8	.	.	PUNCT
ajpf-815	19	1	author(s	author(s	NOUN
ajpf-815	19	2	)	)	PUNCT
ajpf-815	19	3	agree	agree	VERB
ajpf-815	19	4	that	that	SCONJ
ajpf-815	19	5	this	this	DET
ajpf-815	19	6	article	article	NOUN
ajpf-815	19	7	remain	remain	VERB
ajpf-815	19	8	permanently	permanently	ADV
ajpf-815	19	9	open	open	ADJ
ajpf-815	19	10	access	access	NOUN
ajpf-815	19	11	under	under	ADP
ajpf-815	19	12	the	the	DET
ajpf-815	19	13	terms	term	NOUN
ajpf-815	19	14	of	of	ADP
ajpf-815	19	15	the	the	DET
ajpf-815	19	16	creative	creative	ADJ
ajpf-815	19	17	commons	common	NOUN
ajpf-815	19	18	attribution	attribution	NOUN
ajpf-815	19	19	license	license	VERB
ajpf-815	19	20	4.0	4.0	NUM
ajpf-815	19	21	international	international	ADJ
ajpf-815	19	22	license	license	NOUN
ajpf-815	19	23	2	2	NUM
ajpf-815	19	24	herpesvirus	herpesvirus	NOUN
ajpf-815	19	25	is	be	AUX
ajpf-815	19	26	a	a	DET
ajpf-815	19	27	growing	grow	VERB
ajpf-815	19	28	problem	problem	NOUN
ajpf-815	19	29	,	,	PUNCT
ajpf-815	19	30	particularly	particularly	ADV
ajpf-815	19	31	in	in	ADP
ajpf-815	19	32	immunocompromised	immunocompromise	VERB
ajpf-815	19	33	patients	patient	NOUN
ajpf-815	19	34	(	(	PUNCT
ajpf-815	19	35	vadlapudi	vadlapudi	PROPN
ajpf-815	19	36	et	et	PROPN
ajpf-815	19	37	al	al	PROPN
ajpf-815	19	38	.	.	PROPN
ajpf-815	19	39	,	,	PUNCT
ajpf-815	19	40	2013	2013	NUM
ajpf-815	19	41	)	)	PUNCT
ajpf-815	19	42	.	.	PUNCT
ajpf-815	20	1	more	more	ADV
ajpf-815	20	2	recently	recently	ADV
ajpf-815	20	3	,	,	PUNCT
ajpf-815	20	4	outbreaks	outbreak	NOUN
ajpf-815	20	5	of	of	ADP
ajpf-815	20	6	equine	equine	NOUN
ajpf-815	20	7	herpesvirus	herpesvirus	NOUN
ajpf-815	20	8	have	have	AUX
ajpf-815	20	9	had	have	VERB
ajpf-815	20	10	an	an	DET
ajpf-815	20	11	impact	impact	NOUN
ajpf-815	20	12	on	on	ADP
ajpf-815	20	13	the	the	DET
ajpf-815	20	14	equine	equine	NOUN
ajpf-815	20	15	industry	industry	NOUN
ajpf-815	20	16	,	,	PUNCT
ajpf-815	20	17	and	and	CCONJ
ajpf-815	20	18	stimulated	stimulate	VERB
ajpf-815	20	19	interest	interest	NOUN
ajpf-815	20	20	in	in	ADP
ajpf-815	20	21	antiherpetic	antiherpetic	ADJ
ajpf-815	20	22	interventions	intervention	NOUN
ajpf-815	20	23	(	(	PUNCT
ajpf-815	20	24	vissani	vissani	PROPN
ajpf-815	20	25	et	et	PROPN
ajpf-815	20	26	al	al	PROPN
ajpf-815	20	27	.	.	PROPN
ajpf-815	20	28	,	,	PUNCT
ajpf-815	20	29	2016	2016	NUM
ajpf-815	20	30	)	)	PUNCT
ajpf-815	20	31	.	.	PUNCT
ajpf-815	21	1	the	the	DET
ajpf-815	21	2	suhv-1	suhv-1	PROPN
ajpf-815	21	3	,	,	PUNCT
ajpf-815	21	4	also	also	ADV
ajpf-815	21	5	known	know	VERB
ajpf-815	21	6	as	as	ADP
ajpf-815	21	7	pseudorabies	pseudorabie	NOUN
ajpf-815	21	8	virus	virus	NOUN
ajpf-815	21	9	,	,	PUNCT
ajpf-815	21	10	is	be	AUX
ajpf-815	21	11	the	the	DET
ajpf-815	21	12	causative	causative	ADJ
ajpf-815	21	13	agent	agent	NOUN
ajpf-815	21	14	of	of	ADP
ajpf-815	21	15	aujeszky‟s	aujeszky‟s	PRON
ajpf-815	21	16	disease	disease	NOUN
ajpf-815	21	17	affecting	affect	VERB
ajpf-815	21	18	other	other	ADJ
ajpf-815	21	19	mammals	mammal	NOUN
ajpf-815	21	20	besides	besides	SCONJ
ajpf-815	21	21	pigs	pig	NOUN
ajpf-815	21	22	,	,	PUNCT
ajpf-815	21	23	is	be	AUX
ajpf-815	21	24	still	still	ADV
ajpf-815	21	25	present	present	ADJ
ajpf-815	21	26	in	in	ADP
ajpf-815	21	27	wild	wild	ADJ
ajpf-815	21	28	boar	boar	NOUN
ajpf-815	21	29	and	and	CCONJ
ajpf-815	21	30	there	there	PRON
ajpf-815	21	31	are	be	VERB
ajpf-815	21	32	no	no	DET
ajpf-815	21	33	antiviral	antiviral	ADJ
ajpf-815	21	34	drugs	drug	NOUN
ajpf-815	21	35	approved	approve	VERB
ajpf-815	21	36	for	for	ADP
ajpf-815	21	37	veterinary	veterinary	ADJ
ajpf-815	21	38	use	use	NOUN
ajpf-815	21	39	(	(	PUNCT
ajpf-815	21	40	zouharova	zouharova	X
ajpf-815	21	41	et	et	PROPN
ajpf-815	21	42	al	al	PROPN
ajpf-815	21	43	.	.	PROPN
ajpf-815	21	44	,	,	PUNCT
ajpf-815	21	45	2016	2016	NUM
ajpf-815	21	46	)	)	PUNCT
ajpf-815	21	47	.	.	PUNCT
ajpf-815	22	1	therefore	therefore	ADV
ajpf-815	22	2	,	,	PUNCT
ajpf-815	22	3	it	it	PRON
ajpf-815	22	4	is	be	AUX
ajpf-815	22	5	necessary	necessary	ADJ
ajpf-815	22	6	to	to	PART
ajpf-815	22	7	find	find	VERB
ajpf-815	22	8	new	new	ADJ
ajpf-815	22	9	alternative	alternative	ADJ
ajpf-815	22	10	drugs	drug	NOUN
ajpf-815	22	11	against	against	ADP
ajpf-815	22	12	these	these	DET
ajpf-815	22	13	diseases	disease	NOUN
ajpf-815	22	14	that	that	PRON
ajpf-815	22	15	affect	affect	VERB
ajpf-815	22	16	both	both	DET
ajpf-815	22	17	humans	human	NOUN
ajpf-815	22	18	and	and	CCONJ
ajpf-815	22	19	animals	animal	NOUN
ajpf-815	22	20	(	(	PUNCT
ajpf-815	22	21	martinez	martinez	PROPN
ajpf-815	22	22	et	et	PROPN
ajpf-815	22	23	al	al	PROPN
ajpf-815	22	24	.	.	PROPN
ajpf-815	22	25	,	,	PUNCT
ajpf-815	22	26	2015	2015	NUM
ajpf-815	22	27	;	;	PUNCT
ajpf-815	22	28	nocchi	nocchi	PROPN
ajpf-815	22	29	et	et	PROPN
ajpf-815	22	30	al	al	PROPN
ajpf-815	22	31	.	.	PROPN
ajpf-815	22	32	,	,	PUNCT
ajpf-815	22	33	2016	2016	NUM
ajpf-815	22	34	)	)	PUNCT
ajpf-815	22	35	.	.	PUNCT
ajpf-815	23	1	medicinal	medicinal	ADJ
ajpf-815	23	2	plants	plant	NOUN
ajpf-815	23	3	are	be	AUX
ajpf-815	23	4	natural	natural	ADJ
ajpf-815	23	5	resources	resource	NOUN
ajpf-815	23	6	,	,	PUNCT
ajpf-815	23	7	leading	lead	VERB
ajpf-815	23	8	to	to	ADP
ajpf-815	23	9	valuable	valuable	ADJ
ajpf-815	23	10	herbal	herbal	ADJ
ajpf-815	23	11	products	product	NOUN
ajpf-815	23	12	often	often	ADV
ajpf-815	23	13	used	use	VERB
ajpf-815	23	14	to	to	PART
ajpf-815	23	15	treat	treat	VERB
ajpf-815	23	16	a	a	DET
ajpf-815	23	17	large	large	ADJ
ajpf-815	23	18	number	number	NOUN
ajpf-815	23	19	of	of	ADP
ajpf-815	23	20	various	various	ADJ
ajpf-815	23	21	diseases	disease	NOUN
ajpf-815	23	22	in	in	ADP
ajpf-815	23	23	traditional	traditional	ADJ
ajpf-815	23	24	medicine	medicine	NOUN
ajpf-815	23	25	(	(	PUNCT
ajpf-815	23	26	katiyar	katiyar	PROPN
ajpf-815	23	27	et	et	PROPN
ajpf-815	23	28	al	al	PROPN
ajpf-815	23	29	.	.	PROPN
ajpf-815	23	30	,	,	PUNCT
ajpf-815	23	31	2012	2012	NUM
ajpf-815	23	32	;	;	PUNCT
ajpf-815	23	33	wachtel	wachtel	NOUN
ajpf-815	23	34	-	-	PUNCT
ajpf-815	23	35	galor	galor	NOUN
ajpf-815	23	36	and	and	CCONJ
ajpf-815	23	37	benzie	benzie	PROPN
ajpf-815	23	38	,	,	PUNCT
ajpf-815	23	39	2011	2011	NUM
ajpf-815	23	40	)	)	PUNCT
ajpf-815	23	41	.	.	PUNCT
ajpf-815	24	1	the	the	DET
ajpf-815	24	2	south	south	ADJ
ajpf-815	24	3	american	american	ADJ
ajpf-815	24	4	flora	flora	NOUN
ajpf-815	24	5	represents	represent	VERB
ajpf-815	24	6	one	one	NUM
ajpf-815	24	7	of	of	ADP
ajpf-815	24	8	the	the	DET
ajpf-815	24	9	world‟s	world‟s	NOUN
ajpf-815	24	10	richest	rich	ADJ
ajpf-815	24	11	sources	source	NOUN
ajpf-815	24	12	of	of	ADP
ajpf-815	24	13	material	material	NOUN
ajpf-815	24	14	with	with	ADP
ajpf-815	24	15	pharmacological	pharmacological	ADJ
ajpf-815	24	16	activity	activity	NOUN
ajpf-815	24	17	,	,	PUNCT
ajpf-815	24	18	and	and	CCONJ
ajpf-815	24	19	brazil	brazil	PROPN
ajpf-815	24	20	has	have	VERB
ajpf-815	24	21	the	the	DET
ajpf-815	24	22	biggest	big	ADJ
ajpf-815	24	23	vegetal	vegetal	ADJ
ajpf-815	24	24	diversity	diversity	NOUN
ajpf-815	24	25	(	(	PUNCT
ajpf-815	24	26	dutra	dutra	PROPN
ajpf-815	24	27	et	et	PROPN
ajpf-815	24	28	al	al	PROPN
ajpf-815	24	29	.	.	PROPN
ajpf-815	24	30	,	,	PUNCT
ajpf-815	24	31	2016	2016	NUM
ajpf-815	24	32	)	)	PUNCT
ajpf-815	24	33	.	.	PUNCT
ajpf-815	25	1	one	one	NUM
ajpf-815	25	2	of	of	ADP
ajpf-815	25	3	them	they	PRON
ajpf-815	25	4	is	be	AUX
ajpf-815	25	5	the	the	DET
ajpf-815	25	6	“	"	PUNCT
ajpf-815	25	7	cerrado	cerrado	NOUN
ajpf-815	25	8	”	"	PUNCT
ajpf-815	25	9	(	(	PUNCT
ajpf-815	25	10	brazilian	brazilian	ADJ
ajpf-815	25	11	savannah	savannah	PROPN
ajpf-815	25	12	)	)	PUNCT
ajpf-815	25	13	covering	cover	VERB
ajpf-815	25	14	more	more	ADJ
ajpf-815	25	15	than	than	ADP
ajpf-815	25	16	2	2	NUM
ajpf-815	25	17	million	million	NUM
ajpf-815	25	18	km	km	NOUN
ajpf-815	25	19	2	2	NUM
ajpf-815	25	20	and	and	CCONJ
ajpf-815	25	21	land	land	NOUN
ajpf-815	25	22	representing	represent	VERB
ajpf-815	25	23	25	25	NUM
ajpf-815	25	24	%	%	NOUN
ajpf-815	25	25	of	of	ADP
ajpf-815	25	26	the	the	DET
ajpf-815	25	27	area	area	NOUN
ajpf-815	25	28	of	of	ADP
ajpf-815	25	29	the	the	DET
ajpf-815	25	30	country	country	NOUN
ajpf-815	25	31	(	(	PUNCT
ajpf-815	25	32	sawyer	sawyer	NOUN
ajpf-815	25	33	,	,	PUNCT
ajpf-815	25	34	2016	2016	NUM
ajpf-815	25	35	)	)	PUNCT
ajpf-815	25	36	.	.	PUNCT
ajpf-815	26	1	this	this	DET
ajpf-815	26	2	vegetation	vegetation	NOUN
ajpf-815	26	3	consists	consist	VERB
ajpf-815	26	4	of	of	ADP
ajpf-815	26	5	more	more	ADJ
ajpf-815	26	6	than	than	ADP
ajpf-815	26	7	6,000	6,000	NUM
ajpf-815	26	8	vegetal	vegetal	ADJ
ajpf-815	26	9	species	specie	NOUN
ajpf-815	26	10	,	,	PUNCT
ajpf-815	26	11	having	have	VERB
ajpf-815	26	12	many	many	ADJ
ajpf-815	26	13	compounds	compound	NOUN
ajpf-815	26	14	such	such	ADJ
ajpf-815	26	15	as	as	ADP
ajpf-815	26	16	saponins	saponin	NOUN
ajpf-815	26	17	,	,	PUNCT
ajpf-815	26	18	tannis	tanni	NOUN
ajpf-815	26	19	,	,	PUNCT
ajpf-815	26	20	steroids	steroid	NOUN
ajpf-815	26	21	,	,	PUNCT
ajpf-815	26	22	and	and	CCONJ
ajpf-815	26	23	others	other	NOUN
ajpf-815	26	24	(	(	PUNCT
ajpf-815	26	25	bessa	bessa	PROPN
ajpf-815	26	26	et	et	PROPN
ajpf-815	26	27	al	al	PROPN
ajpf-815	26	28	.	.	PROPN
ajpf-815	26	29	,	,	PUNCT
ajpf-815	26	30	2013	2013	NUM
ajpf-815	26	31	)	)	PUNCT
ajpf-815	26	32	,	,	PUNCT
ajpf-815	26	33	with	with	ADP
ajpf-815	26	34	biological	biological	ADJ
ajpf-815	26	35	activities	activity	NOUN
ajpf-815	26	36	including	include	VERB
ajpf-815	26	37	antifungal	antifungal	ADJ
ajpf-815	26	38	,	,	PUNCT
ajpf-815	26	39	antibacterial	antibacterial	ADJ
ajpf-815	26	40	,	,	PUNCT
ajpf-815	26	41	antiprotozoal	antiprotozoal	ADJ
ajpf-815	26	42	and	and	CCONJ
ajpf-815	26	43	antiviral	antiviral	ADJ
ajpf-815	26	44	ones	one	NOUN
ajpf-815	26	45	(	(	PUNCT
ajpf-815	26	46	alves	alves	PROPN
ajpf-815	26	47	et	et	PROPN
ajpf-815	26	48	al	al	PROPN
ajpf-815	26	49	.	.	PROPN
ajpf-815	26	50	,	,	PUNCT
ajpf-815	26	51	2000	2000	NUM
ajpf-815	26	52	;	;	PUNCT
ajpf-815	26	53	mesquita	mesquita	PROPN
ajpf-815	26	54	et	et	PROPN
ajpf-815	26	55	al	al	PROPN
ajpf-815	26	56	.	.	PROPN
ajpf-815	26	57	,	,	PUNCT
ajpf-815	26	58	2005	2005	NUM
ajpf-815	26	59	,	,	PUNCT
ajpf-815	26	60	2007	2007	NUM
ajpf-815	26	61	;	;	PUNCT
ajpf-815	26	62	silva	silva	PROPN
ajpf-815	26	63	junior	junior	PROPN
ajpf-815	26	64	et	et	PROPN
ajpf-815	26	65	al	al	PROPN
ajpf-815	26	66	.	.	PROPN
ajpf-815	26	67	,	,	PUNCT
ajpf-815	26	68	2009	2009	NUM
ajpf-815	26	69	;	;	PUNCT
ajpf-815	26	70	brandão	brandão	NOUN
ajpf-815	26	71	et	et	PROPN
ajpf-815	26	72	al	al	PROPN
ajpf-815	26	73	.	.	PROPN
ajpf-815	26	74	,	,	PUNCT
ajpf-815	26	75	2010	2010	NUM
ajpf-815	26	76	)	)	PUNCT
ajpf-815	26	77	.	.	PUNCT
ajpf-815	27	1	many	many	ADJ
ajpf-815	27	2	plant	plant	NOUN
ajpf-815	27	3	extracts	extract	NOUN
ajpf-815	27	4	have	have	AUX
ajpf-815	27	5	been	be	AUX
ajpf-815	27	6	described	describe	VERB
ajpf-815	27	7	for	for	ADP
ajpf-815	27	8	antiviral	antiviral	ADJ
ajpf-815	27	9	activity	activity	NOUN
ajpf-815	27	10	against	against	ADP
ajpf-815	27	11	herpesviruses	herpesviruse	NOUN
ajpf-815	27	12	in	in	ADP
ajpf-815	27	13	vitro	vitro	X
ajpf-815	27	14	such	such	ADJ
ajpf-815	27	15	as	as	ADP
ajpf-815	27	16	conocephalum	conocephalum	PROPN
ajpf-815	27	17	conicum	conicum	PROPN
ajpf-815	27	18	,	,	PUNCT
ajpf-815	27	19	polypodium	polypodium	NOUN
ajpf-815	27	20	glycyrrhiza	glycyrrhiza	NOUN
ajpf-815	27	21	and	and	CCONJ
ajpf-815	27	22	the	the	DET
ajpf-815	27	23	water	water	NOUN
ajpf-815	27	24	-	-	PUNCT
ajpf-815	27	25	soluble	soluble	ADJ
ajpf-815	27	26	extract	extract	NOUN
ajpf-815	27	27	from	from	ADP
ajpf-815	27	28	the	the	DET
ajpf-815	27	29	narcissus	narcissus	NOUN
ajpf-815	27	30	bulb	bulb	NOUN
ajpf-815	27	31	flos	flos	PROPN
ajpf-815	27	32	verbasci	verbasci	PROPN
ajpf-815	27	33	,	,	PUNCT
ajpf-815	27	34	showed	show	VERB
ajpf-815	27	35	anti	anti	ADJ
ajpf-815	27	36	-	-	ADJ
ajpf-815	27	37	hsv	hsv	ADJ
ajpf-815	27	38	activity	activity	NOUN
ajpf-815	27	39	.	.	PUNCT
ajpf-815	28	1	the	the	DET
ajpf-815	28	2	aqueous	aqueous	ADJ
ajpf-815	28	3	extracts	extract	NOUN
ajpf-815	28	4	of	of	ADP
ajpf-815	28	5	helichrysum	helichrysum	NOUN
ajpf-815	28	6	aureonitens	aureoniten	NOUN
ajpf-815	28	7	(	(	PUNCT
ajpf-815	28	8	asteraceae	asteraceae	PROPN
ajpf-815	28	9	)	)	PUNCT
ajpf-815	28	10	shoots	shoot	NOUN
ajpf-815	28	11	inhibited	inhibit	VERB
ajpf-815	28	12	hsv-1	hsv-1	PUNCT
ajpf-815	28	13	(	(	PUNCT
ajpf-815	28	14	chattopadhyay	chattopadhyay	NOUN
ajpf-815	28	15	and	and	CCONJ
ajpf-815	28	16	khan	khan	PROPN
ajpf-815	28	17	,	,	PUNCT
ajpf-815	28	18	2008	2008	NUM
ajpf-815	28	19	)	)	PUNCT
ajpf-815	28	20	.	.	PUNCT
ajpf-815	29	1	compounds	compound	NOUN
ajpf-815	29	2	in	in	ADP
ajpf-815	29	3	green	green	ADJ
ajpf-815	29	4	tea	tea	NOUN
ajpf-815	29	5	extract	extract	NOUN
ajpf-815	29	6	could	could	AUX
ajpf-815	29	7	also	also	ADV
ajpf-815	29	8	inhibit	inhibit	VERB
ajpf-815	29	9	hsv-1	hsv-1	ADJ
ajpf-815	29	10	and	and	CCONJ
ajpf-815	29	11	black	black	ADJ
ajpf-815	29	12	tea	tea	NOUN
ajpf-815	29	13	extract	extract	NOUN
ajpf-815	29	14	enriched	enrich	VERB
ajpf-815	29	15	with	with	ADP
ajpf-815	29	16	theaflavins	theaflavin	NOUN
ajpf-815	29	17	has	have	VERB
ajpf-815	29	18	the	the	DET
ajpf-815	29	19	potential	potential	NOUN
ajpf-815	29	20	to	to	PART
ajpf-815	29	21	prevent	prevent	VERB
ajpf-815	29	22	the	the	DET
ajpf-815	29	23	spread	spread	NOUN
ajpf-815	29	24	of	of	ADP
ajpf-815	29	25	hsv-1	hsv-1	PRON
ajpf-815	29	26	(	(	PUNCT
ajpf-815	29	27	cantatore	cantatore	ADV
ajpf-815	29	28	et	et	PROPN
ajpf-815	29	29	al	al	PROPN
ajpf-815	29	30	.	.	PROPN
ajpf-815	29	31	,	,	PUNCT
ajpf-815	29	32	2013	2013	NUM
ajpf-815	29	33	)	)	PUNCT
ajpf-815	29	34	.	.	PUNCT
ajpf-815	30	1	moreover	moreover	ADV
ajpf-815	30	2	,	,	PUNCT
ajpf-815	30	3	lithraea	lithraea	ADJ
ajpf-815	30	4	molleiodes	molleiode	NOUN
ajpf-815	30	5	,	,	PUNCT
ajpf-815	30	6	sebastiana	sebastiana	PROPN
ajpf-815	30	7	brasiliensis	brasiliensis	NOUN
ajpf-815	30	8	and	and	CCONJ
ajpf-815	30	9	sebastiania	sebastiania	NOUN
ajpf-815	30	10	klotzschiana	klotzschiana	PROPN
ajpf-815	30	11	used	use	VERB
ajpf-815	30	12	against	against	ADP
ajpf-815	30	13	infectious	infectious	ADJ
ajpf-815	30	14	diseases	disease	NOUN
ajpf-815	30	15	showed	show	VERB
ajpf-815	30	16	antiherpetic	antiherpetic	ADJ
ajpf-815	30	17	activity	activity	NOUN
ajpf-815	30	18	with	with	ADP
ajpf-815	30	19	no	no	DET
ajpf-815	30	20	cytotoxicity	cytotoxicity	NOUN
ajpf-815	30	21	,	,	PUNCT
ajpf-815	30	22	as	as	SCONJ
ajpf-815	30	23	did	do	VERB
ajpf-815	30	24	the	the	DET
ajpf-815	30	25	aqueous	aqueous	ADJ
ajpf-815	30	26	extract	extract	NOUN
ajpf-815	30	27	of	of	ADP
ajpf-815	30	28	beta	beta	ADJ
ajpf-815	30	29	vulgaris	vulgaris	NOUN
ajpf-815	30	30	(	(	PUNCT
ajpf-815	30	31	betancourgalvis	betancourgalvis	X
ajpf-815	30	32	et	et	PROPN
ajpf-815	30	33	al	al	PROPN
ajpf-815	30	34	.	.	PROPN
ajpf-815	30	35	,	,	PUNCT
ajpf-815	30	36	1999	1999	NUM
ajpf-815	30	37	)	)	PUNCT
ajpf-815	30	38	.	.	PUNCT
ajpf-815	31	1	the	the	DET
ajpf-815	31	2	aqueous	aqueous	ADJ
ajpf-815	31	3	extracts	extract	NOUN
ajpf-815	31	4	from	from	ADP
ajpf-815	31	5	b.	b.	PROPN
ajpf-815	31	6	vulgaris	vulgaris	PROPN
ajpf-815	31	7	and	and	CCONJ
ajpf-815	31	8	s.	s.	PROPN
ajpf-815	31	9	brasiliensis	brasiliensis	PROPN
ajpf-815	31	10	also	also	ADV
ajpf-815	31	11	exhibited	exhibit	VERB
ajpf-815	31	12	antiviral	antiviral	ADJ
ajpf-815	31	13	activity	activity	NOUN
ajpf-815	31	14	against	against	ADP
ajpf-815	31	15	swine	swine	ADJ
ajpf-815	31	16	herpesvirus	herpesvirus	NOUN
ajpf-815	31	17	(	(	PUNCT
ajpf-815	31	18	koseki	koseki	PROPN
ajpf-815	31	19	et	et	PROPN
ajpf-815	31	20	al	al	PROPN
ajpf-815	31	21	.	.	PROPN
ajpf-815	31	22	,	,	PUNCT
ajpf-815	31	23	1990	1990	NUM
ajpf-815	31	24	;	;	PUNCT
ajpf-815	31	25	simoni	simoni	PROPN
ajpf-815	31	26	et	et	PROPN
ajpf-815	31	27	al	al	PROPN
ajpf-815	31	28	.	.	PROPN
ajpf-815	31	29	,	,	PUNCT
ajpf-815	31	30	2014	2014	NUM
ajpf-815	31	31	)	)	PUNCT
ajpf-815	31	32	and	and	CCONJ
ajpf-815	31	33	cecropia	cecropia	PROPN
ajpf-815	31	34	pachystachya	pachystachya	PROPN
ajpf-815	31	35	,	,	PUNCT
ajpf-815	31	36	melochia	melochia	PROPN
ajpf-815	31	37	villosa	villosa	PROPN
ajpf-815	31	38	and	and	CCONJ
ajpf-815	31	39	p.	p.	PROPN
ajpf-815	31	40	acuminatum	acuminatum	NOUN
ajpf-815	31	41	presented	present	VERB
ajpf-815	31	42	the	the	DET
ajpf-815	31	43	most	most	ADV
ajpf-815	31	44	relevant	relevant	ADJ
ajpf-815	31	45	results	result	NOUN
ajpf-815	31	46	against	against	ADP
ajpf-815	31	47	bovine	bovine	NOUN
ajpf-815	31	48	and	and	CCONJ
ajpf-815	31	49	swine	swine	ADJ
ajpf-815	31	50	herpesviruses	herpesviruse	NOUN
ajpf-815	31	51	(	(	PUNCT
ajpf-815	31	52	simoni	simoni	PROPN
ajpf-815	31	53	et	et	PROPN
ajpf-815	31	54	al	al	PROPN
ajpf-815	31	55	.	.	PROPN
ajpf-815	31	56	,	,	PUNCT
ajpf-815	31	57	2014	2014	NUM
ajpf-815	31	58	)	)	PUNCT
ajpf-815	31	59	.	.	PUNCT
ajpf-815	32	1	simoni	simoni	PROPN
ajpf-815	32	2	et	et	PROPN
ajpf-815	32	3	al	al	PROPN
ajpf-815	32	4	.	.	PROPN
ajpf-815	33	1	(	(	PUNCT
ajpf-815	33	2	2007	2007	NUM
ajpf-815	33	3	)	)	PUNCT
ajpf-815	33	4	reported	report	VERB
ajpf-815	33	5	on	on	ADP
ajpf-815	33	6	the	the	DET
ajpf-815	33	7	in	in	X
ajpf-815	33	8	vitro	vitro	X
ajpf-815	33	9	research	research	NOUN
ajpf-815	33	10	for	for	ADP
ajpf-815	33	11	potential	potential	ADJ
ajpf-815	33	12	antiviral	antiviral	ADJ
ajpf-815	33	13	properties	property	NOUN
ajpf-815	33	14	of	of	ADP
ajpf-815	33	15	the	the	DET
ajpf-815	33	16	16	16	NUM
ajpf-815	33	17	species	specie	NOUN
ajpf-815	33	18	collected	collect	VERB
ajpf-815	33	19	from	from	ADP
ajpf-815	33	20	the	the	DET
ajpf-815	33	21	brazilian	brazilian	ADJ
ajpf-815	33	22	cerrado	cerrado	NOUN
ajpf-815	33	23	against	against	ADP
ajpf-815	33	24	bovine	bovine	NOUN
ajpf-815	33	25	herpesvirus	herpesvirus	NOUN
ajpf-815	33	26	(	(	PUNCT
ajpf-815	33	27	bohv-1	bohv-1	NUM
ajpf-815	33	28	)	)	PUNCT
ajpf-815	33	29	,	,	PUNCT
ajpf-815	33	30	infectious	infectious	ADJ
ajpf-815	33	31	bursal	bursal	NOUN
ajpf-815	33	32	disease	disease	NOUN
ajpf-815	33	33	virus	virus	NOUN
ajpf-815	33	34	(	(	PUNCT
ajpf-815	33	35	ibdv	ibdv	PROPN
ajpf-815	33	36	)	)	PUNCT
ajpf-815	33	37	and	and	CCONJ
ajpf-815	33	38	avian	avian	ADJ
ajpf-815	33	39	reovirus	reovirus	NOUN
ajpf-815	33	40	.	.	PUNCT
ajpf-815	34	1	they	they	PRON
ajpf-815	34	2	found	find	VERB
ajpf-815	34	3	8	8	NUM
ajpf-815	34	4	plant	plant	NOUN
ajpf-815	34	5	extracts	extract	NOUN
ajpf-815	34	6	active	active	ADJ
ajpf-815	34	7	against	against	ADP
ajpf-815	34	8	bohv-1	bohv-1	NUM
ajpf-815	34	9	including	include	VERB
ajpf-815	34	10	byrsonima	byrsonima	PROPN
ajpf-815	34	11	intermedia	intermedia	PROPN
ajpf-815	34	12	,	,	PUNCT
ajpf-815	34	13	banisteriopsis	banisteriopsis	NOUN
ajpf-815	34	14	variabilis	variabilis	PROPN
ajpf-815	34	15	,	,	PUNCT
ajpf-815	34	16	stryphodendron	stryphodendron	PROPN
ajpf-815	34	17	adstringens	adstringens	PROPN
ajpf-815	34	18	and	and	CCONJ
ajpf-815	34	19	xylopia	xylopia	PROPN
ajpf-815	34	20	aromatica	aromatica	PROPN
ajpf-815	34	21	.	.	PUNCT
ajpf-815	35	1	species	specie	NOUN
ajpf-815	35	2	of	of	ADP
ajpf-815	35	3	banisteriopsis	banisteriopsis	NOUN
ajpf-815	35	4	are	be	AUX
ajpf-815	35	5	described	describe	VERB
ajpf-815	35	6	as	as	ADP
ajpf-815	35	7	having	have	VERB
ajpf-815	35	8	antioxidant	antioxidant	ADJ
ajpf-815	35	9	and	and	CCONJ
ajpf-815	35	10	antibacterial	antibacterial	ADJ
ajpf-815	35	11	properties	property	NOUN
ajpf-815	35	12	,	,	PUNCT
ajpf-815	35	13	while	while	SCONJ
ajpf-815	35	14	also	also	ADV
ajpf-815	35	15	inhibiting	inhibit	VERB
ajpf-815	35	16	the	the	DET
ajpf-815	35	17	activity	activity	NOUN
ajpf-815	35	18	of	of	ADP
ajpf-815	35	19	monoamine	monoamine	ADJ
ajpf-815	35	20	oxidases	oxidase	NOUN
ajpf-815	35	21	.	.	PUNCT
ajpf-815	36	1	banisteriopsis	banisteriopsis	PROPN
ajpf-815	36	2	caapi	caapi	NOUN
ajpf-815	36	3	is	be	AUX
ajpf-815	36	4	the	the	DET
ajpf-815	36	5	most	most	ADV
ajpf-815	36	6	studied	study	VERB
ajpf-815	36	7	species	specie	NOUN
ajpf-815	36	8	of	of	ADP
ajpf-815	36	9	this	this	DET
ajpf-815	36	10	genus	genus	NOUN
ajpf-815	36	11	because	because	SCONJ
ajpf-815	36	12	it	it	PRON
ajpf-815	36	13	is	be	AUX
ajpf-815	36	14	used	use	VERB
ajpf-815	36	15	by	by	ADP
ajpf-815	36	16	some	some	DET
ajpf-815	36	17	religious	religious	ADJ
ajpf-815	36	18	groups	group	NOUN
ajpf-815	36	19	in	in	ADP
ajpf-815	36	20	brazil	brazil	PROPN
ajpf-815	36	21	as	as	ADP
ajpf-815	36	22	an	an	DET
ajpf-815	36	23	ingredient	ingredient	NOUN
ajpf-815	36	24	of	of	ADP
ajpf-815	36	25	the	the	DET
ajpf-815	36	26	drink	drink	NOUN
ajpf-815	36	27	locally	locally	ADV
ajpf-815	36	28	known	know	VERB
ajpf-815	36	29	as	as	ADP
ajpf-815	36	30	ayahuasca	ayahuasca	NOUN
ajpf-815	36	31	.	.	PUNCT
ajpf-815	37	1	chemical	chemical	NOUN
ajpf-815	37	2	compounds	compound	NOUN
ajpf-815	37	3	identified	identify	VERB
ajpf-815	37	4	in	in	ADP
ajpf-815	37	5	this	this	DET
ajpf-815	37	6	plant	plant	NOUN
ajpf-815	37	7	species	specie	NOUN
ajpf-815	37	8	include	include	VERB
ajpf-815	37	9	alkaloids	alkaloid	NOUN
ajpf-815	37	10	,	,	PUNCT
ajpf-815	37	11	harmine	harmine	NOUN
ajpf-815	37	12	and	and	CCONJ
ajpf-815	37	13	harmaline	harmaline	PROPN
ajpf-815	37	14	(	(	PUNCT
ajpf-815	37	15	wang	wang	PROPN
ajpf-815	37	16	et	et	PROPN
ajpf-815	37	17	al	al	PROPN
ajpf-815	37	18	.	.	PROPN
ajpf-815	37	19	,	,	PUNCT
ajpf-815	37	20	2010	2010	NUM
ajpf-815	37	21	;	;	PUNCT
ajpf-815	37	22	santos	santos	PROPN
ajpf-815	37	23	et	et	PROPN
ajpf-815	37	24	al	al	PROPN
ajpf-815	37	25	.	.	PROPN
ajpf-815	37	26	,	,	PUNCT
ajpf-815	37	27	2017	2017	NUM
ajpf-815	37	28	)	)	PUNCT
ajpf-815	37	29	.	.	PUNCT
ajpf-815	38	1	b.	b.	PROPN
ajpf-815	38	2	intermedia	intermedia	PROPN
ajpf-815	38	3	belonging	belong	VERB
ajpf-815	38	4	to	to	ADP
ajpf-815	38	5	the	the	DET
ajpf-815	38	6	malpighiaceae	malpighiaceae	ADJ
ajpf-815	38	7	family	family	NOUN
ajpf-815	38	8	popularly	popularly	ADV
ajpf-815	38	9	known	know	VERB
ajpf-815	38	10	as	as	ADP
ajpf-815	38	11	“	"	PUNCT
ajpf-815	38	12	murici	murici	NOUN
ajpf-815	38	13	”	"	PUNCT
ajpf-815	38	14	has	have	AUX
ajpf-815	38	15	been	be	AUX
ajpf-815	38	16	used	use	VERB
ajpf-815	38	17	in	in	ADP
ajpf-815	38	18	folk	folk	NOUN
ajpf-815	38	19	medicine	medicine	NOUN
ajpf-815	38	20	to	to	PART
ajpf-815	38	21	treat	treat	VERB
ajpf-815	38	22	fever	fever	NOUN
ajpf-815	38	23	,	,	PUNCT
ajpf-815	38	24	as	as	ADP
ajpf-815	38	25	diuretic	diuretic	ADJ
ajpf-815	38	26	,	,	PUNCT
ajpf-815	38	27	for	for	ADP
ajpf-815	38	28	skin	skin	NOUN
ajpf-815	38	29	infections	infection	NOUN
ajpf-815	38	30	and	and	CCONJ
ajpf-815	38	31	ulcers	ulcer	NOUN
ajpf-815	38	32	.	.	PUNCT
ajpf-815	39	1	b.	b.	PROPN
ajpf-815	39	2	intermedia	intermedia	PROPN
ajpf-815	39	3	is	be	AUX
ajpf-815	39	4	described	describe	VERB
ajpf-815	39	5	mainly	mainly	ADV
ajpf-815	39	6	as	as	ADP
ajpf-815	39	7	being	be	AUX
ajpf-815	39	8	antimicrobial	antimicrobial	ADJ
ajpf-815	39	9	and	and	CCONJ
ajpf-815	39	10	as	as	ADP
ajpf-815	39	11	anti	anti	ADJ
ajpf-815	39	12	-	-	ADJ
ajpf-815	39	13	inflammatory	inflammatory	ADJ
ajpf-815	39	14	(	(	PUNCT
ajpf-815	39	15	moreira	moreira	PROPN
ajpf-815	39	16	et	et	PROPN
ajpf-815	39	17	al	al	PROPN
ajpf-815	39	18	.	.	PROPN
ajpf-815	39	19	,	,	PUNCT
ajpf-815	39	20	2011	2011	NUM
ajpf-815	39	21	;	;	PUNCT
ajpf-815	39	22	sannomiya	sannomiya	PROPN
ajpf-815	39	23	et	et	PROPN
ajpf-815	39	24	.	.	PUNCT
ajpf-815	40	1	al	al	PROPN
ajpf-815	40	2	.	.	PROPN
ajpf-815	40	3	,	,	PUNCT
ajpf-815	40	4	2007	2007	NUM
ajpf-815	40	5	)	)	PUNCT
ajpf-815	40	6	.	.	PUNCT
ajpf-815	41	1	s.	s.	PROPN
ajpf-815	41	2	adstringens	adstringens	PROPN
ajpf-815	41	3	is	be	AUX
ajpf-815	41	4	one	one	NUM
ajpf-815	41	5	of	of	ADP
ajpf-815	41	6	the	the	DET
ajpf-815	41	7	most	most	ADV
ajpf-815	41	8	widely	widely	ADV
ajpf-815	41	9	used	use	VERB
ajpf-815	41	10	medicinal	medicinal	ADJ
ajpf-815	41	11	species	specie	NOUN
ajpf-815	41	12	by	by	ADP
ajpf-815	41	13	the	the	DET
ajpf-815	41	14	brazilian	brazilian	ADJ
ajpf-815	41	15	population	population	NOUN
ajpf-815	41	16	.	.	PUNCT
ajpf-815	42	1	the	the	DET
ajpf-815	42	2	stem	stem	NOUN
ajpf-815	42	3	bark	bark	NOUN
ajpf-815	42	4	is	be	AUX
ajpf-815	42	5	usually	usually	ADV
ajpf-815	42	6	used	use	VERB
ajpf-815	42	7	to	to	PART
ajpf-815	42	8	treat	treat	VERB
ajpf-815	42	9	leucorrhea	leucorrhea	NOUN
ajpf-815	42	10	,	,	PUNCT
ajpf-815	42	11	gonorrhea	gonorrhea	NOUN
ajpf-815	42	12	,	,	PUNCT
ajpf-815	42	13	vulvo	vulvo	NOUN
ajpf-815	42	14	-	-	PUNCT
ajpf-815	42	15	vaginal	vaginal	ADJ
ajpf-815	42	16	candidiasis	candidiasis	NOUN
ajpf-815	42	17	,	,	PUNCT
ajpf-815	42	18	gastritis	gastritis	NOUN
ajpf-815	42	19	,	,	PUNCT
ajpf-815	42	20	sore	sore	ADJ
ajpf-815	42	21	throat	throat	NOUN
ajpf-815	42	22	,	,	PUNCT
ajpf-815	42	23	diarrhea	diarrhea	NOUN
ajpf-815	42	24	and	and	CCONJ
ajpf-815	42	25	bleeding	bleeding	NOUN
ajpf-815	42	26	(	(	PUNCT
ajpf-815	42	27	costa	costa	PROPN
ajpf-815	42	28	et	et	PROPN
ajpf-815	42	29	al	al	PROPN
ajpf-815	42	30	.	.	PROPN
ajpf-815	42	31	,	,	PUNCT
ajpf-815	42	32	2010	2010	NUM
ajpf-815	42	33	)	)	PUNCT
ajpf-815	42	34	.	.	PUNCT
ajpf-815	43	1	extracts	extract	NOUN
ajpf-815	43	2	from	from	ADP
ajpf-815	43	3	the	the	DET
ajpf-815	43	4	leaves	leave	NOUN
ajpf-815	43	5	present	present	ADJ
ajpf-815	43	6	trypanocidal	trypanocidal	ADJ
ajpf-815	43	7	activity	activity	NOUN
ajpf-815	43	8	associated	associate	VERB
ajpf-815	43	9	with	with	ADP
ajpf-815	43	10	the	the	DET
ajpf-815	43	11	chemical	chemical	NOUN
ajpf-815	43	12	compound	compound	NOUN
ajpf-815	43	13	tannin	tannin	NOUN
ajpf-815	43	14	(	(	PUNCT
ajpf-815	43	15	ishida	ishida	PROPN
ajpf-815	43	16	et	et	PROPN
ajpf-815	43	17	al	al	PROPN
ajpf-815	43	18	.	.	PROPN
ajpf-815	43	19	,	,	PUNCT
ajpf-815	43	20	2009	2009	NUM
ajpf-815	43	21	)	)	PUNCT
ajpf-815	43	22	.	.	PUNCT
ajpf-815	44	1	extracts	extract	NOUN
ajpf-815	44	2	from	from	ADP
ajpf-815	44	3	x.	x.	NOUN
ajpf-815	44	4	aromatica	aromatica	PROPN
ajpf-815	44	5	have	have	AUX
ajpf-815	44	6	been	be	AUX
ajpf-815	44	7	described	describe	VERB
ajpf-815	44	8	for	for	ADP
ajpf-815	44	9	antibacterial	antibacterial	ADJ
ajpf-815	44	10	,	,	PUNCT
ajpf-815	44	11	antifungal	antifungal	ADJ
ajpf-815	44	12	,	,	PUNCT
ajpf-815	44	13	insecticidal	insecticidal	NOUN
ajpf-815	44	14	,	,	PUNCT
ajpf-815	44	15	antimicrobial	antimicrobial	ADJ
ajpf-815	44	16	,	,	PUNCT
ajpf-815	44	17	and	and	CCONJ
ajpf-815	44	18	antiparasitic	antiparasitic	ADJ
ajpf-815	44	19	activities	activity	NOUN
ajpf-815	44	20	.	.	PUNCT
ajpf-815	45	1	many	many	ADJ
ajpf-815	45	2	compounds	compound	NOUN
ajpf-815	45	3	in	in	ADP
ajpf-815	45	4	this	this	DET
ajpf-815	45	5	genus	genus	NOUN
ajpf-815	45	6	have	have	AUX
ajpf-815	45	7	been	be	AUX
ajpf-815	45	8	identified	identify	VERB
ajpf-815	45	9	,	,	PUNCT
ajpf-815	45	10	but	but	CCONJ
ajpf-815	45	11	the	the	DET
ajpf-815	45	12	triterpenoids	triterpenoid	NOUN
ajpf-815	45	13	are	be	AUX
ajpf-815	45	14	present	present	ADJ
ajpf-815	45	15	in	in	ADP
ajpf-815	45	16	higher	high	ADJ
ajpf-815	45	17	concentrations	concentration	NOUN
ajpf-815	45	18	(	(	PUNCT
ajpf-815	45	19	stashenko	stashenko	PROPN
ajpf-815	45	20	et	et	PROPN
ajpf-815	45	21	al	al	PROPN
ajpf-815	45	22	.	.	PROPN
ajpf-815	45	23	,	,	PUNCT
ajpf-815	45	24	2004	2004	NUM
ajpf-815	45	25	;	;	PUNCT
ajpf-815	46	1	costa	costa	PROPN
ajpf-815	46	2	et	et	PROPN
ajpf-815	46	3	al	al	PROPN
ajpf-815	46	4	.	.	PROPN
ajpf-815	46	5	,	,	PUNCT
ajpf-815	46	6	2013	2013	NUM
ajpf-815	46	7	)	)	PUNCT
ajpf-815	46	8	.	.	PUNCT
ajpf-815	47	1	the	the	DET
ajpf-815	47	2	aim	aim	NOUN
ajpf-815	47	3	of	of	ADP
ajpf-815	47	4	this	this	DET
ajpf-815	47	5	work	work	NOUN
ajpf-815	47	6	was	be	AUX
ajpf-815	47	7	continue	continue	VERB
ajpf-815	47	8	the	the	DET
ajpf-815	47	9	search	search	NOUN
ajpf-815	47	10	with	with	ADP
ajpf-815	47	11	these	these	DET
ajpf-815	47	12	same	same	ADJ
ajpf-815	47	13	eight	eight	NUM
ajpf-815	47	14	positive	positive	ADJ
ajpf-815	47	15	plant	plant	NOUN
ajpf-815	47	16	extracts	extract	NOUN
ajpf-815	47	17	to	to	PART
ajpf-815	47	18	evaluate	evaluate	VERB
ajpf-815	47	19	the	the	DET
ajpf-815	47	20	antiviral	antiviral	ADJ
ajpf-815	47	21	activity	activity	NOUN
ajpf-815	47	22	against	against	ADP
ajpf-815	47	23	equine	equine	NOUN
ajpf-815	47	24	,	,	PUNCT
ajpf-815	47	25	swine	swine	ADJ
ajpf-815	47	26	and	and	CCONJ
ajpf-815	47	27	human	human	ADJ
ajpf-815	47	28	herpesviruses	herpesviruse	NOUN
ajpf-815	47	29	together	together	ADV
ajpf-815	47	30	with	with	ADP
ajpf-815	47	31	additional	additional	ADJ
ajpf-815	47	32	studies	study	NOUN
ajpf-815	47	33	of	of	ADP
ajpf-815	47	34	antiviral	antiviral	ADJ
ajpf-815	47	35	and	and	CCONJ
ajpf-815	47	36	virucidal	virucidal	NOUN
ajpf-815	47	37	potential	potential	NOUN
ajpf-815	47	38	.	.	PUNCT
ajpf-815	48	1	additionally	additionally	ADV
ajpf-815	48	2	,	,	PUNCT
ajpf-815	48	3	the	the	DET
ajpf-815	48	4	phytochemical	phytochemical	ADJ
ajpf-815	48	5	profile	profile	NOUN
ajpf-815	48	6	of	of	ADP
ajpf-815	48	7	the	the	DET
ajpf-815	48	8	extract	extract	NOUN
ajpf-815	48	9	from	from	ADP
ajpf-815	48	10	b.	b.	PROPN
ajpf-815	48	11	intermedia	intermedia	PROPN
ajpf-815	48	12	,	,	PUNCT
ajpf-815	48	13	which	which	PRON
ajpf-815	48	14	displayed	display	VERB
ajpf-815	48	15	higher	high	ADJ
ajpf-815	48	16	antiviral	antiviral	ADJ
ajpf-815	48	17	activity	activity	NOUN
ajpf-815	48	18	,	,	PUNCT
ajpf-815	48	19	was	be	AUX
ajpf-815	48	20	performed	perform	VERB
ajpf-815	48	21	by	by	ADP
ajpf-815	48	22	hplc	hplc	PROPN
ajpf-815	48	23	/	/	SYM
ajpf-815	48	24	ms	ms	NOUN
ajpf-815	48	25	analysis	analysis	NOUN
ajpf-815	48	26	.	.	PUNCT
ajpf-815	49	1	materials	material	NOUN
ajpf-815	49	2	and	and	CCONJ
ajpf-815	49	3	methods	method	NOUN
ajpf-815	49	4	plant	plant	NOUN
ajpf-815	49	5	materials	material	NOUN
ajpf-815	49	6	the	the	DET
ajpf-815	49	7	“	"	PUNCT
ajpf-815	49	8	cerrado	cerrado	NOUN
ajpf-815	49	9	”	"	PUNCT
ajpf-815	49	10	plant	plant	NOUN
ajpf-815	49	11	species	species	PROPN
ajpf-815	49	12	b.	b.	PROPN
ajpf-815	49	13	variabilis	variabilis	PROPN
ajpf-815	49	14	b.	b.	PROPN
ajpf-815	49	15	gates	gates	PROPN
ajpf-815	49	16	,	,	PUNCT
ajpf-815	49	17	b.	b.	PROPN
ajpf-815	49	18	intermedia	intermedia	PROPN
ajpf-815	49	19	a.	a.	PROPN
ajpf-815	49	20	juss	juss	PROPN
ajpf-815	49	21	.	.	PROPN
ajpf-815	49	22	,	,	PUNCT
ajpf-815	49	23	campomanesia	campomanesia	PROPN
ajpf-815	49	24	xanthocarpa	xanthocarpa	PROPN
ajpf-815	49	25	o.	o.	PROPN
ajpf-815	49	26	berg	berg	PROPN
ajpf-815	49	27	,	,	PUNCT
ajpf-815	49	28	erythroxylum	erythroxylum	PROPN
ajpf-815	49	29	deciduum	deciduum	PROPN
ajpf-815	49	30	a.	a.	PROPN
ajpf-815	49	31	st.-hil	st.-hil	PROPN
ajpf-815	49	32	.	.	PROPN
ajpf-815	49	33	,	,	PUNCT
ajpf-815	49	34	lacistema	lacistema	NOUN
ajpf-815	49	35	hasslerianum	hasslerianum	PROPN
ajpf-815	49	36	chodat	chodat	NOUN
ajpf-815	49	37	,	,	PUNCT
ajpf-815	49	38	ocotea	ocotea	NOUN
ajpf-815	49	39	pulchella	pulchella	NOUN
ajpf-815	49	40	(	(	PUNCT
ajpf-815	49	41	nees	nee	NOUN
ajpf-815	49	42	)	)	PUNCT
ajpf-815	49	43	mez	mez	PROPN
ajpf-815	49	44	,	,	PUNCT
ajpf-815	49	45	s.	s.	PROPN
ajpf-815	49	46	adstringens	adstringens	PROPN
ajpf-815	49	47	(	(	PUNCT
ajpf-815	49	48	mart	mart	PROPN
ajpf-815	49	49	.	.	PUNCT
ajpf-815	49	50	)	)	PUNCT
ajpf-815	50	1	coville	coville	PROPN
ajpf-815	50	2	,	,	PUNCT
ajpf-815	50	3	and	and	CCONJ
ajpf-815	50	4	x.	x.	NOUN
ajpf-815	50	5	aromatica	aromatica	PROPN
ajpf-815	50	6	(	(	PUNCT
ajpf-815	50	7	lam	lam	PROPN
ajpf-815	50	8	.	.	PUNCT
ajpf-815	50	9	)	)	PUNCT
ajpf-815	51	1	mart	mart	PROPN
ajpf-815	51	2	were	be	AUX
ajpf-815	51	3	collected	collect	VERB
ajpf-815	51	4	in	in	ADP
ajpf-815	51	5	mogi	mogi	NOUN
ajpf-815	51	6	-	-	PUNCT
ajpf-815	51	7	guaçu	guaçu	PROPN
ajpf-815	51	8	(	(	PUNCT
ajpf-815	51	9	22º18‟s	22º18‟s	NUM
ajpf-815	51	10	and	and	CCONJ
ajpf-815	51	11	47º20‟w	47º20‟w	NUM
ajpf-815	51	12	)	)	PUNCT
ajpf-815	51	13	,	,	PUNCT
ajpf-815	51	14	são	são	PROPN
ajpf-815	51	15	paulo	paulo	PROPN
ajpf-815	51	16	state	state	PROPN
ajpf-815	51	17	,	,	PUNCT
ajpf-815	51	18	brazil	brazil	PROPN
ajpf-815	51	19	.	.	PUNCT
ajpf-815	52	1	the	the	DET
ajpf-815	52	2	specimens	specimen	NOUN
ajpf-815	52	3	were	be	AUX
ajpf-815	52	4	authenticated	authenticate	VERB
ajpf-815	52	5	by	by	ADP
ajpf-815	52	6	a	a	DET
ajpf-815	52	7	taxonomist	taxonomist	NOUN
ajpf-815	52	8	in	in	ADP
ajpf-815	52	9	the	the	DET
ajpf-815	52	10	herbarium	herbarium	NOUN
ajpf-815	52	11	of	of	ADP
ajpf-815	52	12	the	the	DET
ajpf-815	52	13	instituto	instituto	PROPN
ajpf-815	52	14	de	de	PROPN
ajpf-815	52	15	botânica	botânica	PROPN
ajpf-815	52	16	,	,	PUNCT
ajpf-815	52	17	são	são	PROPN
ajpf-815	52	18	paulo	paulo	PROPN
ajpf-815	52	19	,	,	PUNCT
ajpf-815	52	20	dr	dr	PROPN
ajpf-815	52	21	.	.	PROPN
ajpf-815	52	22	eduardo	eduardo	PROPN
ajpf-815	52	23	luis	luis	PROPN
ajpf-815	52	24	martins	martins	PROPN
ajpf-815	52	25	catharino	catharino	NOUN
ajpf-815	52	26	.	.	PUNCT
ajpf-815	53	1	preparation	preparation	NOUN
ajpf-815	53	2	of	of	ADP
ajpf-815	53	3	crude	crude	ADJ
ajpf-815	53	4	extracts	extract	NOUN
ajpf-815	53	5	crude	crude	ADJ
ajpf-815	53	6	aqueous	aqueous	ADJ
ajpf-815	53	7	extracts	extract	NOUN
ajpf-815	53	8	were	be	AUX
ajpf-815	53	9	prepared	prepare	VERB
ajpf-815	53	10	by	by	ADP
ajpf-815	53	11	grinding	grind	VERB
ajpf-815	53	12	dried	dry	VERB
ajpf-815	53	13	leaves	leave	NOUN
ajpf-815	53	14	with	with	ADP
ajpf-815	53	15	de	de	ADJ
ajpf-815	53	16	-	-	ADJ
ajpf-815	53	17	ionized	ionized	ADJ
ajpf-815	53	18	distilled	distil	VERB
ajpf-815	53	19	water	water	NOUN
ajpf-815	53	20	(	(	PUNCT
ajpf-815	53	21	10	10	NUM
ajpf-815	53	22	%	%	NOUN
ajpf-815	53	23	,	,	PUNCT
ajpf-815	53	24	w	w	PROPN
ajpf-815	53	25	/	/	SYM
ajpf-815	53	26	v	v	NOUN
ajpf-815	53	27	)	)	PUNCT
ajpf-815	53	28	in	in	ADP
ajpf-815	53	29	a	a	DET
ajpf-815	53	30	mixer	mixer	NOUN
ajpf-815	53	31	and	and	CCONJ
ajpf-815	53	32	maintenance	maintenance	NOUN
ajpf-815	53	33	at	at	ADP
ajpf-815	53	34	4ºc	4ºc	ADJ
ajpf-815	53	35	overnight	overnight	ADV
ajpf-815	53	36	.	.	PUNCT
ajpf-815	54	1	the	the	DET
ajpf-815	54	2	aqueous	aqueous	ADJ
ajpf-815	54	3	extracts	extract	NOUN
ajpf-815	54	4	were	be	AUX
ajpf-815	54	5	filtered	filter	VERB
ajpf-815	54	6	on	on	ADP
ajpf-815	54	7	whatman-1	whatman-1	PROPN
ajpf-815	54	8	filter	filter	NOUN
ajpf-815	54	9	paper	paper	NOUN
ajpf-815	54	10	and	and	CCONJ
ajpf-815	54	11	freeze	freeze	NOUN
ajpf-815	54	12	-	-	PUNCT
ajpf-815	54	13	dried	dry	VERB
ajpf-815	54	14	in	in	ADP
ajpf-815	54	15	flex	flex	ADJ
ajpf-815	54	16	-	-	PUNCT
ajpf-815	54	17	dry	dry	ADJ
ajpf-815	54	18	mp	mp	NOUN
ajpf-815	54	19	fts	fts	PROPN
ajpf-815	54	20	systems	system	NOUN
ajpf-815	54	21	.	.	PUNCT
ajpf-815	55	1	lyophilized	lyophilized	ADJ
ajpf-815	55	2	extracts	extract	NOUN
ajpf-815	55	3	were	be	AUX
ajpf-815	55	4	dissolved	dissolve	VERB
ajpf-815	55	5	in	in	ADP
ajpf-815	55	6	equal	equal	ADJ
ajpf-815	55	7	parts	part	NOUN
ajpf-815	55	8	of	of	ADP
ajpf-815	55	9	sterile	sterile	ADJ
ajpf-815	55	10	de	de	ADJ
ajpf-815	55	11	-	-	ADJ
ajpf-815	55	12	ionized	ionize	VERB
ajpf-815	55	13	distilled	distil	VERB
ajpf-815	55	14	water	water	NOUN
ajpf-815	55	15	and	and	CCONJ
ajpf-815	55	16	eagle	eagle	ADJ
ajpf-815	55	17	minimum	minimum	ADJ
ajpf-815	55	18	essential	essential	ADJ
ajpf-815	55	19	medium	medium	NOUN
ajpf-815	55	20	(	(	PUNCT
ajpf-815	55	21	mem	mem	X
ajpf-815	55	22	2x	2x	NUM
ajpf-815	55	23	)	)	PUNCT
ajpf-815	55	24	at	at	ADP
ajpf-815	55	25	a	a	DET
ajpf-815	55	26	final	final	ADJ
ajpf-815	55	27	concentration	concentration	NOUN
ajpf-815	55	28	of	of	ADP
ajpf-815	55	29	10,000	10,000	NUM
ajpf-815	55	30	,	,	PUNCT
ajpf-815	55	31	4,000	4,000	NUM
ajpf-815	55	32	or	or	CCONJ
ajpf-815	55	33	2,000	2,000	NUM
ajpf-815	55	34	3	3	NUM
ajpf-815	55	35	µg	µg	NOUN
ajpf-815	55	36	/	/	SYM
ajpf-815	55	37	ml	ml	NOUN
ajpf-815	55	38	.	.	PUNCT
ajpf-815	56	1	the	the	DET
ajpf-815	56	2	extracts	extract	NOUN
ajpf-815	56	3	were	be	AUX
ajpf-815	56	4	centrifuged	centrifuge	VERB
ajpf-815	56	5	at	at	ADP
ajpf-815	56	6	2,500	2,500	NUM
ajpf-815	56	7	g/10	g/10	ADJ
ajpf-815	56	8	min	min	NOUN
ajpf-815	56	9	in	in	ADP
ajpf-815	56	10	a	a	DET
ajpf-815	56	11	hettich	hettich	NOUN
ajpf-815	56	12	zentrifugen	zentrifugen	PROPN
ajpf-815	56	13	model	model	PROPN
ajpf-815	56	14	rotina	rotina	PROPN
ajpf-815	56	15	r	r	PROPN
ajpf-815	56	16	and	and	CCONJ
ajpf-815	56	17	sterilized	sterilize	VERB
ajpf-815	56	18	by	by	ADP
ajpf-815	56	19	filtration	filtration	NOUN
ajpf-815	56	20	(	(	PUNCT
ajpf-815	56	21	0.22	0.22	NUM
ajpf-815	56	22	µm	µm	ADP
ajpf-815	56	23	filter	filter	NOUN
ajpf-815	56	24	)	)	PUNCT
ajpf-815	56	25	.	.	PUNCT
ajpf-815	57	1	hplc	hplc	PROPN
ajpf-815	57	2	/	/	SYM
ajpf-815	57	3	ms	ms	NOUN
ajpf-815	57	4	analysis	analysis	NOUN
ajpf-815	57	5	crude	crude	ADJ
ajpf-815	57	6	aqueous	aqueous	ADJ
ajpf-815	57	7	extract	extract	NOUN
ajpf-815	57	8	from	from	ADP
ajpf-815	57	9	b.	b.	PROPN
ajpf-815	57	10	intermedia	intermedia	PROPN
ajpf-815	57	11	was	be	AUX
ajpf-815	57	12	filtered	filter	VERB
ajpf-815	57	13	on	on	ADP
ajpf-815	57	14	a	a	DET
ajpf-815	57	15	seppak	seppak	NOUN
ajpf-815	57	16	column	column	NOUN
ajpf-815	57	17	using	use	VERB
ajpf-815	57	18	meoh	meoh	PROPN
ajpf-815	57	19	as	as	ADP
ajpf-815	57	20	eluent	eluent	NOUN
ajpf-815	57	21	.	.	PUNCT
ajpf-815	58	1	samples	sample	NOUN
ajpf-815	58	2	containing	contain	VERB
ajpf-815	58	3	1	1	NUM
ajpf-815	58	4	ml	ml	NOUN
ajpf-815	58	5	of	of	ADP
ajpf-815	58	6	the	the	DET
ajpf-815	58	7	crude	crude	ADJ
ajpf-815	58	8	extract	extract	NOUN
ajpf-815	58	9	was	be	AUX
ajpf-815	58	10	analyzed	analyze	VERB
ajpf-815	58	11	by	by	ADP
ajpf-815	58	12	hplc	hplc	NOUN
ajpf-815	58	13	using	use	VERB
ajpf-815	58	14	a	a	DET
ajpf-815	58	15	luna	luna	PROPN
ajpf-815	58	16	c-18	c-18	PROPN
ajpf-815	58	17	(	(	PUNCT
ajpf-815	58	18	phenomenex	phenomenex	ADV
ajpf-815	58	19	)	)	PUNCT
ajpf-815	58	20	column	column	NOUN
ajpf-815	58	21	(	(	PUNCT
ajpf-815	58	22	5	5	NUM
ajpf-815	58	23	mm	mm	NOUN
ajpf-815	58	24	,	,	PUNCT
ajpf-815	58	25	250	250	NUM
ajpf-815	58	26	x	x	SYM
ajpf-815	58	27	4	4	NUM
ajpf-815	58	28	mm	mm	NOUN
ajpf-815	58	29	)	)	PUNCT
ajpf-815	58	30	,	,	PUNCT
ajpf-815	58	31	with	with	ADP
ajpf-815	58	32	a	a	DET
ajpf-815	58	33	gradient	gradient	NOUN
ajpf-815	58	34	from	from	ADP
ajpf-815	58	35	meoh	meoh	NOUN
ajpf-815	58	36	:	:	PUNCT
ajpf-815	58	37	h2o	h2o	PRON
ajpf-815	58	38	:	:	PUNCT
ajpf-815	58	39	hccoh	hccoh	NOUN
ajpf-815	58	40	1	1	NUM
ajpf-815	58	41	%	%	NOUN
ajpf-815	58	42	75:25	75:25	NUM
ajpf-815	58	43	(	(	PUNCT
ajpf-815	58	44	0	0	NUM
ajpf-815	58	45	min	min	NOUN
ajpf-815	58	46	)	)	PUNCT
ajpf-815	58	47	to	to	PART
ajpf-815	58	48	meoh	meoh	VERB
ajpf-815	58	49	100	100	NUM
ajpf-815	58	50	%	%	NOUN
ajpf-815	58	51	(	(	PUNCT
ajpf-815	58	52	30	30	NUM
ajpf-815	58	53	min	min	NOUN
ajpf-815	58	54	)	)	PUNCT
ajpf-815	58	55	,	,	PUNCT
ajpf-815	58	56	flow	flow	NOUN
ajpf-815	58	57	rate	rate	NOUN
ajpf-815	58	58	1.0	1.0	NUM
ajpf-815	58	59	ml	ml	NOUN
ajpf-815	58	60	/	/	SYM
ajpf-815	58	61	min	min	NOUN
ajpf-815	58	62	and	and	CCONJ
ajpf-815	58	63	detection	detection	NOUN
ajpf-815	58	64	at	at	ADP
ajpf-815	58	65	254	254	NUM
ajpf-815	58	66	nm	nm	NOUN
ajpf-815	58	67	.	.	PUNCT
ajpf-815	59	1	hplc	hplc	PROPN
ajpf-815	59	2	/	/	SYM
ajpf-815	59	3	ms	ms	PROPN
ajpf-815	59	4	(	(	PUNCT
ajpf-815	59	5	negative	negative	ADJ
ajpf-815	59	6	form	form	NOUN
ajpf-815	59	7	)	)	PUNCT
ajpf-815	59	8	were	be	AUX
ajpf-815	59	9	acquired	acquire	VERB
ajpf-815	59	10	on	on	ADP
ajpf-815	59	11	a	a	DET
ajpf-815	59	12	bruker	bruker	NOUN
ajpf-815	59	13	microtof	microtof	NOUN
ajpf-815	59	14	-	-	PUNCT
ajpf-815	59	15	qii	qii	NOUN
ajpf-815	59	16	coupled	couple	VERB
ajpf-815	59	17	to	to	ADP
ajpf-815	59	18	an	an	DET
ajpf-815	59	19	apollo	apollo	PROPN
ajpf-815	59	20	ion	ion	NOUN
ajpf-815	59	21	source	source	NOUN
ajpf-815	59	22	set	set	VERB
ajpf-815	59	23	as	as	SCONJ
ajpf-815	59	24	follows	follow	VERB
ajpf-815	59	25	:	:	PUNCT
ajpf-815	59	26	dry	dry	ADJ
ajpf-815	59	27	temperature	temperature	NOUN
ajpf-815	59	28	at	at	ADP
ajpf-815	59	29	180	180	NUM
ajpf-815	59	30	°	°	NOUN
ajpf-815	59	31	c	c	NOUN
ajpf-815	59	32	and	and	CCONJ
ajpf-815	59	33	voltage	voltage	NOUN
ajpf-815	59	34	at	at	ADP
ajpf-815	59	35	4.5	4.5	NUM
ajpf-815	59	36	kv	kv	PROPN
ajpf-815	59	37	.	.	PUNCT
ajpf-815	60	1	the	the	DET
ajpf-815	60	2	mass	mass	PROPN
ajpf-815	60	3	/	/	SYM
ajpf-815	60	4	charge	charge	NOUN
ajpf-815	60	5	ratios	ratio	NOUN
ajpf-815	60	6	were	be	AUX
ajpf-815	60	7	detected	detect	VERB
ajpf-815	60	8	in	in	ADP
ajpf-815	60	9	scan	scan	PROPN
ajpf-815	60	10	(	(	PUNCT
ajpf-815	60	11	m	m	PROPN
ajpf-815	60	12	/	/	SYM
ajpf-815	60	13	z	z	PROPN
ajpf-815	60	14	100–1200	100–1200	NUM
ajpf-815	60	15	da	da	NOUN
ajpf-815	60	16	)	)	PUNCT
ajpf-815	60	17	and	and	CCONJ
ajpf-815	60	18	product	product	NOUN
ajpf-815	60	19	ion	ion	NOUN
ajpf-815	60	20	scan	scan	NOUN
ajpf-815	60	21	(	(	PUNCT
ajpf-815	60	22	m	m	NOUN
ajpf-815	60	23	/	/	SYM
ajpf-815	60	24	z	z	PROPN
ajpf-815	60	25	50–1200	50–1200	NUM
ajpf-815	60	26	da	da	NOUN
ajpf-815	60	27	)	)	PUNCT
ajpf-815	60	28	modes	mode	NOUN
ajpf-815	60	29	,	,	PUNCT
ajpf-815	60	30	using	use	VERB
ajpf-815	60	31	the	the	DET
ajpf-815	60	32	same	same	ADJ
ajpf-815	60	33	chromatographic	chromatographic	ADJ
ajpf-815	60	34	method	method	NOUN
ajpf-815	60	35	described	describe	VERB
ajpf-815	60	36	above	above	ADV
ajpf-815	60	37	.	.	PUNCT
ajpf-815	61	1	cell	cell	NOUN
ajpf-815	61	2	cultures	culture	NOUN
ajpf-815	61	3	and	and	CCONJ
ajpf-815	61	4	viruses	viruse	VERB
ajpf-815	61	5	the	the	DET
ajpf-815	61	6	equine	equine	NOUN
ajpf-815	61	7	herpesvirus	herpesvirus	NOUN
ajpf-815	61	8	1	1	NUM
ajpf-815	61	9	(	(	PUNCT
ajpf-815	61	10	ehv-1	ehv-1	NUM
ajpf-815	61	11	)	)	PUNCT
ajpf-815	61	12	,	,	PUNCT
ajpf-815	61	13	strain	strain	VERB
ajpf-815	61	14	a4/72	a4/72	NOUN
ajpf-815	61	15	(	(	PUNCT
ajpf-815	61	16	moreira	moreira	PROPN
ajpf-815	61	17	et	et	PROPN
ajpf-815	61	18	al	al	PROPN
ajpf-815	61	19	.	.	PROPN
ajpf-815	61	20	,	,	PUNCT
ajpf-815	61	21	1998	1998	NUM
ajpf-815	61	22	)	)	PUNCT
ajpf-815	61	23	and	and	CCONJ
ajpf-815	61	24	the	the	DET
ajpf-815	61	25	herpes	herpe	NOUN
ajpf-815	61	26	simplex	simplex	NOUN
ajpf-815	61	27	virus	virus	NOUN
ajpf-815	61	28	1	1	NUM
ajpf-815	61	29	(	(	PUNCT
ajpf-815	61	30	hsv-1	hsv-1	NUM
ajpf-815	61	31	)	)	PUNCT
ajpf-815	61	32	,	,	PUNCT
ajpf-815	61	33	strain	strain	VERB
ajpf-815	61	34	kos	kos	PROPN
ajpf-815	61	35	(	(	PUNCT
ajpf-815	61	36	silva	silva	PROPN
ajpf-815	61	37	et	et	PROPN
ajpf-815	61	38	al	al	PROPN
ajpf-815	61	39	.	.	PROPN
ajpf-815	61	40	,	,	PUNCT
ajpf-815	61	41	2010	2010	NUM
ajpf-815	61	42	)	)	PUNCT
ajpf-815	61	43	were	be	AUX
ajpf-815	61	44	propagated	propagate	VERB
ajpf-815	61	45	in	in	ADP
ajpf-815	61	46	vero	vero	PROPN
ajpf-815	61	47	(	(	PUNCT
ajpf-815	61	48	african	african	ADJ
ajpf-815	61	49	green	green	ADJ
ajpf-815	61	50	monkey	monkey	NOUN
ajpf-815	61	51	–	–	PUNCT
ajpf-815	61	52	atcc	atcc	ADJ
ajpf-815	61	53	ccl	ccl	PROPN
ajpf-815	61	54	81	81	NUM
ajpf-815	61	55	)	)	PUNCT
ajpf-815	61	56	.	.	PUNCT
ajpf-815	62	1	the	the	DET
ajpf-815	62	2	swine	swine	ADJ
ajpf-815	62	3	herpesvirus	herpesvirus	NOUN
ajpf-815	62	4	1	1	NUM
ajpf-815	62	5	(	(	PUNCT
ajpf-815	62	6	suhv-1	suhv-1	NOUN
ajpf-815	62	7	)	)	PUNCT
ajpf-815	62	8	strain	strain	NOUN
ajpf-815	62	9	np	np	INTJ
ajpf-815	62	10	(	(	PUNCT
ajpf-815	62	11	nova	nova	PROPN
ajpf-815	62	12	prata	prata	PROPN
ajpf-815	62	13	)	)	PUNCT
ajpf-815	62	14	(	(	PUNCT
ajpf-815	62	15	fonseca	fonseca	PROPN
ajpf-815	62	16	et	et	PROPN
ajpf-815	62	17	al	al	PROPN
ajpf-815	62	18	.	.	PROPN
ajpf-815	62	19	,	,	PUNCT
ajpf-815	62	20	2010	2010	NUM
ajpf-815	62	21	)	)	PUNCT
ajpf-815	62	22	was	be	AUX
ajpf-815	62	23	propagated	propagate	VERB
ajpf-815	62	24	in	in	ADP
ajpf-815	62	25	mdbk	mdbk	NOUN
ajpf-815	62	26	(	(	PUNCT
ajpf-815	62	27	mardin	mardin	PROPN
ajpf-815	62	28	and	and	CCONJ
ajpf-815	62	29	darby	darby	PROPN
ajpf-815	62	30	bovine	bovine	PROPN
ajpf-815	62	31	kidney	kidney	PROPN
ajpf-815	62	32	–	–	PUNCT
ajpf-815	62	33	atcc	atcc	ADJ
ajpf-815	62	34	ccl	ccl	PROPN
ajpf-815	62	35	22	22	NUM
ajpf-815	62	36	)	)	PUNCT
ajpf-815	62	37	.	.	PUNCT
ajpf-815	63	1	all	all	DET
ajpf-815	63	2	cells	cell	NOUN
ajpf-815	63	3	were	be	AUX
ajpf-815	63	4	grown	grow	VERB
ajpf-815	63	5	in	in	ADP
ajpf-815	63	6	mem	mem	ADJ
ajpf-815	63	7	with	with	ADP
ajpf-815	63	8	10	10	NUM
ajpf-815	63	9	%	%	NOUN
ajpf-815	63	10	fetal	fetal	ADJ
ajpf-815	63	11	bovine	bovine	NOUN
ajpf-815	63	12	serum	serum	NOUN
ajpf-815	63	13	(	(	PUNCT
ajpf-815	63	14	fbs	fbs	PROPN
ajpf-815	63	15	)	)	PUNCT
ajpf-815	63	16	(	(	PUNCT
ajpf-815	63	17	simoni	simoni	PROPN
ajpf-815	63	18	et	et	PROPN
ajpf-815	63	19	al	al	PROPN
ajpf-815	63	20	,	,	PUNCT
ajpf-815	63	21	2007	2007	NUM
ajpf-815	63	22	)	)	PUNCT
ajpf-815	63	23	.	.	PUNCT
ajpf-815	64	1	cytotoxicity	cytotoxicity	NOUN
ajpf-815	64	2	assay	assay	VERB
ajpf-815	64	3	the	the	DET
ajpf-815	64	4	assays	assay	NOUN
ajpf-815	64	5	were	be	AUX
ajpf-815	64	6	performed	perform	VERB
ajpf-815	64	7	using	use	VERB
ajpf-815	64	8	96well	96well	NUM
ajpf-815	64	9	microtiter	microtiter	NOUN
ajpf-815	64	10	plates	plate	NOUN
ajpf-815	64	11	with	with	ADP
ajpf-815	64	12	30,000	30,000	NUM
ajpf-815	64	13	cell	cell	NOUN
ajpf-815	64	14	/	/	SYM
ajpf-815	64	15	well	well	INTJ
ajpf-815	64	16	.	.	PUNCT
ajpf-815	65	1	after	after	ADP
ajpf-815	65	2	24	24	NUM
ajpf-815	65	3	h	h	NOUN
ajpf-815	65	4	of	of	ADP
ajpf-815	65	5	incubation	incubation	NOUN
ajpf-815	65	6	at	at	ADP
ajpf-815	65	7	37ºc	37ºc	NOUN
ajpf-815	65	8	in	in	ADP
ajpf-815	65	9	a	a	DET
ajpf-815	65	10	humidified	humidified	ADJ
ajpf-815	65	11	5	5	NUM
ajpf-815	65	12	%	%	NOUN
ajpf-815	65	13	co2	co2	NOUN
ajpf-815	65	14	atmosphere	atmosphere	NOUN
ajpf-815	65	15	,	,	PUNCT
ajpf-815	65	16	each	each	DET
ajpf-815	65	17	cell	cell	NOUN
ajpf-815	65	18	type	type	NOUN
ajpf-815	65	19	was	be	AUX
ajpf-815	65	20	exposed	expose	VERB
ajpf-815	65	21	to	to	ADP
ajpf-815	65	22	decreasing	decrease	VERB
ajpf-815	65	23	concentrations	concentration	NOUN
ajpf-815	65	24	of	of	ADP
ajpf-815	65	25	plant	plant	NOUN
ajpf-815	65	26	extract	extract	NOUN
ajpf-815	65	27	in	in	ADP
ajpf-815	65	28	triplicate	triplicate	NOUN
ajpf-815	65	29	.	.	PUNCT
ajpf-815	66	1	any	any	DET
ajpf-815	66	2	cell	cell	NOUN
ajpf-815	66	3	morphology	morphology	NOUN
ajpf-815	66	4	alteration	alteration	NOUN
ajpf-815	66	5	was	be	AUX
ajpf-815	66	6	observed	observe	VERB
ajpf-815	66	7	at	at	ADP
ajpf-815	66	8	light	light	ADJ
ajpf-815	66	9	microscopy	microscopy	NOUN
ajpf-815	66	10	during	during	ADP
ajpf-815	66	11	the	the	DET
ajpf-815	66	12	next	next	ADJ
ajpf-815	66	13	3	3	NUM
ajpf-815	66	14	days	day	NOUN
ajpf-815	66	15	to	to	PART
ajpf-815	66	16	determine	determine	VERB
ajpf-815	66	17	the	the	DET
ajpf-815	66	18	maximum	maximum	ADJ
ajpf-815	66	19	non	non	ADJ
ajpf-815	66	20	-	-	ADJ
ajpf-815	66	21	cytotoxic	cytotoxic	ADJ
ajpf-815	66	22	concentration	concentration	NOUN
ajpf-815	66	23	(	(	PUNCT
ajpf-815	66	24	mncc	mncc	ADJ
ajpf-815	66	25	)	)	PUNCT
ajpf-815	66	26	.	.	PUNCT
ajpf-815	67	1	monolayers	monolayer	NOUN
ajpf-815	67	2	of	of	ADP
ajpf-815	67	3	cells	cell	NOUN
ajpf-815	67	4	incubated	incubate	VERB
ajpf-815	67	5	only	only	ADV
ajpf-815	67	6	with	with	ADP
ajpf-815	67	7	mem	mem	ADJ
ajpf-815	67	8	were	be	AUX
ajpf-815	67	9	used	use	VERB
ajpf-815	67	10	as	as	ADP
ajpf-815	67	11	a	a	DET
ajpf-815	67	12	control	control	NOUN
ajpf-815	67	13	.	.	PUNCT
ajpf-815	68	1	antiviral	antiviral	ADJ
ajpf-815	68	2	assay	assay	VERB
ajpf-815	68	3	for	for	ADP
ajpf-815	68	4	the	the	DET
ajpf-815	68	5	assays	assay	NOUN
ajpf-815	68	6	,	,	PUNCT
ajpf-815	68	7	mdbk	mdbk	NOUN
ajpf-815	68	8	or	or	CCONJ
ajpf-815	68	9	vero	vero	PROPN
ajpf-815	68	10	cells	cell	NOUN
ajpf-815	68	11	were	be	AUX
ajpf-815	68	12	prepared	prepare	VERB
ajpf-815	68	13	in	in	ADP
ajpf-815	68	14	96	96	NUM
ajpf-815	68	15	-	-	PUNCT
ajpf-815	68	16	well	well	NOUN
ajpf-815	68	17	microplates	microplate	NOUN
ajpf-815	68	18	at	at	ADP
ajpf-815	68	19	density	density	NOUN
ajpf-815	68	20	of	of	ADP
ajpf-815	68	21	3	3	NUM
ajpf-815	68	22	×	×	NOUN
ajpf-815	68	23	10	10	NUM
ajpf-815	68	24	4	4	NUM
ajpf-815	68	25	cells	cell	NOUN
ajpf-815	68	26	per	per	ADP
ajpf-815	68	27	well	well	ADV
ajpf-815	68	28	and	and	CCONJ
ajpf-815	68	29	incubated	incubate	VERB
ajpf-815	68	30	for	for	ADP
ajpf-815	68	31	24	24	NUM
ajpf-815	68	32	h	h	NOUN
ajpf-815	68	33	at	at	ADP
ajpf-815	68	34	37ºc	37ºc	NOUN
ajpf-815	68	35	with	with	ADP
ajpf-815	68	36	5	5	NUM
ajpf-815	68	37	%	%	NOUN
ajpf-815	68	38	co2	co2	NOUN
ajpf-815	68	39	.	.	PUNCT
ajpf-815	69	1	after	after	ADP
ajpf-815	69	2	24	24	NUM
ajpf-815	69	3	h	h	NOUN
ajpf-815	69	4	of	of	ADP
ajpf-815	69	5	incubation	incubation	NOUN
ajpf-815	69	6	,	,	PUNCT
ajpf-815	69	7	the	the	DET
ajpf-815	69	8	medium	medium	NOUN
ajpf-815	69	9	was	be	AUX
ajpf-815	69	10	poured	pour	VERB
ajpf-815	69	11	off	off	ADP
ajpf-815	69	12	and	and	CCONJ
ajpf-815	69	13	100	100	NUM
ajpf-815	69	14	µl	µl	NOUN
ajpf-815	69	15	of	of	ADP
ajpf-815	69	16	extracts	extract	NOUN
ajpf-815	69	17	at	at	ADP
ajpf-815	69	18	dilutions	dilution	NOUN
ajpf-815	69	19	corresponding	correspond	VERB
ajpf-815	69	20	at	at	ADP
ajpf-815	69	21	mncc	mncc	ADJ
ajpf-815	69	22	were	be	AUX
ajpf-815	69	23	added	add	VERB
ajpf-815	69	24	.	.	PUNCT
ajpf-815	70	1	the	the	DET
ajpf-815	70	2	cells	cell	NOUN
ajpf-815	70	3	were	be	AUX
ajpf-815	70	4	incubated	incubate	VERB
ajpf-815	70	5	for	for	ADP
ajpf-815	70	6	1	1	NUM
ajpf-815	70	7	h	h	NOUN
ajpf-815	70	8	and	and	CCONJ
ajpf-815	70	9	after	after	ADP
ajpf-815	70	10	this	this	DET
ajpf-815	70	11	period	period	NOUN
ajpf-815	70	12	,	,	PUNCT
ajpf-815	70	13	50	50	NUM
ajpf-815	70	14	µl	µl	NOUN
ajpf-815	70	15	of	of	ADP
ajpf-815	70	16	logarithmic	logarithmic	ADJ
ajpf-815	70	17	dilutions	dilution	NOUN
ajpf-815	70	18	of	of	ADP
ajpf-815	70	19	viruses	virus	NOUN
ajpf-815	70	20	were	be	AUX
ajpf-815	70	21	inoculated	inoculate	VERB
ajpf-815	70	22	for	for	ADP
ajpf-815	70	23	96	96	NUM
ajpf-815	70	24	h.	h.	PROPN
ajpf-815	70	25	mdbk	mdbk	PROPN
ajpf-815	70	26	cells	cell	NOUN
ajpf-815	70	27	were	be	AUX
ajpf-815	70	28	infected	infect	VERB
ajpf-815	70	29	with	with	ADP
ajpf-815	70	30	suhv-1	suhv-1	NUM
ajpf-815	70	31	and	and	CCONJ
ajpf-815	70	32	vero	vero	PROPN
ajpf-815	70	33	cells	cell	NOUN
ajpf-815	70	34	were	be	AUX
ajpf-815	70	35	infected	infect	VERB
ajpf-815	70	36	with	with	ADP
ajpf-815	70	37	ehv-1	ehv-1	NUM
ajpf-815	70	38	or	or	CCONJ
ajpf-815	70	39	hsv-1	hsv-1	PRON
ajpf-815	70	40	.	.	PUNCT
ajpf-815	71	1	controls	control	NOUN
ajpf-815	71	2	consisted	consist	VERB
ajpf-815	71	3	of	of	ADP
ajpf-815	71	4	untreated	untreated	ADJ
ajpf-815	71	5	infected	infect	VERB
ajpf-815	71	6	(	(	PUNCT
ajpf-815	71	7	virus	virus	NOUN
ajpf-815	71	8	titer	titer	NOUN
ajpf-815	71	9	)	)	PUNCT
ajpf-815	71	10	,	,	PUNCT
ajpf-815	71	11	treated	treat	VERB
ajpf-815	71	12	non	non	ADJ
ajpf-815	71	13	-	-	ADJ
ajpf-815	71	14	infected	infected	ADJ
ajpf-815	71	15	(	(	PUNCT
ajpf-815	71	16	extract	extract	NOUN
ajpf-815	71	17	control	control	NOUN
ajpf-815	71	18	)	)	PUNCT
ajpf-815	71	19	,	,	PUNCT
ajpf-815	71	20	untreated	untreate	VERB
ajpf-815	71	21	non	non	ADJ
ajpf-815	71	22	-	-	ADJ
ajpf-815	71	23	infected	infected	ADJ
ajpf-815	71	24	(	(	PUNCT
ajpf-815	71	25	cell	cell	NOUN
ajpf-815	71	26	control	control	NOUN
ajpf-815	71	27	)	)	PUNCT
ajpf-815	71	28	cells	cell	NOUN
ajpf-815	71	29	.	.	PUNCT
ajpf-815	72	1	in	in	ADP
ajpf-815	72	2	addition	addition	NOUN
ajpf-815	72	3	,	,	PUNCT
ajpf-815	72	4	to	to	PART
ajpf-815	72	5	verify	verify	VERB
ajpf-815	72	6	if	if	SCONJ
ajpf-815	72	7	the	the	DET
ajpf-815	72	8	antiviral	antiviral	ADJ
ajpf-815	72	9	activity	activity	NOUN
ajpf-815	72	10	of	of	ADP
ajpf-815	72	11	the	the	DET
ajpf-815	72	12	extract	extract	NOUN
ajpf-815	72	13	remained	remain	VERB
ajpf-815	72	14	below	below	ADP
ajpf-815	72	15	its	its	PRON
ajpf-815	72	16	mncc	mncc	ADJ
ajpf-815	72	17	,	,	PUNCT
ajpf-815	72	18	a	a	DET
ajpf-815	72	19	dose	dose	NOUN
ajpf-815	72	20	-	-	PUNCT
ajpf-815	72	21	response	response	NOUN
ajpf-815	72	22	experiment	experiment	NOUN
ajpf-815	72	23	was	be	AUX
ajpf-815	72	24	carried	carry	VERB
ajpf-815	72	25	out	out	ADP
ajpf-815	72	26	using	use	VERB
ajpf-815	72	27	it	it	PRON
ajpf-815	72	28	at	at	ADP
ajpf-815	72	29	range	range	NOUN
ajpf-815	72	30	of	of	ADP
ajpf-815	72	31	250	250	NUM
ajpf-815	72	32	until	until	ADP
ajpf-815	72	33	1.9	1.9	NUM
ajpf-815	72	34	µg	µg	NOUN
ajpf-815	72	35	/	/	SYM
ajpf-815	72	36	ml	ml	NOUN
ajpf-815	72	37	.	.	PUNCT
ajpf-815	73	1	direct	direct	ADJ
ajpf-815	73	2	anti	anti	NOUN
ajpf-815	73	3	-	-	ADJ
ajpf-815	73	4	herpes	herpe	NOUN
ajpf-815	73	5	assay	assay	VERB
ajpf-815	73	6	the	the	DET
ajpf-815	73	7	assay	assay	NOUN
ajpf-815	73	8	was	be	AUX
ajpf-815	73	9	described	describe	VERB
ajpf-815	73	10	previously	previously	ADV
ajpf-815	73	11	by	by	ADP
ajpf-815	73	12	simoni	simoni	PROPN
ajpf-815	73	13	et	et	PROPN
ajpf-815	73	14	al	al	PROPN
ajpf-815	73	15	.	.	PROPN
ajpf-815	74	1	(	(	PUNCT
ajpf-815	74	2	1996	1996	NUM
ajpf-815	74	3	)	)	PUNCT
ajpf-815	74	4	.	.	PUNCT
ajpf-815	75	1	briefly	briefly	NOUN
ajpf-815	75	2	,	,	PUNCT
ajpf-815	75	3	100	100	NUM
ajpf-815	75	4	µl	µl	ADP
ajpf-815	75	5	of	of	ADP
ajpf-815	75	6	each	each	DET
ajpf-815	75	7	extract	extract	NOUN
ajpf-815	75	8	at	at	ADP
ajpf-815	75	9	mncc	mncc	ADV
ajpf-815	75	10	was	be	AUX
ajpf-815	75	11	mixed	mix	VERB
ajpf-815	75	12	with	with	ADP
ajpf-815	75	13	100	100	NUM
ajpf-815	75	14	µl	µl	NOUN
ajpf-815	75	15	of	of	ADP
ajpf-815	75	16	logarithmic	logarithmic	ADJ
ajpf-815	75	17	dilutions	dilution	NOUN
ajpf-815	75	18	of	of	ADP
ajpf-815	75	19	each	each	DET
ajpf-815	75	20	virus	virus	NOUN
ajpf-815	75	21	,	,	PUNCT
ajpf-815	75	22	incubated	incubate	VERB
ajpf-815	75	23	at	at	ADP
ajpf-815	75	24	37	37	NUM
ajpf-815	75	25	°	°	ADP
ajpf-815	75	26	c	c	NOUN
ajpf-815	75	27	in	in	ADP
ajpf-815	75	28	5	5	NUM
ajpf-815	75	29	%	%	NOUN
ajpf-815	75	30	co2	co2	NOUN
ajpf-815	75	31	for	for	ADP
ajpf-815	75	32	1	1	NUM
ajpf-815	75	33	h.	h.	NOUN
ajpf-815	75	34	then	then	ADV
ajpf-815	75	35	,	,	PUNCT
ajpf-815	75	36	50	50	NUM
ajpf-815	75	37	µl	µl	NOUN
ajpf-815	75	38	of	of	ADP
ajpf-815	75	39	mixture	mixture	NOUN
ajpf-815	75	40	was	be	AUX
ajpf-815	75	41	inoculated	inoculate	VERB
ajpf-815	75	42	at	at	ADP
ajpf-815	75	43	the	the	DET
ajpf-815	75	44	monolayers	monolayer	NOUN
ajpf-815	75	45	in	in	ADP
ajpf-815	75	46	each	each	DET
ajpf-815	75	47	well	well	NOUN
ajpf-815	75	48	of	of	ADP
ajpf-815	75	49	a	a	DET
ajpf-815	75	50	96	96	NUM
ajpf-815	75	51	-	-	PUNCT
ajpf-815	75	52	well	well	NOUN
ajpf-815	75	53	plate	plate	NOUN
ajpf-815	75	54	.	.	PUNCT
ajpf-815	76	1	in	in	ADP
ajpf-815	76	2	addition	addition	NOUN
ajpf-815	76	3	,	,	PUNCT
ajpf-815	76	4	to	to	PART
ajpf-815	76	5	verify	verify	VERB
ajpf-815	76	6	if	if	SCONJ
ajpf-815	76	7	the	the	DET
ajpf-815	76	8	direct	direct	ADJ
ajpf-815	76	9	antiherpes	antiherpe	NOUN
ajpf-815	76	10	effect	effect	NOUN
ajpf-815	76	11	of	of	ADP
ajpf-815	76	12	the	the	DET
ajpf-815	76	13	extract	extract	NOUN
ajpf-815	76	14	remained	remain	VERB
ajpf-815	76	15	below	below	ADP
ajpf-815	76	16	its	its	PRON
ajpf-815	76	17	mncc	mncc	ADJ
ajpf-815	76	18	,	,	PUNCT
ajpf-815	76	19	a	a	DET
ajpf-815	76	20	doseresponse	doseresponse	NOUN
ajpf-815	76	21	experiment	experiment	NOUN
ajpf-815	76	22	was	be	AUX
ajpf-815	76	23	carried	carry	VERB
ajpf-815	76	24	out	out	ADP
ajpf-815	76	25	using	use	VERB
ajpf-815	76	26	it	it	PRON
ajpf-815	76	27	at	at	ADP
ajpf-815	76	28	range	range	NOUN
ajpf-815	76	29	of	of	ADP
ajpf-815	76	30	250	250	NUM
ajpf-815	76	31	until	until	ADP
ajpf-815	76	32	1.9	1.9	NUM
ajpf-815	76	33	µg	µg	NOUN
ajpf-815	76	34	/	/	SYM
ajpf-815	76	35	ml	ml	NOUN
ajpf-815	76	36	.	.	PUNCT
ajpf-815	77	1	mtt	mtt	PROPN
ajpf-815	77	2	assay	assay	VERB
ajpf-815	77	3	the	the	DET
ajpf-815	77	4	mtt	mtt	NOUN
ajpf-815	77	5	assay	assay	NOUN
ajpf-815	77	6	was	be	AUX
ajpf-815	77	7	performed	perform	VERB
ajpf-815	77	8	to	to	PART
ajpf-815	77	9	confirm	confirm	VERB
ajpf-815	77	10	qualitatively	qualitatively	ADV
ajpf-815	77	11	the	the	DET
ajpf-815	77	12	mncc	mncc	NOUN
ajpf-815	77	13	and	and	CCONJ
ajpf-815	77	14	the	the	DET
ajpf-815	77	15	antiviral	antiviral	ADJ
ajpf-815	77	16	activity	activity	NOUN
ajpf-815	77	17	of	of	ADP
ajpf-815	77	18	the	the	DET
ajpf-815	77	19	extracts	extract	NOUN
ajpf-815	77	20	that	that	PRON
ajpf-815	77	21	presented	present	VERB
ajpf-815	77	22	pi%	pi%	NOUN
ajpf-815	77	23	more	more	ADJ
ajpf-815	77	24	than	than	ADP
ajpf-815	77	25	97	97	NUM
ajpf-815	77	26	%	%	NOUN
ajpf-815	77	27	.	.	PUNCT
ajpf-815	78	1	cells	cell	NOUN
ajpf-815	78	2	in	in	ADP
ajpf-815	78	3	a	a	DET
ajpf-815	78	4	96	96	NUM
ajpf-815	78	5	-	-	PUNCT
ajpf-815	78	6	well	well	NOUN
ajpf-815	78	7	microplate	microplate	NOUN
ajpf-815	78	8	were	be	AUX
ajpf-815	78	9	incubated	incubate	VERB
ajpf-815	78	10	with	with	ADP
ajpf-815	78	11	100	100	NUM
ajpf-815	78	12	μl	μl	ADJ
ajpf-815	78	13	/	/	SYM
ajpf-815	78	14	well	well	ADV
ajpf-815	78	15	of	of	ADP
ajpf-815	78	16	increasing	increase	VERB
ajpf-815	78	17	concentrations	concentration	NOUN
ajpf-815	78	18	of	of	ADP
ajpf-815	78	19	crude	crude	ADJ
ajpf-815	78	20	extracts	extract	NOUN
ajpf-815	78	21	in	in	ADP
ajpf-815	78	22	quadruplicate	quadruplicate	NOUN
ajpf-815	78	23	with	with	ADP
ajpf-815	78	24	at	at	ADV
ajpf-815	78	25	least	least	ADV
ajpf-815	78	26	5	5	NUM
ajpf-815	78	27	different	different	ADJ
ajpf-815	78	28	concentrations	concentration	NOUN
ajpf-815	78	29	.	.	PUNCT
ajpf-815	79	1	thereafter	thereafter	ADV
ajpf-815	79	2	,	,	PUNCT
ajpf-815	79	3	100	100	NUM
ajpf-815	79	4	tcid	tcid	NOUN
ajpf-815	79	5	of	of	ADP
ajpf-815	79	6	virus	virus	NOUN
ajpf-815	79	7	was	be	AUX
ajpf-815	79	8	added	add	VERB
ajpf-815	79	9	.	.	PUNCT
ajpf-815	80	1	after	after	ADP
ajpf-815	80	2	incubation	incubation	NOUN
ajpf-815	80	3	for	for	ADP
ajpf-815	80	4	72	72	NUM
ajpf-815	80	5	h	h	NOUN
ajpf-815	80	6	,	,	PUNCT
ajpf-815	80	7	the	the	DET
ajpf-815	80	8	medium	medium	NOUN
ajpf-815	80	9	was	be	AUX
ajpf-815	80	10	removed	remove	VERB
ajpf-815	80	11	and	and	CCONJ
ajpf-815	80	12	added	add	VERB
ajpf-815	80	13	on	on	ADP
ajpf-815	80	14	cell	cell	NOUN
ajpf-815	80	15	monolayer	monolayer	NOUN
ajpf-815	80	16	50	50	NUM
ajpf-815	80	17	µl	µl	NOUN
ajpf-815	80	18	of	of	ADP
ajpf-815	80	19	mtt	mtt	NOUN
ajpf-815	80	20	(	(	PUNCT
ajpf-815	80	21	1	1	NUM
ajpf-815	80	22	mg	mg	NUM
ajpf-815	80	23	/	/	SYM
ajpf-815	80	24	ml	ml	NOUN
ajpf-815	80	25	)	)	PUNCT
ajpf-815	80	26	to	to	ADP
ajpf-815	80	27	each	each	DET
ajpf-815	80	28	well	well	ADV
ajpf-815	80	29	.	.	PUNCT
ajpf-815	81	1	the	the	DET
ajpf-815	81	2	microplate	microplate	NOUN
ajpf-815	81	3	was	be	AUX
ajpf-815	81	4	then	then	ADV
ajpf-815	81	5	incubated	incubate	VERB
ajpf-815	81	6	at	at	ADP
ajpf-815	81	7	37ºc	37ºc	NOUN
ajpf-815	81	8	for	for	ADP
ajpf-815	81	9	4	4	NUM
ajpf-815	81	10	h.	h.	NOUN
ajpf-815	81	11	the	the	DET
ajpf-815	81	12	supernatant	supernatant	NOUN
ajpf-815	81	13	was	be	AUX
ajpf-815	81	14	then	then	ADV
ajpf-815	81	15	removed	remove	VERB
ajpf-815	81	16	from	from	ADP
ajpf-815	81	17	each	each	DET
ajpf-815	81	18	well	well	NOUN
ajpf-815	81	19	without	without	ADP
ajpf-815	81	20	disturbing	disturb	VERB
ajpf-815	81	21	the	the	DET
ajpf-815	81	22	cell	cell	NOUN
ajpf-815	81	23	clusters	cluster	NOUN
ajpf-815	81	24	containing	contain	VERB
ajpf-815	81	25	formazan	formazan	ADJ
ajpf-815	81	26	crystals	crystal	NOUN
ajpf-815	81	27	.	.	PUNCT
ajpf-815	82	1	to	to	PART
ajpf-815	82	2	solubilize	solubilize	VERB
ajpf-815	82	3	the	the	DET
ajpf-815	82	4	formazan	formazan	PROPN
ajpf-815	82	5	crystal	crystal	NOUN
ajpf-815	82	6	,	,	PUNCT
ajpf-815	82	7	100	100	NUM
ajpf-815	82	8	µl	µl	NOUN
ajpf-815	82	9	of	of	ADP
ajpf-815	82	10	sds	sds	PROPN
ajpf-815	82	11	was	be	AUX
ajpf-815	82	12	added	add	VERB
ajpf-815	82	13	and	and	CCONJ
ajpf-815	82	14	the	the	DET
ajpf-815	82	15	microplate	microplate	NOUN
ajpf-815	82	16	was	be	AUX
ajpf-815	82	17	incubated	incubate	VERB
ajpf-815	82	18	again	again	ADV
ajpf-815	82	19	overnight	overnight	ADV
ajpf-815	82	20	.	.	PUNCT
ajpf-815	83	1	the	the	DET
ajpf-815	83	2	absorbance	absorbance	NOUN
ajpf-815	83	3	of	of	ADP
ajpf-815	83	4	the	the	DET
ajpf-815	83	5	wells	well	NOUN
ajpf-815	83	6	was	be	AUX
ajpf-815	83	7	read	read	VERB
ajpf-815	83	8	in	in	ADP
ajpf-815	83	9	a	a	DET
ajpf-815	83	10	computer	computer	NOUN
ajpf-815	83	11	-	-	PUNCT
ajpf-815	83	12	controlled	control	VERB
ajpf-815	83	13	microplate	microplate	NOUN
ajpf-815	83	14	reader	reader	NOUN
ajpf-815	83	15	(	(	PUNCT
ajpf-815	83	16	spectra	spectra	PROPN
ajpf-815	83	17	max	max	PROPN
ajpf-815	83	18	plus	plus	CCONJ
ajpf-815	83	19	384	384	NUM
ajpf-815	83	20	)	)	PUNCT
ajpf-815	83	21	at	at	ADP
ajpf-815	83	22	540	540	NUM
ajpf-815	83	23	nm	nm	ADJ
ajpf-815	83	24	wavelengths	wavelength	NOUN
ajpf-815	83	25	.	.	PUNCT
ajpf-815	84	1	the	the	DET
ajpf-815	84	2	50	50	NUM
ajpf-815	84	3	%	%	NOUN
ajpf-815	84	4	cytotoxic	cytotoxic	ADJ
ajpf-815	84	5	concentration	concentration	NOUN
ajpf-815	84	6	(	(	PUNCT
ajpf-815	84	7	cc50	cc50	PROPN
ajpf-815	84	8	)	)	PUNCT
ajpf-815	84	9	of	of	ADP
ajpf-815	84	10	the	the	DET
ajpf-815	84	11	test	test	NOUN
ajpf-815	84	12	compound	compound	NOUN
ajpf-815	84	13	was	be	AUX
ajpf-815	84	14	defined	define	VERB
ajpf-815	84	15	as	as	ADP
ajpf-815	84	16	the	the	DET
ajpf-815	84	17	concentration	concentration	NOUN
ajpf-815	84	18	that	that	PRON
ajpf-815	84	19	reduced	reduce	VERB
ajpf-815	84	20	the	the	DET
ajpf-815	84	21	absorbance	absorbance	NOUN
ajpf-815	84	22	of	of	ADP
ajpf-815	84	23	mock	mock	ADJ
ajpf-815	84	24	-	-	PUNCT
ajpf-815	84	25	infected	infect	VERB
ajpf-815	84	26	cells	cell	NOUN
ajpf-815	84	27	by	by	ADP
ajpf-815	84	28	50	50	NUM
ajpf-815	84	29	%	%	NOUN
ajpf-815	84	30	of	of	ADP
ajpf-815	84	31	that	that	PRON
ajpf-815	84	32	of	of	ADP
ajpf-815	84	33	the	the	DET
ajpf-815	84	34	control	control	NOUN
ajpf-815	84	35	.	.	PUNCT
ajpf-815	85	1	the	the	DET
ajpf-815	85	2	50	50	NUM
ajpf-815	85	3	%	%	NOUN
ajpf-815	85	4	antiviral	antiviral	ADJ
ajpf-815	85	5	effective	effective	ADJ
ajpf-815	85	6	concentration	concentration	NOUN
ajpf-815	85	7	(	(	PUNCT
ajpf-815	85	8	ic50	ic50	PROPN
ajpf-815	85	9	)	)	PUNCT
ajpf-815	85	10	was	be	AUX
ajpf-815	85	11	expressed	express	VERB
ajpf-815	85	12	as	as	ADP
ajpf-815	85	13	the	the	DET
ajpf-815	85	14	concentration	concentration	NOUN
ajpf-815	85	15	that	that	PRON
ajpf-815	85	16	achieved	achieve	VERB
ajpf-815	85	17	50	50	NUM
ajpf-815	85	18	%	%	NOUN
ajpf-815	85	19	protection	protection	NOUN
ajpf-815	85	20	of	of	ADP
ajpf-815	85	21	virusinfected	virusinfecte	VERB
ajpf-815	85	22	cells	cell	NOUN
ajpf-815	85	23	from	from	ADP
ajpf-815	85	24	the	the	DET
ajpf-815	85	25	hsv-1	hsv-1	ADJ
ajpf-815	85	26	,	,	PUNCT
ajpf-815	85	27	ehv-1	ehv-1	PUNCT
ajpf-815	85	28	and	and	CCONJ
ajpf-815	85	29	suhv-1	suhv-1	NUM
ajpf-815	85	30	induced	induced	ADJ
ajpf-815	85	31	destruction	destruction	NOUN
ajpf-815	85	32	(	(	PUNCT
ajpf-815	85	33	takeuchi	takeuchi	PROPN
ajpf-815	85	34	et	et	PROPN
ajpf-815	85	35	al	al	PROPN
ajpf-815	85	36	.	.	PROPN
ajpf-815	85	37	,	,	PUNCT
ajpf-815	85	38	1991	1991	NUM
ajpf-815	85	39	)	)	PUNCT
ajpf-815	85	40	.	.	PUNCT
ajpf-815	86	1	data	datum	NOUN
ajpf-815	86	2	and	and	CCONJ
ajpf-815	86	3	statistical	statistical	ADJ
ajpf-815	86	4	analysis	analysis	NOUN
ajpf-815	86	5	the	the	DET
ajpf-815	86	6	antiviral	antiviral	ADJ
ajpf-815	86	7	and	and	CCONJ
ajpf-815	86	8	virucidal	virucidal	NOUN
ajpf-815	86	9	activities	activity	NOUN
ajpf-815	86	10	were	be	AUX
ajpf-815	86	11	based	base	VERB
ajpf-815	86	12	on	on	ADP
ajpf-815	86	13	reduction	reduction	NOUN
ajpf-815	86	14	of	of	ADP
ajpf-815	86	15	viral	viral	ADJ
ajpf-815	86	16	titers	titer	NOUN
ajpf-815	86	17	using	use	VERB
ajpf-815	86	18	cpe	cpe	NOUN
ajpf-815	86	19	criteria	criterion	NOUN
ajpf-815	86	20	.	.	PUNCT
ajpf-815	87	1	values	value	NOUN
ajpf-815	87	2	were	be	AUX
ajpf-815	87	3	expressed	express	VERB
ajpf-815	87	4	as	as	ADP
ajpf-815	87	5	titer	titer	NOUN
ajpf-815	87	6	(	(	PUNCT
ajpf-815	87	7	tcid	tcid	NOUN
ajpf-815	87	8	50	50	NUM
ajpf-815	87	9	µl	µl	NOUN
ajpf-815	87	10	)	)	PUNCT
ajpf-815	87	11	(	(	PUNCT
ajpf-815	87	12	reed	reed	NOUN
ajpf-815	87	13	and	and	CCONJ
ajpf-815	87	14	muench	muench	ADJ
ajpf-815	87	15	,	,	PUNCT
ajpf-815	87	16	1938	1938	NUM
ajpf-815	87	17	)	)	PUNCT
ajpf-815	87	18	and	and	CCONJ
ajpf-815	87	19	viral	viral	ADJ
ajpf-815	87	20	inhibition	inhibition	NOUN
ajpf-815	87	21	index	index	NOUN
ajpf-815	87	22	(	(	PUNCT
ajpf-815	87	23	vii	vii	PROPN
ajpf-815	87	24	)	)	PUNCT
ajpf-815	87	25	calculated	calculate	VERB
ajpf-815	87	26	as	as	ADP
ajpf-815	87	27	the	the	DET
ajpf-815	87	28	difference	difference	NOUN
ajpf-815	87	29	of	of	ADP
ajpf-815	87	30	virus	virus	NOUN
ajpf-815	87	31	titer	titer	NOUN
ajpf-815	87	32	between	between	ADP
ajpf-815	87	33	treated	treat	VERB
ajpf-815	87	34	and	and	CCONJ
ajpf-815	87	35	untreated	untreated	ADJ
ajpf-815	87	36	infected	infected	ADJ
ajpf-815	87	37	control	control	NOUN
ajpf-815	87	38	cultures	culture	NOUN
ajpf-815	87	39	.	.	PUNCT
ajpf-815	88	1	the	the	DET
ajpf-815	88	2	vii	vii	PROPN
ajpf-815	88	3	was	be	AUX
ajpf-815	88	4	considered	consider	VERB
ajpf-815	88	5	positive	positive	ADJ
ajpf-815	88	6	when	when	SCONJ
ajpf-815	88	7	≥	≥	X
ajpf-815	88	8	1.5	1.5	NUM
ajpf-815	88	9	(	(	PUNCT
ajpf-815	88	10	barros	barros	PROPN
ajpf-815	88	11	et	et	PROPN
ajpf-815	88	12	al	al	PROPN
ajpf-815	88	13	.	.	PROPN
ajpf-815	88	14	,	,	PUNCT
ajpf-815	88	15	2012	2012	NUM
ajpf-815	88	16	)	)	PUNCT
ajpf-815	88	17	.	.	PUNCT
ajpf-815	89	1	the	the	DET
ajpf-815	89	2	50	50	NUM
ajpf-815	89	3	%	%	NOUN
ajpf-815	89	4	cytotoxic	cytotoxic	ADJ
ajpf-815	89	5	(	(	PUNCT
ajpf-815	89	6	cc50	cc50	PROPN
ajpf-815	89	7	)	)	PUNCT
ajpf-815	89	8	and	and	CCONJ
ajpf-815	89	9	50	50	NUM
ajpf-815	89	10	%	%	NOUN
ajpf-815	89	11	inhibition	inhibition	NOUN
ajpf-815	89	12	(	(	PUNCT
ajpf-815	89	13	ic50	ic50	PROPN
ajpf-815	89	14	)	)	PUNCT
ajpf-815	89	15	concentrations	concentration	NOUN
ajpf-815	89	16	were	be	AUX
ajpf-815	89	17	calculated	calculate	VERB
ajpf-815	89	18	from	from	ADP
ajpf-815	89	19	concentration	concentration	NOUN
ajpf-815	89	20	-	-	PUNCT
ajpf-815	89	21	effect	effect	NOUN
ajpf-815	89	22	curves	curve	NOUN
ajpf-815	89	23	obtained	obtain	VERB
ajpf-815	89	24	from	from	ADP
ajpf-815	89	25	nonlinear	nonlinear	ADJ
ajpf-815	89	26	regression	regression	NOUN
ajpf-815	89	27	analysis	analysis	NOUN
ajpf-815	89	28	of	of	ADP
ajpf-815	89	29	concentration	concentration	NOUN
ajpf-815	89	30	-	-	PUNCT
ajpf-815	89	31	effect	effect	NOUN
ajpf-815	89	32	curves	curve	NOUN
ajpf-815	89	33	by	by	ADP
ajpf-815	89	34	the	the	DET
ajpf-815	89	35	graphpad	graphpad	NOUN
ajpf-815	89	36	prism	prism	NOUN
ajpf-815	89	37	5	5	NUM
ajpf-815	89	38	demo	demo	NOUN
ajpf-815	89	39	program	program	NOUN
ajpf-815	89	40	.	.	PUNCT
ajpf-815	90	1	the	the	DET
ajpf-815	90	2	results	result	NOUN
ajpf-815	90	3	were	be	AUX
ajpf-815	90	4	obtained	obtain	VERB
ajpf-815	90	5	from	from	ADP
ajpf-815	90	6	triplicate	triplicate	NOUN
ajpf-815	90	7	independent	independent	ADJ
ajpf-815	90	8	assays	assay	NOUN
ajpf-815	90	9	.	.	PUNCT
ajpf-815	91	1	the	the	DET
ajpf-815	91	2	percentage	percentage	NOUN
ajpf-815	91	3	of	of	ADP
ajpf-815	91	4	cytotoxicity	cytotoxicity	NOUN
ajpf-815	91	5	was	be	AUX
ajpf-815	91	6	calculated	calculate	VERB
ajpf-815	91	7	as	as	ADP
ajpf-815	91	8	[	[	X
ajpf-815	91	9	(	(	PUNCT
ajpf-815	91	10	a	a	DET
ajpf-815	91	11	–	–	PUNCT
ajpf-815	91	12	b)/a	b)/a	PROPN
ajpf-815	91	13	]	]	PUNCT
ajpf-815	91	14	×	×	NOUN
ajpf-815	91	15	100	100	NUM
ajpf-815	91	16	,	,	PUNCT
ajpf-815	91	17	where	where	SCONJ
ajpf-815	91	18	a	a	PRON
ajpf-815	91	19	and	and	CCONJ
ajpf-815	91	20	b	b	NOUN
ajpf-815	91	21	are	be	AUX
ajpf-815	91	22	the	the	DET
ajpf-815	91	23	od540	od540	PROPN
ajpf-815	91	24	of	of	ADP
ajpf-815	91	25	untreated	untreated	ADJ
ajpf-815	91	26	and	and	CCONJ
ajpf-815	91	27	of	of	ADP
ajpf-815	91	28	treated	treat	VERB
ajpf-815	91	29	cells	cell	NOUN
ajpf-815	91	30	,	,	PUNCT
ajpf-815	91	31	respectively	respectively	ADV
ajpf-815	91	32	.	.	PUNCT
ajpf-815	92	1	the	the	DET
ajpf-815	92	2	percentages	percentage	NOUN
ajpf-815	92	3	of	of	ADP
ajpf-815	92	4	protection	protection	NOUN
ajpf-815	92	5	were	be	AUX
ajpf-815	92	6	calculated	calculate	VERB
ajpf-815	92	7	as	as	ADP
ajpf-815	92	8	[	[	X
ajpf-815	92	9	(	(	PUNCT
ajpf-815	92	10	a	a	DET
ajpf-815	92	11	−	−	PROPN
ajpf-815	92	12	b	b	NOUN
ajpf-815	92	13	)	)	PUNCT
ajpf-815	92	14	×	×	NOUN
ajpf-815	92	15	100/(c	100/(c	NUM
ajpf-815	92	16	−	−	PROPN
ajpf-815	92	17	b	b	NOUN
ajpf-815	92	18	)	)	PUNCT
ajpf-815	92	19	]	]	PUNCT
ajpf-815	92	20	,	,	PUNCT
ajpf-815	92	21	where	where	SCONJ
ajpf-815	92	22	a	a	DET
ajpf-815	92	23	,	,	PUNCT
ajpf-815	92	24	b	b	NOUN
ajpf-815	92	25	and	and	CCONJ
ajpf-815	92	26	c	c	PROPN
ajpf-815	92	27	indicate	indicate	VERB
ajpf-815	92	28	the	the	DET
ajpf-815	92	29	absorbance	absorbance	NOUN
ajpf-815	92	30	of	of	ADP
ajpf-815	92	31	the	the	DET
ajpf-815	92	32	extracts	extract	NOUN
ajpf-815	92	33	/	/	SYM
ajpf-815	92	34	fractions	fraction	NOUN
ajpf-815	92	35	,	,	PUNCT
ajpf-815	92	36	virus	virus	NOUN
ajpf-815	92	37	and	and	CCONJ
ajpf-815	92	38	cell	cell	NOUN
ajpf-815	92	39	controls	control	NOUN
ajpf-815	92	40	,	,	PUNCT
ajpf-815	92	41	respectively	respectively	ADV
ajpf-815	92	42	.	.	PUNCT
ajpf-815	93	1	each	each	PRON
ajpf-815	93	2	obtained	obtain	VERB
ajpf-815	93	3	ec50	ec50	PROPN
ajpf-815	93	4	value	value	NOUN
ajpf-815	93	5	was	be	AUX
ajpf-815	93	6	defined	define	VERB
ajpf-815	93	7	as	as	ADP
ajpf-815	93	8	the	the	DET
ajpf-815	93	9	effective	effective	ADJ
ajpf-815	93	10	concentration	concentration	NOUN
ajpf-815	93	11	that	that	PRON
ajpf-815	93	12	reduced	reduce	VERB
ajpf-815	93	13	the	the	DET
ajpf-815	93	14	absorbance	absorbance	NOUN
ajpf-815	93	15	of	of	ADP
ajpf-815	93	16	infected	infected	ADJ
ajpf-815	93	17	cells	cell	NOUN
ajpf-815	93	18	to	to	ADP
ajpf-815	93	19	50	50	NUM
ajpf-815	93	20	%	%	NOUN
ajpf-815	93	21	when	when	SCONJ
ajpf-815	93	22	compared	compare	VERB
ajpf-815	93	23	with	with	ADP
ajpf-815	93	24	cell	cell	NOUN
ajpf-815	93	25	and	and	CCONJ
ajpf-815	93	26	virus	virus	NOUN
ajpf-815	93	27	controls	control	NOUN
ajpf-815	93	28	.	.	PUNCT
ajpf-815	94	1	the	the	DET
ajpf-815	94	2	selectivity	selectivity	NOUN
ajpf-815	94	3	index	index	NOUN
ajpf-815	94	4	(	(	PUNCT
ajpf-815	94	5	si	si	X
ajpf-815	94	6	)	)	PUNCT
ajpf-815	94	7	was	be	AUX
ajpf-815	94	8	determined	determine	VERB
ajpf-815	94	9	by	by	ADP
ajpf-815	94	10	the	the	DET
ajpf-815	94	11	ratio	ratio	NOUN
ajpf-815	94	12	of	of	ADP
ajpf-815	94	13	cc50	cc50	PROPN
ajpf-815	94	14	to	to	ADP
ajpf-815	94	15	ec50	ec50	PROPN
ajpf-815	94	16	and	and	CCONJ
ajpf-815	94	17	expressed	express	VERB
ajpf-815	94	18	as	as	ADP
ajpf-815	94	19	mean	mean	NOUN
ajpf-815	94	20	±	±	NUM
ajpf-815	94	21	s.e.m	s.e.m	NOUN
ajpf-815	94	22	.	.	PUNCT
ajpf-815	95	1	the	the	DET
ajpf-815	95	2	statistically	statistically	ADV
ajpf-815	95	3	different	different	ADJ
ajpf-815	95	4	effects	effect	NOUN
ajpf-815	95	5	of	of	ADP
ajpf-815	95	6	tested	test	VERB
ajpf-815	95	7	extracts	extract	NOUN
ajpf-815	95	8	on	on	ADP
ajpf-815	95	9	the	the	DET
ajpf-815	95	10	inhibition	inhibition	NOUN
ajpf-815	95	11	of	of	ADP
ajpf-815	95	12	virus	virus	NOUN
ajpf-815	95	13	replication	replication	NOUN
ajpf-815	95	14	were	be	AUX
ajpf-815	95	15	compared	compare	VERB
ajpf-815	95	16	with	with	ADP
ajpf-815	95	17	the	the	DET
ajpf-815	95	18	control	control	NOUN
ajpf-815	95	19	group	group	NOUN
ajpf-815	95	20	using	use	VERB
ajpf-815	95	21	the	the	DET
ajpf-815	95	22	student‟s	student‟s	PROPN
ajpf-815	95	23	t	t	NOUN
ajpf-815	95	24	-	-	PUNCT
ajpf-815	95	25	test	test	NOUN
ajpf-815	95	26	with	with	ADP
ajpf-815	95	27	p≤0.05	p≤0.05	NOUN
ajpf-815	95	28	for	for	ADP
ajpf-815	95	29	significant	significant	ADJ
ajpf-815	95	30	result	result	NOUN
ajpf-815	95	31	.	.	PUNCT
ajpf-815	96	1	results	result	NOUN
ajpf-815	96	2	cytotoxicity	cytotoxicity	VERB
ajpf-815	96	3	the	the	DET
ajpf-815	96	4	mnccs	mnccs	NOUN
ajpf-815	96	5	of	of	ADP
ajpf-815	96	6	the	the	DET
ajpf-815	96	7	extracts	extract	NOUN
ajpf-815	96	8	were	be	AUX
ajpf-815	96	9	determined	determine	VERB
ajpf-815	96	10	in	in	ADP
ajpf-815	96	11	two	two	NUM
ajpf-815	96	12	different	different	ADJ
ajpf-815	96	13	cell	cell	NOUN
ajpf-815	96	14	lines	line	NOUN
ajpf-815	96	15	,	,	PUNCT
ajpf-815	96	16	mdbk	mdbk	NOUN
ajpf-815	96	17	and	and	CCONJ
ajpf-815	96	18	vero	vero	PROPN
ajpf-815	96	19	and	and	CCONJ
ajpf-815	96	20	the	the	DET
ajpf-815	96	21	concentrations	concentration	NOUN
ajpf-815	96	22	used	use	VERB
ajpf-815	96	23	in	in	ADP
ajpf-815	96	24	bioassays	bioassay	NOUN
ajpf-815	96	25	are	be	AUX
ajpf-815	96	26	presented	present	VERB
ajpf-815	96	27	in	in	ADP
ajpf-815	96	28	table	table	NOUN
ajpf-815	96	29	1	1	NUM
ajpf-815	96	30	.	.	PUNCT
ajpf-815	97	1	in	in	ADP
ajpf-815	97	2	vero	vero	PROPN
ajpf-815	97	3	cells	cell	NOUN
ajpf-815	97	4	,	,	PUNCT
ajpf-815	97	5	the	the	DET
ajpf-815	97	6	cc50	cc50	PROPN
ajpf-815	97	7	was	be	AUX
ajpf-815	97	8	lower	low	ADJ
ajpf-815	97	9	than	than	ADP
ajpf-815	97	10	that	that	DET
ajpf-815	97	11	one	one	NUM
ajpf-815	97	12	observed	observe	VERB
ajpf-815	97	13	in	in	ADP
ajpf-815	97	14	mdbk	mdbk	NOUN
ajpf-815	97	15	cells	cell	NOUN
ajpf-815	97	16	.	.	PUNCT
ajpf-815	98	1	x.	x.	PROPN
ajpf-815	98	2	aromatica	aromatica	PROPN
ajpf-815	98	3	presented	present	VERB
ajpf-815	98	4	the	the	DET
ajpf-815	98	5	lowest	low	ADJ
ajpf-815	98	6	cytotoxic	cytotoxic	NOUN
ajpf-815	98	7	to	to	ADP
ajpf-815	98	8	vero	vero	PROPN
ajpf-815	98	9	and	and	CCONJ
ajpf-815	98	10	mdbk	mdbk	ADJ
ajpf-815	98	11	cells	cell	NOUN
ajpf-815	98	12	with	with	ADP
ajpf-815	98	13	mncc	mncc	NOUN
ajpf-815	98	14	of	of	ADP
ajpf-815	98	15	1250	1250	NUM
ajpf-815	98	16	and	and	CCONJ
ajpf-815	98	17	625	625	NUM
ajpf-815	98	18	µg	µg	ADV
ajpf-815	98	19	/	/	SYM
ajpf-815	98	20	ml	ml	NOUN
ajpf-815	98	21	,	,	PUNCT
ajpf-815	98	22	respectively	respectively	ADV
ajpf-815	98	23	.	.	PUNCT
ajpf-815	99	1	the	the	DET
ajpf-815	99	2	extract	extract	NOUN
ajpf-815	99	3	from	from	ADP
ajpf-815	99	4	o.	o.	NOUN
ajpf-815	99	5	pulchella	pulchella	NOUN
ajpf-815	99	6	was	be	AUX
ajpf-815	99	7	the	the	DET
ajpf-815	99	8	most	most	ADV
ajpf-815	99	9	cytotoxic	cytotoxic	ADJ
ajpf-815	99	10	for	for	ADP
ajpf-815	99	11	both	both	DET
ajpf-815	99	12	cell	cell	NOUN
ajpf-815	99	13	lines	line	NOUN
ajpf-815	99	14	with	with	ADP
ajpf-815	99	15	4	4	NUM
ajpf-815	99	16	table	table	NOUN
ajpf-815	99	17	1	1	NUM
ajpf-815	99	18	.	.	PUNCT
ajpf-815	99	19	antiviral	antiviral	ADJ
ajpf-815	99	20	activity	activity	NOUN
ajpf-815	99	21	of	of	ADP
ajpf-815	99	22	extracts	extract	NOUN
ajpf-815	99	23	at	at	ADP
ajpf-815	99	24	mncc	mncc	ADV
ajpf-815	99	25	and	and	CCONJ
ajpf-815	99	26	cc50	cc50	PROPN
ajpf-815	99	27	against	against	ADP
ajpf-815	99	28	hsv-1	hsv-1	PRON
ajpf-815	99	29	,	,	PUNCT
ajpf-815	99	30	ehv-1	ehv-1	PUNCT
ajpf-815	99	31	and	and	CCONJ
ajpf-815	99	32	suhv-1	suhv-1	PROPN
ajpf-815	99	33	.	.	PROPN
ajpf-815	99	34	plant	plant	NOUN
ajpf-815	99	35	extract	extract	VERB
ajpf-815	99	36	mncc	mncc	ADV
ajpf-815	99	37	a	a	DET
ajpf-815	99	38	vero	vero	PROPN
ajpf-815	99	39	cc50	cc50	PROPN
ajpf-815	99	40	b	b	PROPN
ajpf-815	99	41	hsv-1	hsv-1	PRON
ajpf-815	99	42	c	c	X
ajpf-815	99	43	ehv-1	ehv-1	PUNCT
ajpf-815	99	44	mncc	mncc	X
ajpf-815	99	45	mdbk	mdbk	NOUN
ajpf-815	99	46	cc50	cc50	PROPN
ajpf-815	99	47	suhv-1	suhv-1	NUM
ajpf-815	99	48	banisteriopsis	banisteriopsis	NOUN
ajpf-815	99	49	variabilis	variabili	VERB
ajpf-815	99	50	625	625	NUM
ajpf-815	99	51	435.8	435.8	NUM
ajpf-815	99	52	2.25	2.25	NUM
ajpf-815	99	53	3.75	3.75	NUM
ajpf-815	99	54	312	312	NUM
ajpf-815	99	55	>	>	SYM
ajpf-815	99	56	2,000	2,000	NUM
ajpf-815	99	57	3.24	3.24	NUM
ajpf-815	99	58	byrsonima	byrsonima	NOUN
ajpf-815	99	59	intermedia	intermedia	PROPN
ajpf-815	99	60	31.2	31.2	NUM
ajpf-815	99	61	141.1	141.1	NUM
ajpf-815	99	62	3.25	3.25	NUM
ajpf-815	99	63	4.87	4.87	NUM
ajpf-815	99	64	250	250	NUM
ajpf-815	99	65	782.1	782.1	NUM
ajpf-815	99	66	5.45	5.45	NUM
ajpf-815	99	67	campomanesia	campomanesia	NOUN
ajpf-815	99	68	xanthocarpa	xanthocarpa	PROPN
ajpf-815	99	69	62.5	62.5	NUM
ajpf-815	99	70	n.t	n.t	NOUN
ajpf-815	99	71	0	0	NUM
ajpf-815	99	72	0.62	0.62	NUM
ajpf-815	99	73	250	250	NUM
ajpf-815	99	74	1,299	1,299	NUM
ajpf-815	99	75	2.0	2.0	NUM
ajpf-815	99	76	erythroxilum	erythroxilum	NOUN
ajpf-815	99	77	deciduum	deciduum	PROPN
ajpf-815	99	78	125	125	NUM
ajpf-815	99	79	n.t	n.t	PROPN
ajpf-815	99	80	.	.	PROPN
ajpf-815	99	81	1.0	1.0	NUM
ajpf-815	99	82	0.26	0.26	NUM
ajpf-815	99	83	31.2	31.2	NUM
ajpf-815	99	84	n.t	n.t	PROPN
ajpf-815	99	85	.	.	PROPN
ajpf-815	99	86	1.16	1.16	NUM
ajpf-815	99	87	lacistema	lacistema	NOUN
ajpf-815	99	88	hasslerianum	hasslerianum	PRON
ajpf-815	99	89	62.5	62.5	NUM
ajpf-815	99	90	n.t	n.t	PROPN
ajpf-815	99	91	.	.	PROPN
ajpf-815	99	92	0.5	0.5	NUM
ajpf-815	99	93	0.26	0.26	NUM
ajpf-815	99	94	62.5	62.5	NUM
ajpf-815	99	95	821	821	NUM
ajpf-815	99	96	2.0	2.0	NUM
ajpf-815	99	97	ocotea	ocotea	NOUN
ajpf-815	99	98	pulchella	pulchella	NOUN
ajpf-815	99	99	31.2	31.2	NUM
ajpf-815	99	100	n.t	n.t	NOUN
ajpf-815	99	101	.	.	PROPN
ajpf-815	99	102	0	0	NUM
ajpf-815	100	1	0.26	0.26	NUM
ajpf-815	100	2	31.2	31.2	NUM
ajpf-815	100	3	290.9	290.9	NUM
ajpf-815	100	4	1.76	1.76	NUM
ajpf-815	100	5	stryphodendron	stryphodendron	PROPN
ajpf-815	100	6	adstringens	adstringens	PROPN
ajpf-815	100	7	625	625	NUM
ajpf-815	100	8	n.t	n.t	PROPN
ajpf-815	100	9	.	.	PROPN
ajpf-815	100	10	2.75	2.75	NUM
ajpf-815	100	11	1.0	1.0	NUM
ajpf-815	100	12	62.5	62.5	NUM
ajpf-815	100	13	>	>	PUNCT
ajpf-815	100	14	2,000	2,000	NUM
ajpf-815	100	15	2.0	2.0	NUM
ajpf-815	100	16	xylopia	xylopia	NOUN
ajpf-815	100	17	aromatica	aromatica	PROPN
ajpf-815	100	18	1250	1250	NUM
ajpf-815	100	19	203.1	203.1	NUM
ajpf-815	100	20	1.5	1.5	NUM
ajpf-815	100	21	1.76	1.76	NUM
ajpf-815	100	22	625	625	NUM
ajpf-815	100	23	>	>	SYM
ajpf-815	100	24	2000	2000	NUM
ajpf-815	100	25	3.24	3.24	NUM
ajpf-815	100	26	a	a	DET
ajpf-815	100	27	:	:	PUNCT
ajpf-815	100	28	mncc	mncc	ADJ
ajpf-815	100	29	:	:	PUNCT
ajpf-815	100	30	maximum	maximum	ADJ
ajpf-815	100	31	non	non	ADJ
ajpf-815	100	32	-	-	ADJ
ajpf-815	100	33	cytotoxic	cytotoxic	ADJ
ajpf-815	100	34	concentration	concentration	NOUN
ajpf-815	100	35	;	;	PUNCT
ajpf-815	100	36	hsv-1	hsv-1	NUM
ajpf-815	100	37	:	:	PUNCT
ajpf-815	100	38	human	human	ADJ
ajpf-815	100	39	herpesvirus	herpesvirus	NOUN
ajpf-815	100	40	type	type	NOUN
ajpf-815	100	41	1	1	NUM
ajpf-815	100	42	suhv-1	suhv-1	NUM
ajpf-815	100	43	:	:	PUNCT
ajpf-815	100	44	swine	swine	ADJ
ajpf-815	100	45	herpesvirus	herpesvirus	NOUN
ajpf-815	100	46	type	type	NOUN
ajpf-815	100	47	1	1	NUM
ajpf-815	100	48	;	;	PUNCT
ajpf-815	100	49	ehv-1	ehv-1	NUM
ajpf-815	100	50	:	:	PUNCT
ajpf-815	100	51	equid	equid	ADJ
ajpf-815	100	52	herpesvirus	herpesvirus	NOUN
ajpf-815	100	53	type	type	NOUN
ajpf-815	100	54	1	1	NUM
ajpf-815	100	55	;	;	PUNCT
ajpf-815	100	56	b	b	X
ajpf-815	100	57	:	:	PUNCT
ajpf-815	100	58	50	50	NUM
ajpf-815	100	59	%	%	NOUN
ajpf-815	100	60	cytotoxic	cytotoxic	ADJ
ajpf-815	100	61	concentration	concentration	NOUN
ajpf-815	100	62	(	(	PUNCT
ajpf-815	100	63	μg	μg	NOUN
ajpf-815	100	64	/	/	SYM
ajpf-815	100	65	ml	ml	PROPN
ajpf-815	100	66	)	)	PUNCT
ajpf-815	100	67	;	;	PUNCT
ajpf-815	101	1	c	c	X
ajpf-815	101	2	:	:	PUNCT
ajpf-815	101	3	vii	vii	ADJ
ajpf-815	101	4	:	:	PUNCT
ajpf-815	101	5	viral	viral	ADJ
ajpf-815	101	6	inhibition	inhibition	NOUN
ajpf-815	101	7	index	index	NOUN
ajpf-815	101	8	;	;	PUNCT
ajpf-815	101	9	n.t	n.t	PROPN
ajpf-815	101	10	.	.	PROPN
ajpf-815	101	11	:	:	PUNCT
ajpf-815	102	1	cc50	cc50	PROPN
ajpf-815	102	2	not	not	PART
ajpf-815	102	3	tested	test	VERB
ajpf-815	102	4	.	.	PUNCT
ajpf-815	103	1	table	table	NOUN
ajpf-815	103	2	2	2	NUM
ajpf-815	103	3	.	.	PUNCT
ajpf-815	104	1	direct	direct	ADJ
ajpf-815	104	2	anti	anti	ADJ
ajpf-815	104	3	-	-	ADJ
ajpf-815	104	4	herpes	herpes	ADJ
ajpf-815	104	5	effect	effect	NOUN
ajpf-815	104	6	of	of	ADP
ajpf-815	104	7	extracts	extract	NOUN
ajpf-815	104	8	at	at	ADP
ajpf-815	104	9	mncc	mncc	ADV
ajpf-815	104	10	against	against	ADP
ajpf-815	104	11	herpes	herpe	NOUN
ajpf-815	104	12	simplex	simplex	NOUN
ajpf-815	104	13	virus	virus	NOUN
ajpf-815	104	14	,	,	PUNCT
ajpf-815	104	15	equine	equine	NOUN
ajpf-815	104	16	herpesvirus	herpesvirus	NOUN
ajpf-815	104	17	and	and	CCONJ
ajpf-815	104	18	swine	swine	ADJ
ajpf-815	104	19	herpesvirus	herpesvirus	NOUN
ajpf-815	104	20	in	in	ADP
ajpf-815	104	21	cell	cell	NOUN
ajpf-815	104	22	cultures	culture	NOUN
ajpf-815	104	23	.	.	PUNCT
ajpf-815	105	1	plant	plant	NOUN
ajpf-815	105	2	extract	extract	NOUN
ajpf-815	105	3	vii	vii	PROPN
ajpf-815	105	4	a	a	DET
ajpf-815	105	5	vii	vii	PROPN
ajpf-815	105	6	vii	vii	PROPN
ajpf-815	105	7	hsv-1	hsv-1	X
ajpf-815	105	8	b	b	PROPN
ajpf-815	105	9	ehv-1	ehv-1	ADV
ajpf-815	105	10	c	c	PROPN
ajpf-815	105	11	suhv-1	suhv-1	PROPN
ajpf-815	105	12	d	d	PROPN
ajpf-815	105	13	banisteriopsis	banisteriopsis	NOUN
ajpf-815	105	14	variabilis	variabili	VERB
ajpf-815	105	15	3.0	3.0	NUM
ajpf-815	105	16	3.67	3.67	NUM
ajpf-815	105	17	3.34	3.34	NUM
ajpf-815	105	18	byrsonima	byrsonima	NOUN
ajpf-815	105	19	intermedia	intermedia	PROPN
ajpf-815	105	20	4.5	4.5	NUM
ajpf-815	105	21	4.0	4.0	NUM
ajpf-815	105	22	5.22	5.22	NUM
ajpf-815	105	23	stryphodendron	stryphodendron	PROPN
ajpf-815	105	24	adstringens	adstringens	PROPN
ajpf-815	105	25	n.t	n.t	PROPN
ajpf-815	105	26	.	.	PROPN
ajpf-815	105	27	n.t	n.t	PROPN
ajpf-815	105	28	.	.	PROPN
ajpf-815	105	29	0.75	0.75	NUM
ajpf-815	105	30	xylopia	xylopia	PROPN
ajpf-815	105	31	aromatica	aromatica	PROPN
ajpf-815	105	32	1.5	1.5	NUM
ajpf-815	105	33	0.84	0.84	NUM
ajpf-815	105	34	1.67	1.67	NUM
ajpf-815	105	35	a	a	DET
ajpf-815	105	36	:	:	PUNCT
ajpf-815	105	37	vii	vii	ADJ
ajpf-815	105	38	:	:	PUNCT
ajpf-815	105	39	viral	viral	ADJ
ajpf-815	105	40	inhibition	inhibition	NOUN
ajpf-815	105	41	index	index	NOUN
ajpf-815	105	42	;	;	PUNCT
ajpf-815	105	43	b	b	X
ajpf-815	105	44	:	:	PUNCT
ajpf-815	105	45	human	human	ADJ
ajpf-815	105	46	herpesvirus	herpesvirus	NOUN
ajpf-815	105	47	type	type	NOUN
ajpf-815	105	48	1	1	NUM
ajpf-815	105	49	;	;	PUNCT
ajpf-815	105	50	c	c	X
ajpf-815	105	51	:	:	PUNCT
ajpf-815	105	52	equid	equid	ADJ
ajpf-815	105	53	herpesvirus	herpesvirus	NOUN
ajpf-815	105	54	type	type	NOUN
ajpf-815	105	55	1	1	NUM
ajpf-815	105	56	;	;	PUNCT
ajpf-815	106	1	d	d	X
ajpf-815	106	2	:	:	PUNCT
ajpf-815	106	3	swine	swine	ADJ
ajpf-815	106	4	herpesvirus	herpesvirus	NOUN
ajpf-815	106	5	type	type	NOUN
ajpf-815	106	6	1	1	NUM
ajpf-815	106	7	;	;	PUNCT
ajpf-815	106	8	n.t	n.t	PROPN
ajpf-815	106	9	.	.	PROPN
ajpf-815	106	10	:	:	PUNCT
ajpf-815	106	11	not	not	PART
ajpf-815	106	12	tested	test	VERB
ajpf-815	106	13	.	.	PUNCT
ajpf-815	107	1	mncc	mncc	ADJ
ajpf-815	107	2	:	:	PUNCT
ajpf-815	107	3	maximum	maximum	ADJ
ajpf-815	107	4	non	non	ADJ
ajpf-815	107	5	-	-	ADJ
ajpf-815	107	6	cytotoxic	cytotoxic	ADJ
ajpf-815	107	7	concentration	concentration	NOUN
ajpf-815	107	8	.	.	PUNCT
ajpf-815	108	1	mncc	mncc	ADV
ajpf-815	108	2	of	of	ADP
ajpf-815	108	3	31.2	31.2	NUM
ajpf-815	108	4	µg	µg	NOUN
ajpf-815	108	5	/	/	SYM
ajpf-815	108	6	ml	ml	NOUN
ajpf-815	108	7	.	.	PUNCT
ajpf-815	109	1	the	the	DET
ajpf-815	109	2	other	other	ADJ
ajpf-815	109	3	extracts	extract	NOUN
ajpf-815	109	4	showed	show	VERB
ajpf-815	109	5	mncc	mncc	ADJ
ajpf-815	109	6	ranging	ranging	NOUN
ajpf-815	109	7	between	between	ADP
ajpf-815	109	8	these	these	DET
ajpf-815	109	9	values	value	NOUN
ajpf-815	109	10	for	for	ADP
ajpf-815	109	11	both	both	DET
ajpf-815	109	12	cells	cell	NOUN
ajpf-815	109	13	.	.	PUNCT
ajpf-815	110	1	for	for	ADP
ajpf-815	110	2	suhv-1and	suhv-1and	NOUN
ajpf-815	110	3	hsv-1	hsv-1	X
ajpf-815	110	4	,	,	PUNCT
ajpf-815	110	5	while	while	SCONJ
ajpf-815	110	6	the	the	DET
ajpf-815	110	7	extracts	extract	NOUN
ajpf-815	110	8	from	from	ADP
ajpf-815	110	9	s.	s.	PROPN
ajpf-815	110	10	adstringens	adstringens	PROPN
ajpf-815	110	11	had	have	VERB
ajpf-815	110	12	action	action	NOUN
ajpf-815	110	13	only	only	ADV
ajpf-815	110	14	on	on	ADP
ajpf-815	110	15	hsv-1	hsv-1	ADJ
ajpf-815	110	16	.	.	PUNCT
ajpf-815	111	1	antiviral	antiviral	ADJ
ajpf-815	111	2	activity	activity	NOUN
ajpf-815	111	3	results	result	NOUN
ajpf-815	111	4	are	be	AUX
ajpf-815	111	5	presented	present	VERB
ajpf-815	111	6	in	in	ADP
ajpf-815	111	7	table	table	NOUN
ajpf-815	111	8	1	1	NUM
ajpf-815	111	9	.	.	PUNCT
ajpf-815	112	1	the	the	DET
ajpf-815	112	2	extracts	extract	NOUN
ajpf-815	112	3	from	from	ADP
ajpf-815	112	4	b.	b.	PROPN
ajpf-815	112	5	variabilis	variabilis	PROPN
ajpf-815	112	6	,	,	PUNCT
ajpf-815	112	7	b.	b.	PROPN
ajpf-815	112	8	intermedia	intermedia	PROPN
ajpf-815	112	9	,	,	PUNCT
ajpf-815	112	10	s.	s.	PROPN
ajpf-815	112	11	adstringens	adstringens	PROPN
ajpf-815	112	12	and	and	CCONJ
ajpf-815	112	13	x.	x.	PROPN
ajpf-815	112	14	aromatica	aromatica	PROPN
ajpf-815	112	15	presented	present	VERB
ajpf-815	112	16	vii	vii	PROPN
ajpf-815	112	17	greater	great	ADJ
ajpf-815	112	18	than	than	ADP
ajpf-815	112	19	or	or	CCONJ
ajpf-815	112	20	equal	equal	ADJ
ajpf-815	112	21	to	to	ADP
ajpf-815	112	22	1.5	1.5	NUM
ajpf-815	112	23	for	for	ADP
ajpf-815	112	24	hsv-1	hsv-1	PRON
ajpf-815	112	25	.	.	PUNCT
ajpf-815	113	1	the	the	DET
ajpf-815	113	2	extracts	extract	NOUN
ajpf-815	113	3	of	of	ADP
ajpf-815	113	4	b.	b.	PROPN
ajpf-815	113	5	variabilis	variabilis	PROPN
ajpf-815	113	6	,	,	PUNCT
ajpf-815	113	7	b.	b.	PROPN
ajpf-815	113	8	intermedia	intermedia	PROPN
ajpf-815	113	9	and	and	CCONJ
ajpf-815	113	10	x.	x.	PROPN
ajpf-815	113	11	aromatica	aromatica	PROPN
ajpf-815	113	12	were	be	AUX
ajpf-815	113	13	positive	positive	ADJ
ajpf-815	113	14	for	for	ADP
ajpf-815	113	15	ehv-1	ehv-1	PUNCT
ajpf-815	113	16	while	while	SCONJ
ajpf-815	113	17	the	the	DET
ajpf-815	113	18	extracts	extract	NOUN
ajpf-815	113	19	b.	b.	PROPN
ajpf-815	113	20	variabilis	variabilis	PROPN
ajpf-815	113	21	,	,	PUNCT
ajpf-815	113	22	b.	b.	PROPN
ajpf-815	113	23	intermedia	intermedia	PROPN
ajpf-815	113	24	,	,	PUNCT
ajpf-815	113	25	c.	c.	PROPN
ajpf-815	113	26	xanthocarpa	xanthocarpa	PROPN
ajpf-815	113	27	,	,	PUNCT
ajpf-815	113	28	l.	l.	PROPN
ajpf-815	113	29	hasslerianum	hasslerianum	PROPN
ajpf-815	113	30	,	,	PUNCT
ajpf-815	113	31	o.	o.	NOUN
ajpf-815	113	32	pulchella	pulchella	NOUN
ajpf-815	113	33	,	,	PUNCT
ajpf-815	113	34	s.	s.	PROPN
ajpf-815	113	35	adstringens	adstringens	PROPN
ajpf-815	113	36	and	and	CCONJ
ajpf-815	113	37	x.	x.	PROPN
ajpf-815	113	38	aromatica	aromatica	PROPN
ajpf-815	113	39	were	be	AUX
ajpf-815	113	40	effective	effective	ADJ
ajpf-815	113	41	for	for	ADP
ajpf-815	113	42	suhv-1	suhv-1	NUM
ajpf-815	113	43	.	.	PUNCT
ajpf-815	113	44	direct	direct	ADJ
ajpf-815	113	45	anti	anti	ADJ
ajpf-815	113	46	-	-	ADJ
ajpf-815	113	47	herpes	herpes	ADJ
ajpf-815	113	48	effect	effect	NOUN
ajpf-815	113	49	assays	assay	NOUN
ajpf-815	113	50	to	to	PART
ajpf-815	113	51	study	study	VERB
ajpf-815	113	52	the	the	DET
ajpf-815	113	53	direct	direct	ADJ
ajpf-815	113	54	anti	anti	ADJ
ajpf-815	113	55	-	-	ADJ
ajpf-815	113	56	herpes	herpes	ADJ
ajpf-815	113	57	effect	effect	NOUN
ajpf-815	113	58	were	be	AUX
ajpf-815	113	59	done	do	VERB
ajpf-815	113	60	only	only	ADV
ajpf-815	113	61	with	with	ADP
ajpf-815	113	62	the	the	DET
ajpf-815	113	63	extracts	extract	NOUN
ajpf-815	113	64	that	that	PRON
ajpf-815	113	65	were	be	AUX
ajpf-815	113	66	effective	effective	ADJ
ajpf-815	113	67	for	for	ADP
ajpf-815	113	68	at	at	ADV
ajpf-815	113	69	least	least	ADV
ajpf-815	113	70	two	two	NUM
ajpf-815	113	71	of	of	ADP
ajpf-815	113	72	the	the	DET
ajpf-815	113	73	viruses	virus	NOUN
ajpf-815	113	74	tested	test	VERB
ajpf-815	113	75	in	in	ADP
ajpf-815	113	76	the	the	DET
ajpf-815	113	77	antiviral	antiviral	ADJ
ajpf-815	113	78	assays	assay	NOUN
ajpf-815	113	79	.	.	PUNCT
ajpf-815	114	1	these	these	DET
ajpf-815	114	2	results	result	NOUN
ajpf-815	114	3	are	be	AUX
ajpf-815	114	4	presented	present	VERB
ajpf-815	114	5	in	in	ADP
ajpf-815	114	6	table	table	NOUN
ajpf-815	114	7	2	2	NUM
ajpf-815	114	8	.	.	PUNCT
ajpf-815	115	1	the	the	DET
ajpf-815	115	2	extracts	extract	NOUN
ajpf-815	115	3	of	of	ADP
ajpf-815	115	4	b.	b.	PROPN
ajpf-815	115	5	variabilis	variabilis	PROPN
ajpf-815	115	6	and	and	CCONJ
ajpf-815	115	7	b.	b.	PROPN
ajpf-815	115	8	intermedia	intermedia	PROPN
ajpf-815	115	9	,	,	PUNCT
ajpf-815	115	10	presented	present	VERB
ajpf-815	115	11	an	an	DET
ajpf-815	115	12	inhibition	inhibition	NOUN
ajpf-815	115	13	against	against	ADP
ajpf-815	115	14	the	the	DET
ajpf-815	115	15	three	three	NUM
ajpf-815	115	16	viruses	virus	NOUN
ajpf-815	115	17	with	with	ADP
ajpf-815	115	18	vii	vii	PROPN
ajpf-815	115	19	greater	great	ADJ
ajpf-815	115	20	or	or	CCONJ
ajpf-815	115	21	equal	equal	ADJ
ajpf-815	115	22	to	to	ADP
ajpf-815	115	23	3.0	3.0	NUM
ajpf-815	115	24	.	.	PUNCT
ajpf-815	116	1	x.	x.	PROPN
ajpf-815	116	2	aromatica	aromatica	PROPN
ajpf-815	116	3	was	be	AUX
ajpf-815	116	4	only	only	ADV
ajpf-815	116	5	effective	effective	ADJ
ajpf-815	116	6	additional	additional	ADJ
ajpf-815	116	7	studies	study	NOUN
ajpf-815	116	8	with	with	ADP
ajpf-815	116	9	byrsonima	byrsonima	PROPN
ajpf-815	116	10	intermedia	intermedia	PROPN
ajpf-815	116	11	b.	b.	PROPN
ajpf-815	116	12	intermedia	intermedia	PROPN
ajpf-815	116	13	was	be	AUX
ajpf-815	116	14	selected	select	VERB
ajpf-815	116	15	for	for	ADP
ajpf-815	116	16	additional	additional	ADJ
ajpf-815	116	17	studies	study	NOUN
ajpf-815	116	18	and	and	CCONJ
ajpf-815	116	19	to	to	PART
ajpf-815	116	20	characterize	characterize	VERB
ajpf-815	116	21	its	its	PRON
ajpf-815	116	22	antiviral	antiviral	ADJ
ajpf-815	116	23	properties	property	NOUN
ajpf-815	116	24	because	because	SCONJ
ajpf-815	116	25	it	it	PRON
ajpf-815	116	26	showed	show	VERB
ajpf-815	116	27	the	the	DET
ajpf-815	116	28	highest	high	ADJ
ajpf-815	116	29	values	value	NOUN
ajpf-815	116	30	of	of	ADP
ajpf-815	116	31	vii	vii	PROPN
ajpf-815	116	32	against	against	ADP
ajpf-815	116	33	all	all	DET
ajpf-815	116	34	herpesviruses	herpesviruse	NOUN
ajpf-815	116	35	.	.	PUNCT
ajpf-815	117	1	table	table	NOUN
ajpf-815	117	2	3	3	NUM
ajpf-815	117	3	shows	show	VERB
ajpf-815	117	4	the	the	DET
ajpf-815	117	5	results	result	NOUN
ajpf-815	117	6	of	of	ADP
ajpf-815	117	7	the	the	DET
ajpf-815	117	8	cytotoxic	cytotoxic	ADJ
ajpf-815	117	9	,	,	PUNCT
ajpf-815	117	10	antiviral	antiviral	ADJ
ajpf-815	117	11	activities	activity	NOUN
ajpf-815	117	12	and	and	CCONJ
ajpf-815	117	13	selectivity	selectivity	NOUN
ajpf-815	117	14	index	index	NOUN
ajpf-815	117	15	(	(	PUNCT
ajpf-815	117	16	si	si	X
ajpf-815	117	17	)	)	PUNCT
ajpf-815	117	18	obtained	obtain	VERB
ajpf-815	117	19	from	from	ADP
ajpf-815	117	20	b.	b.	PROPN
ajpf-815	117	21	intermedia	intermedia	PROPN
ajpf-815	117	22	extracts	extract	NOUN
ajpf-815	117	23	.	.	PUNCT
ajpf-815	118	1	the	the	DET
ajpf-815	118	2	mncc	mncc	NOUN
ajpf-815	118	3	of	of	ADP
ajpf-815	118	4	b.	b.	PROPN
ajpf-815	118	5	intermedia	intermedia	PROPN
ajpf-815	118	6	extracts	extract	NOUN
ajpf-815	118	7	that	that	PRON
ajpf-815	118	8	did	do	AUX
ajpf-815	118	9	not	not	PART
ajpf-815	118	10	cause	cause	VERB
ajpf-815	118	11	alterations	alteration	NOUN
ajpf-815	118	12	in	in	ADP
ajpf-815	118	13	the	the	DET
ajpf-815	118	14	morphology	morphology	NOUN
ajpf-815	118	15	of	of	ADP
ajpf-815	118	16	the	the	DET
ajpf-815	118	17	cells	cell	NOUN
ajpf-815	118	18	visible	visible	ADJ
ajpf-815	118	19	under	under	ADP
ajpf-815	118	20	the	the	DET
ajpf-815	118	21	optical	optical	ADJ
ajpf-815	118	22	microscope	microscope	NOUN
ajpf-815	118	23	(	(	PUNCT
ajpf-815	118	24	table	table	NOUN
ajpf-815	118	25	2	2	NUM
ajpf-815	118	26	)	)	PUNCT
ajpf-815	118	27	were	be	AUX
ajpf-815	118	28	lower	low	ADJ
ajpf-815	118	29	than	than	ADP
ajpf-815	118	30	that	that	PRON
ajpf-815	118	31	obtained	obtain	VERB
ajpf-815	118	32	with	with	ADP
ajpf-815	118	33	cc50	cc50	PROPN
ajpf-815	118	34	of	of	ADP
ajpf-815	118	35	141.1	141.1	NUM
ajpf-815	118	36	for	for	ADP
ajpf-815	118	37	vero	vero	PROPN
ajpf-815	118	38	cells	cell	NOUN
ajpf-815	118	39	and	and	CCONJ
ajpf-815	118	40	782.1	782.1	NUM
ajpf-815	118	41	for	for	ADP
ajpf-815	118	42	mdbk	mdbk	NOUN
ajpf-815	118	43	cells	cell	NOUN
ajpf-815	118	44	.	.	PUNCT
ajpf-815	119	1	b.	b.	PROPN
ajpf-815	119	2	intermedia	intermedia	PROPN
ajpf-815	119	3	presented	present	VERB
ajpf-815	119	4	si	si	PROPN
ajpf-815	119	5	values	value	NOUN
ajpf-815	119	6	of	of	ADP
ajpf-815	119	7	41.76	41.76	NUM
ajpf-815	119	8	±	±	NUM
ajpf-815	119	9	0.04	0.04	NUM
ajpf-815	119	10	;	;	PUNCT
ajpf-815	119	11	4.12	4.12	NUM
ajpf-815	119	12	±	±	NUM
ajpf-815	119	13	0.1	0.1	NUM
ajpf-815	119	14	and	and	CCONJ
ajpf-815	119	15	193.97	193.97	NUM
ajpf-815	119	16	±	±	NUM
ajpf-815	119	17	0.09	0.09	NUM
ajpf-815	119	18	respectively	respectively	ADV
ajpf-815	119	19	against	against	ADP
ajpf-815	119	20	hsv-1	hsv-1	PRON
ajpf-815	119	21	,	,	PUNCT
ajpf-815	119	22	eqhv-1	eqhv-1	NUM
ajpf-815	119	23	and	and	CCONJ
ajpf-815	119	24	suhv-1	suhv-1	PROPN
ajpf-815	119	25	.	.	PROPN
ajpf-815	119	26	figure	figure	NOUN
ajpf-815	119	27	1	1	NUM
ajpf-815	119	28	shows	show	VERB
ajpf-815	119	29	the	the	DET
ajpf-815	119	30	antiviral	antiviral	ADJ
ajpf-815	119	31	activity	activity	NOUN
ajpf-815	119	32	of	of	ADP
ajpf-815	119	33	extract	extract	NOUN
ajpf-815	119	34	from	from	ADP
ajpf-815	119	35	b.	b.	PROPN
ajpf-815	119	36	intermedia	intermedia	PROPN
ajpf-815	119	37	at	at	ADP
ajpf-815	119	38	8	8	NUM
ajpf-815	119	39	set	set	VERB
ajpf-815	119	40	concentrations	concentration	NOUN
ajpf-815	119	41	against	against	ADP
ajpf-815	119	42	the	the	DET
ajpf-815	119	43	three	three	NUM
ajpf-815	119	44	viruses	virus	NOUN
ajpf-815	119	45	showing	show	VERB
ajpf-815	119	46	that	that	DET
ajpf-815	119	47	treatment	treatment	NOUN
ajpf-815	119	48	with	with	ADP
ajpf-815	119	49	b.	b.	PROPN
ajpf-815	119	50	intermedia	intermedia	PROPN
ajpf-815	119	51	extract	extract	NOUN
ajpf-815	119	52	resulted	result	VERB
ajpf-815	119	53	in	in	ADP
ajpf-815	119	54	reduced	reduced	ADJ
ajpf-815	119	55	viral	viral	ADJ
ajpf-815	119	56	titers	titer	NOUN
ajpf-815	119	57	in	in	ADP
ajpf-815	119	58	dose	dose	NOUN
ajpf-815	119	59	-	-	PUNCT
ajpf-815	119	60	response	response	NOUN
ajpf-815	119	61	curves	curve	NOUN
ajpf-815	119	62	.	.	PUNCT
ajpf-815	120	1	at	at	ADP
ajpf-815	120	2	15.6	15.6	NUM
ajpf-815	120	3	µg	µg	NOUN
ajpf-815	120	4	/	/	SYM
ajpf-815	120	5	ml	ml	NOUN
ajpf-815	120	6	,	,	PUNCT
ajpf-815	120	7	the	the	DET
ajpf-815	120	8	initial	initial	ADJ
ajpf-815	120	9	reduction	reduction	NOUN
ajpf-815	120	10	occurred	occur	VERB
ajpf-815	120	11	firstly	firstly	ADV
ajpf-815	120	12	with	with	ADP
ajpf-815	120	13	suhv-1	suhv-1	NUM
ajpf-815	120	14	and	and	CCONJ
ajpf-815	120	15	then	then	ADV
ajpf-815	120	16	with	with	ADP
ajpf-815	120	17	ehv-1	ehv-1	ADV
ajpf-815	120	18	and	and	CCONJ
ajpf-815	120	19	hsv-1	hsv-1	X
ajpf-815	120	20	at	at	ADP
ajpf-815	120	21	62.5	62.5	NUM
ajpf-815	120	22	µg	µg	NOUN
ajpf-815	120	23	/	/	SYM
ajpf-815	120	24	ml	ml	NOUN
ajpf-815	120	25	.	.	PUNCT
ajpf-815	121	1	at	at	ADP
ajpf-815	121	2	250	250	NUM
ajpf-815	121	3	µg	µg	ADV
ajpf-815	121	4	/	/	SYM
ajpf-815	121	5	ml	ml	NOUN
ajpf-815	121	6	,	,	PUNCT
ajpf-815	121	7	the	the	DET
ajpf-815	121	8	greater	great	ADJ
ajpf-815	121	9	vii	vii	PROPN
ajpf-815	121	10	was	be	AUX
ajpf-815	121	11	also	also	ADV
ajpf-815	121	12	obtained	obtain	VERB
ajpf-815	121	13	with	with	ADP
ajpf-815	121	14	5	5	NUM
ajpf-815	121	15	table	table	NOUN
ajpf-815	121	16	3	3	NUM
ajpf-815	121	17	.	.	PUNCT
ajpf-815	121	18	selectivity	selectivity	NOUN
ajpf-815	121	19	index	index	NOUN
ajpf-815	121	20	,	,	PUNCT
ajpf-815	121	21	cytotoxic	cytotoxic	ADJ
ajpf-815	121	22	and	and	CCONJ
ajpf-815	121	23	antiviral	antiviral	ADJ
ajpf-815	121	24	activities	activity	NOUN
ajpf-815	121	25	from	from	ADP
ajpf-815	121	26	b.	b.	PROPN
ajpf-815	121	27	intermedia	intermedia	PROPN
ajpf-815	121	28	aqueous	aqueous	ADJ
ajpf-815	121	29	extract	extract	NOUN
ajpf-815	121	30	against	against	ADP
ajpf-815	121	31	swine	swine	ADJ
ajpf-815	121	32	herpesvirus	herpesvirus	NOUN
ajpf-815	121	33	,	,	PUNCT
ajpf-815	121	34	equine	equine	NOUN
ajpf-815	121	35	herpesvirus	herpesvirus	NOUN
ajpf-815	121	36	and	and	CCONJ
ajpf-815	121	37	herpes	herpe	NOUN
ajpf-815	121	38	simplex	simplex	NOUN
ajpf-815	121	39	virus	virus	NOUN
ajpf-815	121	40	by	by	ADP
ajpf-815	121	41	the	the	DET
ajpf-815	121	42	mtt	mtt	NOUN
ajpf-815	121	43	assay	assay	VERB
ajpf-815	121	44	.	.	PUNCT
ajpf-815	122	1	plant	plant	NOUN
ajpf-815	122	2	extract	extract	VERB
ajpf-815	122	3	vero	vero	PROPN
ajpf-815	122	4	hsv-1	hsv-1	X
ajpf-815	122	5	si	si	PROPN
ajpf-815	122	6	c	c	PROPN
ajpf-815	122	7	eqhv-1	eqhv-1	NUM
ajpf-815	122	8	si	si	NOUN
ajpf-815	122	9	mdbk	mdbk	NOUN
ajpf-815	122	10	suhv-1	suhv-1	PROPN
ajpf-815	122	11	cc50	cc50	PROPN
ajpf-815	122	12	a	a	DET
ajpf-815	122	13	ic50	ic50	PROPN
ajpf-815	122	14	b	b	PROPN
ajpf-815	122	15	ic50	ic50	PROPN
ajpf-815	122	16	cc50	cc50	PROPN
ajpf-815	122	17	ic50	ic50	PROPN
ajpf-815	122	18	si	si	PROPN
ajpf-815	123	1	byrsonima	byrsonima	NOUN
ajpf-815	123	2	intermedia	intermedia	PROPN
ajpf-815	123	3	141.1	141.1	NUM
ajpf-815	123	4	3.37	3.37	NUM
ajpf-815	123	5	41.76	41.76	NUM
ajpf-815	123	6	±	±	NUM
ajpf-815	123	7	0.04	0.04	NUM
ajpf-815	123	8	34.24	34.24	NUM
ajpf-815	123	9	4.12	4.12	NUM
ajpf-815	123	10	±	±	NUM
ajpf-815	123	11	0.1	0.1	NUM
ajpf-815	123	12	782.1	782.1	NUM
ajpf-815	123	13	4.03	4.03	NUM
ajpf-815	123	14	193.97	193.97	NUM
ajpf-815	123	15	±	±	NUM
ajpf-815	123	16	0.09	0.09	NUM
ajpf-815	123	17	a	a	DET
ajpf-815	123	18	:	:	PUNCT
ajpf-815	123	19	50	50	NUM
ajpf-815	123	20	%	%	NOUN
ajpf-815	123	21	cytotoxic	cytotoxic	ADJ
ajpf-815	123	22	concentration	concentration	NOUN
ajpf-815	123	23	(	(	PUNCT
ajpf-815	123	24	μg	μg	NOUN
ajpf-815	123	25	/	/	SYM
ajpf-815	123	26	ml	ml	PROPN
ajpf-815	123	27	)	)	PUNCT
ajpf-815	123	28	;	;	PUNCT
ajpf-815	123	29	b	b	X
ajpf-815	123	30	:	:	PUNCT
ajpf-815	123	31	50	50	NUM
ajpf-815	123	32	%	%	NOUN
ajpf-815	123	33	inhibitory	inhibitory	ADJ
ajpf-815	123	34	concentration	concentration	NOUN
ajpf-815	123	35	(	(	PUNCT
ajpf-815	123	36	μg	μg	NOUN
ajpf-815	123	37	/	/	SYM
ajpf-815	123	38	ml	ml	PROPN
ajpf-815	123	39	)	)	PUNCT
ajpf-815	123	40	;	;	PUNCT
ajpf-815	123	41	c	c	X
ajpf-815	123	42	:	:	PUNCT
ajpf-815	123	43	si	si	PROPN
ajpf-815	123	44	seletivity	seletivity	PROPN
ajpf-815	123	45	index	index	NOUN
ajpf-815	123	46	ratio	ratio	NOUN
ajpf-815	123	47	of	of	ADP
ajpf-815	123	48	cc50	cc50	PROPN
ajpf-815	123	49	to	to	ADP
ajpf-815	123	50	ic50	ic50	PROPN
ajpf-815	123	51	.	.	PUNCT
ajpf-815	124	1	suhv-1	suhv-1	X
ajpf-815	124	2	:	:	PUNCT
ajpf-815	124	3	swine	swine	ADJ
ajpf-815	124	4	herpesvirus	herpesvirus	NOUN
ajpf-815	124	5	type	type	NOUN
ajpf-815	124	6	1	1	NUM
ajpf-815	124	7	;	;	PUNCT
ajpf-815	124	8	ehv-1	ehv-1	NUM
ajpf-815	124	9	:	:	PUNCT
ajpf-815	124	10	equid	equid	ADJ
ajpf-815	124	11	herpesvirus	herpesvirus	NOUN
ajpf-815	124	12	type	type	NOUN
ajpf-815	124	13	1	1	NUM
ajpf-815	124	14	;	;	PUNCT
ajpf-815	124	15	hsv-1	hsv-1	NUM
ajpf-815	124	16	:	:	PUNCT
ajpf-815	124	17	human	human	ADJ
ajpf-815	124	18	herpesvirus	herpesvirus	NOUN
ajpf-815	124	19	type	type	NOUN
ajpf-815	124	20	1	1	NUM
ajpf-815	124	21	.	.	NOUN
ajpf-815	124	22	7	7	NUM
ajpf-815	124	23	6	6	NUM
ajpf-815	124	24	5	5	NUM
ajpf-815	124	25	4	4	NUM
ajpf-815	124	26	vii	vii	PROPN
ajpf-815	124	27	3	3	NUM
ajpf-815	124	28	2	2	NUM
ajpf-815	124	29	1	1	NUM
ajpf-815	124	30	0	0	NUM
ajpf-815	124	31	1.9	1.9	NUM
ajpf-815	124	32	3.9	3.9	NUM
ajpf-815	124	33	7.8	7.8	NUM
ajpf-815	124	34	15.6	15.6	NUM
ajpf-815	124	35	31.2	31.2	NUM
ajpf-815	124	36	62.5	62.5	NUM
ajpf-815	124	37	125	125	NUM
ajpf-815	124	38	250	250	NUM
ajpf-815	124	39	suhv-1	suhv-1	NUM
ajpf-815	124	40	eqhv-1	eqhv-1	NUM
ajpf-815	124	41	hsv-1	hsv-1	X
ajpf-815	124	42	concentration	concentration	NOUN
ajpf-815	124	43	(	(	PUNCT
ajpf-815	124	44	µg	µg	NOUN
ajpf-815	124	45	/	/	SYM
ajpf-815	124	46	ml	ml	NOUN
ajpf-815	124	47	)	)	PUNCT
ajpf-815	124	48	figure	figure	NOUN
ajpf-815	124	49	1	1	NUM
ajpf-815	124	50	.	.	PUNCT
ajpf-815	124	51	antiviral	antiviral	ADJ
ajpf-815	124	52	activity	activity	NOUN
ajpf-815	124	53	of	of	ADP
ajpf-815	124	54	different	different	ADJ
ajpf-815	124	55	concentration	concentration	NOUN
ajpf-815	124	56	of	of	ADP
ajpf-815	124	57	extract	extract	NOUN
ajpf-815	124	58	from	from	ADP
ajpf-815	124	59	b.	b.	PROPN
ajpf-815	124	60	intermedia	intermedia	PROPN
ajpf-815	124	61	against	against	ADP
ajpf-815	124	62	swine	swine	ADJ
ajpf-815	124	63	herpesvirus	herpesvirus	NOUN
ajpf-815	124	64	type	type	NOUN
ajpf-815	124	65	1	1	NUM
ajpf-815	124	66	(	(	PUNCT
ajpf-815	124	67	suhv-1	suhv-1	NUM
ajpf-815	124	68	)	)	PUNCT
ajpf-815	124	69	;	;	PUNCT
ajpf-815	124	70	equine	equine	NOUN
ajpf-815	124	71	herpesvirus	herpesvirus	NOUN
ajpf-815	124	72	type	type	NOUN
ajpf-815	124	73	1	1	NUM
ajpf-815	124	74	(	(	PUNCT
ajpf-815	124	75	ehv-1	ehv-1	NUM
ajpf-815	124	76	)	)	PUNCT
ajpf-815	124	77	;	;	PUNCT
ajpf-815	124	78	human	human	ADJ
ajpf-815	124	79	herpesvirus	herpesvirus	NOUN
ajpf-815	124	80	type	type	NOUN
ajpf-815	124	81	1	1	NUM
ajpf-815	124	82	(	(	PUNCT
ajpf-815	124	83	hsv-1	hsv-1	NUM
ajpf-815	124	84	)	)	PUNCT
ajpf-815	124	85	;	;	PUNCT
ajpf-815	124	86	vii	vii	PROPN
ajpf-815	124	87	:	:	PUNCT
ajpf-815	124	88	viral	viral	ADJ
ajpf-815	124	89	inhibition	inhibition	NOUN
ajpf-815	124	90	index	index	NOUN
ajpf-815	124	91	.	.	PUNCT
ajpf-815	125	1	suhv-1	suhv-1	NUM
ajpf-815	125	2	followed	follow	VERB
ajpf-815	125	3	by	by	ADP
ajpf-815	125	4	ehv-1	ehv-1	PUNCT
ajpf-815	125	5	and	and	CCONJ
ajpf-815	125	6	hsv	hsv	PROPN
ajpf-815	125	7	.	.	PUNCT
ajpf-815	126	1	likewise	likewise	ADV
ajpf-815	126	2	,	,	PUNCT
ajpf-815	126	3	figure	figure	NOUN
ajpf-815	126	4	2	2	NUM
ajpf-815	126	5	shows	show	VERB
ajpf-815	126	6	the	the	DET
ajpf-815	126	7	direct	direct	ADJ
ajpf-815	126	8	anti	anti	ADJ
ajpf-815	126	9	-	-	ADJ
ajpf-815	126	10	herpes	herpes	ADJ
ajpf-815	126	11	effect	effect	NOUN
ajpf-815	126	12	against	against	ADP
ajpf-815	126	13	suhv-1	suhv-1	NUM
ajpf-815	126	14	,	,	PUNCT
ajpf-815	126	15	ehv-1	ehv-1	PUNCT
ajpf-815	126	16	and	and	CCONJ
ajpf-815	126	17	hsv-1	hsv-1	X
ajpf-815	126	18	showing	show	VERB
ajpf-815	126	19	that	that	DET
ajpf-815	126	20	treatment	treatment	NOUN
ajpf-815	126	21	of	of	ADP
ajpf-815	126	22	virions	virion	NOUN
ajpf-815	126	23	with	with	ADP
ajpf-815	126	24	this	this	DET
ajpf-815	126	25	various	various	ADJ
ajpf-815	126	26	concentrations	concentration	NOUN
ajpf-815	126	27	of	of	ADP
ajpf-815	126	28	extracts	extract	NOUN
ajpf-815	126	29	for	for	ADP
ajpf-815	126	30	one	one	NUM
ajpf-815	126	31	hour	hour	NOUN
ajpf-815	126	32	resulted	result	VERB
ajpf-815	126	33	in	in	ADP
ajpf-815	126	34	reduced	reduced	ADJ
ajpf-815	126	35	viral	viral	ADJ
ajpf-815	126	36	titers	titer	NOUN
ajpf-815	126	37	.	.	PUNCT
ajpf-815	127	1	the	the	DET
ajpf-815	127	2	extracts	extract	NOUN
ajpf-815	127	3	were	be	AUX
ajpf-815	127	4	active	active	ADJ
ajpf-815	127	5	at	at	ADP
ajpf-815	127	6	the	the	DET
ajpf-815	127	7	concentrations	concentration	NOUN
ajpf-815	127	8	range	range	VERB
ajpf-815	127	9	250	250	NUM
ajpf-815	127	10	to	to	PART
ajpf-815	127	11	31.2	31.2	NUM
ajpf-815	127	12	µg	µg	NOUN
ajpf-815	127	13	/	/	SYM
ajpf-815	127	14	ml	ml	NOUN
ajpf-815	127	15	.	.	PUNCT
ajpf-815	128	1	at	at	ADP
ajpf-815	128	2	3.9	3.9	NUM
ajpf-815	128	3	µg	µg	NOUN
ajpf-815	128	4	/	/	SYM
ajpf-815	128	5	ml	ml	NOUN
ajpf-815	128	6	,	,	PUNCT
ajpf-815	128	7	the	the	DET
ajpf-815	128	8	reduction	reduction	NOUN
ajpf-815	128	9	occurred	occur	VERB
ajpf-815	128	10	firstly	firstly	ADV
ajpf-815	128	11	with	with	ADP
ajpf-815	128	12	suhv-1	suhv-1	NUM
ajpf-815	128	13	and	and	CCONJ
ajpf-815	128	14	then	then	ADV
ajpf-815	128	15	with	with	ADP
ajpf-815	128	16	ehv-1	ehv-1	ADV
ajpf-815	128	17	and	and	CCONJ
ajpf-815	128	18	hsv-1	hsv-1	PRON
ajpf-815	128	19	at	at	ADP
ajpf-815	128	20	7.8	7.8	NUM
ajpf-815	128	21	µg	µg	NOUN
ajpf-815	128	22	/	/	SYM
ajpf-815	128	23	ml	ml	NOUN
ajpf-815	128	24	.	.	PUNCT
ajpf-815	129	1	at	at	ADP
ajpf-815	129	2	250	250	NUM
ajpf-815	129	3	µg	µg	ADV
ajpf-815	129	4	/	/	SYM
ajpf-815	129	5	ml	ml	NOUN
ajpf-815	129	6	,	,	PUNCT
ajpf-815	129	7	the	the	DET
ajpf-815	129	8	greater	great	ADJ
ajpf-815	129	9	vii	vii	PROPN
ajpf-815	129	10	was	be	AUX
ajpf-815	129	11	obtained	obtain	VERB
ajpf-815	129	12	for	for	ADP
ajpf-815	129	13	suhv-1	suhv-1	NUM
ajpf-815	129	14	and	and	CCONJ
ajpf-815	129	15	ehv-1	ehv-1	X
ajpf-815	129	16	followed	follow	VERB
ajpf-815	129	17	by	by	ADP
ajpf-815	129	18	hsv	hsv	PROPN
ajpf-815	129	19	.	.	PUNCT
ajpf-815	130	1	phytochemical	phytochemical	ADJ
ajpf-815	130	2	profile	profile	NOUN
ajpf-815	130	3	of	of	ADP
ajpf-815	130	4	byrsonima	byrsonima	NOUN
ajpf-815	130	5	intermedia	intermedia	PROPN
ajpf-815	130	6	as	as	ADP
ajpf-815	130	7	follow	follow	NOUN
ajpf-815	130	8	-	-	PUNCT
ajpf-815	130	9	up	up	NOUN
ajpf-815	130	10	,	,	PUNCT
ajpf-815	130	11	the	the	DET
ajpf-815	130	12	b.	b.	PROPN
ajpf-815	130	13	intermedia	intermedia	PROPN
ajpf-815	130	14	extract	extract	PROPN
ajpf-815	130	15	was	be	AUX
ajpf-815	130	16	subjected	subject	VERB
ajpf-815	130	17	in	in	ADP
ajpf-815	130	18	the	the	DET
ajpf-815	130	19	current	current	ADJ
ajpf-815	130	20	study	study	NOUN
ajpf-815	130	21	to	to	ADP
ajpf-815	130	22	hplc	hplc	PROPN
ajpf-815	130	23	/	/	SYM
ajpf-815	130	24	ms	ms	NOUN
ajpf-815	130	25	analysis	analysis	NOUN
ajpf-815	130	26	(	(	PUNCT
ajpf-815	130	27	figure	figure	NOUN
ajpf-815	130	28	3	3	NUM
ajpf-815	130	29	)	)	PUNCT
ajpf-815	130	30	.	.	PUNCT
ajpf-815	131	1	the	the	DET
ajpf-815	131	2	peak	peak	NOUN
ajpf-815	131	3	at	at	ADP
ajpf-815	131	4	rt	rt	PROPN
ajpf-815	131	5	=	=	SYM
ajpf-815	131	6	10.2	10.2	NUM
ajpf-815	131	7	min	min	NOUN
ajpf-815	131	8	corresponds	correspond	NOUN
ajpf-815	131	9	to	to	ADP
ajpf-815	131	10	a	a	DET
ajpf-815	131	11	[	[	X
ajpf-815	131	12	m	m	ADJ
ajpf-815	131	13	–	–	PUNCT
ajpf-815	131	14	h	h	NOUN
ajpf-815	131	15	]	]	X
ajpf-815	131	16	quasimolecular	quasimolecular	ADJ
ajpf-815	131	17	ion	ion	NOUN
ajpf-815	131	18	peak	peak	NOUN
ajpf-815	131	19	at	at	ADP
ajpf-815	131	20	m	m	PROPN
ajpf-815	131	21	/	/	SYM
ajpf-815	131	22	z	z	PROPN
ajpf-815	131	23	169	169	NUM
ajpf-815	131	24	,	,	PUNCT
ajpf-815	131	25	suggesting	suggest	VERB
ajpf-815	131	26	the	the	DET
ajpf-815	131	27	occurrence	occurrence	NOUN
ajpf-815	131	28	of	of	ADP
ajpf-815	131	29	gallic	gallic	ADJ
ajpf-815	131	30	acid	acid	NOUN
ajpf-815	131	31	(	(	PUNCT
ajpf-815	131	32	a	a	NOUN
ajpf-815	131	33	)	)	PUNCT
ajpf-815	131	34	.	.	PUNCT
ajpf-815	132	1	the	the	DET
ajpf-815	132	2	second	second	ADJ
ajpf-815	132	3	peak	peak	NOUN
ajpf-815	132	4	,	,	PUNCT
ajpf-815	132	5	detected	detect	VERB
ajpf-815	132	6	at	at	ADP
ajpf-815	132	7	rt	rt	PROPN
ajpf-815	132	8	=	=	PROPN
ajpf-815	132	9	13.6	13.6	NUM
ajpf-815	132	10	min	min	NOUN
ajpf-815	132	11	corresponds	correspond	VERB
ajpf-815	132	12	to	to	ADP
ajpf-815	132	13	a	a	DET
ajpf-815	132	14	[	[	X
ajpf-815	132	15	m	m	ADJ
ajpf-815	132	16	–	–	PUNCT
ajpf-815	132	17	h	h	NOUN
ajpf-815	132	18	]	]	X
ajpf-815	132	19	quasimolecular	quasimolecular	ADJ
ajpf-815	132	20	ion	ion	NOUN
ajpf-815	132	21	peak	peak	NOUN
ajpf-815	132	22	at	at	ADP
ajpf-815	132	23	m	m	PROPN
ajpf-815	132	24	/	/	SYM
ajpf-815	132	25	z	z	PROPN
ajpf-815	132	26	301	301	NUM
ajpf-815	132	27	,	,	PUNCT
ajpf-815	132	28	suggesting	suggest	VERB
ajpf-815	132	29	the	the	DET
ajpf-815	132	30	presence	presence	NOUN
ajpf-815	132	31	of	of	ADP
ajpf-815	132	32	flavonoid	flavonoid	PROPN
ajpf-815	132	33	quercetin	quercetin	NOUN
ajpf-815	132	34	(	(	PUNCT
ajpf-815	132	35	b	b	NOUN
ajpf-815	132	36	)	)	PUNCT
ajpf-815	132	37	.	.	PUNCT
ajpf-815	133	1	discussion	discussion	NOUN
ajpf-815	133	2	cytotoxicity	cytotoxicity	NOUN
ajpf-815	133	3	the	the	DET
ajpf-815	133	4	cytotoxic	cytotoxic	ADJ
ajpf-815	133	5	assay	assay	VERB
ajpf-815	133	6	at	at	ADP
ajpf-815	133	7	the	the	DET
ajpf-815	133	8	first	first	ADJ
ajpf-815	133	9	stage	stage	NOUN
ajpf-815	133	10	of	of	ADP
ajpf-815	133	11	screening	screening	NOUN
ajpf-815	133	12	is	be	AUX
ajpf-815	133	13	very	very	ADV
ajpf-815	133	14	important	important	ADJ
ajpf-815	133	15	to	to	PART
ajpf-815	133	16	determine	determine	VERB
ajpf-815	133	17	the	the	DET
ajpf-815	133	18	maximum	maximum	ADJ
ajpf-815	133	19	concentration	concentration	NOUN
ajpf-815	133	20	of	of	ADP
ajpf-815	133	21	the	the	DET
ajpf-815	133	22	aqueous	aqueous	ADJ
ajpf-815	133	23	extract	extract	NOUN
ajpf-815	133	24	that	that	PRON
ajpf-815	133	25	did	do	AUX
ajpf-815	133	26	not	not	PART
ajpf-815	133	27	induce	induce	VERB
ajpf-815	133	28	changes	change	NOUN
ajpf-815	133	29	in	in	ADP
ajpf-815	133	30	cell	cell	NOUN
ajpf-815	133	31	morphology	morphology	NOUN
ajpf-815	133	32	.	.	PUNCT
ajpf-815	134	1	this	this	DET
ajpf-815	134	2	step	step	NOUN
ajpf-815	134	3	is	be	AUX
ajpf-815	134	4	critical	critical	ADJ
ajpf-815	134	5	because	because	SCONJ
ajpf-815	134	6	the	the	DET
ajpf-815	134	7	virus	virus	NOUN
ajpf-815	134	8	is	be	AUX
ajpf-815	134	9	an	an	DET
ajpf-815	134	10	intracellular	intracellular	ADJ
ajpf-815	134	11	parasite	parasite	NOUN
ajpf-815	134	12	and	and	CCONJ
ajpf-815	134	13	uses	use	VERB
ajpf-815	134	14	the	the	DET
ajpf-815	134	15	cell	cell	NOUN
ajpf-815	134	16	machinery	machinery	NOUN
ajpf-815	134	17	to	to	PART
ajpf-815	134	18	replicate	replicate	VERB
ajpf-815	134	19	,	,	PUNCT
ajpf-815	134	20	so	so	SCONJ
ajpf-815	134	21	it	it	PRON
ajpf-815	134	22	must	must	AUX
ajpf-815	134	23	be	be	AUX
ajpf-815	134	24	ensured	ensure	VERB
ajpf-815	134	25	that	that	SCONJ
ajpf-815	134	26	the	the	DET
ajpf-815	134	27	virus	virus	NOUN
ajpf-815	134	28	have	have	VERB
ajpf-815	134	29	the	the	DET
ajpf-815	134	30	ideal	ideal	ADJ
ajpf-815	134	31	conditions	condition	NOUN
ajpf-815	134	32	for	for	ADP
ajpf-815	134	33	their	their	PRON
ajpf-815	134	34	growth	growth	NOUN
ajpf-815	134	35	(	(	PUNCT
ajpf-815	134	36	cos	cos	PROPN
ajpf-815	134	37	et	et	PROPN
ajpf-815	134	38	al	al	PROPN
ajpf-815	134	39	.	.	PROPN
ajpf-815	134	40	,	,	PUNCT
ajpf-815	134	41	2006	2006	NUM
ajpf-815	134	42	)	)	PUNCT
ajpf-815	134	43	.	.	PUNCT
ajpf-815	135	1	the	the	DET
ajpf-815	135	2	study	study	NOUN
ajpf-815	135	3	of	of	ADP
ajpf-815	135	4	cytotoxicity	cytotoxicity	NOUN
ajpf-815	135	5	in	in	ADP
ajpf-815	135	6	different	different	ADJ
ajpf-815	135	7	cell	cell	NOUN
ajpf-815	135	8	lines	line	NOUN
ajpf-815	135	9	is	be	AUX
ajpf-815	135	10	important	important	ADJ
ajpf-815	135	11	because	because	SCONJ
ajpf-815	135	12	one	one	NUM
ajpf-815	135	13	of	of	ADP
ajpf-815	135	14	the	the	DET
ajpf-815	135	15	inherent	inherent	ADJ
ajpf-815	135	16	drawbacks	drawback	NOUN
ajpf-815	135	17	of	of	ADP
ajpf-815	135	18	in	in	ADP
ajpf-815	135	19	vitro	vitro	X
ajpf-815	135	20	antiviral	antiviral	ADJ
ajpf-815	135	21	testing	testing	NOUN
ajpf-815	135	22	is	be	AUX
ajpf-815	135	23	the	the	DET
ajpf-815	135	24	environmental	environmental	ADJ
ajpf-815	135	25	sensitivity	sensitivity	NOUN
ajpf-815	135	26	of	of	ADP
ajpf-815	135	27	animal	animal	NOUN
ajpf-815	135	28	cells	cell	NOUN
ajpf-815	135	29	in	in	ADP
ajpf-815	135	30	culture	culture	NOUN
ajpf-815	135	31	,	,	PUNCT
ajpf-815	135	32	although	although	SCONJ
ajpf-815	135	33	the	the	DET
ajpf-815	135	34	in	in	X
ajpf-815	135	35	vitro	vitro	X
ajpf-815	135	36	methodology	methodology	NOUN
ajpf-815	135	37	is	be	AUX
ajpf-815	135	38	faster	fast	ADJ
ajpf-815	135	39	and	and	CCONJ
ajpf-815	135	40	less	less	ADV
ajpf-815	135	41	costly	costly	ADJ
ajpf-815	135	42	(	(	PUNCT
ajpf-815	135	43	mccutcheon	mccutcheon	PROPN
ajpf-815	135	44	et	et	PROPN
ajpf-815	135	45	al	al	PROPN
ajpf-815	135	46	.	.	PROPN
ajpf-815	135	47	,	,	PUNCT
ajpf-815	135	48	1995	1995	NUM
ajpf-815	135	49	)	)	PUNCT
ajpf-815	135	50	.	.	PUNCT
ajpf-815	136	1	antiviral	antiviral	ADJ
ajpf-815	136	2	activity	activity	NOUN
ajpf-815	136	3	brazilian	brazilian	NOUN
ajpf-815	136	4	cerrado	cerrado	NOUN
ajpf-815	136	5	plants	plant	NOUN
ajpf-815	136	6	may	may	AUX
ajpf-815	136	7	lead	lead	VERB
ajpf-815	136	8	to	to	ADP
ajpf-815	136	9	the	the	DET
ajpf-815	136	10	study	study	NOUN
ajpf-815	136	11	of	of	ADP
ajpf-815	136	12	a	a	DET
ajpf-815	136	13	broad	broad	ADJ
ajpf-815	136	14	source	source	NOUN
ajpf-815	136	15	of	of	ADP
ajpf-815	136	16	new	new	ADJ
ajpf-815	136	17	natural	natural	ADJ
ajpf-815	136	18	compounds	compound	NOUN
ajpf-815	136	19	;	;	PUNCT
ajpf-815	136	20	however	however	ADV
ajpf-815	136	21	,	,	PUNCT
ajpf-815	136	22	most	most	ADJ
ajpf-815	136	23	are	be	AUX
ajpf-815	136	24	6	6	NUM
ajpf-815	136	25	7	7	NUM
ajpf-815	136	26	6	6	NUM
ajpf-815	136	27	5	5	NUM
ajpf-815	136	28	vii	vii	PROPN
ajpf-815	136	29	4	4	NUM
ajpf-815	136	30	3	3	NUM
ajpf-815	136	31	2	2	NUM
ajpf-815	136	32	1	1	NUM
ajpf-815	136	33	0	0	NUM
ajpf-815	136	34	1.9	1.9	NUM
ajpf-815	136	35	3.9	3.9	NUM
ajpf-815	136	36	7.8	7.8	NUM
ajpf-815	136	37	15.6	15.6	NUM
ajpf-815	136	38	31.2	31.2	NUM
ajpf-815	136	39	62.5	62.5	NUM
ajpf-815	136	40	125	125	NUM
ajpf-815	136	41	250	250	NUM
ajpf-815	136	42	hsv-1	hsv-1	X
ajpf-815	136	43	suhv-1	suhv-1	NUM
ajpf-815	136	44	eqhv-1	eqhv-1	NUM
ajpf-815	136	45	concentration	concentration	NOUN
ajpf-815	136	46	(	(	PUNCT
ajpf-815	136	47	µg	µg	NOUN
ajpf-815	136	48	/	/	SYM
ajpf-815	136	49	ml	ml	NOUN
ajpf-815	136	50	)	)	PUNCT
ajpf-815	136	51	figure	figure	NOUN
ajpf-815	136	52	2	2	NUM
ajpf-815	136	53	.	.	PUNCT
ajpf-815	136	54	direct	direct	ADJ
ajpf-815	136	55	anti	anti	ADJ
ajpf-815	136	56	-	-	ADJ
ajpf-815	136	57	herpes	herpes	ADJ
ajpf-815	136	58	effect	effect	NOUN
ajpf-815	136	59	of	of	ADP
ajpf-815	136	60	different	different	ADJ
ajpf-815	136	61	concentrations	concentration	NOUN
ajpf-815	136	62	of	of	ADP
ajpf-815	136	63	extract	extract	NOUN
ajpf-815	136	64	from	from	ADP
ajpf-815	136	65	b.	b.	PROPN
ajpf-815	136	66	intermedia	intermedia	PROPN
ajpf-815	136	67	against	against	ADP
ajpf-815	136	68	swine	swine	ADJ
ajpf-815	136	69	herpesvirus	herpesvirus	NOUN
ajpf-815	136	70	type	type	NOUN
ajpf-815	136	71	1	1	NUM
ajpf-815	136	72	(	(	PUNCT
ajpf-815	136	73	suhv-1	suhv-1	NUM
ajpf-815	136	74	)	)	PUNCT
ajpf-815	136	75	;	;	PUNCT
ajpf-815	136	76	equine	equine	NOUN
ajpf-815	136	77	herpesvirus	herpesvirus	NOUN
ajpf-815	136	78	type	type	NOUN
ajpf-815	136	79	1	1	NUM
ajpf-815	136	80	(	(	PUNCT
ajpf-815	136	81	ehv-1	ehv-1	NUM
ajpf-815	136	82	)	)	PUNCT
ajpf-815	136	83	;	;	PUNCT
ajpf-815	136	84	human	human	ADJ
ajpf-815	136	85	herpesvirus	herpesvirus	NOUN
ajpf-815	136	86	type	type	NOUN
ajpf-815	136	87	1	1	NUM
ajpf-815	136	88	(	(	PUNCT
ajpf-815	136	89	hsv-1	hsv-1	NUM
ajpf-815	136	90	)	)	PUNCT
ajpf-815	136	91	;	;	PUNCT
ajpf-815	136	92	vii	vii	PROPN
ajpf-815	136	93	:	:	PUNCT
ajpf-815	136	94	viral	viral	ADJ
ajpf-815	136	95	inhibition	inhibition	NOUN
ajpf-815	136	96	index	index	NOUN
ajpf-815	136	97	.	.	PUNCT
ajpf-815	137	1	being	be	AUX
ajpf-815	137	2	developed	develop	VERB
ajpf-815	137	3	for	for	ADP
ajpf-815	137	4	use	use	NOUN
ajpf-815	137	5	as	as	ADP
ajpf-815	137	6	antibiotics	antibiotic	NOUN
ajpf-815	137	7	more	more	ADJ
ajpf-815	137	8	than	than	ADP
ajpf-815	137	9	antiviral	antiviral	ADJ
ajpf-815	137	10	drugs	drug	NOUN
ajpf-815	137	11	.	.	PUNCT
ajpf-815	138	1	this	this	PRON
ajpf-815	138	2	is	be	AUX
ajpf-815	138	3	because	because	SCONJ
ajpf-815	138	4	the	the	DET
ajpf-815	138	5	viruses	virus	NOUN
ajpf-815	138	6	present	present	VERB
ajpf-815	138	7	certain	certain	ADJ
ajpf-815	138	8	characteristics	characteristic	NOUN
ajpf-815	138	9	among	among	ADP
ajpf-815	138	10	others	other	NOUN
ajpf-815	138	11	of	of	ADP
ajpf-815	138	12	replicating	replicate	VERB
ajpf-815	138	13	within	within	ADP
ajpf-815	138	14	the	the	DET
ajpf-815	138	15	cell	cell	NOUN
ajpf-815	138	16	and	and	CCONJ
ajpf-815	138	17	persisting	persist	VERB
ajpf-815	138	18	in	in	ADP
ajpf-815	138	19	the	the	DET
ajpf-815	138	20	host	host	NOUN
ajpf-815	138	21	.	.	PUNCT
ajpf-815	139	1	their	their	PRON
ajpf-815	139	2	combat	combat	NOUN
ajpf-815	139	3	must	must	AUX
ajpf-815	139	4	be	be	AUX
ajpf-815	139	5	more	more	ADV
ajpf-815	139	6	rational	rational	ADJ
ajpf-815	139	7	by	by	ADP
ajpf-815	139	8	the	the	DET
ajpf-815	139	9	choice	choice	NOUN
ajpf-815	139	10	of	of	ADP
ajpf-815	139	11	species	specie	NOUN
ajpf-815	139	12	of	of	ADP
ajpf-815	139	13	plants	plant	NOUN
ajpf-815	139	14	that	that	PRON
ajpf-815	139	15	have	have	AUX
ajpf-815	139	16	already	already	ADV
ajpf-815	139	17	been	be	AUX
ajpf-815	139	18	used	use	VERB
ajpf-815	139	19	by	by	ADP
ajpf-815	139	20	the	the	DET
ajpf-815	139	21	population	population	NOUN
ajpf-815	139	22	to	to	PART
ajpf-815	139	23	treat	treat	VERB
ajpf-815	139	24	the	the	DET
ajpf-815	139	25	diseases	disease	NOUN
ajpf-815	139	26	.	.	PUNCT
ajpf-815	140	1	many	many	ADJ
ajpf-815	140	2	brazilian	brazilian	ADJ
ajpf-815	140	3	cerrado	cerrado	NOUN
ajpf-815	140	4	species	specie	NOUN
ajpf-815	140	5	have	have	AUX
ajpf-815	140	6	already	already	ADV
ajpf-815	140	7	been	be	AUX
ajpf-815	140	8	described	describe	VERB
ajpf-815	140	9	as	as	ADP
ajpf-815	140	10	having	have	VERB
ajpf-815	140	11	antiviral	antiviral	ADJ
ajpf-815	140	12	activity	activity	NOUN
ajpf-815	140	13	.	.	PUNCT
ajpf-815	141	1	chattopadhyay	chattopadhyay	PROPN
ajpf-815	141	2	et	et	PROPN
ajpf-815	141	3	al	al	PROPN
ajpf-815	141	4	.	.	PROPN
ajpf-815	142	1	(	(	PUNCT
ajpf-815	142	2	2015	2015	NUM
ajpf-815	142	3	)	)	PUNCT
ajpf-815	142	4	showed	show	VERB
ajpf-815	142	5	that	that	SCONJ
ajpf-815	142	6	byrsonima	byrsonima	NOUN
ajpf-815	142	7	verbascifolia	verbascifolia	NOUN
ajpf-815	142	8	had	have	VERB
ajpf-815	142	9	strong	strong	ADJ
ajpf-815	142	10	anti	anti	ADJ
ajpf-815	142	11	-	-	ADJ
ajpf-815	142	12	hsv	hsv	ADJ
ajpf-815	142	13	activities	activity	NOUN
ajpf-815	142	14	,	,	PUNCT
ajpf-815	142	15	whereas	whereas	SCONJ
ajpf-815	142	16	maldini	maldini	PROPN
ajpf-815	142	17	et	et	PROPN
ajpf-815	142	18	al	al	PROPN
ajpf-815	142	19	.	.	PROPN
ajpf-815	143	1	(	(	PUNCT
ajpf-815	143	2	2011	2011	NUM
ajpf-815	143	3	)	)	PUNCT
ajpf-815	143	4	found	find	VERB
ajpf-815	143	5	that	that	SCONJ
ajpf-815	143	6	b.	b.	PROPN
ajpf-815	143	7	crassifolia	crassifolia	PROPN
ajpf-815	143	8	used	use	VERB
ajpf-815	143	9	as	as	ADP
ajpf-815	143	10	anti	anti	ADJ
ajpf-815	143	11	-	-	ADJ
ajpf-815	143	12	inflammatory	inflammatory	ADJ
ajpf-815	143	13	has	have	AUX
ajpf-815	143	14	been	be	AUX
ajpf-815	143	15	described	describe	VERB
ajpf-815	143	16	as	as	ADP
ajpf-815	143	17	having	have	VERB
ajpf-815	143	18	compounds	compound	NOUN
ajpf-815	143	19	that	that	PRON
ajpf-815	143	20	also	also	ADV
ajpf-815	143	21	display	display	VERB
ajpf-815	143	22	antiviral	antiviral	ADJ
ajpf-815	143	23	activity	activity	NOUN
ajpf-815	143	24	against	against	ADP
ajpf-815	143	25	hsv-1	hsv-1	PRON
ajpf-815	143	26	and	and	CCONJ
ajpf-815	143	27	hiv	hiv	PROPN
ajpf-815	143	28	.	.	PUNCT
ajpf-815	144	1	in	in	ADP
ajpf-815	144	2	the	the	DET
ajpf-815	144	3	present	present	ADJ
ajpf-815	144	4	study	study	NOUN
ajpf-815	144	5	,	,	PUNCT
ajpf-815	144	6	eight	eight	NUM
ajpf-815	144	7	extracts	extract	NOUN
ajpf-815	144	8	reduced	reduce	VERB
ajpf-815	144	9	at	at	ADP
ajpf-815	144	10	least	least	ADJ
ajpf-815	144	11	one	one	NUM
ajpf-815	144	12	of	of	ADP
ajpf-815	144	13	the	the	DET
ajpf-815	144	14	viral	viral	ADJ
ajpf-815	144	15	titers	titer	NOUN
ajpf-815	144	16	,	,	PUNCT
ajpf-815	144	17	as	as	SCONJ
ajpf-815	144	18	compared	compare	VERB
ajpf-815	144	19	to	to	ADP
ajpf-815	144	20	untreated	untreated	ADJ
ajpf-815	144	21	control	control	NOUN
ajpf-815	144	22	cells	cell	NOUN
ajpf-815	144	23	.	.	PUNCT
ajpf-815	145	1	b.	b.	PROPN
ajpf-815	145	2	variabilis	variabilis	PROPN
ajpf-815	145	3	,	,	PUNCT
ajpf-815	145	4	b.	b.	PROPN
ajpf-815	145	5	intermedia	intermedia	PROPN
ajpf-815	145	6	and	and	CCONJ
ajpf-815	145	7	x.	x.	PROPN
ajpf-815	145	8	aromatica	aromatica	PROPN
ajpf-815	145	9	species	specie	NOUN
ajpf-815	145	10	were	be	AUX
ajpf-815	145	11	active	active	ADJ
ajpf-815	145	12	against	against	ADP
ajpf-815	145	13	all	all	DET
ajpf-815	145	14	these	these	DET
ajpf-815	145	15	herpesviruses	herpesviruse	NOUN
ajpf-815	145	16	.	.	PUNCT
ajpf-815	146	1	furthermore	furthermore	ADV
ajpf-815	146	2	,	,	PUNCT
ajpf-815	146	3	a	a	DET
ajpf-815	146	4	strong	strong	ADJ
ajpf-815	146	5	inhibition	inhibition	NOUN
ajpf-815	146	6	was	be	AUX
ajpf-815	146	7	obtained	obtain	VERB
ajpf-815	146	8	from	from	ADP
ajpf-815	146	9	b.	b.	PROPN
ajpf-815	146	10	variabilis	variabilis	PROPN
ajpf-815	146	11	and	and	CCONJ
ajpf-815	146	12	b.	b.	PROPN
ajpf-815	146	13	intermedia	intermedia	PROPN
ajpf-815	146	14	.	.	PUNCT
ajpf-815	147	1	s.	s.	PROPN
ajpf-815	147	2	adstringens	adstringens	PROPN
ajpf-815	147	3	extract	extract	NOUN
ajpf-815	147	4	also	also	ADV
ajpf-815	147	5	showed	show	VERB
ajpf-815	147	6	an	an	DET
ajpf-815	147	7	effective	effective	ADJ
ajpf-815	147	8	inhibition	inhibition	NOUN
ajpf-815	147	9	against	against	ADP
ajpf-815	147	10	suhv-1	suhv-1	NUM
ajpf-815	147	11	and	and	CCONJ
ajpf-815	147	12	hsv-1	hsv-1	PRON
ajpf-815	147	13	.	.	PUNCT
ajpf-815	148	1	extract	extract	NOUN
ajpf-815	148	2	from	from	ADP
ajpf-815	148	3	x.	x.	PROPN
ajpf-815	148	4	aromatica	aromatica	PROPN
ajpf-815	148	5	presented	present	VERB
ajpf-815	148	6	the	the	DET
ajpf-815	148	7	highest	high	ADJ
ajpf-815	148	8	values	value	NOUN
ajpf-815	148	9	of	of	ADP
ajpf-815	148	10	vii	vii	PROPN
ajpf-815	148	11	against	against	ADP
ajpf-815	148	12	suhv-1	suhv-1	PROPN
ajpf-815	148	13	.	.	PUNCT
ajpf-815	148	14	antiviral	antiviral	ADJ
ajpf-815	148	15	activity	activity	NOUN
ajpf-815	148	16	was	be	AUX
ajpf-815	148	17	also	also	ADV
ajpf-815	148	18	observed	observe	VERB
ajpf-815	148	19	for	for	ADP
ajpf-815	148	20	extracts	extract	NOUN
ajpf-815	148	21	from	from	ADP
ajpf-815	148	22	c.	c.	PROPN
ajpf-815	148	23	xanthocarpa	xanthocarpa	PROPN
ajpf-815	148	24	and	and	CCONJ
ajpf-815	148	25	o.	o.	NOUN
ajpf-815	148	26	pulchella	pulchella	NOUN
ajpf-815	148	27	only	only	ADV
ajpf-815	148	28	against	against	ADP
ajpf-815	148	29	suhv-1	suhv-1	PROPN
ajpf-815	148	30	.	.	PUNCT
ajpf-815	149	1	frias	frias	PROPN
ajpf-815	149	2	et	et	PROPN
ajpf-815	149	3	al	al	PROPN
ajpf-815	149	4	.	.	PROPN
ajpf-815	150	1	(	(	PUNCT
ajpf-815	150	2	2012	2012	NUM
ajpf-815	150	3	)	)	PUNCT
ajpf-815	150	4	isolated	isolate	VERB
ajpf-815	150	5	from	from	ADP
ajpf-815	150	6	metanolic	metanolic	ADJ
ajpf-815	150	7	extract	extract	NOUN
ajpf-815	150	8	of	of	ADP
ajpf-815	150	9	b.	b.	PROPN
ajpf-815	150	10	variabilis	variabilis	PROPN
ajpf-815	150	11	,	,	PUNCT
ajpf-815	150	12	the	the	DET
ajpf-815	150	13	flavonoids	flavonoid	NOUN
ajpf-815	150	14	quercetin	quercetin	NOUN
ajpf-815	150	15	,	,	PUNCT
ajpf-815	150	16	rutin	rutin	NOUN
ajpf-815	150	17	,	,	PUNCT
ajpf-815	150	18	and	and	CCONJ
ajpf-815	150	19	apigenin	apigenin	PROPN
ajpf-815	150	20	.	.	PUNCT
ajpf-815	151	1	quercetin	quercetin	NOUN
ajpf-815	151	2	is	be	AUX
ajpf-815	151	3	found	find	VERB
ajpf-815	151	4	in	in	ADP
ajpf-815	151	5	a	a	DET
ajpf-815	151	6	wide	wide	ADJ
ajpf-815	151	7	variety	variety	NOUN
ajpf-815	151	8	of	of	ADP
ajpf-815	151	9	plants	plant	NOUN
ajpf-815	151	10	and	and	CCONJ
ajpf-815	151	11	studies	study	NOUN
ajpf-815	151	12	showed	show	VERB
ajpf-815	151	13	that	that	SCONJ
ajpf-815	151	14	it	it	PRON
ajpf-815	151	15	could	could	AUX
ajpf-815	151	16	reduce	reduce	VERB
ajpf-815	151	17	infectivity	infectivity	NOUN
ajpf-815	151	18	of	of	ADP
ajpf-815	151	19	target	target	NOUN
ajpf-815	151	20	cells	cell	NOUN
ajpf-815	151	21	and	and	CCONJ
ajpf-815	151	22	replication	replication	NOUN
ajpf-815	151	23	against	against	ADP
ajpf-815	151	24	herpesviruses	herpesviruse	NOUN
ajpf-815	151	25	.	.	PUNCT
ajpf-815	152	1	the	the	DET
ajpf-815	152	2	results	result	NOUN
ajpf-815	152	3	of	of	ADP
ajpf-815	152	4	our	our	PRON
ajpf-815	152	5	work	work	NOUN
ajpf-815	152	6	indicated	indicate	VERB
ajpf-815	152	7	that	that	SCONJ
ajpf-815	152	8	the	the	DET
ajpf-815	152	9	extracts	extract	NOUN
ajpf-815	152	10	of	of	ADP
ajpf-815	152	11	b.	b.	PROPN
ajpf-815	152	12	variablis	variablis	PROPN
ajpf-815	152	13	showed	show	VERB
ajpf-815	152	14	inhibitory	inhibitory	ADJ
ajpf-815	152	15	effect	effect	NOUN
ajpf-815	152	16	against	against	ADP
ajpf-815	152	17	the	the	DET
ajpf-815	152	18	three	three	NUM
ajpf-815	152	19	herpesviruses	herpesviruse	NOUN
ajpf-815	152	20	and	and	CCONJ
ajpf-815	152	21	probably	probably	ADV
ajpf-815	152	22	this	this	DET
ajpf-815	152	23	inhibitory	inhibitory	ADJ
ajpf-815	152	24	effect	effect	NOUN
ajpf-815	152	25	is	be	AUX
ajpf-815	152	26	due	due	ADJ
ajpf-815	152	27	to	to	ADP
ajpf-815	152	28	presence	presence	NOUN
ajpf-815	152	29	of	of	ADP
ajpf-815	152	30	these	these	DET
ajpf-815	152	31	flavonoids	flavonoid	NOUN
ajpf-815	152	32	.	.	PUNCT
ajpf-815	153	1	felipe	felipe	PROPN
ajpf-815	153	2	et	et	PROPN
ajpf-815	153	3	al	al	PROPN
ajpf-815	153	4	.	.	PROPN
ajpf-815	153	5	(	(	PUNCT
ajpf-815	153	6	2006	2006	NUM
ajpf-815	153	7	)	)	PUNCT
ajpf-815	153	8	described	describe	VERB
ajpf-815	153	9	the	the	DET
ajpf-815	153	10	inhibition	inhibition	NOUN
ajpf-815	153	11	bohv-1	bohv-1	NUM
ajpf-815	153	12	replication	replication	NOUN
ajpf-815	153	13	of	of	ADP
ajpf-815	153	14	aqueous	aqueous	ADJ
ajpf-815	153	15	extracts	extract	NOUN
ajpf-815	153	16	from	from	ADP
ajpf-815	153	17	s.	s.	PROPN
ajpf-815	153	18	adstringens	adstringens	PROPN
ajpf-815	153	19	stem	stem	VERB
ajpf-815	153	20	bark	bark	NOUN
ajpf-815	153	21	.	.	PUNCT
ajpf-815	154	1	simoni	simoni	PROPN
ajpf-815	154	2	et	et	PROPN
ajpf-815	154	3	al	al	PROPN
ajpf-815	154	4	.	.	PROPN
ajpf-815	155	1	(	(	PUNCT
ajpf-815	155	2	2007	2007	NUM
ajpf-815	155	3	)	)	PUNCT
ajpf-815	155	4	showed	show	VERB
ajpf-815	155	5	that	that	SCONJ
ajpf-815	155	6	the	the	DET
ajpf-815	155	7	leaves	leave	NOUN
ajpf-815	155	8	presented	present	VERB
ajpf-815	155	9	moderate	moderate	ADJ
ajpf-815	155	10	activity	activity	NOUN
ajpf-815	155	11	against	against	ADP
ajpf-815	155	12	bohv-1	bohv-1	NUM
ajpf-815	155	13	.	.	PUNCT
ajpf-815	156	1	in	in	ADP
ajpf-815	156	2	the	the	DET
ajpf-815	156	3	present	present	ADJ
ajpf-815	156	4	work	work	NOUN
ajpf-815	156	5	,	,	PUNCT
ajpf-815	156	6	leaves	leave	VERB
ajpf-815	156	7	extracts	extract	NOUN
ajpf-815	156	8	from	from	ADP
ajpf-815	156	9	s.	s.	PROPN
ajpf-815	156	10	adstringens	adstringens	PROPN
ajpf-815	156	11	also	also	ADV
ajpf-815	156	12	presented	present	VERB
ajpf-815	156	13	moderate	moderate	ADJ
ajpf-815	156	14	activity	activity	NOUN
ajpf-815	156	15	against	against	ADP
ajpf-815	156	16	ehv-1	ehv-1	PUNCT
ajpf-815	156	17	but	but	CCONJ
ajpf-815	156	18	strong	strong	ADJ
ajpf-815	156	19	inhibition	inhibition	NOUN
ajpf-815	156	20	against	against	ADP
ajpf-815	156	21	hsv-1	hsv-1	PRON
ajpf-815	156	22	and	and	CCONJ
ajpf-815	156	23	suhv-1	suhv-1	PROPN
ajpf-815	156	24	.	.	NOUN
ajpf-815	156	25	antiviral	antiviral	ADJ
ajpf-815	156	26	drugs	drug	NOUN
ajpf-815	156	27	have	have	AUX
ajpf-815	156	28	been	be	AUX
ajpf-815	156	29	reported	report	VERB
ajpf-815	156	30	for	for	ADP
ajpf-815	156	31	herpetic	herpetic	ADJ
ajpf-815	156	32	infections	infection	NOUN
ajpf-815	156	33	for	for	ADP
ajpf-815	156	34	both	both	CCONJ
ajpf-815	156	35	human	human	ADJ
ajpf-815	156	36	and	and	CCONJ
ajpf-815	156	37	animal	animal	NOUN
ajpf-815	156	38	herpesviruses	herpesviruse	NOUN
ajpf-815	156	39	.	.	PUNCT
ajpf-815	157	1	although	although	SCONJ
ajpf-815	157	2	the	the	DET
ajpf-815	157	3	regular	regular	ADJ
ajpf-815	157	4	use	use	NOUN
ajpf-815	157	5	of	of	ADP
ajpf-815	157	6	vaccines	vaccine	NOUN
ajpf-815	157	7	helps	help	VERB
ajpf-815	157	8	in	in	ADP
ajpf-815	157	9	improvement	improvement	NOUN
ajpf-815	157	10	of	of	ADP
ajpf-815	157	11	animal	animal	NOUN
ajpf-815	157	12	herds	herd	NOUN
ajpf-815	157	13	and	and	CCONJ
ajpf-815	157	14	avoids	avoid	VERB
ajpf-815	157	15	viral	viral	ADJ
ajpf-815	157	16	shedding	shedding	NOUN
ajpf-815	157	17	,	,	PUNCT
ajpf-815	157	18	treatment	treatment	NOUN
ajpf-815	157	19	of	of	ADP
ajpf-815	157	20	herpesvirus	herpesvirus	NOUN
ajpf-815	157	21	infections	infection	NOUN
ajpf-815	157	22	is	be	AUX
ajpf-815	157	23	not	not	PART
ajpf-815	157	24	completely	completely	ADV
ajpf-815	157	25	prevented	prevent	VERB
ajpf-815	157	26	by	by	ADP
ajpf-815	157	27	immunization	immunization	NOUN
ajpf-815	157	28	(	(	PUNCT
ajpf-815	157	29	gulati	gulati	PROPN
ajpf-815	157	30	et	et	PROPN
ajpf-815	157	31	al	al	PROPN
ajpf-815	157	32	.	.	PROPN
ajpf-815	157	33	,	,	PUNCT
ajpf-815	157	34	2016	2016	NUM
ajpf-815	157	35	;	;	PUNCT
ajpf-815	157	36	maxwell	maxwell	PROPN
ajpf-815	157	37	,	,	PUNCT
ajpf-815	157	38	2017	2017	NUM
ajpf-815	157	39	)	)	PUNCT
ajpf-815	157	40	.	.	PUNCT
ajpf-815	158	1	thus	thus	ADV
ajpf-815	158	2	,	,	PUNCT
ajpf-815	158	3	antiviral	antiviral	ADJ
ajpf-815	158	4	agents	agent	NOUN
ajpf-815	158	5	can	can	AUX
ajpf-815	158	6	be	be	AUX
ajpf-815	158	7	useful	useful	ADJ
ajpf-815	158	8	not	not	PART
ajpf-815	158	9	only	only	ADV
ajpf-815	158	10	as	as	ADP
ajpf-815	158	11	preventives	preventive	NOUN
ajpf-815	158	12	but	but	CCONJ
ajpf-815	158	13	also	also	ADV
ajpf-815	158	14	as	as	ADP
ajpf-815	158	15	therapeutic	therapeutic	ADJ
ajpf-815	158	16	in	in	ADP
ajpf-815	158	17	herpesvirus	herpesvirus	NOUN
ajpf-815	158	18	infections	infection	NOUN
ajpf-815	158	19	which	which	PRON
ajpf-815	158	20	leads	lead	VERB
ajpf-815	158	21	to	to	ADP
ajpf-815	158	22	a	a	DET
ajpf-815	158	23	great	great	ADJ
ajpf-815	158	24	interest	interest	NOUN
ajpf-815	158	25	in	in	ADP
ajpf-815	158	26	discovering	discover	VERB
ajpf-815	158	27	new	new	ADJ
ajpf-815	158	28	effective	effective	ADJ
ajpf-815	158	29	and	and	CCONJ
ajpf-815	158	30	safe	safe	ADJ
ajpf-815	158	31	drugs	drug	NOUN
ajpf-815	158	32	.	.	PUNCT
ajpf-815	159	1	the	the	DET
ajpf-815	159	2	results	result	NOUN
ajpf-815	159	3	of	of	ADP
ajpf-815	159	4	this	this	DET
ajpf-815	159	5	present	present	ADJ
ajpf-815	159	6	work	work	NOUN
ajpf-815	159	7	suggest	suggest	VERB
ajpf-815	159	8	the	the	DET
ajpf-815	159	9	importance	importance	NOUN
ajpf-815	159	10	of	of	ADP
ajpf-815	159	11	searching	search	VERB
ajpf-815	159	12	for	for	ADP
ajpf-815	159	13	new	new	ADJ
ajpf-815	159	14	compounds	compound	NOUN
ajpf-815	159	15	for	for	ADP
ajpf-815	159	16	veterinary	veterinary	ADJ
ajpf-815	159	17	and	and	CCONJ
ajpf-815	159	18	human	human	ADJ
ajpf-815	159	19	medicine	medicine	NOUN
ajpf-815	159	20	in	in	ADP
ajpf-815	159	21	brazilian	brazilian	ADJ
ajpf-815	159	22	cerrado	cerrado	NOUN
ajpf-815	159	23	plants	plant	NOUN
ajpf-815	159	24	because	because	SCONJ
ajpf-815	159	25	they	they	PRON
ajpf-815	159	26	have	have	AUX
ajpf-815	159	27	shown	show	VERB
ajpf-815	159	28	potential	potential	NOUN
ajpf-815	159	29	for	for	ADP
ajpf-815	159	30	developing	develop	VERB
ajpf-815	159	31	new	new	ADJ
ajpf-815	159	32	antivirals	antiviral	NOUN
ajpf-815	159	33	.	.	PUNCT
ajpf-815	160	1	several	several	ADJ
ajpf-815	160	2	plant	plant	NOUN
ajpf-815	160	3	extracts	extract	NOUN
ajpf-815	160	4	with	with	ADP
ajpf-815	160	5	promising	promising	ADJ
ajpf-815	160	6	results	result	NOUN
ajpf-815	160	7	have	have	AUX
ajpf-815	160	8	been	be	AUX
ajpf-815	160	9	described	describe	VERB
ajpf-815	160	10	for	for	ADP
ajpf-815	160	11	their	their	PRON
ajpf-815	160	12	antiviral	antiviral	ADJ
ajpf-815	160	13	potential	potential	NOUN
ajpf-815	160	14	against	against	ADP
ajpf-815	160	15	diverse	diverse	ADJ
ajpf-815	160	16	herpes	herpe	NOUN
ajpf-815	160	17	viruses	virus	NOUN
ajpf-815	160	18	.	.	PUNCT
ajpf-815	161	1	for	for	ADP
ajpf-815	161	2	example	example	NOUN
ajpf-815	161	3	,	,	PUNCT
ajpf-815	161	4	cardamine	cardamine	NOUN
ajpf-815	161	5	angulata	angulata	NOUN
ajpf-815	161	6	,	,	PUNCT
ajpf-815	161	7	conocephalum	conocephalum	NOUN
ajpf-815	161	8	conicum	conicum	NOUN
ajpf-815	161	9	and	and	CCONJ
ajpf-815	161	10	polypodium	polypodium	NOUN
ajpf-815	161	11	glycyrrhiza	glycyrrhiza	NOUN
ajpf-815	161	12	showed	show	VERB
ajpf-815	161	13	activity	activity	NOUN
ajpf-815	161	14	against	against	ADP
ajpf-815	161	15	bovine	bovine	NOUN
ajpf-815	161	16	herpesvirus	herpesvirus	NOUN
ajpf-815	161	17	and	and	CCONJ
ajpf-815	161	18	hsv-1	hsv-1	X
ajpf-815	161	19	(	(	PUNCT
ajpf-815	161	20	mccutcheon	mccutcheon	PROPN
ajpf-815	161	21	et	et	PROPN
ajpf-815	161	22	al	al	PROPN
ajpf-815	161	23	.	.	PROPN
ajpf-815	161	24	,	,	PUNCT
ajpf-815	161	25	1995	1995	NUM
ajpf-815	161	26	)	)	PUNCT
ajpf-815	161	27	.	.	PUNCT
ajpf-815	162	1	aqueous	aqueous	ADJ
ajpf-815	162	2	extract	extract	NOUN
ajpf-815	162	3	from	from	ADP
ajpf-815	162	4	guettarda	guettarda	PROPN
ajpf-815	162	5	angelica	angelica	PROPN
ajpf-815	162	6	seeds	seed	NOUN
ajpf-815	162	7	exhibited	exhibit	VERB
ajpf-815	162	8	strong	strong	ADJ
ajpf-815	162	9	inhibition	inhibition	NOUN
ajpf-815	162	10	for	for	ADP
ajpf-815	162	11	three	three	NUM
ajpf-815	162	12	animal	animal	NOUN
ajpf-815	162	13	herpesviruses	herpesviruse	NOUN
ajpf-815	162	14	including	include	VERB
ajpf-815	162	15	bovine	bovine	NOUN
ajpf-815	162	16	,	,	PUNCT
ajpf-815	162	17	swine	swine	ADJ
ajpf-815	162	18	and	and	CCONJ
ajpf-815	162	19	equine	equine	NOUN
ajpf-815	162	20	herpesviruses	herpesviruse	NOUN
ajpf-815	162	21	1	1	NUM
ajpf-815	162	22	(	(	PUNCT
ajpf-815	162	23	barros	barros	X
ajpf-815	162	24	et	et	PROPN
ajpf-815	162	25	al	al	PROPN
ajpf-815	162	26	.	.	PROPN
ajpf-815	162	27	,	,	PUNCT
ajpf-815	162	28	2012	2012	NUM
ajpf-815	162	29	)	)	PUNCT
ajpf-815	162	30	.	.	PUNCT
ajpf-815	163	1	the	the	DET
ajpf-815	163	2	present	present	ADJ
ajpf-815	163	3	results	result	NOUN
ajpf-815	163	4	were	be	AUX
ajpf-815	163	5	promising	promise	VERB
ajpf-815	163	6	especially	especially	ADV
ajpf-815	163	7	for	for	ADP
ajpf-815	163	8	b.	b.	PROPN
ajpf-815	163	9	intermedia	intermedia	PROPN
ajpf-815	163	10	and	and	CCONJ
ajpf-815	163	11	indicating	indicate	VERB
ajpf-815	163	12	that	that	SCONJ
ajpf-815	163	13	materials	material	NOUN
ajpf-815	163	14	derived	derive	VERB
ajpf-815	163	15	from	from	ADP
ajpf-815	163	16	their	their	PRON
ajpf-815	163	17	7	7	NUM
ajpf-815	163	18	figure	figure	NOUN
ajpf-815	163	19	3	3	NUM
ajpf-815	163	20	.	.	PUNCT
ajpf-815	164	1	hplc	hplc	NOUN
ajpf-815	164	2	analysis	analysis	NOUN
ajpf-815	164	3	of	of	ADP
ajpf-815	164	4	crude	crude	ADJ
ajpf-815	164	5	aqueous	aqueous	ADJ
ajpf-815	164	6	extract	extract	NOUN
ajpf-815	164	7	from	from	ADP
ajpf-815	164	8	b.	b.	PROPN
ajpf-815	164	9	intermedia	intermedia	PROPN
ajpf-815	164	10	leaves	leave	NOUN
ajpf-815	164	11	and	and	CCONJ
ajpf-815	164	12	identified	identify	VERB
ajpf-815	164	13	compounds	compound	NOUN
ajpf-815	164	14	gallic	gallic	NOUN
ajpf-815	164	15	acid	acid	NOUN
ajpf-815	164	16	(	(	PUNCT
ajpf-815	164	17	a	a	NOUN
ajpf-815	164	18	)	)	PUNCT
ajpf-815	164	19	and	and	CCONJ
ajpf-815	164	20	quercetin	quercetin	NOUN
ajpf-815	164	21	(	(	PUNCT
ajpf-815	164	22	b	b	NOUN
ajpf-815	164	23	)	)	PUNCT
ajpf-815	164	24	.	.	PUNCT
ajpf-815	165	1	leaves	leave	NOUN
ajpf-815	165	2	exhibited	exhibit	VERB
ajpf-815	165	3	antiviral	antiviral	ADJ
ajpf-815	165	4	activity	activity	NOUN
ajpf-815	165	5	and	and	CCONJ
ajpf-815	165	6	selectivity	selectivity	NOUN
ajpf-815	165	7	toward	toward	ADP
ajpf-815	165	8	three	three	NUM
ajpf-815	165	9	herpesviruses	herpesviruse	NOUN
ajpf-815	165	10	hsv-1	hsv-1	PRON
ajpf-815	165	11	,	,	PUNCT
ajpf-815	165	12	eqhv-1	eqhv-1	NUM
ajpf-815	165	13	and	and	CCONJ
ajpf-815	165	14	suhv-1	suhv-1	NUM
ajpf-815	165	15	.	.	NOUN
ajpf-815	166	1	in	in	ADP
ajpf-815	166	2	2007	2007	NUM
ajpf-815	166	3	,	,	PUNCT
ajpf-815	166	4	simoni	simoni	PROPN
ajpf-815	166	5	et	et	PROPN
ajpf-815	166	6	al	al	PROPN
ajpf-815	166	7	.	.	PROPN
ajpf-815	167	1	(	(	PUNCT
ajpf-815	167	2	2007	2007	NUM
ajpf-815	167	3	)	)	PUNCT
ajpf-815	167	4	described	describe	VERB
ajpf-815	167	5	the	the	DET
ajpf-815	167	6	antiviral	antiviral	ADJ
ajpf-815	167	7	activity	activity	NOUN
ajpf-815	167	8	of	of	ADP
ajpf-815	167	9	the	the	DET
ajpf-815	167	10	b.	b.	PROPN
ajpf-815	167	11	intermedia	intermedia	PROPN
ajpf-815	167	12	against	against	ADP
ajpf-815	167	13	bovine	bovine	NOUN
ajpf-815	167	14	herpesvirus	herpesvirus	NOUN
ajpf-815	167	15	(	(	PUNCT
ajpf-815	167	16	bohv-1	bohv-1	NUM
ajpf-815	167	17	)	)	PUNCT
ajpf-815	167	18	and	and	CCONJ
ajpf-815	167	19	against	against	ADP
ajpf-815	167	20	avian	avian	ADJ
ajpf-815	167	21	reovirus	reovirus	NOUN
ajpf-815	167	22	indicating	indicate	VERB
ajpf-815	167	23	a	a	DET
ajpf-815	167	24	broad	broad	ADJ
ajpf-815	167	25	spectrum	spectrum	NOUN
ajpf-815	167	26	of	of	ADP
ajpf-815	167	27	action	action	NOUN
ajpf-815	167	28	of	of	ADP
ajpf-815	167	29	this	this	DET
ajpf-815	167	30	plant	plant	NOUN
ajpf-815	167	31	species	specie	NOUN
ajpf-815	167	32	.	.	PUNCT
ajpf-815	168	1	direct	direct	ADJ
ajpf-815	168	2	anti	anti	ADJ
ajpf-815	168	3	-	-	ADJ
ajpf-815	168	4	herpes	herpes	ADJ
ajpf-815	168	5	effect	effect	NOUN
ajpf-815	168	6	to	to	PART
ajpf-815	168	7	verify	verify	VERB
ajpf-815	168	8	if	if	SCONJ
ajpf-815	168	9	the	the	DET
ajpf-815	168	10	mechanism	mechanism	NOUN
ajpf-815	168	11	of	of	ADP
ajpf-815	168	12	action	action	NOUN
ajpf-815	168	13	of	of	ADP
ajpf-815	168	14	extracts	extract	NOUN
ajpf-815	168	15	is	be	AUX
ajpf-815	168	16	also	also	ADV
ajpf-815	168	17	due	due	ADJ
ajpf-815	168	18	to	to	ADP
ajpf-815	168	19	inhibition	inhibition	NOUN
ajpf-815	168	20	on	on	ADP
ajpf-815	168	21	the	the	DET
ajpf-815	168	22	viruses	virus	NOUN
ajpf-815	168	23	in	in	ADP
ajpf-815	168	24	extracellular	extracellular	ADJ
ajpf-815	168	25	conditions	condition	NOUN
ajpf-815	168	26	,	,	PUNCT
ajpf-815	168	27	the	the	DET
ajpf-815	168	28	selected	select	VERB
ajpf-815	168	29	extracts	extract	NOUN
ajpf-815	168	30	showing	show	VERB
ajpf-815	168	31	antiviral	antiviral	ADJ
ajpf-815	168	32	activity	activity	NOUN
ajpf-815	168	33	were	be	AUX
ajpf-815	168	34	studied	study	VERB
ajpf-815	168	35	.	.	PUNCT
ajpf-815	169	1	many	many	ADJ
ajpf-815	169	2	plants	plant	NOUN
ajpf-815	169	3	may	may	AUX
ajpf-815	169	4	exhibit	exhibit	VERB
ajpf-815	169	5	different	different	ADJ
ajpf-815	169	6	mechanisms	mechanism	NOUN
ajpf-815	169	7	of	of	ADP
ajpf-815	169	8	viral	viral	ADJ
ajpf-815	169	9	inhibition	inhibition	NOUN
ajpf-815	169	10	acting	act	VERB
ajpf-815	169	11	on	on	ADP
ajpf-815	169	12	more	more	ADJ
ajpf-815	169	13	than	than	ADP
ajpf-815	169	14	one	one	NUM
ajpf-815	169	15	target	target	NOUN
ajpf-815	169	16	during	during	ADP
ajpf-815	169	17	viral	viral	ADJ
ajpf-815	169	18	replication	replication	NOUN
ajpf-815	169	19	.	.	PUNCT
ajpf-815	170	1	the	the	DET
ajpf-815	170	2	opuntia	opuntia	PROPN
ajpf-815	170	3	streptacantha	streptacantha	PROPN
ajpf-815	170	4	inhibited	inhibit	VERB
ajpf-815	170	5	virus	virus	NOUN
ajpf-815	170	6	replication	replication	NOUN
ajpf-815	170	7	and	and	CCONJ
ajpf-815	170	8	inactivated	inactivated	ADJ
ajpf-815	170	9	extracellular	extracellular	ADJ
ajpf-815	170	10	virus	virus	NOUN
ajpf-815	170	11	,	,	PUNCT
ajpf-815	170	12	such	such	ADJ
ajpf-815	170	13	as	as	ADP
ajpf-815	170	14	hsv	hsv	PROPN
ajpf-815	170	15	,	,	PUNCT
ajpf-815	170	16	equine	equine	NOUN
ajpf-815	170	17	herpes	herpe	NOUN
ajpf-815	170	18	virus	virus	NOUN
ajpf-815	170	19	,	,	PUNCT
ajpf-815	170	20	pseudorabies	pseudorabie	NOUN
ajpf-815	170	21	virus	virus	NOUN
ajpf-815	170	22	(	(	PUNCT
ajpf-815	170	23	jassim	jassim	NOUN
ajpf-815	170	24	and	and	CCONJ
ajpf-815	170	25	naji	naji	PROPN
ajpf-815	170	26	,	,	PUNCT
ajpf-815	170	27	2003	2003	NUM
ajpf-815	170	28	)	)	PUNCT
ajpf-815	170	29	.	.	PUNCT
ajpf-815	171	1	bidens	bidens	PROPN
ajpf-815	171	2	pilosa	pilosa	PROPN
ajpf-815	171	3	extract	extract	NOUN
ajpf-815	171	4	was	be	AUX
ajpf-815	171	5	effective	effective	ADJ
ajpf-815	171	6	against	against	ADP
ajpf-815	171	7	hsv-1	hsv-1	PRON
ajpf-815	171	8	and	and	CCONJ
ajpf-815	171	9	hsv-2	hsv-2	PUNCT
ajpf-815	171	10	with	with	ADP
ajpf-815	171	11	potent	potent	ADJ
ajpf-815	171	12	virucidal	virucidal	NOUN
ajpf-815	171	13	activity	activity	NOUN
ajpf-815	171	14	(	(	PUNCT
ajpf-815	171	15	vadlapudi	vadlapudi	NOUN
ajpf-815	171	16	et	et	PROPN
ajpf-815	171	17	al	al	PROPN
ajpf-815	171	18	.	.	PROPN
ajpf-815	171	19	,	,	PUNCT
ajpf-815	171	20	2013	2013	NUM
ajpf-815	171	21	)	)	PUNCT
ajpf-815	171	22	.	.	PUNCT
ajpf-815	172	1	virucidal	virucidal	NOUN
ajpf-815	172	2	activity	activity	NOUN
ajpf-815	172	3	has	have	AUX
ajpf-815	172	4	also	also	ADV
ajpf-815	172	5	been	be	AUX
ajpf-815	172	6	described	describe	VERB
ajpf-815	172	7	in	in	ADP
ajpf-815	172	8	crude	crude	ADJ
ajpf-815	172	9	hydroethanolic	hydroethanolic	NOUN
ajpf-815	172	10	extract	extract	NOUN
ajpf-815	172	11	from	from	ADP
ajpf-815	172	12	the	the	DET
ajpf-815	172	13	stem	stem	NOUN
ajpf-815	172	14	bark	bark	NOUN
ajpf-815	172	15	of	of	ADP
ajpf-815	172	16	s.	s.	PROPN
ajpf-815	172	17	terebinthifolia	terebinthifolia	PROPN
ajpf-815	172	18	and	and	CCONJ
ajpf-815	172	19	was	be	AUX
ajpf-815	172	20	effective	effective	ADJ
ajpf-815	172	21	against	against	ADP
ajpf-815	172	22	hvs-1	hvs-1	NOUN
ajpf-815	172	23	in	in	ADP
ajpf-815	172	24	the	the	DET
ajpf-815	172	25	attachment	attachment	NOUN
ajpf-815	172	26	and	and	CCONJ
ajpf-815	172	27	penetration	penetration	NOUN
ajpf-815	172	28	stages	stage	NOUN
ajpf-815	172	29	(	(	PUNCT
ajpf-815	172	30	nocchi	nocchi	NOUN
ajpf-815	172	31	et	et	PROPN
ajpf-815	172	32	al	al	PROPN
ajpf-815	172	33	.	.	PROPN
ajpf-815	172	34	,	,	PUNCT
ajpf-815	172	35	2016	2016	NUM
ajpf-815	172	36	)	)	PUNCT
ajpf-815	172	37	.	.	PUNCT
ajpf-815	173	1	moreover	moreover	ADV
ajpf-815	173	2	,	,	PUNCT
ajpf-815	173	3	hot	hot	ADJ
ajpf-815	173	4	water	water	NOUN
ajpf-815	173	5	extract	extract	NOUN
ajpf-815	173	6	of	of	ADP
ajpf-815	173	7	b.	b.	PROPN
ajpf-815	173	8	pilosa	pilosa	PROPN
ajpf-815	173	9	showed	show	VERB
ajpf-815	173	10	potent	potent	ADJ
ajpf-815	173	11	inhibitory	inhibitory	ADJ
ajpf-815	173	12	activity	activity	NOUN
ajpf-815	173	13	against	against	ADP
ajpf-815	173	14	hsv-1	hsv-1	PUNCT
ajpf-815	173	15	and	and	CCONJ
ajpf-815	173	16	hsv-2	hsv-2	PUNCT
ajpf-815	173	17	in	in	ADP
ajpf-815	173	18	vero	vero	PROPN
ajpf-815	173	19	cells	cell	NOUN
ajpf-815	173	20	.	.	PUNCT
ajpf-815	174	1	the	the	DET
ajpf-815	174	2	authors	author	NOUN
ajpf-815	174	3	suggest	suggest	VERB
ajpf-815	174	4	multiple	multiple	ADJ
ajpf-815	174	5	targets	target	NOUN
ajpf-815	174	6	of	of	ADP
ajpf-815	174	7	activity	activity	NOUN
ajpf-815	174	8	because	because	SCONJ
ajpf-815	174	9	this	this	DET
ajpf-815	174	10	extract	extract	NOUN
ajpf-815	174	11	showed	show	VERB
ajpf-815	174	12	virucidal	virucidal	ADJ
ajpf-815	174	13	activity	activity	NOUN
ajpf-815	174	14	to	to	PART
ajpf-815	174	15	block	block	VERB
ajpf-815	174	16	the	the	DET
ajpf-815	174	17	binding	binding	NOUN
ajpf-815	174	18	of	of	ADP
ajpf-815	174	19	virus	virus	NOUN
ajpf-815	174	20	to	to	PART
ajpf-815	174	21	host	host	NOUN
ajpf-815	174	22	cells	cell	NOUN
ajpf-815	174	23	and	and	CCONJ
ajpf-815	174	24	viral	viral	ADJ
ajpf-815	174	25	cell	cell	NOUN
ajpf-815	174	26	penetration	penetration	NOUN
ajpf-815	174	27	.	.	PUNCT
ajpf-815	175	1	the	the	DET
ajpf-815	175	2	b.	b.	PROPN
ajpf-815	175	3	pilosa	pilosa	PROPN
ajpf-815	175	4	extract	extract	NOUN
ajpf-815	175	5	also	also	ADV
ajpf-815	175	6	inhibits	inhibit	VERB
ajpf-815	175	7	virus	virus	NOUN
ajpf-815	175	8	adsorption	adsorption	NOUN
ajpf-815	175	9	to	to	ADP
ajpf-815	175	10	cells	cell	NOUN
ajpf-815	175	11	and	and	CCONJ
ajpf-815	175	12	affects	affect	VERB
ajpf-815	175	13	some	some	DET
ajpf-815	175	14	intracellular	intracellular	ADJ
ajpf-815	175	15	steps	step	NOUN
ajpf-815	175	16	of	of	ADP
ajpf-815	175	17	viral	viral	ADJ
ajpf-815	175	18	replication	replication	NOUN
ajpf-815	175	19	(	(	PUNCT
ajpf-815	175	20	nakama	nakama	PROPN
ajpf-815	175	21	et	et	PROPN
ajpf-815	175	22	al	al	PROPN
ajpf-815	175	23	.	.	PROPN
ajpf-815	175	24	,	,	PUNCT
ajpf-815	175	25	2012	2012	NUM
ajpf-815	175	26	)	)	PUNCT
ajpf-815	175	27	.	.	PUNCT
ajpf-815	176	1	these	these	DET
ajpf-815	176	2	findings	finding	NOUN
ajpf-815	176	3	are	be	AUX
ajpf-815	176	4	in	in	ADP
ajpf-815	176	5	agreement	agreement	NOUN
ajpf-815	176	6	with	with	ADP
ajpf-815	176	7	those	those	PRON
ajpf-815	176	8	observed	observe	VERB
ajpf-815	176	9	in	in	ADP
ajpf-815	176	10	this	this	DET
ajpf-815	176	11	study	study	NOUN
ajpf-815	176	12	.	.	PUNCT
ajpf-815	177	1	additional	additional	ADJ
ajpf-815	177	2	studies	study	NOUN
ajpf-815	177	3	with	with	ADP
ajpf-815	177	4	byrsonima	byrsonima	NOUN
ajpf-815	177	5	intermedia	intermedia	PROPN
ajpf-815	177	6	the	the	DET
ajpf-815	177	7	extracts	extract	NOUN
ajpf-815	177	8	from	from	ADP
ajpf-815	177	9	b.	b.	PROPN
ajpf-815	177	10	intermedia	intermedia	PROPN
ajpf-815	177	11	were	be	AUX
ajpf-815	177	12	tested	test	VERB
ajpf-815	177	13	in	in	ADP
ajpf-815	177	14	their	their	PRON
ajpf-815	177	15	8	8	NUM
ajpf-815	177	16	maximum	maximum	ADJ
ajpf-815	177	17	non	non	ADJ
ajpf-815	177	18	-	-	ADJ
ajpf-815	177	19	toxic	toxic	ADJ
ajpf-815	177	20	concentrations	concentration	NOUN
ajpf-815	177	21	in	in	ADP
ajpf-815	177	22	which	which	PRON
ajpf-815	177	23	no	no	DET
ajpf-815	177	24	alteration	alteration	NOUN
ajpf-815	177	25	of	of	ADP
ajpf-815	177	26	normal	normal	ADJ
ajpf-815	177	27	cell	cell	NOUN
ajpf-815	177	28	morphology	morphology	NOUN
ajpf-815	177	29	was	be	AUX
ajpf-815	177	30	observed	observe	VERB
ajpf-815	177	31	,	,	PUNCT
ajpf-815	177	32	and	and	CCONJ
ajpf-815	177	33	the	the	DET
ajpf-815	177	34	cc50	cc50	PROPN
ajpf-815	177	35	for	for	ADP
ajpf-815	177	36	both	both	CCONJ
ajpf-815	177	37	mdbk	mdbk	NOUN
ajpf-815	177	38	and	and	CCONJ
ajpf-815	177	39	vero	vero	PROPN
ajpf-815	177	40	cells	cell	NOUN
ajpf-815	177	41	was	be	AUX
ajpf-815	177	42	obtained	obtain	VERB
ajpf-815	177	43	.	.	PUNCT
ajpf-815	178	1	therefore	therefore	ADV
ajpf-815	178	2	,	,	PUNCT
ajpf-815	178	3	the	the	DET
ajpf-815	178	4	extract	extract	NOUN
ajpf-815	178	5	showed	show	VERB
ajpf-815	178	6	no	no	DET
ajpf-815	178	7	toxicity	toxicity	NOUN
ajpf-815	178	8	even	even	ADV
ajpf-815	178	9	when	when	SCONJ
ajpf-815	178	10	used	use	VERB
ajpf-815	178	11	at	at	ADP
ajpf-815	178	12	high	high	ADJ
ajpf-815	178	13	concentrations	concentration	NOUN
ajpf-815	178	14	in	in	ADP
ajpf-815	178	15	the	the	DET
ajpf-815	178	16	reduction	reduction	NOUN
ajpf-815	178	17	of	of	ADP
ajpf-815	178	18	viral	viral	ADJ
ajpf-815	178	19	titers	titer	NOUN
ajpf-815	178	20	assay	assay	VERB
ajpf-815	178	21	and	and	CCONJ
ajpf-815	178	22	direct	direct	ADJ
ajpf-815	178	23	anti	anti	ADJ
ajpf-815	178	24	-	-	ADJ
ajpf-815	178	25	herpes	herpe	NOUN
ajpf-815	178	26	assay	assay	NOUN
ajpf-815	178	27	.	.	PUNCT
ajpf-815	179	1	further	far	ADV
ajpf-815	179	2	,	,	PUNCT
ajpf-815	179	3	b.	b.	PROPN
ajpf-815	179	4	intermedia	intermedia	PROPN
ajpf-815	179	5	extracts	extract	NOUN
ajpf-815	179	6	showed	show	VERB
ajpf-815	179	7	anti	anti	ADJ
ajpf-815	179	8	-	-	ADJ
ajpf-815	179	9	herpes	herpes	ADJ
ajpf-815	179	10	activity	activity	NOUN
ajpf-815	179	11	in	in	ADP
ajpf-815	179	12	a	a	DET
ajpf-815	179	13	concentration	concentration	NOUN
ajpf-815	179	14	-	-	PUNCT
ajpf-815	179	15	dependent	dependent	ADJ
ajpf-815	179	16	manner	manner	NOUN
ajpf-815	179	17	in	in	ADP
ajpf-815	179	18	both	both	DET
ajpf-815	179	19	assays	assay	NOUN
ajpf-815	179	20	,	,	PUNCT
ajpf-815	179	21	suggesting	suggest	VERB
ajpf-815	179	22	that	that	SCONJ
ajpf-815	179	23	this	this	DET
ajpf-815	179	24	effect	effect	NOUN
ajpf-815	179	25	may	may	AUX
ajpf-815	179	26	have	have	AUX
ajpf-815	179	27	occurred	occur	VERB
ajpf-815	179	28	either	either	CCONJ
ajpf-815	179	29	acting	act	VERB
ajpf-815	179	30	directly	directly	ADV
ajpf-815	179	31	on	on	ADP
ajpf-815	179	32	the	the	DET
ajpf-815	179	33	viral	viral	ADJ
ajpf-815	179	34	particle	particle	NOUN
ajpf-815	179	35	or	or	CCONJ
ajpf-815	179	36	in	in	ADP
ajpf-815	179	37	other	other	ADJ
ajpf-815	179	38	stages	stage	NOUN
ajpf-815	179	39	of	of	ADP
ajpf-815	179	40	the	the	DET
ajpf-815	179	41	replicative	replicative	ADJ
ajpf-815	179	42	cycle	cycle	NOUN
ajpf-815	179	43	.	.	PUNCT
ajpf-815	180	1	additional	additional	ADJ
ajpf-815	180	2	studies	study	NOUN
ajpf-815	180	3	should	should	AUX
ajpf-815	180	4	be	be	AUX
ajpf-815	180	5	done	do	VERB
ajpf-815	180	6	to	to	PART
ajpf-815	180	7	study	study	VERB
ajpf-815	180	8	the	the	DET
ajpf-815	180	9	mechanism	mechanism	NOUN
ajpf-815	180	10	of	of	ADP
ajpf-815	180	11	action	action	NOUN
ajpf-815	180	12	of	of	ADP
ajpf-815	180	13	extracts	extract	NOUN
ajpf-815	180	14	of	of	ADP
ajpf-815	180	15	b.	b.	PROPN
ajpf-815	180	16	intermedia	intermedia	PROPN
ajpf-815	180	17	against	against	ADP
ajpf-815	180	18	those	those	DET
ajpf-815	180	19	herpesviruses	herpesviruse	NOUN
ajpf-815	180	20	indicating	indicate	VERB
ajpf-815	180	21	at	at	ADP
ajpf-815	180	22	which	which	DET
ajpf-815	180	23	stage	stage	NOUN
ajpf-815	180	24	the	the	DET
ajpf-815	180	25	extract	extract	NOUN
ajpf-815	180	26	has	have	VERB
ajpf-815	180	27	activity	activity	NOUN
ajpf-815	180	28	against	against	ADP
ajpf-815	180	29	viruses	virus	NOUN
ajpf-815	180	30	.	.	PUNCT
ajpf-815	181	1	phytochemical	phytochemical	ADJ
ajpf-815	181	2	profile	profile	NOUN
ajpf-815	181	3	using	use	VERB
ajpf-815	181	4	dereplication	dereplication	NOUN
ajpf-815	181	5	procedures	procedure	NOUN
ajpf-815	181	6	by	by	ADP
ajpf-815	181	7	hplc	hplc	PROPN
ajpf-815	181	8	/	/	SYM
ajpf-815	181	9	ms	ms	PROPN
ajpf-815	181	10	,	,	PUNCT
ajpf-815	181	11	the	the	DET
ajpf-815	181	12	occurrence	occurrence	NOUN
ajpf-815	181	13	of	of	ADP
ajpf-815	181	14	gallic	gallic	ADJ
ajpf-815	181	15	acid	acid	NOUN
ajpf-815	181	16	and	and	CCONJ
ajpf-815	181	17	quercetin	quercetin	NOUN
ajpf-815	181	18	in	in	ADP
ajpf-815	181	19	the	the	DET
ajpf-815	181	20	active	active	ADJ
ajpf-815	181	21	extracts	extract	NOUN
ajpf-815	181	22	from	from	ADP
ajpf-815	181	23	b.	b.	PROPN
ajpf-815	181	24	intermedia	intermedia	PROPN
ajpf-815	181	25	was	be	AUX
ajpf-815	181	26	identified	identify	VERB
ajpf-815	181	27	.	.	PUNCT
ajpf-815	182	1	as	as	SCONJ
ajpf-815	182	2	previously	previously	ADV
ajpf-815	182	3	reported	report	VERB
ajpf-815	182	4	,	,	PUNCT
ajpf-815	182	5	these	these	DET
ajpf-815	182	6	compounds	compound	NOUN
ajpf-815	182	7	were	be	AUX
ajpf-815	182	8	detected	detect	VERB
ajpf-815	182	9	in	in	ADP
ajpf-815	182	10	the	the	DET
ajpf-815	182	11	meoh	meoh	NOUN
ajpf-815	182	12	leaves	leave	VERB
ajpf-815	182	13	extract	extract	VERB
ajpf-815	182	14	from	from	ADP
ajpf-815	182	15	b.	b.	PROPN
ajpf-815	182	16	intermedia	intermedia	PROPN
ajpf-815	182	17	which	which	PRON
ajpf-815	182	18	displayed	display	VERB
ajpf-815	182	19	mutagenic	mutagenic	ADJ
ajpf-815	182	20	activity	activity	NOUN
ajpf-815	182	21	(	(	PUNCT
ajpf-815	182	22	sannomiya	sannomiya	NOUN
ajpf-815	182	23	et	et	PROPN
ajpf-815	182	24	al	al	PROPN
ajpf-815	182	25	.	.	PROPN
ajpf-815	182	26	,	,	PUNCT
ajpf-815	182	27	2007	2007	NUM
ajpf-815	182	28	)	)	PUNCT
ajpf-815	182	29	.	.	PUNCT
ajpf-815	183	1	gallic	gallic	NOUN
ajpf-815	183	2	acid	acid	PROPN
ajpf-815	183	3	is	be	AUX
ajpf-815	183	4	a	a	DET
ajpf-815	183	5	phenolic	phenolic	ADJ
ajpf-815	183	6	compound	compound	NOUN
ajpf-815	183	7	present	present	ADJ
ajpf-815	183	8	in	in	ADP
ajpf-815	183	9	many	many	ADJ
ajpf-815	183	10	plants	plant	NOUN
ajpf-815	183	11	,	,	PUNCT
ajpf-815	183	12	fruits	fruit	NOUN
ajpf-815	183	13	and	and	CCONJ
ajpf-815	183	14	vegetables	vegetable	NOUN
ajpf-815	183	15	.	.	PUNCT
ajpf-815	184	1	studies	study	NOUN
ajpf-815	184	2	have	have	AUX
ajpf-815	184	3	demonstrated	demonstrate	VERB
ajpf-815	184	4	that	that	SCONJ
ajpf-815	184	5	gallic	gallic	NOUN
ajpf-815	184	6	acid	acid	NOUN
ajpf-815	184	7	exhibits	exhibit	VERB
ajpf-815	184	8	a	a	DET
ajpf-815	184	9	strong	strong	ADJ
ajpf-815	184	10	inhibitory	inhibitory	ADJ
ajpf-815	184	11	effect	effect	NOUN
ajpf-815	184	12	against	against	ADP
ajpf-815	184	13	several	several	ADJ
ajpf-815	184	14	viruses	virus	NOUN
ajpf-815	184	15	such	such	ADJ
ajpf-815	184	16	as	as	ADP
ajpf-815	184	17	the	the	DET
ajpf-815	184	18	herpes	herpe	NOUN
ajpf-815	184	19	simplex	simplex	NOUN
ajpf-815	184	20	virus	virus	NOUN
ajpf-815	184	21	,	,	PUNCT
ajpf-815	184	22	hepatite	hepatite	PROPN
ajpf-815	184	23	c	c	PROPN
ajpf-815	184	24	virus	virus	NOUN
ajpf-815	184	25	,	,	PUNCT
ajpf-815	184	26	hiv	hiv	PROPN
ajpf-815	184	27	and	and	CCONJ
ajpf-815	184	28	enterovirus	enterovirus	NOUN
ajpf-815	184	29	71	71	NUM
ajpf-815	184	30	.	.	PUNCT
ajpf-815	185	1	therefore	therefore	ADV
ajpf-815	185	2	,	,	PUNCT
ajpf-815	185	3	the	the	DET
ajpf-815	185	4	potential	potential	ADJ
ajpf-815	185	5	activity	activity	NOUN
ajpf-815	185	6	observed	observe	VERB
ajpf-815	185	7	by	by	ADP
ajpf-815	185	8	ga	ga	PROPN
ajpf-815	185	9	suggests	suggest	VERB
ajpf-815	185	10	that	that	SCONJ
ajpf-815	185	11	this	this	DET
ajpf-815	185	12	activity	activity	NOUN
ajpf-815	185	13	is	be	AUX
ajpf-815	185	14	due	due	ADJ
ajpf-815	185	15	to	to	ADP
ajpf-815	185	16	the	the	DET
ajpf-815	185	17	hydrophobic	hydrophobic	NOUN
ajpf-815	185	18	interaction	interaction	NOUN
ajpf-815	185	19	between	between	ADP
ajpf-815	185	20	the	the	DET
ajpf-815	185	21	functional	functional	ADJ
ajpf-815	185	22	group	group	NOUN
ajpf-815	185	23	,	,	PUNCT
ajpf-815	185	24	(	(	PUNCT
ajpf-815	185	25	hydroxyl	hydroxyl	NOUN
ajpf-815	185	26	)	)	PUNCT
ajpf-815	185	27	and	and	CCONJ
ajpf-815	185	28	virion	virion	NOUN
ajpf-815	185	29	components	component	NOUN
ajpf-815	185	30	of	of	ADP
ajpf-815	185	31	enveloped	envelop	VERB
ajpf-815	185	32	herpesvirus	herpesvirus	NOUN
ajpf-815	185	33	.	.	PUNCT
ajpf-815	186	1	in	in	ADP
ajpf-815	186	2	addition	addition	NOUN
ajpf-815	186	3	,	,	PUNCT
ajpf-815	186	4	gallic	gallic	NOUN
ajpf-815	186	5	acid	acid	PROPN
ajpf-815	186	6	showed	show	VERB
ajpf-815	186	7	an	an	DET
ajpf-815	186	8	inhibitory	inhibitory	ADJ
ajpf-815	186	9	effect	effect	NOUN
ajpf-815	186	10	in	in	ADP
ajpf-815	186	11	a	a	DET
ajpf-815	186	12	time	time	NOUN
ajpf-815	186	13	-	-	PUNCT
ajpf-815	186	14	dependent	dependent	ADJ
ajpf-815	186	15	manner	manner	NOUN
ajpf-815	186	16	,	,	PUNCT
ajpf-815	186	17	notably	notably	ADV
ajpf-815	186	18	similar	similar	ADJ
ajpf-815	186	19	to	to	ADP
ajpf-815	186	20	the	the	DET
ajpf-815	186	21	current	current	ADJ
ajpf-815	186	22	study	study	NOUN
ajpf-815	186	23	(	(	PUNCT
ajpf-815	186	24	govea‑	govea‑	PROPN
ajpf-815	186	25	salas	salas	PROPN
ajpf-815	186	26	et	et	PROPN
ajpf-815	186	27	al	al	PROPN
ajpf-815	186	28	.	.	PROPN
ajpf-815	186	29	,	,	PUNCT
ajpf-815	186	30	2016	2016	NUM
ajpf-815	186	31	)	)	PUNCT
ajpf-815	186	32	.	.	PUNCT
ajpf-815	187	1	quercetin	quercetin	NOUN
ajpf-815	187	2	,	,	PUNCT
ajpf-815	187	3	a	a	DET
ajpf-815	187	4	flavonoid	flavonoid	NOUN
ajpf-815	187	5	found	find	VERB
ajpf-815	187	6	in	in	ADP
ajpf-815	187	7	several	several	ADJ
ajpf-815	187	8	plant	plant	NOUN
ajpf-815	187	9	species	specie	NOUN
ajpf-815	187	10	,	,	PUNCT
ajpf-815	187	11	including	include	VERB
ajpf-815	187	12	fruits	fruit	NOUN
ajpf-815	187	13	and	and	CCONJ
ajpf-815	187	14	edible	edible	ADJ
ajpf-815	187	15	vegetables	vegetable	NOUN
ajpf-815	187	16	,	,	PUNCT
ajpf-815	187	17	displayed	display	VERB
ajpf-815	187	18	several	several	ADJ
ajpf-815	187	19	biological	biological	ADJ
ajpf-815	187	20	potentials	potential	NOUN
ajpf-815	187	21	(	(	PUNCT
ajpf-815	187	22	sharma	sharma	PROPN
ajpf-815	187	23	et	et	PROPN
ajpf-815	187	24	al	al	PROPN
ajpf-815	187	25	.	.	PROPN
ajpf-815	187	26	,	,	PUNCT
ajpf-815	187	27	2018	2018	NUM
ajpf-815	187	28	)	)	PUNCT
ajpf-815	187	29	,	,	PUNCT
ajpf-815	187	30	including	include	VERB
ajpf-815	187	31	antiviral	antiviral	NOUN
ajpf-815	187	32	against	against	ADP
ajpf-815	187	33	hsv-1	hsv-1	PRON
ajpf-815	187	34	(	(	PUNCT
ajpf-815	187	35	garrett	garrett	PROPN
ajpf-815	187	36	et	et	PROPN
ajpf-815	187	37	al	al	PROPN
ajpf-815	187	38	.	.	PROPN
ajpf-815	187	39	,	,	PUNCT
ajpf-815	187	40	2012	2012	NUM
ajpf-815	187	41	)	)	PUNCT
ajpf-815	187	42	.	.	PUNCT
ajpf-815	188	1	additionally	additionally	ADV
ajpf-815	188	2	,	,	PUNCT
ajpf-815	188	3	choi	choi	PROPN
ajpf-815	188	4	et	et	PROPN
ajpf-815	188	5	al	al	PROPN
ajpf-815	188	6	.	.	PROPN
ajpf-815	189	1	(	(	PUNCT
ajpf-815	189	2	2009	2009	NUM
ajpf-815	189	3	)	)	PUNCT
ajpf-815	189	4	described	describe	VERB
ajpf-815	189	5	that	that	SCONJ
ajpf-815	189	6	quercetin-3	quercetin-3	NOUN
ajpf-815	189	7	-	-	PUNCT
ajpf-815	189	8	rhamnoside	rhamnoside	NOUN
ajpf-815	189	9	from	from	ADP
ajpf-815	189	10	houttynia	houttynia	NOUN
ajpf-815	189	11	cordata	cordata	NOUN
ajpf-815	189	12	extract	extract	NOUN
ajpf-815	189	13	inhibit	inhibit	VERB
ajpf-815	189	14	influenza	influenza	NOUN
ajpf-815	189	15	a	a	DET
ajpf-815	189	16	replication	replication	NOUN
ajpf-815	189	17	in	in	ADP
ajpf-815	189	18	the	the	DET
ajpf-815	189	19	initial	initial	ADJ
ajpf-815	189	20	stage	stage	NOUN
ajpf-815	189	21	of	of	ADP
ajpf-815	189	22	virus	virus	NOUN
ajpf-815	189	23	infection	infection	NOUN
ajpf-815	189	24	by	by	ADP
ajpf-815	189	25	indirect	indirect	ADJ
ajpf-815	189	26	interaction	interaction	NOUN
ajpf-815	189	27	with	with	ADP
ajpf-815	189	28	virus	virus	NOUN
ajpf-815	189	29	particles	particle	NOUN
ajpf-815	189	30	.	.	PUNCT
ajpf-815	190	1	new	new	ADJ
ajpf-815	190	2	studies	study	NOUN
ajpf-815	190	3	are	be	AUX
ajpf-815	190	4	needed	need	VERB
ajpf-815	190	5	to	to	PART
ajpf-815	190	6	bring	bring	VERB
ajpf-815	190	7	the	the	DET
ajpf-815	190	8	active	active	ADJ
ajpf-815	190	9	substances	substance	NOUN
ajpf-815	190	10	present	present	ADJ
ajpf-815	190	11	in	in	ADP
ajpf-815	190	12	b.	b.	PROPN
ajpf-815	190	13	intermedia	intermedia	PROPN
ajpf-815	190	14	extract	extract	NOUN
ajpf-815	190	15	and	and	CCONJ
ajpf-815	190	16	to	to	PART
ajpf-815	190	17	identify	identify	VERB
ajpf-815	190	18	in	in	ADP
ajpf-815	190	19	detail	detail	NOUN
ajpf-815	190	20	the	the	DET
ajpf-815	190	21	ways	way	NOUN
ajpf-815	190	22	in	in	ADP
ajpf-815	190	23	which	which	PRON
ajpf-815	190	24	they	they	PRON
ajpf-815	190	25	act	act	VERB
ajpf-815	190	26	.	.	PUNCT
ajpf-815	191	1	the	the	DET
ajpf-815	191	2	other	other	ADJ
ajpf-815	191	3	extracts	extract	NOUN
ajpf-815	191	4	that	that	PRON
ajpf-815	191	5	can	can	AUX
ajpf-815	191	6	be	be	AUX
ajpf-815	191	7	considered	consider	VERB
ajpf-815	191	8	promising	promise	VERB
ajpf-815	191	9	must	must	AUX
ajpf-815	191	10	also	also	ADV
ajpf-815	191	11	pass	pass	VERB
ajpf-815	191	12	through	through	ADP
ajpf-815	191	13	the	the	DET
ajpf-815	191	14	processes	process	NOUN
ajpf-815	191	15	of	of	ADP
ajpf-815	191	16	fractionation	fractionation	NOUN
ajpf-815	191	17	and	and	CCONJ
ajpf-815	191	18	isolation	isolation	NOUN
ajpf-815	191	19	of	of	ADP
ajpf-815	191	20	substances	substance	NOUN
ajpf-815	191	21	in	in	ADP
ajpf-815	191	22	order	order	NOUN
ajpf-815	191	23	to	to	PART
ajpf-815	191	24	verify	verify	VERB
ajpf-815	191	25	the	the	DET
ajpf-815	191	26	potential	potential	NOUN
ajpf-815	191	27	of	of	ADP
ajpf-815	191	28	this	this	DET
ajpf-815	191	29	activity	activity	NOUN
ajpf-815	191	30	.	.	PUNCT
ajpf-815	192	1	all	all	PRON
ajpf-815	192	2	of	of	ADP
ajpf-815	192	3	them	they	PRON
ajpf-815	192	4	here	here	ADV
ajpf-815	192	5	have	have	AUX
ajpf-815	192	6	shown	show	VERB
ajpf-815	192	7	their	their	PRON
ajpf-815	192	8	potential	potential	NOUN
ajpf-815	192	9	to	to	PART
ajpf-815	192	10	lead	lead	VERB
ajpf-815	192	11	to	to	ADP
ajpf-815	192	12	the	the	DET
ajpf-815	192	13	development	development	NOUN
ajpf-815	192	14	of	of	ADP
ajpf-815	192	15	an	an	DET
ajpf-815	192	16	alternative	alternative	ADJ
ajpf-815	192	17	therapy	therapy	NOUN
ajpf-815	192	18	for	for	ADP
ajpf-815	192	19	the	the	DET
ajpf-815	192	20	treatment	treatment	NOUN
ajpf-815	192	21	of	of	ADP
ajpf-815	192	22	such	such	ADJ
ajpf-815	192	23	important	important	ADJ
ajpf-815	192	24	infections	infection	NOUN
ajpf-815	192	25	worldwide	worldwide	ADV
ajpf-815	192	26	.	.	PUNCT
ajpf-815	193	1	conclusion	conclusion	NOUN
ajpf-815	193	2	this	this	DET
ajpf-815	193	3	study	study	NOUN
ajpf-815	193	4	has	have	AUX
ajpf-815	193	5	demonstrated	demonstrate	VERB
ajpf-815	193	6	a	a	DET
ajpf-815	193	7	broad	broad	ADJ
ajpf-815	193	8	antiviral	antiviral	ADJ
ajpf-815	193	9	activity	activity	NOUN
ajpf-815	193	10	of	of	ADP
ajpf-815	193	11	brazilian	brazilian	ADJ
ajpf-815	193	12	cerrado	cerrado	NOUN
ajpf-815	193	13	plants	plant	NOUN
ajpf-815	193	14	and	and	CCONJ
ajpf-815	193	15	indicated	indicate	VERB
ajpf-815	193	16	that	that	SCONJ
ajpf-815	193	17	they	they	PRON
ajpf-815	193	18	can	can	AUX
ajpf-815	193	19	be	be	AUX
ajpf-815	193	20	effective	effective	ADJ
ajpf-815	193	21	potential	potential	ADJ
ajpf-815	193	22	candidates	candidate	NOUN
ajpf-815	193	23	for	for	ADP
ajpf-815	193	24	the	the	DET
ajpf-815	193	25	development	development	NOUN
ajpf-815	193	26	of	of	ADP
ajpf-815	193	27	new	new	ADJ
ajpf-815	193	28	strategies	strategy	NOUN
ajpf-815	193	29	to	to	PART
ajpf-815	193	30	treat	treat	VERB
ajpf-815	193	31	viral	viral	ADJ
ajpf-815	193	32	infections	infection	NOUN
ajpf-815	193	33	.	.	PUNCT
ajpf-815	194	1	b.	b.	PROPN
ajpf-815	194	2	intermedia	intermedia	PROPN
ajpf-815	194	3	was	be	AUX
ajpf-815	194	4	chosen	choose	VERB
ajpf-815	194	5	for	for	ADP
ajpf-815	194	6	further	further	ADJ
ajpf-815	194	7	research	research	NOUN
ajpf-815	194	8	as	as	ADV
ajpf-815	194	9	well	well	ADV
ajpf-815	194	10	as	as	ADP
ajpf-815	194	11	gallic	gallic	ADJ
ajpf-815	194	12	acid	acid	NOUN
ajpf-815	194	13	and	and	CCONJ
ajpf-815	194	14	quercetin	quercetin	NOUN
ajpf-815	194	15	all	all	PRON
ajpf-815	194	16	necessary	necessary	ADJ
ajpf-815	194	17	to	to	PART
ajpf-815	194	18	elucidate	elucidate	VERB
ajpf-815	194	19	the	the	DET
ajpf-815	194	20	mechanism	mechanism	NOUN
ajpf-815	194	21	of	of	ADP
ajpf-815	194	22	action	action	NOUN
ajpf-815	194	23	of	of	ADP
ajpf-815	194	24	the	the	DET
ajpf-815	194	25	extract	extract	NOUN
ajpf-815	194	26	or	or	CCONJ
ajpf-815	194	27	compounds	compound	VERB
ajpf-815	194	28	both	both	PRON
ajpf-815	194	29	on	on	ADP
ajpf-815	194	30	herpesviruses	herpesviruse	NOUN
ajpf-815	194	31	replication	replication	NOUN
ajpf-815	194	32	and	and	CCONJ
ajpf-815	194	33	on	on	ADP
ajpf-815	194	34	direct	direct	ADJ
ajpf-815	194	35	antiviral	antiviral	ADJ
ajpf-815	194	36	effect	effect	NOUN
ajpf-815	194	37	.	.	PUNCT
ajpf-815	195	1	conflict	conflict	NOUN
ajpf-815	195	2	of	of	ADP
ajpf-815	195	3	interests	interest	NOUN
ajpf-815	195	4	the	the	DET
ajpf-815	195	5	authors	author	NOUN
ajpf-815	195	6	have	have	AUX
ajpf-815	195	7	not	not	PART
ajpf-815	195	8	declared	declare	VERB
ajpf-815	195	9	any	any	DET
ajpf-815	195	10	conflict	conflict	NOUN
ajpf-815	195	11	of	of	ADP
ajpf-815	195	12	interests	interest	NOUN
ajpf-815	195	13	.	.	PUNCT
ajpf-815	196	1	acknowledgements	acknowledgement	NOUN
ajpf-815	196	2	the	the	DET
ajpf-815	196	3	authors	author	NOUN
ajpf-815	196	4	are	be	AUX
ajpf-815	196	5	thankful	thankful	ADJ
ajpf-815	196	6	to	to	ADP
ajpf-815	196	7	the	the	DET
ajpf-815	196	8	enrica	enrica	PROPN
ajpf-815	196	9	g.	g.	PROPN
ajpf-815	196	10	d‟alessandro	d‟alessandro	NOUN
ajpf-815	196	11	for	for	ADP
ajpf-815	196	12	reviewing	review	VERB
ajpf-815	196	13	english	english	PROPN
ajpf-815	196	14	.	.	PUNCT
ajpf-815	197	1	references	reference	NOUN
ajpf-815	197	2	alves	alves	PROPN
ajpf-815	197	3	tma	tma	PROPN
ajpf-815	197	4	,	,	PUNCT
ajpf-815	197	5	silva	silva	PROPN
ajpf-815	197	6	af	af	PROPN
ajpf-815	197	7	,	,	PUNCT
ajpf-815	197	8	brandão	brandão	PROPN
ajpf-815	197	9	m	m	PROPN
ajpf-815	197	10	,	,	PUNCT
ajpf-815	197	11	grandi	grandi	X
ajpf-815	197	12	tsm	tsm	NOUN
ajpf-815	197	13	,	,	PUNCT
ajpf-815	197	14	smânia	smânia	PROPN
ajpf-815	197	15	efa	efa	PROPN
ajpf-815	197	16	,	,	PUNCT
ajpf-815	197	17	smânia	smânia	PROPN
ajpf-815	197	18	jr	jr	PROPN
ajpf-815	197	19	a	a	PROPN
ajpf-815	197	20	,	,	PUNCT
ajpf-815	197	21	zani	zani	NOUN
ajpf-815	197	22	cl	cl	NOUN
ajpf-815	197	23	(	(	PUNCT
ajpf-815	197	24	2000	2000	NUM
ajpf-815	197	25	)	)	PUNCT
ajpf-815	197	26	.	.	PUNCT
ajpf-815	198	1	biological	biological	ADJ
ajpf-815	198	2	screening	screening	NOUN
ajpf-815	198	3	of	of	ADP
ajpf-815	198	4	brazilian	brazilian	ADJ
ajpf-815	198	5	medicinal	medicinal	ADJ
ajpf-815	198	6	plants	plant	NOUN
ajpf-815	198	7	.	.	PUNCT
ajpf-815	199	1	mem	mem	PROPN
ajpf-815	199	2	.	.	PROPN
ajpf-815	199	3	inst	inst	PROPN
ajpf-815	199	4	.	.	PUNCT
ajpf-815	200	1	oswaldo	oswaldo	PROPN
ajpf-815	200	2	cruz	cruz	PROPN
ajpf-815	200	3	95(3):367	95(3):367	NUM
ajpf-815	200	4	-	-	SYM
ajpf-815	200	5	373	373	NUM
ajpf-815	200	6	.	.	PUNCT
ajpf-815	200	7	betancour	betancour	NOUN
ajpf-815	200	8	-	-	PUNCT
ajpf-815	200	9	galvis	galvis	ADJ
ajpf-815	200	10	l	l	NOUN
ajpf-815	200	11	,	,	PUNCT
ajpf-815	200	12	saez	saez	PROPN
ajpf-815	200	13	j	j	PROPN
ajpf-815	200	14	,	,	PUNCT
ajpf-815	200	15	granados	granados	PROPN
ajpf-815	200	16	h	h	PROPN
ajpf-815	200	17	,	,	PUNCT
ajpf-815	200	18	salazar	salazar	NOUN
ajpf-815	200	19	a	a	PRON
ajpf-815	200	20	,	,	PUNCT
ajpf-815	200	21	ossa	ossa	PROPN
ajpf-815	200	22	j	j	PROPN
ajpf-815	200	23	(	(	PUNCT
ajpf-815	200	24	1999	1999	NUM
ajpf-815	200	25	)	)	PUNCT
ajpf-815	200	26	.	.	PUNCT
ajpf-815	201	1	antitumor	antitumor	PROPN
ajpf-815	201	2	and	and	CCONJ
ajpf-815	201	3	antiviral	antiviral	ADJ
ajpf-815	201	4	activity	activity	NOUN
ajpf-815	201	5	of	of	ADP
ajpf-815	201	6	colombian	colombian	ADJ
ajpf-815	201	7	medicinal	medicinal	ADJ
ajpf-815	201	8	plants	plant	NOUN
ajpf-815	201	9	extracts	extract	NOUN
ajpf-815	201	10	.	.	PUNCT
ajpf-815	202	1	mem	mem	PROPN
ajpf-815	202	2	.	.	PROPN
ajpf-815	202	3	inst	inst	PROPN
ajpf-815	202	4	.	.	PUNCT
ajpf-815	203	1	oswaldo	oswaldo	PROPN
ajpf-815	203	2	cruz	cruz	PROPN
ajpf-815	203	3	94(4):531	94(4):531	PROPN
ajpf-815	203	4	-	-	SYM
ajpf-815	203	5	535	535	NUM
ajpf-815	203	6	.	.	PUNCT
ajpf-815	204	1	brandão	brandão	PROPN
ajpf-815	204	2	gc	gc	PROPN
ajpf-815	204	3	,	,	PUNCT
ajpf-815	204	4	kroon	kroon	PROPN
ajpf-815	204	5	eg	eg	PROPN
ajpf-815	204	6	,	,	PUNCT
ajpf-815	204	7	dos	do	VERB
ajpf-815	204	8	santos	santos	PROPN
ajpf-815	204	9	jr	jr	PROPN
ajpf-815	204	10	,	,	PUNCT
ajpf-815	204	11	stehmann	stehmann	PROPN
ajpf-815	204	12	jr	jr	PROPN
ajpf-815	204	13	,	,	PUNCT
ajpf-815	204	14	lombardi	lombardi	PROPN
ajpf-815	204	15	ja	ja	PROPN
ajpf-815	204	16	,	,	PUNCT
ajpf-815	204	17	braga	braga	PROPN
ajpf-815	204	18	de	de	PROPN
ajpf-815	204	19	oliveira	oliveira	PROPN
ajpf-815	204	20	a	a	PROPN
ajpf-815	204	21	(	(	PUNCT
ajpf-815	204	22	2010	2010	NUM
ajpf-815	204	23	)	)	PUNCT
ajpf-815	204	24	.	.	PUNCT
ajpf-815	205	1	antiviral	antiviral	ADJ
ajpf-815	205	2	activity	activity	NOUN
ajpf-815	205	3	of	of	ADP
ajpf-815	205	4	bignoniaceae	bignoniaceae	PROPN
ajpf-815	205	5	species	specie	NOUN
ajpf-815	205	6	occurring	occur	VERB
ajpf-815	205	7	in	in	ADP
ajpf-815	205	8	the	the	DET
ajpf-815	205	9	state	state	NOUN
ajpf-815	205	10	of	of	ADP
ajpf-815	205	11	minas	minas	PROPN
ajpf-815	205	12	gerais	gerais	PROPN
ajpf-815	205	13	(	(	PUNCT
ajpf-815	205	14	brazil	brazil	PROPN
ajpf-815	205	15	):	):	PUNCT
ajpf-815	205	16	part	part	NOUN
ajpf-815	205	17	1	1	NUM
ajpf-815	205	18	.	.	PUNCT
ajpf-815	206	1	lett	lett	PROPN
ajpf-815	206	2	.	.	PUNCT
ajpf-815	206	3	appl	appl	PROPN
ajpf-815	206	4	.	.	PUNCT
ajpf-815	207	1	microbiol	microbiol	PROPN
ajpf-815	207	2	.	.	PUNCT
ajpf-815	208	1	51(4):469	51(4):469	NOUN
ajpf-815	208	2	-	-	SYM
ajpf-815	208	3	476	476	NUM
ajpf-815	208	4	.	.	PUNCT
ajpf-815	209	1	barros	barros	PROPN
ajpf-815	209	2	av	av	PROPN
ajpf-815	209	3	,	,	PUNCT
ajpf-815	209	4	araújo	araújo	VERB
ajpf-815	209	5	lm	lm	PROPN
ajpf-815	209	6	,	,	PUNCT
ajpf-815	209	7	oliveira	oliveira	PROPN
ajpf-815	209	8	ff	ff	PROPN
ajpf-815	209	9	,	,	PUNCT
ajpf-815	209	10	conceicao	conceicao	PROPN
ajpf-815	209	11	ao	ao	PROPN
ajpf-815	209	12	,	,	PUNCT
ajpf-815	209	13	simoni	simoni	PROPN
ajpf-815	209	14	ic	ic	PROPN
ajpf-815	209	15	,	,	PUNCT
ajpf-815	209	16	fernandes	fernandes	PROPN
ajpf-815	209	17	mjb	mjb	PROPN
ajpf-815	209	18	,	,	PUNCT
ajpf-815	209	19	arns	arns	PROPN
ajpf-815	209	20	cw	cw	PROPN
ajpf-815	209	21	(	(	PUNCT
ajpf-815	209	22	2012	2012	NUM
ajpf-815	209	23	)	)	PUNCT
ajpf-815	209	24	.	.	PUNCT
ajpf-815	210	1	in	in	ADP
ajpf-815	210	2	vitro	vitro	X
ajpf-815	210	3	evaluation	evaluation	NOUN
ajpf-815	210	4	of	of	ADP
ajpf-815	210	5	the	the	DET
ajpf-815	210	6	antiviral	antiviral	ADJ
ajpf-815	210	7	potential	potential	NOUN
ajpf-815	210	8	of	of	ADP
ajpf-815	210	9	guettarda	guettarda	PROPN
ajpf-815	210	10	angelica	angelica	PROPN
ajpf-815	210	11	against	against	ADP
ajpf-815	210	12	animal	animal	NOUN
ajpf-815	210	13	herpesviruses	herpesviruse	NOUN
ajpf-815	210	14	.	.	PUNCT
ajpf-815	211	1	acta	acta	PROPN
ajpf-815	211	2	sci	sci	PROPN
ajpf-815	211	3	.	.	PUNCT
ajpf-815	212	1	vet	vet	NOUN
ajpf-815	212	2	.	.	PUNCT
ajpf-815	213	1	4:1068	4:1068	X
ajpf-815	213	2	.	.	PUNCT
ajpf-815	214	1	bessa	bessa	PROPN
ajpf-815	214	2	ngfdei	ngfdei	PROPN
ajpf-815	214	3	,	,	PUNCT
ajpf-815	214	4	borges	borges	PROPN
ajpf-815	214	5	jcm	jcm	PROPN
ajpf-815	214	6	,	,	PUNCT
ajpf-815	214	7	beserra	beserra	VERB
ajpf-815	214	8	fp	fp	PROPN
ajpf-815	214	9	,	,	PUNCT
ajpf-815	214	10	carvalho	carvalho	PROPN
ajpf-815	214	11	rha	rha	PROPN
ajpf-815	214	12	,	,	PUNCT
ajpf-815	214	13	pereira	pereira	PROPN
ajpf-815	214	14	mab	mab	PROPN
ajpf-815	214	15	,	,	PUNCT
ajpf-815	214	16	fagundes	fagunde	NOUN
ajpf-815	214	17	r	r	NOUN
ajpf-815	214	18	,	,	PUNCT
ajpf-815	214	19	campos	campos	PROPN
ajpf-815	214	20	sl	sl	PROPN
ajpf-815	214	21	,	,	PUNCT
ajpf-815	214	22	ribeiro	ribeiro	PROPN
ajpf-815	214	23	lu	lu	PROPN
ajpf-815	214	24	,	,	PUNCT
ajpf-815	214	25	quirino	quirino	PROPN
ajpf-815	214	26	ms	ms	PROPN
ajpf-815	214	27	,	,	PUNCT
ajpf-815	214	28	chagas	chagas	PROPN
ajpf-815	214	29	jr	jr	PROPN
ajpf-815	214	30	af	af	PROPN
ajpf-815	214	31	,	,	PUNCT
ajpf-815	214	32	alves	alve	VERB
ajpf-815	214	33	a	a	PRON
ajpf-815	214	34	(	(	PUNCT
ajpf-815	214	35	2013	2013	NUM
ajpf-815	214	36	)	)	PUNCT
ajpf-815	214	37	.	.	PUNCT
ajpf-815	215	1	prospecção	prospecção	PROPN
ajpf-815	215	2	fitoquímica	fitoquímica	PROPN
ajpf-815	215	3	preliminar	preliminar	PROPN
ajpf-815	215	4	de	de	PROPN
ajpf-815	215	5	plantas	plantas	X
ajpf-815	215	6	nativas	nativas	PROPN
ajpf-815	215	7	do	do	AUX
ajpf-815	215	8	cerrado	cerrado	PROPN
ajpf-815	215	9	de	de	X
ajpf-815	215	10	uso	uso	PROPN
ajpf-815	215	11	popular	popular	ADJ
ajpf-815	215	12	medicinal	medicinal	PROPN
ajpf-815	215	13	pela	pela	PROPN
ajpf-815	215	14	comunidade	comunidade	PROPN
ajpf-815	215	15	rural	rural	PROPN
ajpf-815	215	16	do	do	VERB
ajpf-815	215	17	assentamento	assentamento	ADP
ajpf-815	215	18	vale	vale	ADJ
ajpf-815	215	19	verde	verde	PROPN
ajpf-815	215	20	-	-	PUNCT
ajpf-815	215	21	tocantins	tocantin	NOUN
ajpf-815	215	22	.	.	PUNCT
ajpf-815	216	1	braz	braz	PROPN
ajpf-815	216	2	.	.	PUNCT
ajpf-815	217	1	j.	j.	PROPN
ajpf-815	217	2	med	med	PROPN
ajpf-815	217	3	.	.	PUNCT
ajpf-815	218	1	plants	plant	VERB
ajpf-815	218	2	15(4):692707	15(4):692707	NUM
ajpf-815	218	3	.	.	PUNCT
ajpf-815	219	1	cantatore	cantatore	PROPN
ajpf-815	219	2	a	a	PRON
ajpf-815	219	3	,	,	PUNCT
ajpf-815	219	4	randall	randall	NOUN
ajpf-815	219	5	sd	sd	PROPN
ajpf-815	219	6	,	,	PUNCT
ajpf-815	219	7	traum	traum	PROPN
ajpf-815	219	8	d	d	PROPN
ajpf-815	219	9	,	,	PUNCT
ajpf-815	219	10	adams	adams	PROPN
ajpf-815	219	11	sd	sd	PROPN
ajpf-815	219	12	(	(	PUNCT
ajpf-815	219	13	2013	2013	NUM
ajpf-815	219	14	)	)	PUNCT
ajpf-815	219	15	.	.	PUNCT
ajpf-815	220	1	effect	effect	NOUN
ajpf-815	220	2	of	of	ADP
ajpf-815	220	3	black	black	ADJ
ajpf-815	220	4	tea	tea	NOUN
ajpf-815	220	5	extract	extract	NOUN
ajpf-815	220	6	on	on	ADP
ajpf-815	220	7	herpes	herpe	NOUN
ajpf-815	220	8	simplex	simplex	NOUN
ajpf-815	220	9	virus-1	virus-1	ADP
ajpf-815	220	10	infection	infection	NOUN
ajpf-815	220	11	of	of	ADP
ajpf-815	220	12	cultured	cultured	ADJ
ajpf-815	220	13	cells	cell	NOUN
ajpf-815	220	14	.	.	PUNCT
ajpf-815	221	1	bmc	bmc	PROPN
ajpf-815	221	2	complement	complement	PROPN
ajpf-815	221	3	.	.	PUNCT
ajpf-815	222	1	altern	altern	NOUN
ajpf-815	222	2	.	.	PUNCT
ajpf-815	223	1	med	med	PROPN
ajpf-815	223	2	.	.	PUNCT
ajpf-815	224	1	13:139	13:139	PROPN
ajpf-815	224	2	.	.	PUNCT
ajpf-815	225	1	chattopadhyay	chattopadhyay	PROPN
ajpf-815	225	2	d	d	PROPN
ajpf-815	225	3	,	,	PUNCT
ajpf-815	225	4	khan	khan	PROPN
ajpf-815	225	5	mth	mth	NOUN
ajpf-815	225	6	(	(	PUNCT
ajpf-815	225	7	2008	2008	NUM
ajpf-815	225	8	)	)	PUNCT
ajpf-815	225	9	.	.	PUNCT
ajpf-815	226	1	ethnomedicines	ethnomedicine	NOUN
ajpf-815	226	2	and	and	CCONJ
ajpf-815	226	3	ethnomedicinal	ethnomedicinal	ADJ
ajpf-815	226	4	phytophores	phytophore	NOUN
ajpf-815	226	5	against	against	ADP
ajpf-815	226	6	herpesviruses	herpesviruse	NOUN
ajpf-815	226	7	.	.	PUNCT
ajpf-815	227	1	biotechnol	biotechnol	PROPN
ajpf-815	227	2	.	.	PUNCT
ajpf-815	228	1	annu	annu	PROPN
ajpf-815	228	2	.	.	PUNCT
ajpf-815	229	1	rev	rev	PROPN
ajpf-815	229	2	.	.	PROPN
ajpf-815	229	3	14:297	14:297	PROPN
ajpf-815	229	4	-	-	PUNCT
ajpf-815	229	5	348	348	NUM
ajpf-815	229	6	.	.	PUNCT
ajpf-815	230	1	chattopadhyay	chattopadhyay	PROPN
ajpf-815	230	2	d	d	PROPN
ajpf-815	230	3	,	,	PUNCT
ajpf-815	230	4	ojha	ojha	PROPN
ajpf-815	230	5	d	d	PROPN
ajpf-815	230	6	,	,	PUNCT
ajpf-815	230	7	mondal	mondal	PROPN
ajpf-815	230	8	s	s	PROPN
ajpf-815	230	9	,	,	PUNCT
ajpf-815	230	10	goswami	goswami	PROPN
ajpf-815	230	11	d.	d.	PROPN
ajpf-815	230	12	(	(	PUNCT
ajpf-815	230	13	2015	2015	NUM
ajpf-815	230	14	)	)	PUNCT
ajpf-815	230	15	chapter	chapter	NOUN
ajpf-815	230	16	8	8	NUM
ajpf-815	230	17	–	–	PUNCT
ajpf-815	230	18	validation	validation	NOUN
ajpf-815	230	19	of	of	ADP
ajpf-815	230	20	antiviral	antiviral	ADJ
ajpf-815	230	21	potential	potential	NOUN
ajpf-815	230	22	of	of	ADP
ajpf-815	230	23	herbal	herbal	ADJ
ajpf-815	230	24	ethnomedicine	ethnomedicine	NOUN
ajpf-815	230	25	.	.	PUNCT
ajpf-815	231	1	evid	evid	PROPN
ajpf-815	231	2	.	.	PUNCT
ajpf-815	232	1	based	base	VERB
ajpf-815	232	2	valid	valid	ADJ
ajpf-815	232	3	.	.	PUNCT
ajpf-815	233	1	herbal	herbal	PROPN
ajpf-815	233	2	med	med	PROPN
ajpf-815	233	3	.	.	PUNCT
ajpf-815	234	1	175	175	NUM
ajpf-815	234	2	-	-	SYM
ajpf-815	234	3	200	200	NUM
ajpf-815	234	4	.	.	PUNCT
ajpf-815	235	1	choi	choi	PROPN
ajpf-815	235	2	hj	hj	PROPN
ajpf-815	235	3	,	,	PUNCT
ajpf-815	235	4	kim	kim	PROPN
ajpf-815	235	5	jh	jh	PROPN
ajpf-815	235	6	,	,	PUNCT
ajpf-815	235	7	lee	lee	PROPN
ajpf-815	235	8	ch	ch	PROPN
ajpf-815	235	9	,	,	PUNCT
ajpf-815	235	10	ahn	ahn	PROPN
ajpf-815	235	11	yj	yj	PROPN
ajpf-815	235	12	,	,	PUNCT
ajpf-815	235	13	song	song	NOUN
ajpf-815	235	14	jh	jh	PROPN
ajpf-815	235	15	baek	baek	NOUN
ajpf-815	235	16	sh	sh	PROPN
ajpf-815	236	1	(	(	PUNCT
ajpf-815	236	2	2009	2009	NUM
ajpf-815	236	3	)	)	PUNCT
ajpf-815	236	4	.	.	PUNCT
ajpf-815	237	1	antiviral	antiviral	ADJ
ajpf-815	237	2	activity	activity	NOUN
ajpf-815	237	3	of	of	ADP
ajpf-815	237	4	quercetin	quercetin	NOUN
ajpf-815	237	5	7	7	NUM
ajpf-815	237	6	-	-	PUNCT
ajpf-815	237	7	rhamnoside	rhamnoside	NOUN
ajpf-815	237	8	against	against	ADP
ajpf-815	237	9	porcine	porcine	NOUN
ajpf-815	237	10	epidemic	epidemic	NOUN
ajpf-815	237	11	diarrhea	diarrhea	NOUN
ajpf-815	237	12	virus	virus	NOUN
ajpf-815	237	13	.	.	PUNCT
ajpf-815	238	1	antiviral	antiviral	ADJ
ajpf-815	238	2	res	re	NOUN
ajpf-815	238	3	.	.	PUNCT
ajpf-815	239	1	81(1):77	81(1):77	PROPN
ajpf-815	239	2	-	-	PUNCT
ajpf-815	239	3	81	81	NUM
ajpf-815	239	4	.	.	PUNCT
ajpf-815	240	1	cos	cos	PROPN
ajpf-815	240	2	p	p	PROPN
ajpf-815	240	3	,	,	PUNCT
ajpf-815	240	4	vlietinck	vlietinck	PROPN
ajpf-815	240	5	aj	aj	PROPN
ajpf-815	240	6	,	,	PUNCT
ajpf-815	240	7	vanden	vanden	PROPN
ajpf-815	240	8	berghe	berghe	PROPN
ajpf-815	240	9	d	d	NOUN
ajpf-815	240	10	,	,	PUNCT
ajpf-815	240	11	maesa	maesa	PROPN
ajpf-815	240	12	l	l	NOUN
ajpf-815	240	13	(	(	PUNCT
ajpf-815	240	14	2006	2006	NUM
ajpf-815	240	15	)	)	PUNCT
ajpf-815	240	16	.	.	PUNCT
ajpf-815	241	1	anti	anti	ADJ
ajpf-815	241	2	-	-	ADJ
ajpf-815	241	3	infective	infective	ADJ
ajpf-815	241	4	potential	potential	NOUN
ajpf-815	241	5	of	of	ADP
ajpf-815	241	6	natural	natural	ADJ
ajpf-815	241	7	products	product	NOUN
ajpf-815	241	8	:	:	PUNCT
ajpf-815	241	9	how	how	SCONJ
ajpf-815	241	10	to	to	PART
ajpf-815	241	11	develop	develop	VERB
ajpf-815	241	12	a	a	DET
ajpf-815	241	13	stronger	strong	ADJ
ajpf-815	241	14	in	in	ADP
ajpf-815	241	15	vitro	vitro	X
ajpf-815	241	16	„	„	PUNCT
ajpf-815	241	17	proof	proof	NOUN
ajpf-815	241	18	-	-	PUNCT
ajpf-815	241	19	of	of	ADP
ajpf-815	241	20	-	-	PUNCT
ajpf-815	241	21	concept‟.	concept‟.	NOUN
ajpf-815	241	22	j.	j.	PROPN
ajpf-815	241	23	ethnopharmacol	ethnopharmacol	PROPN
ajpf-815	241	24	.	.	PUNCT
ajpf-815	242	1	106(3):290	106(3):290	NUM
ajpf-815	242	2	-	-	SYM
ajpf-815	242	3	302	302	NUM
ajpf-815	242	4	.	.	PUNCT
ajpf-815	243	1	costa	costa	PROPN
ajpf-815	243	2	ma	ma	PROPN
ajpf-815	243	3	,	,	PUNCT
ajpf-815	243	4	ishida	ishida	PROPN
ajpf-815	243	5	k	k	PROPN
ajpf-815	243	6	,	,	PUNCT
ajpf-815	243	7	kaplum	kaplum	PROPN
ajpf-815	243	8	v	v	NOUN
ajpf-815	243	9	,	,	PUNCT
ajpf-815	243	10	koslyk	koslyk	ADJ
ajpf-815	243	11	eda	eda	PROPN
ajpf-815	243	12	,	,	PUNCT
ajpf-815	243	13	mello	mello	PROPN
ajpf-815	243	14	jcp	jcp	PROPN
ajpf-815	243	15	,	,	PUNCT
ajpf-815	243	16	uedanakamura	uedanakamura	PROPN
ajpf-815	243	17	t	t	PROPN
ajpf-815	243	18	,	,	PUNCT
ajpf-815	243	19	dias	dias	PROPN
ajpf-815	243	20	filho	filho	PROPN
ajpf-815	243	21	bp	bp	PROPN
ajpf-815	243	22	,	,	PUNCT
ajpf-815	243	23	nakamura	nakamura	PROPN
ajpf-815	243	24	cv	cv	PROPN
ajpf-815	243	25	(	(	PUNCT
ajpf-815	243	26	2010	2010	NUM
ajpf-815	243	27	)	)	PUNCT
ajpf-815	243	28	.	.	PUNCT
ajpf-815	244	1	safety	safety	NOUN
ajpf-815	244	2	evaluation	evaluation	NOUN
ajpf-815	244	3	of	of	ADP
ajpf-815	244	4	proanthocyanidin	proanthocyanidin	VERB
ajpf-815	244	5	polymer	polymer	NOUN
ajpf-815	244	6	-	-	PUNCT
ajpf-815	244	7	rich	rich	ADJ
ajpf-815	244	8	fraction	fraction	NOUN
ajpf-815	244	9	obtained	obtain	VERB
ajpf-815	244	10	from	from	ADP
ajpf-815	244	11	stem	stem	NOUN
ajpf-815	244	12	bark	bark	NOUN
ajpf-815	244	13	of	of	ADP
ajpf-815	244	14	stryphnodendron	stryphnodendron	PROPN
ajpf-815	244	15	adstringens	adstringens	PROPN
ajpf-815	244	16	(	(	PUNCT
ajpf-815	244	17	barbatimao	barbatimao	PROPN
ajpf-815	244	18	)	)	PUNCT
ajpf-815	244	19	for	for	ADP
ajpf-815	244	20	use	use	NOUN
ajpf-815	244	21	as	as	ADP
ajpf-815	244	22	a	a	DET
ajpf-815	244	23	pharmacological	pharmacological	ADJ
ajpf-815	244	24	agent	agent	NOUN
ajpf-815	244	25	.	.	PUNCT
ajpf-815	245	1	regul	regul	NOUN
ajpf-815	245	2	.	.	PUNCT
ajpf-815	246	1	toxicol	toxicol	PROPN
ajpf-815	246	2	.	.	PUNCT
ajpf-815	247	1	pharmacol	pharmacol	PROPN
ajpf-815	247	2	.	.	PUNCT
ajpf-815	248	1	58(2):330	58(2):330	NUM
ajpf-815	248	2	-	-	SYM
ajpf-815	248	3	335	335	NUM
ajpf-815	248	4	.	.	PUNCT
ajpf-815	249	1	costa	costa	PROPN
ajpf-815	249	2	ev	ev	PROPN
ajpf-815	249	3	,	,	PUNCT
ajpf-815	249	4	silva	silva	NOUN
ajpf-815	249	5	tb	tb	PROPN
ajpf-815	249	6	,	,	PUNCT
ajpf-815	249	7	menezes	menezes	PROPN
ajpf-815	249	8	lra	lra	PROPN
ajpf-815	249	9	,	,	PUNCT
ajpf-815	249	10	ribeiro	ribeiro	PROPN
ajpf-815	249	11	lhg	lhg	PROPN
ajpf-815	249	12	,	,	PUNCT
ajpf-815	249	13	gadelha	gadelha	VERB
ajpf-815	249	14	fr	fr	PROPN
ajpf-815	249	15	,	,	PUNCT
ajpf-815	249	16	carvalho	carvalho	PROPN
ajpf-815	249	17	je	je	PROPN
ajpf-815	249	18	,	,	PUNCT
ajpf-815	249	19	souza	souza	PROPN
ajpf-815	249	20	lmb	lmb	PROPN
ajpf-815	249	21	,	,	PUNCT
ajpf-815	249	22	silva	silva	NOUN
ajpf-815	249	23	man	man	NOUN
ajpf-815	249	24	,	,	PUNCT
ajpf-815	249	25	siqueira	siqueira	NOUN
ajpf-815	249	26	cat	cat	NOUN
ajpf-815	249	27	,	,	PUNCT
ajpf-815	249	28	salvador	salvador	PROPN
ajpf-815	249	29	mj	mj	PROPN
ajpf-815	249	30	(	(	PUNCT
ajpf-815	249	31	2013	2013	NUM
ajpf-815	249	32	):	):	PUNCT
ajpf-815	249	33	biological	biological	ADJ
ajpf-815	249	34	activities	activity	NOUN
ajpf-815	249	35	of	of	ADP
ajpf-815	249	36	the	the	DET
ajpf-815	249	37	essential	essential	ADJ
ajpf-815	249	38	oil	oil	NOUN
ajpf-815	249	39	from	from	ADP
ajpf-815	249	40	the	the	DET
ajpf-815	249	41	leaves	leave	NOUN
ajpf-815	249	42	of	of	ADP
ajpf-815	249	43	xylopia	xylopia	PROPN
ajpf-815	249	44	laevigata	laevigata	PROPN
ajpf-815	249	45	(	(	PUNCT
ajpf-815	249	46	annonaceae	annonaceae	PROPN
ajpf-815	249	47	)	)	PUNCT
ajpf-815	249	48	,	,	PUNCT
ajpf-815	249	49	j.	j.	PROPN
ajpf-815	249	50	essential	essential	ADJ
ajpf-815	249	51	oil	oil	NOUN
ajpf-815	249	52	res	re	NOUN
ajpf-815	249	53	.	.	PUNCT
ajpf-815	250	1	25(3):179	25(3):179	NOUN
ajpf-815	250	2	-	-	SYM
ajpf-815	250	3	185	185	NUM
ajpf-815	250	4	.	.	PUNCT
ajpf-815	251	1	dutra	dutra	PROPN
ajpf-815	251	2	rc	rc	PROPN
ajpf-815	251	3	,	,	PUNCT
ajpf-815	251	4	campos	campos	PROPN
ajpf-815	251	5	mm	mm	PROPN
ajpf-815	251	6	,	,	PUNCT
ajpf-815	251	7	santos	santos	PROPN
ajpf-815	251	8	ars	ars	PROPN
ajpf-815	251	9	,	,	PUNCT
ajpf-815	251	10	calixto	calixto	PROPN
ajpf-815	251	11	jb	jb	PROPN
ajpf-815	251	12	.	.	PUNCT
ajpf-815	252	1	(	(	PUNCT
ajpf-815	252	2	2016	2016	NUM
ajpf-815	252	3	)	)	PUNCT
ajpf-815	252	4	.	.	PUNCT
ajpf-815	253	1	medicinal	medicinal	ADJ
ajpf-815	253	2	plants	plant	NOUN
ajpf-815	253	3	in	in	ADP
ajpf-815	253	4	brazil	brazil	PROPN
ajpf-815	253	5	:	:	PUNCT
ajpf-815	253	6	pharmacological	pharmacological	ADJ
ajpf-815	253	7	studies	study	NOUN
ajpf-815	253	8	,	,	PUNCT
ajpf-815	253	9	drug	drug	NOUN
ajpf-815	253	10	discovery	discovery	NOUN
ajpf-815	253	11	,	,	PUNCT
ajpf-815	253	12	challenges	challenge	VERB
ajpf-815	253	13	9	9	NUM
ajpf-815	253	14	and	and	CCONJ
ajpf-815	253	15	perspectives	perspective	NOUN
ajpf-815	253	16	.	.	PUNCT
ajpf-815	254	1	pharm	pharm	NOUN
ajpf-815	254	2	.	.	PUNCT
ajpf-815	255	1	res	re	NOUN
ajpf-815	255	2	.	.	PUNCT
ajpf-815	256	1	112:4	112:4	NUM
ajpf-815	256	2	-	-	SYM
ajpf-815	256	3	29	29	NUM
ajpf-815	256	4	.	.	PUNCT
ajpf-815	257	1	felipe	felipe	PROPN
ajpf-815	257	2	amm	amm	PROPN
ajpf-815	257	3	,	,	PUNCT
ajpf-815	257	4	rincão	rincão	PROPN
ajpf-815	257	5	vp	vp	PROPN
ajpf-815	257	6	,	,	PUNCT
ajpf-815	257	7	benati	benati	PROPN
ajpf-815	257	8	fj	fj	PROPN
ajpf-815	257	9	,	,	PUNCT
ajpf-815	257	10	linhares	linhare	NOUN
ajpf-815	257	11	rec	rec	PROPN
ajpf-815	257	12	,	,	PUNCT
ajpf-815	257	13	galina	galina	PROPN
ajpf-815	257	14	kj	kj	PROPN
ajpf-815	257	15	,	,	PUNCT
ajpf-815	257	16	de	de	PROPN
ajpf-815	257	17	toledo	toledo	PROPN
ajpf-815	257	18	cem	cem	PROPN
ajpf-815	257	19	,	,	PUNCT
ajpf-815	257	20	lopes	lopes	PROPN
ajpf-815	257	21	gc	gc	PROPN
ajpf-815	257	22	,	,	PUNCT
ajpf-815	257	23	de	de	PROPN
ajpf-815	257	24	mello	mello	PROPN
ajpf-815	257	25	jc	jc	PROPN
ajpf-815	257	26	,	,	PUNCT
ajpf-815	257	27	nozawa	nozawa	PROPN
ajpf-815	257	28	c	c	PROPN
ajpf-815	257	29	(	(	PUNCT
ajpf-815	257	30	2006	2006	NUM
ajpf-815	257	31	)	)	PUNCT
ajpf-815	257	32	.	.	PUNCT
ajpf-815	258	1	antiviral	antiviral	ADJ
ajpf-815	258	2	effect	effect	NOUN
ajpf-815	258	3	of	of	ADP
ajpf-815	258	4	guazuma	guazuma	PROPN
ajpf-815	258	5	ulmifolia	ulmifolia	PROPN
ajpf-815	258	6	and	and	CCONJ
ajpf-815	258	7	stryphnodendron	stryphnodendron	PROPN
ajpf-815	258	8	adstringens	adstringen	NOUN
ajpf-815	258	9	on	on	ADP
ajpf-815	258	10	poliovirus	poliovirus	NOUN
ajpf-815	258	11	and	and	CCONJ
ajpf-815	258	12	bovine	bovine	NOUN
ajpf-815	258	13	herpesvirus	herpesvirus	NOUN
ajpf-815	258	14	.	.	PUNCT
ajpf-815	259	1	biol	biol	PROPN
ajpf-815	259	2	.	.	PUNCT
ajpf-815	260	1	pharm	pharm	PROPN
ajpf-815	260	2	.	.	PUNCT
ajpf-815	261	1	bull	bull	NOUN
ajpf-815	261	2	.	.	PUNCT
ajpf-815	262	1	29(6):10921095	29(6):10921095	NUM
ajpf-815	262	2	.	.	PUNCT
ajpf-815	262	3	fonseca	fonseca	PROPN
ajpf-815	262	4	aajr	aajr	PROPN
ajpf-815	262	5	,	,	PUNCT
ajpf-815	262	6	carmagos	carmago	NOUN
ajpf-815	262	7	mf	mf	VERB
ajpf-815	262	8	,	,	PUNCT
ajpf-815	262	9	d´ambros	d´ambros	PROPN
ajpf-815	262	10	rmf	rmf	PROPN
ajpf-815	262	11	,	,	PUNCT
ajpf-815	262	12	braga	braga	PROPN
ajpf-815	262	13	ac	ac	PROPN
ajpf-815	262	14	,	,	PUNCT
ajpf-815	262	15	ciaccizanella	ciaccizanella	PROPN
ajpf-815	262	16	j	j	PROPN
ajpf-815	262	17	,	,	PUNCT
ajpf-815	262	18	heinemann	heinemann	PROPN
ajpf-815	262	19	mb	mb	PROPN
ajpf-815	262	20	,	,	PUNCT
ajpf-815	262	21	leite	leite	PROPN
ajpf-815	262	22	rc	rc	PROPN
ajpf-815	262	23	,	,	PUNCT
ajpf-815	262	24	reis	reis	NOUN
ajpf-815	262	25	jkp	jkp	NOUN
ajpf-815	262	26	(	(	PUNCT
ajpf-815	262	27	2010	2010	NUM
ajpf-815	262	28	)	)	PUNCT
ajpf-815	262	29	.	.	PUNCT
ajpf-815	263	1	diagnóstico	diagnóstico	PROPN
ajpf-815	263	2	e	e	PROPN
ajpf-815	263	3	genotipagem	genotipagem	PROPN
ajpf-815	263	4	do	do	AUX
ajpf-815	263	5	vírus	vírus	PROPN
ajpf-815	263	6	da	da	PROPN
ajpf-815	263	7	pseudoraiva	pseudoraiva	PROPN
ajpf-815	263	8	por	por	PROPN
ajpf-815	263	9	nested	nest	VERB
ajpf-815	263	10	-	-	PUNCT
ajpf-815	263	11	pcr	pcr	NOUN
ajpf-815	263	12	e	e	NOUN
ajpf-815	263	13	análise	análise	PROPN
ajpf-815	263	14	de	de	PROPN
ajpf-815	263	15	restrição	restrição	PROPN
ajpf-815	263	16	enzimática	enzimática	PROPN
ajpf-815	263	17	.	.	PUNCT
ajpf-815	264	1	ciênc	ciênc	PROPN
ajpf-815	264	2	.	.	PUNCT
ajpf-815	265	1	rural	rural	ADJ
ajpf-815	265	2	40(4):921	40(4):921	PROPN
ajpf-815	265	3	-	-	SYM
ajpf-815	265	4	927	927	NUM
ajpf-815	265	5	.	.	PUNCT
ajpf-815	266	1	frias	frias	PROPN
ajpf-815	266	2	ua	ua	PROPN
ajpf-815	266	3	,	,	PUNCT
ajpf-815	266	4	costa	costa	PROPN
ajpf-815	266	5	mcm	mcm	PROPN
ajpf-815	266	6	,	,	PUNCT
ajpf-815	266	7	takahashi	takahashi	PROPN
ajpf-815	266	8	ja	ja	PROPN
ajpf-815	266	9	,	,	PUNCT
ajpf-815	266	10	oki	oki	NOUN
ajpf-815	266	11	y	y	PROPN
ajpf-815	266	12	(	(	PUNCT
ajpf-815	266	13	2012	2012	NUM
ajpf-815	266	14	)	)	PUNCT
ajpf-815	266	15	.	.	PUNCT
ajpf-815	267	1	banisteriopsis	banisteriopsis	PROPN
ajpf-815	267	2	species	specie	NOUN
ajpf-815	267	3	:	:	PUNCT
ajpf-815	267	4	a	a	DET
ajpf-815	267	5	source	source	NOUN
ajpf-815	267	6	of	of	ADP
ajpf-815	267	7	bioactive	bioactive	NOUN
ajpf-815	267	8	of	of	ADP
ajpf-815	267	9	potential	potential	ADJ
ajpf-815	267	10	medical	medical	ADJ
ajpf-815	267	11	application	application	NOUN
ajpf-815	267	12	.	.	PUNCT
ajpf-815	268	1	int	int	NOUN
ajpf-815	268	2	.	.	PUNCT
ajpf-815	269	1	j.	j.	PROPN
ajpf-815	269	2	biotechnol	biotechnol	PROPN
ajpf-815	269	3	.	.	PUNCT
ajpf-815	270	1	wellness	wellness	NOUN
ajpf-815	270	2	ind	ind	PROPN
ajpf-815	270	3	.	.	PUNCT
ajpf-815	271	1	1(3):163	1(3):163	NUM
ajpf-815	271	2	-	-	SYM
ajpf-815	271	3	171	171	NUM
ajpf-815	271	4	.	.	PUNCT
ajpf-815	272	1	garrett	garrett	PROPN
ajpf-815	272	2	r	r	PROPN
ajpf-815	272	3	,	,	PUNCT
ajpf-815	272	4	romanos	romanos	PROPN
ajpf-815	272	5	mtv	mtv	PROPN
ajpf-815	272	6	,	,	PUNCT
ajpf-815	272	7	borges	borges	PROPN
ajpf-815	272	8	rm	rm	PROPN
ajpf-815	272	9	,	,	PUNCT
ajpf-815	272	10	santos	santos	PROPN
ajpf-815	272	11	mg	mg	PROPN
ajpf-815	272	12	,	,	PUNCT
ajpf-815	272	13	rocha	rocha	PROPN
ajpf-815	272	14	l	l	PROPN
ajpf-815	272	15	,	,	PUNCT
ajpf-815	272	16	silva	silva	PROPN
ajpf-815	272	17	ajrd	ajrd	PROPN
ajpf-815	272	18	(	(	PUNCT
ajpf-815	272	19	2012	2012	NUM
ajpf-815	272	20	)	)	PUNCT
ajpf-815	272	21	.	.	PUNCT
ajpf-815	273	1	antiherpetic	antiherpetic	ADJ
ajpf-815	273	2	activity	activity	NOUN
ajpf-815	273	3	of	of	ADP
ajpf-815	273	4	a	a	DET
ajpf-815	273	5	flavonoid	flavonoid	NOUN
ajpf-815	273	6	fraction	fraction	NOUN
ajpf-815	273	7	from	from	ADP
ajpf-815	273	8	ocotea	ocotea	PROPN
ajpf-815	273	9	notata	notata	PROPN
ajpf-815	273	10	leaves	leave	NOUN
ajpf-815	273	11	.	.	PUNCT
ajpf-815	274	1	rev	rev	PROPN
ajpf-815	274	2	.	.	PROPN
ajpf-815	274	3	bras	bras	PROPN
ajpf-815	274	4	.	.	PUNCT
ajpf-815	275	1	farmacogn	farmacogn	PROPN
ajpf-815	275	2	.	.	PUNCT
ajpf-815	276	1	22(2):306	22(2):306	PROPN
ajpf-815	276	2	-	-	PUNCT
ajpf-815	276	3	313	313	NUM
ajpf-815	276	4	.	.	PUNCT
ajpf-815	277	1	govea	govea	PROPN
ajpf-815	277	2	-	-	PUNCT
ajpf-815	277	3	salas	salas	PROPN
ajpf-815	277	4	m	m	PROPN
ajpf-815	277	5	,	,	PUNCT
ajpf-815	277	6	rivas	rivas	PROPN
ajpf-815	277	7	-	-	PUNCT
ajpf-815	277	8	estilla	estilla	PROPN
ajpf-815	277	9	am	am	NOUN
ajpf-815	277	10	,	,	PUNCT
ajpf-815	277	11	rodríguez	rodríguez	NOUN
ajpf-815	277	12	-	-	PUNCT
ajpf-815	277	13	herrera	herrera	NOUN
ajpf-815	277	14	r	r	NOUN
ajpf-815	277	15	,	,	PUNCT
ajpf-815	277	16	lozanosepúlveda	lozanosepúlveda	PROPN
ajpf-815	277	17	sa	sa	PROPN
ajpf-815	277	18	,	,	PUNCT
ajpf-815	277	19	aguilar	aguilar	PROPN
ajpf-815	277	20	-	-	PUNCT
ajpf-815	277	21	gonzalez	gonzalez	PROPN
ajpf-815	277	22	cn	cn	PROPN
ajpf-815	277	23	,	,	PUNCT
ajpf-815	277	24	zugasti	zugasti	PROPN
ajpf-815	277	25	-	-	PUNCT
ajpf-815	277	26	cruz	cruz	PROPN
ajpf-815	277	27	a	a	PRON
ajpf-815	277	28	,	,	PUNCT
ajpf-815	277	29	salasvillalobos	salasvillalobos	PROPN
ajpf-815	277	30	tb	tb	NOUN
ajpf-815	277	31	,	,	PUNCT
ajpf-815	277	32	morlett	morlett	NOUN
ajpf-815	277	33	-	-	PUNCT
ajpf-815	277	34	chávez	chávez	PROPN
ajpf-815	277	35	ja	ja	PROPN
ajpf-815	277	36	(	(	PUNCT
ajpf-815	277	37	2016	2016	NUM
ajpf-815	277	38	)	)	PUNCT
ajpf-815	277	39	.	.	PUNCT
ajpf-815	278	1	gallic	gallic	NOUN
ajpf-815	278	2	acid	acid	PROPN
ajpf-815	278	3	decreases	decrease	VERB
ajpf-815	278	4	hepatitis	hepatitis	PROPN
ajpf-815	278	5	c	c	PROPN
ajpf-815	278	6	virus	virus	NOUN
ajpf-815	278	7	expression	expression	NOUN
ajpf-815	278	8	through	through	ADP
ajpf-815	278	9	its	its	PRON
ajpf-815	278	10	antioxidant	antioxidant	ADJ
ajpf-815	278	11	capacity	capacity	NOUN
ajpf-815	278	12	.	.	PUNCT
ajpf-815	279	1	exp	exp	NOUN
ajpf-815	279	2	.	.	PROPN
ajpf-815	279	3	therap	therap	PROPN
ajpf-815	279	4	.	.	PUNCT
ajpf-815	280	1	med	med	PROPN
ajpf-815	280	2	.	.	PUNCT
ajpf-815	281	1	11:619	11:619	NUM
ajpf-815	281	2	-	-	SYM
ajpf-815	281	3	624	624	NUM
ajpf-815	281	4	.	.	PUNCT
ajpf-815	282	1	gulati	gulati	PROPN
ajpf-815	282	2	br	br	PROPN
ajpf-815	282	3	,	,	PUNCT
ajpf-815	282	4	anagha	anagha	PROPN
ajpf-815	282	5	g	g	PROPN
ajpf-815	282	6	,	,	PUNCT
ajpf-815	282	7	riyesh	riyesh	PROPN
ajpf-815	282	8	t	t	PROPN
ajpf-815	282	9	,	,	PUNCT
ajpf-815	282	10	khurana	khurana	PROPN
ajpf-815	282	11	sk	sk	PROPN
ajpf-815	282	12	(	(	PUNCT
ajpf-815	282	13	2016	2016	NUM
ajpf-815	282	14	)	)	PUNCT
ajpf-815	282	15	.	.	PUNCT
ajpf-815	283	1	emergence	emergence	NOUN
ajpf-815	283	2	of	of	ADP
ajpf-815	283	3	equine	equine	NOUN
ajpf-815	283	4	herpes	herpe	NOUN
ajpf-815	283	5	virus	virus	NOUN
ajpf-815	283	6	1	1	NUM
ajpf-815	283	7	myeloencephalopathy	myeloencephalopathy	ADJ
ajpf-815	283	8	:	:	PUNCT
ajpf-815	283	9	a	a	DET
ajpf-815	283	10	brief	brief	ADJ
ajpf-815	283	11	review	review	NOUN
ajpf-815	283	12	.	.	PUNCT
ajpf-815	284	1	j.	j.	PROPN
ajpf-815	284	2	exp	exp	PROPN
ajpf-815	284	3	.	.	PUNCT
ajpf-815	285	1	biol	biol	PROPN
ajpf-815	285	2	.	.	PUNCT
ajpf-815	286	1	agric	agric	PROPN
ajpf-815	286	2	.	.	PUNCT
ajpf-815	287	1	sci	sci	PROPN
ajpf-815	287	2	.	.	PROPN
ajpf-815	288	1	4	4	NUM
ajpf-815	288	2	:	:	PUNCT
ajpf-815	288	3	s132	s132	PROPN
ajpf-815	288	4	-	-	SYM
ajpf-815	288	5	138	138	NUM
ajpf-815	288	6	.	.	PUNCT
ajpf-815	289	1	ishida	ishida	PROPN
ajpf-815	289	2	k	k	PROPN
ajpf-815	289	3	,	,	PUNCT
ajpf-815	289	4	rozental	rozental	PROPN
ajpf-815	289	5	s	s	PROPN
ajpf-815	289	6	,	,	PUNCT
ajpf-815	289	7	mello	mello	PROPN
ajpf-815	289	8	jcp	jcp	PROPN
ajpf-815	289	9	,	,	PUNCT
ajpf-815	289	10	nakamura	nakamura	PROPN
ajpf-815	289	11	cv	cv	PROPN
ajpf-815	289	12	(	(	PUNCT
ajpf-815	289	13	2009	2009	NUM
ajpf-815	289	14	)	)	PUNCT
ajpf-815	289	15	.	.	PUNCT
ajpf-815	290	1	activity	activity	NOUN
ajpf-815	290	2	of	of	ADP
ajpf-815	290	3	tannins	tannin	NOUN
ajpf-815	290	4	from	from	ADP
ajpf-815	290	5	stryphnodendron	stryphnodendron	PROPN
ajpf-815	290	6	adstringens	adstringen	NOUN
ajpf-815	290	7	on	on	ADP
ajpf-815	290	8	cryptococcus	cryptococcus	PROPN
ajpf-815	290	9	neoformans	neoforman	NOUN
ajpf-815	290	10	:	:	PUNCT
ajpf-815	290	11	effects	effect	NOUN
ajpf-815	290	12	on	on	ADP
ajpf-815	290	13	growth	growth	NOUN
ajpf-815	290	14	,	,	PUNCT
ajpf-815	290	15	capsule	capsule	NOUN
ajpf-815	290	16	size	size	NOUN
ajpf-815	290	17	and	and	CCONJ
ajpf-815	290	18	pigmentation	pigmentation	NOUN
ajpf-815	290	19	.	.	PUNCT
ajpf-815	291	1	ann	ann	PROPN
ajpf-815	291	2	.	.	PUNCT
ajpf-815	292	1	clin	clin	PROPN
ajpf-815	292	2	.	.	PUNCT
ajpf-815	293	1	microbiol	microbiol	PROPN
ajpf-815	293	2	.	.	PUNCT
ajpf-815	294	1	antimicrob	antimicrob	PROPN
ajpf-815	294	2	.	.	PUNCT
ajpf-815	295	1	8:29	8:29	NUM
ajpf-815	295	2	.	.	PUNCT
ajpf-815	295	3	jassim	jassim	PROPN
ajpf-815	295	4	saa	saa	PROPN
ajpf-815	295	5	,	,	PUNCT
ajpf-815	295	6	naji	naji	PROPN
ajpf-815	295	7	ma	ma	PROPN
ajpf-815	295	8	(	(	PUNCT
ajpf-815	295	9	2003	2003	NUM
ajpf-815	295	10	)	)	PUNCT
ajpf-815	295	11	.	.	PUNCT
ajpf-815	296	1	novel	novel	ADJ
ajpf-815	296	2	antiviral	antiviral	ADJ
ajpf-815	296	3	agents	agent	NOUN
ajpf-815	296	4	:	:	PUNCT
ajpf-815	296	5	a	a	DET
ajpf-815	296	6	medicinal	medicinal	ADJ
ajpf-815	296	7	plant	plant	NOUN
ajpf-815	296	8	perspective	perspective	NOUN
ajpf-815	296	9	.	.	PUNCT
ajpf-815	297	1	j.	j.	PROPN
ajpf-815	297	2	appl	appl	PROPN
ajpf-815	297	3	.	.	PROPN
ajpf-815	298	1	microbiol	microbiol	PROPN
ajpf-815	298	2	.	.	PUNCT
ajpf-815	299	1	95:412	95:412	NUM
ajpf-815	299	2	-	-	SYM
ajpf-815	299	3	427	427	NUM
ajpf-815	299	4	.	.	PUNCT
ajpf-815	300	1	katiyar	katiyar	PROPN
ajpf-815	300	2	c	c	PROPN
ajpf-815	300	3	,	,	PUNCT
ajpf-815	300	4	gupta	gupta	PROPN
ajpf-815	300	5	a	a	PRON
ajpf-815	300	6	,	,	PUNCT
ajpf-815	300	7	kanjilal	kanjilal	NOUN
ajpf-815	300	8	s	s	PART
ajpf-815	300	9	,	,	PUNCT
ajpf-815	300	10	katiyar	katiyar	PROPN
ajpf-815	300	11	s	s	PROPN
ajpf-815	300	12	(	(	PUNCT
ajpf-815	300	13	2012	2012	NUM
ajpf-815	300	14	)	)	PUNCT
ajpf-815	300	15	.	.	PUNCT
ajpf-815	301	1	drug	drug	NOUN
ajpf-815	301	2	discovery	discovery	PROPN
ajpf-815	301	3	from	from	ADP
ajpf-815	301	4	plant	plant	NOUN
ajpf-815	301	5	sources	source	NOUN
ajpf-815	301	6	:	:	PUNCT
ajpf-815	301	7	an	an	DET
ajpf-815	301	8	integrated	integrated	ADJ
ajpf-815	301	9	approach	approach	NOUN
ajpf-815	301	10	.	.	PUNCT
ajpf-815	302	1	ayu	ayu	PROPN
ajpf-815	302	2	33:10	33:10	NUM
ajpf-815	302	3	-	-	SYM
ajpf-815	302	4	9	9	NUM
ajpf-815	302	5	.	.	PUNCT
ajpf-815	303	1	koseki	koseki	PROPN
ajpf-815	304	1	i	i	PRON
ajpf-815	304	2	,	,	PUNCT
ajpf-815	304	3	simoni	simoni	PROPN
ajpf-815	304	4	ic	ic	PROPN
ajpf-815	304	5	,	,	PUNCT
ajpf-815	304	6	nakamura	nakamura	VERB
ajpf-815	304	7	it	it	PRON
ajpf-815	304	8	,	,	PUNCT
ajpf-815	304	9	noronha	noronha	PROPN
ajpf-815	304	10	ab	ab	PROPN
ajpf-815	304	11	,	,	PUNCT
ajpf-815	304	12	costa	costa	PROPN
ajpf-815	304	13	ss	ss	PROPN
ajpf-815	305	1	(	(	PUNCT
ajpf-815	305	2	1990	1990	NUM
ajpf-815	305	3	)	)	PUNCT
ajpf-815	305	4	.	.	PUNCT
ajpf-815	306	1	antiviral	antiviral	ADJ
ajpf-815	306	2	activity	activity	NOUN
ajpf-815	306	3	of	of	ADP
ajpf-815	306	4	plant	plant	NOUN
ajpf-815	306	5	extracts	extract	NOUN
ajpf-815	306	6	against	against	ADP
ajpf-815	306	7	aphovirus	aphovirus	NOUN
ajpf-815	306	8	,	,	PUNCT
ajpf-815	306	9	pseudorabies	pseudorabie	NOUN
ajpf-815	306	10	virus	virus	NOUN
ajpf-815	306	11	and	and	CCONJ
ajpf-815	306	12	pestivirus	pestivirus	NOUN
ajpf-815	306	13	in	in	ADP
ajpf-815	306	14	cell	cell	NOUN
ajpf-815	306	15	cutures	cuture	NOUN
ajpf-815	306	16	.	.	PUNCT
ajpf-815	307	1	microb	microb	PROPN
ajpf-815	307	2	.	.	PUNCT
ajpf-815	308	1	lett	lett	PROPN
ajpf-815	308	2	.	.	PUNCT
ajpf-815	309	1	44:19	44:19	NUM
ajpf-815	309	2	-	-	SYM
ajpf-815	309	3	30	30	NUM
ajpf-815	309	4	.	.	PUNCT
ajpf-815	310	1	mccutcheon	mccutcheon	PROPN
ajpf-815	310	2	ar	ar	PROPN
ajpf-815	310	3	,	,	PUNCT
ajpf-815	310	4	roberts	roberts	PROPN
ajpf-815	310	5	te	te	PROPN
ajpf-815	310	6	,	,	PUNCT
ajpf-815	310	7	gibbons	gibbon	NOUN
ajpf-815	310	8	e	e	PROPN
ajpf-815	310	9	,	,	PUNCT
ajpf-815	310	10	ellis	ellis	PROPN
ajpf-815	310	11	sm	sm	PROPN
ajpf-815	310	12	,	,	PUNCT
ajpf-815	310	13	babiuk	babiuk	PROPN
ajpf-815	310	14	la	la	PROPN
ajpf-815	310	15	,	,	PUNCT
ajpf-815	310	16	hancock	hancock	PROPN
ajpf-815	310	17	rew	rew	PROPN
ajpf-815	310	18	,	,	PUNCT
ajpf-815	310	19	towers	tower	NOUN
ajpf-815	310	20	ghn	ghn	NOUN
ajpf-815	310	21	(	(	PUNCT
ajpf-815	310	22	1995	1995	NUM
ajpf-815	310	23	)	)	PUNCT
ajpf-815	310	24	.	.	PUNCT
ajpf-815	311	1	antiviral	antiviral	ADJ
ajpf-815	311	2	screening	screening	NOUN
ajpf-815	311	3	of	of	ADP
ajpf-815	311	4	british	british	ADJ
ajpf-815	311	5	columbian	columbian	ADJ
ajpf-815	311	6	medicinal	medicinal	ADJ
ajpf-815	311	7	plants	plant	NOUN
ajpf-815	311	8	.	.	PUNCT
ajpf-815	312	1	j.	j.	PROPN
ajpf-815	312	2	ethnopharmacol	ethnopharmacol	PROPN
ajpf-815	312	3	.	.	PUNCT
ajpf-815	313	1	49(2):101	49(2):101	NOUN
ajpf-815	313	2	-	-	PUNCT
ajpf-815	313	3	110	110	NUM
ajpf-815	313	4	.	.	PUNCT
ajpf-815	314	1	maldini	maldini	PROPN
ajpf-815	314	2	m	m	PROPN
ajpf-815	314	3	,	,	PUNCT
ajpf-815	314	4	montoro	montoro	PROPN
ajpf-815	314	5	p	p	NOUN
ajpf-815	314	6	,	,	PUNCT
ajpf-815	314	7	pizza	pizza	NOUN
ajpf-815	314	8	c	c	NOUN
ajpf-815	314	9	(	(	PUNCT
ajpf-815	314	10	2011	2011	NUM
ajpf-815	314	11	)	)	PUNCT
ajpf-815	314	12	.	.	PUNCT
ajpf-815	315	1	phenolic	phenolic	ADJ
ajpf-815	315	2	compounds	compound	NOUN
ajpf-815	315	3	from	from	ADP
ajpf-815	315	4	byrsonima	byrsonima	PROPN
ajpf-815	315	5	crassifolia	crassifolia	PROPN
ajpf-815	315	6	l.	l.	PROPN
ajpf-815	315	7	bark	bark	PROPN
ajpf-815	315	8	:	:	PUNCT
ajpf-815	315	9	phytochemical	phytochemical	ADJ
ajpf-815	315	10	investigation	investigation	NOUN
ajpf-815	315	11	and	and	CCONJ
ajpf-815	315	12	quantitative	quantitative	ADJ
ajpf-815	315	13	analysis	analysis	NOUN
ajpf-815	315	14	by	by	ADP
ajpf-815	315	15	lc	lc	PROPN
ajpf-815	315	16	-	-	PUNCT
ajpf-815	315	17	esi	esi	PROPN
ajpf-815	315	18	ms	ms	PROPN
ajpf-815	315	19	/	/	SYM
ajpf-815	315	20	ms	ms	PROPN
ajpf-815	315	21	.	.	PROPN
ajpf-815	315	22	j.	j.	PROPN
ajpf-815	315	23	pharm	pharm	PROPN
ajpf-815	315	24	.	.	PUNCT
ajpf-815	315	25	biomed	biome	VERB
ajpf-815	315	26	.	.	PUNCT
ajpf-815	316	1	anal	anal	ADJ
ajpf-815	316	2	.	.	PUNCT
ajpf-815	317	1	56:1	56:1	NUM
ajpf-815	317	2	-	-	SYM
ajpf-815	317	3	6	6	NUM
ajpf-815	317	4	.	.	PUNCT
ajpf-815	318	1	martinez	martinez	PROPN
ajpf-815	318	2	jp	jp	PROPN
ajpf-815	318	3	,	,	PUNCT
ajpf-815	318	4	sasse	sasse	PROPN
ajpf-815	318	5	f	f	PROPN
ajpf-815	318	6	,	,	PUNCT
ajpf-815	318	7	brönstrup	brönstrup	PROPN
ajpf-815	318	8	m	m	PROPN
ajpf-815	318	9	,	,	PUNCT
ajpf-815	318	10	diez	diez	PROPN
ajpf-815	318	11	j	j	PROPN
ajpf-815	318	12	,	,	PUNCT
ajpf-815	318	13	meyerhans	meyerhan	VERB
ajpf-815	318	14	a	a	DET
ajpf-815	318	15	(	(	PUNCT
ajpf-815	318	16	2015	2015	NUM
ajpf-815	318	17	)	)	PUNCT
ajpf-815	318	18	.	.	PUNCT
ajpf-815	319	1	antiviral	antiviral	ADJ
ajpf-815	319	2	drug	drug	NOUN
ajpf-815	319	3	discovery	discovery	NOUN
ajpf-815	319	4	:	:	PUNCT
ajpf-815	319	5	broad	broad	ADJ
ajpf-815	319	6	-	-	PUNCT
ajpf-815	319	7	spectrum	spectrum	NOUN
ajpf-815	319	8	drugs	drug	NOUN
ajpf-815	319	9	from	from	ADP
ajpf-815	319	10	nature	nature	NOUN
ajpf-815	319	11	.	.	PUNCT
ajpf-815	320	1	nat	nat	PROPN
ajpf-815	320	2	.	.	PUNCT
ajpf-815	321	1	prod	prod	PROPN
ajpf-815	321	2	.	.	PUNCT
ajpf-815	322	1	rep	rep	PROPN
ajpf-815	322	2	.	.	PROPN
ajpf-815	323	1	32(1):29	32(1):29	NUM
ajpf-815	323	2	-	-	SYM
ajpf-815	323	3	48	48	NUM
ajpf-815	323	4	.	.	PUNCT
ajpf-815	324	1	maxwell	maxwell	PROPN
ajpf-815	324	2	lk	lk	PROPN
ajpf-815	324	3	(	(	PUNCT
ajpf-815	324	4	2017	2017	NUM
ajpf-815	324	5	)	)	PUNCT
ajpf-815	324	6	.	.	PUNCT
ajpf-815	325	1	antiherpetic	antiherpetic	ADJ
ajpf-815	325	2	drugs	drug	NOUN
ajpf-815	325	3	in	in	ADP
ajpf-815	325	4	equine	equine	NOUN
ajpf-815	325	5	medicine	medicine	NOUN
ajpf-815	325	6	.	.	PUNCT
ajpf-815	326	1	vet	vet	NOUN
ajpf-815	326	2	.	.	PUNCT
ajpf-815	327	1	clin	clin	PROPN
ajpf-815	327	2	.	.	PUNCT
ajpf-815	328	1	equine	equine	PROPN
ajpf-815	328	2	33(1):99	33(1):99	PROPN
ajpf-815	328	3	-	-	SYM
ajpf-815	328	4	125	125	NUM
ajpf-815	328	5	.	.	PUNCT
ajpf-815	329	1	mesquita	mesquita	PROPN
ajpf-815	329	2	ml	ml	PROPN
ajpf-815	329	3	,	,	PUNCT
ajpf-815	329	4	desrivot	desrivot	PROPN
ajpf-815	329	5	j	j	PROPN
ajpf-815	329	6	,	,	PUNCT
ajpf-815	329	7	bories	bories	PROPN
ajpf-815	329	8	fc	fc	PROPN
ajpf-815	329	9	,	,	PUNCT
ajpf-815	329	10	fournet	fournet	NOUN
ajpf-815	329	11	a	a	PRON
ajpf-815	329	12	,	,	PUNCT
ajpf-815	329	13	paula	paula	PROPN
ajpf-815	329	14	je	je	PROPN
ajpf-815	329	15	,	,	PUNCT
ajpf-815	329	16	grellier	grellier	NOUN
ajpf-815	329	17	p	p	NOUN
ajpf-815	329	18	,	,	PUNCT
ajpf-815	329	19	espindola	espindola	ADJ
ajpf-815	329	20	ls	ls	X
ajpf-815	329	21	(	(	PUNCT
ajpf-815	329	22	2005	2005	NUM
ajpf-815	329	23	)	)	PUNCT
ajpf-815	329	24	.	.	PUNCT
ajpf-815	330	1	antileishmanial	antileishmanial	ADJ
ajpf-815	330	2	and	and	CCONJ
ajpf-815	330	3	trypanocidal	trypanocidal	ADJ
ajpf-815	330	4	activity	activity	NOUN
ajpf-815	330	5	of	of	ADP
ajpf-815	330	6	brazilian	brazilian	ADJ
ajpf-815	330	7	cerrado	cerrado	NOUN
ajpf-815	330	8	plants	plant	NOUN
ajpf-815	330	9	.	.	PUNCT
ajpf-815	331	1	mem	mem	PROPN
ajpf-815	331	2	.	.	PROPN
ajpf-815	331	3	inst	inst	PROPN
ajpf-815	331	4	.	.	PUNCT
ajpf-815	332	1	oswaldo	oswaldo	PROPN
ajpf-815	332	2	cruz	cruz	PROPN
ajpf-815	332	3	100(7):783	100(7):783	PROPN
ajpf-815	332	4	-	-	PUNCT
ajpf-815	332	5	787	787	NUM
ajpf-815	332	6	.	.	PUNCT
ajpf-815	333	1	mesquita	mesquita	PROPN
ajpf-815	333	2	ml	ml	PROPN
ajpf-815	333	3	,	,	PUNCT
ajpf-815	333	4	grellier	grellier	NOUN
ajpf-815	333	5	p	p	NOUN
ajpf-815	333	6	,	,	PUNCT
ajpf-815	333	7	mambu	mambu	PROPN
ajpf-815	333	8	l	l	NOUN
ajpf-815	333	9	,	,	PUNCT
ajpf-815	333	10	de	de	PROPN
ajpf-815	333	11	paula	paula	PROPN
ajpf-815	333	12	je	je	PROPN
ajpf-815	333	13	,	,	PUNCT
ajpf-815	333	14	espindola	espindola	PROPN
ajpf-815	333	15	ls	ls	X
ajpf-815	333	16	(	(	PUNCT
ajpf-815	333	17	2007	2007	NUM
ajpf-815	333	18	)	)	PUNCT
ajpf-815	333	19	.	.	PUNCT
ajpf-815	334	1	in	in	ADP
ajpf-815	334	2	vitro	vitro	X
ajpf-815	334	3	antiplasmodial	antiplasmodial	ADJ
ajpf-815	334	4	activity	activity	NOUN
ajpf-815	334	5	of	of	ADP
ajpf-815	334	6	brazilian	brazilian	ADJ
ajpf-815	334	7	cerrado	cerrado	NOUN
ajpf-815	334	8	plants	plant	NOUN
ajpf-815	334	9	used	use	VERB
ajpf-815	334	10	as	as	ADP
ajpf-815	334	11	traditional	traditional	ADJ
ajpf-815	334	12	remedies	remedy	NOUN
ajpf-815	334	13	.	.	PUNCT
ajpf-815	335	1	j.	j.	PROPN
ajpf-815	335	2	ethnopharmacol	ethnopharmacol	PROPN
ajpf-815	335	3	.	.	PUNCT
ajpf-815	336	1	110(1):165	110(1):165	NUM
ajpf-815	336	2	-	-	SYM
ajpf-815	336	3	170	170	NUM
ajpf-815	336	4	.	.	PUNCT
ajpf-815	337	1	moreira	moreira	PROPN
ajpf-815	337	2	n	n	CCONJ
ajpf-815	337	3	,	,	PUNCT
ajpf-815	337	4	kruger	kruger	PROPN
ajpf-815	337	5	er	er	INTJ
ajpf-815	337	6	,	,	PUNCT
ajpf-815	337	7	warth	warth	NOUN
ajpf-815	337	8	jfg	jfg	PROPN
ajpf-815	337	9	,	,	PUNCT
ajpf-815	337	10	biesdorf	biesdorf	PROPN
ajpf-815	337	11	sm	sm	PROPN
ajpf-815	337	12	,	,	PUNCT
ajpf-815	337	13	goularte	goularte	PROPN
ajpf-815	337	14	mmm	mmm	PROPN
ajpf-815	337	15	,	,	PUNCT
ajpf-815	337	16	weiss	weiss	PROPN
ajpf-815	337	17	rr	rr	PROPN
ajpf-815	337	18	(	(	PUNCT
ajpf-815	337	19	1998	1998	NUM
ajpf-815	337	20	)	)	PUNCT
ajpf-815	337	21	.	.	PUNCT
ajpf-815	338	1	aspectos	aspectos	PROPN
ajpf-815	338	2	etiológicos	etiológico	NOUN
ajpf-815	338	3	e	e	PROPN
ajpf-815	338	4	epidemiológicos	epidemiológicos	PROPN
ajpf-815	338	5	do	do	VERB
ajpf-815	338	6	aborto	aborto	PROPN
ajpf-815	338	7	equino	equino	PROPN
ajpf-815	338	8	.	.	PUNCT
ajpf-815	339	1	arch	arch	NOUN
ajpf-815	339	2	.	.	PUNCT
ajpf-815	340	1	vet	vet	NOUN
ajpf-815	340	2	.	.	PUNCT
ajpf-815	341	1	sci	sci	PROPN
ajpf-815	341	2	.	.	PUNCT
ajpf-815	342	1	3(1):25	3(1):25	NUM
ajpf-815	342	2	-	-	SYM
ajpf-815	342	3	30	30	NUM
ajpf-815	342	4	.	.	PUNCT
ajpf-815	342	5	moreira	moreira	PROPN
ajpf-815	342	6	lq	lq	PROPN
ajpf-815	342	7	,	,	PUNCT
ajpf-815	342	8	vilela	vilela	PROPN
ajpf-815	342	9	fc	fc	PROPN
ajpf-815	342	10	,	,	PUNCT
ajpf-815	342	11	orlandi	orlandi	VERB
ajpf-815	342	12	l	l	PROPN
ajpf-815	342	13	,	,	PUNCT
ajpf-815	342	14	dias	dias	PROPN
ajpf-815	342	15	df	df	PROPN
ajpf-815	342	16	,	,	PUNCT
ajpf-815	342	17	santos	santos	PROPN
ajpf-815	342	18	ala	ala	PROPN
ajpf-815	342	19	,	,	PUNCT
ajpf-815	342	20	silva	silva	PROPN
ajpf-815	342	21	ma	ma	PROPN
ajpf-815	342	22	,	,	PUNCT
ajpf-815	342	23	paiva	paiva	PROPN
ajpf-815	342	24	r	r	PROPN
ajpf-815	342	25	,	,	PUNCT
ajpf-815	342	26	alves	alve	NOUN
ajpf-815	342	27	-	-	PUNCT
ajpf-815	342	28	da	da	PROPN
ajpf-815	342	29	-	-	PUNCT
ajpf-815	342	30	silva	silva	NOUN
ajpf-815	342	31	g	g	PROPN
ajpf-815	342	32	,	,	PUNCT
ajpf-815	342	33	giusti	giusti	PROPN
ajpf-815	342	34	-	-	PUNCT
ajpf-815	342	35	paiva	paiva	NOUN
ajpf-815	342	36	a	a	PRON
ajpf-815	342	37	(	(	PUNCT
ajpf-815	342	38	2011	2011	NUM
ajpf-815	342	39	)	)	PUNCT
ajpf-815	342	40	.	.	PUNCT
ajpf-815	343	1	anti	anti	ADJ
ajpf-815	343	2	-	-	ADJ
ajpf-815	343	3	inflammatory	inflammatory	ADJ
ajpf-815	343	4	effect	effect	NOUN
ajpf-815	343	5	of	of	ADP
ajpf-815	343	6	extract	extract	NOUN
ajpf-815	343	7	and	and	CCONJ
ajpf-815	343	8	fractions	fraction	NOUN
ajpf-815	343	9	from	from	ADP
ajpf-815	343	10	the	the	DET
ajpf-815	343	11	leaves	leave	NOUN
ajpf-815	343	12	of	of	ADP
ajpf-815	343	13	byrsonima	byrsonima	NOUN
ajpf-815	343	14	intermedia	intermedia	PROPN
ajpf-815	343	15	a.	a.	PROPN
ajpf-815	343	16	juss	juss	PROPN
ajpf-815	343	17	.	.	PUNCT
ajpf-815	344	1	in	in	ADP
ajpf-815	344	2	rats	rat	NOUN
ajpf-815	344	3	.	.	PUNCT
ajpf-815	345	1	j.	j.	PROPN
ajpf-815	345	2	ethnopharmacol	ethnopharmacol	PROPN
ajpf-815	345	3	.	.	PUNCT
ajpf-815	346	1	138(2):610	138(2):610	NUM
ajpf-815	346	2	-	-	SYM
ajpf-815	346	3	615	615	NUM
ajpf-815	346	4	.	.	PUNCT
ajpf-815	347	1	nakama	nakama	PROPN
ajpf-815	347	2	s	s	PART
ajpf-815	347	3	,	,	PUNCT
ajpf-815	347	4	tamaki	tamaki	PROPN
ajpf-815	347	5	k	k	PROPN
ajpf-815	347	6	,	,	PUNCT
ajpf-815	347	7	ishikawa	ishikawa	PROPN
ajpf-815	347	8	c	c	PROPN
ajpf-815	347	9	,	,	PUNCT
ajpf-815	347	10	tadano	tadano	ADJ
ajpf-815	347	11	m	m	PROPN
ajpf-815	347	12	,	,	PUNCT
ajpf-815	347	13	mori	mori	PROPN
ajpf-815	347	14	n	n	PROPN
ajpf-815	347	15	(	(	PUNCT
ajpf-815	347	16	2012	2012	NUM
ajpf-815	347	17	)	)	PUNCT
ajpf-815	347	18	.	.	PUNCT
ajpf-815	348	1	efficacy	efficacy	NOUN
ajpf-815	348	2	of	of	ADP
ajpf-815	348	3	bidens	bidens	PROPN
ajpf-815	348	4	pilosa	pilosa	PROPN
ajpf-815	348	5	extract	extract	VERB
ajpf-815	348	6	against	against	ADP
ajpf-815	348	7	herpes	herpe	NOUN
ajpf-815	348	8	simplex	simplex	NOUN
ajpf-815	348	9	virus	virus	NOUN
ajpf-815	348	10	infection	infection	NOUN
ajpf-815	348	11	in	in	ADP
ajpf-815	348	12	vitro	vitro	X
ajpf-815	348	13	and	and	CCONJ
ajpf-815	348	14	in	in	ADP
ajpf-815	348	15	vivo	vivo	NOUN
ajpf-815	348	16	.	.	PUNCT
ajpf-815	349	1	evidence	evidence	NOUN
ajpf-815	349	2	-	-	PUNCT
ajpf-815	349	3	based	base	VERB
ajpf-815	349	4	complement	complement	NOUN
ajpf-815	349	5	.	.	PUNCT
ajpf-815	350	1	altern	altern	PROPN
ajpf-815	350	2	.	.	PUNCT
ajpf-815	351	1	med	med	PROPN
ajpf-815	351	2	.	.	PUNCT
ajpf-815	352	1	2012:413453	2012:413453	X
ajpf-815	352	2	.	.	PUNCT
ajpf-815	352	3	nocchi	nocchi	PROPN
ajpf-815	352	4	sr	sr	PROPN
ajpf-815	352	5	,	,	PUNCT
ajpf-815	352	6	de	de	PROPN
ajpf-815	352	7	moura	moura	PROPN
ajpf-815	352	8	-	-	ADJ
ajpf-815	352	9	costa	costa	ADJ
ajpf-815	352	10	gf	gf	PROPN
ajpf-815	352	11	,	,	PUNCT
ajpf-815	352	12	novello	novello	PROPN
ajpf-815	352	13	cr	cr	PROPN
ajpf-815	352	14	,	,	PUNCT
ajpf-815	352	15	rodrigues	rodrigues	PROPN
ajpf-815	352	16	j	j	PROPN
ajpf-815	352	17	,	,	PUNCT
ajpf-815	352	18	longhini	longhini	NOUN
ajpf-815	352	19	r	r	NOUN
ajpf-815	352	20	,	,	PUNCT
ajpf-815	352	21	de	de	PROPN
ajpf-815	352	22	mello	mello	PROPN
ajpf-815	352	23	jcp	jcp	PROPN
ajpf-815	352	24	,	,	PUNCT
ajpf-815	352	25	ueda	ueda	PROPN
ajpf-815	352	26	-	-	PUNCT
ajpf-815	352	27	nakamura	nakamura	PROPN
ajpf-815	352	28	t	t	PROPN
ajpf-815	352	29	(	(	PUNCT
ajpf-815	352	30	2016	2016	NUM
ajpf-815	352	31	)	)	PUNCT
ajpf-815	352	32	.	.	PUNCT
ajpf-815	353	1	in	in	ADP
ajpf-815	353	2	vitro	vitro	X
ajpf-815	353	3	cytotoxicity	cytotoxicity	NOUN
ajpf-815	353	4	and	and	CCONJ
ajpf-815	353	5	antiherpes	antiherpe	NOUN
ajpf-815	353	6	simplex	simplex	NOUN
ajpf-815	353	7	virus	virus	NOUN
ajpf-815	353	8	type	type	NOUN
ajpf-815	353	9	1	1	NUM
ajpf-815	353	10	activity	activity	NOUN
ajpf-815	353	11	of	of	ADP
ajpf-815	353	12	hydroethanolic	hydroethanolic	ADJ
ajpf-815	353	13	extract	extract	NOUN
ajpf-815	353	14	,	,	PUNCT
ajpf-815	353	15	fractions	fraction	NOUN
ajpf-815	353	16	,	,	PUNCT
ajpf-815	353	17	and	and	CCONJ
ajpf-815	353	18	isolated	isolated	ADJ
ajpf-815	353	19	compounds	compound	NOUN
ajpf-815	353	20	from	from	ADP
ajpf-815	353	21	stem	stem	NOUN
ajpf-815	353	22	bark	bark	NOUN
ajpf-815	353	23	of	of	ADP
ajpf-815	353	24	schinus	schinus	PROPN
ajpf-815	353	25	terebinthifolius	terebinthifolius	PROPN
ajpf-815	353	26	raddi	raddi	PROPN
ajpf-815	353	27	.	.	PUNCT
ajpf-815	354	1	pharmacogn	pharmacogn	PROPN
ajpf-815	354	2	.	.	PUNCT
ajpf-815	355	1	mag	mag	PROPN
ajpf-815	355	2	.	.	PUNCT
ajpf-815	356	1	12(46):160	12(46):160	NUM
ajpf-815	356	2	-	-	SYM
ajpf-815	356	3	164	164	NUM
ajpf-815	356	4	.	.	PUNCT
ajpf-815	357	1	reed	reed	PROPN
ajpf-815	357	2	lj	lj	PROPN
ajpf-815	357	3	,	,	PUNCT
ajpf-815	357	4	muench	muench	ADJ
ajpf-815	357	5	h	h	NOUN
ajpf-815	357	6	(	(	PUNCT
ajpf-815	357	7	1938	1938	NUM
ajpf-815	357	8	)	)	PUNCT
ajpf-815	357	9	.	.	PUNCT
ajpf-815	358	1	simple	simple	ADJ
ajpf-815	358	2	method	method	NOUN
ajpf-815	358	3	of	of	ADP
ajpf-815	358	4	estimating	estimate	VERB
ajpf-815	358	5	fifty	fifty	NUM
ajpf-815	358	6	percent	percent	NOUN
ajpf-815	358	7	and	and	CCONJ
ajpf-815	358	8	point	point	NOUN
ajpf-815	358	9	.	.	PUNCT
ajpf-815	359	1	am	be	AUX
ajpf-815	359	2	.	.	PUNCT
ajpf-815	360	1	j.	j.	PROPN
ajpf-815	360	2	hyg	hyg	PROPN
ajpf-815	360	3	.	.	PUNCT
ajpf-815	361	1	27(3):493	27(3):493	NUM
ajpf-815	361	2	-	-	PUNCT
ajpf-815	361	3	497	497	NUM
ajpf-815	361	4	.	.	PUNCT
ajpf-815	362	1	riaz	riaz	PROPN
ajpf-815	362	2	a	a	PRON
ajpf-815	362	3	,	,	PUNCT
ajpf-815	362	4	murtaz	murtaz	PROPN
ajpf-815	362	5	-	-	PUNCT
ajpf-815	362	6	ul	ul	PROPN
ajpf-815	362	7	-	-	PROPN
ajpf-815	362	8	hasan	hasan	PROPN
ajpf-815	362	9	k	k	PROPN
ajpf-815	362	10	,	,	PUNCT
ajpf-815	362	11	akhtar	akhtar	PROPN
ajpf-815	362	12	n	n	PROPN
ajpf-815	362	13	(	(	PUNCT
ajpf-815	362	14	2017	2017	NUM
ajpf-815	362	15	)	)	PUNCT
ajpf-815	362	16	.	.	PUNCT
ajpf-815	363	1	recent	recent	ADJ
ajpf-815	363	2	understanding	understanding	NOUN
ajpf-815	363	3	of	of	ADP
ajpf-815	363	4	the	the	DET
ajpf-815	363	5	classification	classification	NOUN
ajpf-815	363	6	and	and	CCONJ
ajpf-815	363	7	life	life	NOUN
ajpf-815	363	8	cycle	cycle	NOUN
ajpf-815	363	9	of	of	ADP
ajpf-815	363	10	herpesvirus	herpesvirus	NOUN
ajpf-815	363	11	:	:	PUNCT
ajpf-815	363	12	a	a	DET
ajpf-815	363	13	review	review	NOUN
ajpf-815	363	14	.	.	PUNCT
ajpf-815	364	1	sci	sci	PROPN
ajpf-815	364	2	.	.	PROPN
ajpf-815	364	3	lett	lett	PROPN
ajpf-815	364	4	.	.	PUNCT
ajpf-815	365	1	5(2):195	5(2):195	NUM
ajpf-815	365	2	-	-	SYM
ajpf-815	365	3	207	207	NUM
ajpf-815	365	4	.	.	PUNCT
ajpf-815	366	1	sannomiya	sannomiya	PROPN
ajpf-815	366	2	m	m	PROPN
ajpf-815	366	3	,	,	PUNCT
ajpf-815	366	4	cardoso	cardoso	PROPN
ajpf-815	366	5	cr	cr	PROPN
ajpf-815	366	6	,	,	PUNCT
ajpf-815	366	7	figueiredo	figueiredo	VERB
ajpf-815	366	8	me	i	PRON
ajpf-815	366	9	,	,	PUNCT
ajpf-815	366	10	rodrigues	rodrigues	PROPN
ajpf-815	366	11	cm	cm	PROPN
ajpf-815	366	12	,	,	PUNCT
ajpf-815	366	13	santos	santos	PROPN
ajpf-815	366	14	lc	lc	PROPN
ajpf-815	366	15	,	,	PUNCT
ajpf-815	366	16	santos	santos	PROPN
ajpf-815	366	17	fv	fv	PROPN
ajpf-815	366	18	,	,	PUNCT
ajpf-815	366	19	serpeloni	serpeloni	NOUN
ajpf-815	366	20	jm	jm	PROPN
ajpf-815	366	21	,	,	PUNCT
ajpf-815	366	22	cólus	cólus	PROPN
ajpf-815	366	23	ims	ims	PROPN
ajpf-815	366	24	,	,	PUNCT
ajpf-815	366	25	vilegas	vilegas	NOUN
ajpf-815	366	26	w	w	PROPN
ajpf-815	366	27	,	,	PUNCT
ajpf-815	366	28	varanda	varanda	PROPN
ajpf-815	366	29	ea	ea	PROPN
ajpf-815	366	30	(	(	PUNCT
ajpf-815	366	31	2007	2007	NUM
ajpf-815	366	32	)	)	PUNCT
ajpf-815	366	33	.	.	PUNCT
ajpf-815	367	1	mutagenic	mutagenic	ADJ
ajpf-815	367	2	evaluation	evaluation	NOUN
ajpf-815	367	3	and	and	CCONJ
ajpf-815	367	4	chemical	chemical	NOUN
ajpf-815	367	5	investigation	investigation	NOUN
ajpf-815	367	6	of	of	ADP
ajpf-815	367	7	byrsonima	byrsonima	PROPN
ajpf-815	367	8	intermedia	intermedia	PROPN
ajpf-815	367	9	a.	a.	PROPN
ajpf-815	367	10	juss	juss	PROPN
ajpf-815	367	11	.	.	PUNCT
ajpf-815	368	1	leaf	leaf	NOUN
ajpf-815	368	2	extracts	extract	NOUN
ajpf-815	368	3	.	.	PUNCT
ajpf-815	369	1	j.	j.	PROPN
ajpf-815	369	2	ethnopharmacol	ethnopharmacol	PROPN
ajpf-815	369	3	.	.	PUNCT
ajpf-815	370	1	112(2):319	112(2):319	PROPN
ajpf-815	370	2	-	-	PUNCT
ajpf-815	370	3	326	326	NUM
ajpf-815	370	4	.	.	PUNCT
ajpf-815	371	1	santos	santos	PROPN
ajpf-815	371	2	afa	afa	PROPN
ajpf-815	371	3	,	,	PUNCT
ajpf-815	371	4	vieira	vieira	PROPN
ajpf-815	371	5	als	al	NOUN
ajpf-815	371	6	,	,	PUNCT
ajpf-815	371	7	pic	pic	NOUN
ajpf-815	371	8	-	-	PUNCT
ajpf-815	371	9	taylor	taylor	PROPN
ajpf-815	371	10	a	a	PROPN
ajpf-815	371	11	,	,	PUNCT
ajpf-815	371	12	caldas	caldas	PROPN
ajpf-815	371	13	ed	ed	NOUN
ajpf-815	371	14	(	(	PUNCT
ajpf-815	371	15	2017	2017	NUM
ajpf-815	371	16	)	)	PUNCT
ajpf-815	371	17	.	.	PUNCT
ajpf-815	372	1	reproductive	reproductive	ADJ
ajpf-815	372	2	effects	effect	NOUN
ajpf-815	372	3	of	of	ADP
ajpf-815	372	4	the	the	DET
ajpf-815	372	5	psychoactive	psychoactive	ADJ
ajpf-815	372	6	beverage	beverage	NOUN
ajpf-815	372	7	ayahuasca	ayahuasca	NOUN
ajpf-815	372	8	in	in	ADP
ajpf-815	372	9	male	male	PROPN
ajpf-815	372	10	wistar	wistar	PROPN
ajpf-815	372	11	rats	rat	NOUN
ajpf-815	372	12	after	after	ADP
ajpf-815	372	13	chronic	chronic	ADJ
ajpf-815	372	14	exposure	exposure	NOUN
ajpf-815	372	15	.	.	PUNCT
ajpf-815	373	1	rev	rev	PROPN
ajpf-815	373	2	.	.	PROPN
ajpf-815	373	3	bras	bras	PROPN
ajpf-815	373	4	.	.	PUNCT
ajpf-815	374	1	farmacog	farmacog	PROPN
ajpf-815	374	2	.	.	PUNCT
ajpf-815	375	1	27(3):353	27(3):353	NUM
ajpf-815	375	2	-	-	SYM
ajpf-815	375	3	360	360	NUM
ajpf-815	375	4	.	.	PUNCT
ajpf-815	376	1	sawyer	sawyer	PROPN
ajpf-815	376	2	dr	dr	PROPN
ajpf-815	376	3	(	(	PUNCT
ajpf-815	376	4	2016	2016	NUM
ajpf-815	376	5	)	)	PUNCT
ajpf-815	376	6	.	.	PUNCT
ajpf-815	377	1	ecosystem	ecosystem	NOUN
ajpf-815	377	2	profile	profile	NOUN
ajpf-815	377	3	:	:	PUNCT
ajpf-815	377	4	cerrado	cerrado	VERB
ajpf-815	377	5	biodiversity	biodiversity	NOUN
ajpf-815	377	6	hotspot	hotspot	NOUN
ajpf-815	377	7	.	.	PUNCT
ajpf-815	378	1	available	available	ADJ
ajpf-815	378	2	at	at	ADP
ajpf-815	378	3	:	:	PUNCT
ajpf-815	378	4	http://legacy.cepf.net/sitecollectiondocuments/cerrado/cerradoecos	http://legacy.cepf.net/sitecollectiondocuments/cerrado/cerradoecos	PROPN
ajpf-815	378	5	ystemprofile-en.pdf	ystemprofile-en.pdf	PROPN
ajpf-815	378	6	sharma	sharma	PROPN
ajpf-815	378	7	a	a	PROPN
ajpf-815	378	8	,	,	PUNCT
ajpf-815	378	9	kashyap	kashyap	PROPN
ajpf-815	378	10	d	d	PROPN
ajpf-815	378	11	,	,	PUNCT
ajpf-815	378	12	sak	sak	PROPN
ajpf-815	378	13	k	k	PROPN
ajpf-815	378	14	,	,	PUNCT
ajpf-815	378	15	tuli	tuli	PROPN
ajpf-815	378	16	hs	hs	PROPN
ajpf-815	378	17	,	,	PUNCT
ajpf-815	378	18	sharma	sharma	PROPN
ajpf-815	378	19	ak	ak	PROPN
ajpf-815	378	20	(	(	PUNCT
ajpf-815	378	21	2018	2018	NUM
ajpf-815	378	22	)	)	PUNCT
ajpf-815	378	23	.	.	PUNCT
ajpf-815	379	1	therapeutic	therapeutic	ADJ
ajpf-815	379	2	charm	charm	NOUN
ajpf-815	379	3	of	of	ADP
ajpf-815	379	4	quercetin	quercetin	NOUN
ajpf-815	379	5	and	and	CCONJ
ajpf-815	379	6	its	its	PRON
ajpf-815	379	7	derivatives	derivative	NOUN
ajpf-815	379	8	:	:	PUNCT
ajpf-815	379	9	a	a	DET
ajpf-815	379	10	review	review	NOUN
ajpf-815	379	11	of	of	ADP
ajpf-815	379	12	research	research	NOUN
ajpf-815	379	13	and	and	CCONJ
ajpf-815	379	14	patents	patent	NOUN
ajpf-815	379	15	.	.	PUNCT
ajpf-815	380	1	pharm	pharm	NOUN
ajpf-815	380	2	.	.	PUNCT
ajpf-815	381	1	pat	pat	PROPN
ajpf-815	381	2	anal	anal	PROPN
ajpf-815	381	3	.	.	PUNCT
ajpf-815	382	1	7(1):15	7(1):15	NUM
ajpf-815	382	2	-	-	SYM
ajpf-815	382	3	32	32	NUM
ajpf-815	382	4	.	.	PUNCT
ajpf-815	383	1	silva	silva	PROPN
ajpf-815	383	2	it	it	PRON
ajpf-815	383	3	,	,	PUNCT
ajpf-815	383	4	costa	costa	PROPN
ajpf-815	383	5	gm	gm	PROPN
ajpf-815	383	6	,	,	PUNCT
ajpf-815	383	7	stoco	stoco	NOUN
ajpf-815	383	8	ph	ph	VERB
ajpf-815	383	9	,	,	PUNCT
ajpf-815	383	10	schenkel	schenkel	NOUN
ajpf-815	383	11	ep	ep	PROPN
ajpf-815	383	12	,	,	PUNCT
ajpf-815	383	13	reginatto	reginatto	PROPN
ajpf-815	383	14	fh	fh	PROPN
ajpf-815	383	15	,	,	PUNCT
ajpf-815	383	16	simões	simões	ADJ
ajpf-815	383	17	cm	cm	PROPN
ajpf-815	383	18	(	(	PUNCT
ajpf-815	383	19	2010	2010	NUM
ajpf-815	383	20	)	)	PUNCT
ajpf-815	383	21	.	.	PUNCT
ajpf-815	384	1	in	in	ADP
ajpf-815	384	2	vitro	vitro	X
ajpf-815	384	3	antiherpes	antiherpe	NOUN
ajpf-815	384	4	effects	effect	NOUN
ajpf-815	384	5	of	of	ADP
ajpf-815	384	6	a	a	DET
ajpf-815	384	7	c	c	NOUN
ajpf-815	384	8	-	-	PUNCT
ajpf-815	384	9	glycosylflavonoid	glycosylflavonoid	ADJ
ajpf-815	384	10	-	-	PUNCT
ajpf-815	384	11	enriched	enrich	VERB
ajpf-815	384	12	fraction	fraction	NOUN
ajpf-815	384	13	of	of	ADP
ajpf-815	384	14	cecropia	cecropia	PROPN
ajpf-815	384	15	glaziovii	glaziovii	PROPN
ajpf-815	384	16	sneth	sneth	PROPN
ajpf-815	384	17	.	.	PUNCT
ajpf-815	385	1	lett	lett	PROPN
ajpf-815	385	2	.	.	PUNCT
ajpf-815	385	3	appl	appl	PROPN
ajpf-815	385	4	.	.	PUNCT
ajpf-815	386	1	microbiol	microbiol	PROPN
ajpf-815	386	2	.	.	PUNCT
ajpf-815	387	1	51(2):143148	51(2):143148	NUM
ajpf-815	387	2	.	.	PUNCT
ajpf-815	387	3	silva	silva	PROPN
ajpf-815	387	4	junior	junior	PROPN
ajpf-815	387	5	ie	ie	PROPN
ajpf-815	387	6	,	,	PUNCT
ajpf-815	387	7	cechinel	cechinel	VERB
ajpf-815	387	8	filho	filho	NOUN
ajpf-815	387	9	v	v	NOUN
ajpf-815	387	10	,	,	PUNCT
ajpf-815	387	11	zacchino	zacchino	PROPN
ajpf-815	387	12	sa	sa	PROPN
ajpf-815	387	13	,	,	PUNCT
ajpf-815	387	14	lima	lima	PROPN
ajpf-815	387	15	jc	jc	PROPN
ajpf-815	387	16	,	,	PUNCT
ajpf-815	387	17	martins	martin	VERB
ajpf-815	387	18	dt	dt	NOUN
ajpf-815	387	19	(	(	PUNCT
ajpf-815	387	20	2009	2009	NUM
ajpf-815	387	21	)	)	PUNCT
ajpf-815	387	22	.	.	PUNCT
ajpf-815	388	1	antimicrobial	antimicrobial	ADJ
ajpf-815	388	2	screening	screening	NOUN
ajpf-815	388	3	of	of	ADP
ajpf-815	388	4	some	some	DET
ajpf-815	388	5	medicinal	medicinal	ADJ
ajpf-815	388	6	plants	plant	NOUN
ajpf-815	388	7	from	from	ADP
ajpf-815	388	8	mato	mato	PROPN
ajpf-815	388	9	grosso	grosso	PROPN
ajpf-815	388	10	cerrado	cerrado	PROPN
ajpf-815	388	11	.	.	PUNCT
ajpf-815	389	1	rev	rev	PROPN
ajpf-815	389	2	.	.	PROPN
ajpf-815	389	3	bras	bras	PROPN
ajpf-815	389	4	.	.	PUNCT
ajpf-815	390	1	farmacog	farmacog	PROPN
ajpf-815	390	2	.	.	PUNCT
ajpf-815	391	1	19(1):242	19(1):242	PROPN
ajpf-815	391	2	-	-	SYM
ajpf-815	391	3	248	248	NUM
ajpf-815	391	4	.	.	PUNCT
ajpf-815	392	1	simoni	simoni	PROPN
ajpf-815	392	2	ic	ic	PROPN
ajpf-815	392	3	,	,	PUNCT
ajpf-815	392	4	fernandes	fernandes	PROPN
ajpf-815	392	5	mjb	mjb	PROPN
ajpf-815	392	6	,	,	PUNCT
ajpf-815	392	7	gonçalves	gonçalves	PROPN
ajpf-815	392	8	cr	cr	PROPN
ajpf-815	392	9	,	,	PUNCT
ajpf-815	392	10	almeida	almeida	PROPN
ajpf-815	392	11	ap	ap	PROPN
ajpf-815	392	12	,	,	PUNCT
ajpf-815	392	13	costa	costa	PROPN
ajpf-815	392	14	ss	ss	PROPN
ajpf-815	392	15	,	,	PUNCT
ajpf-815	392	16	lima	lima	PROPN
ajpf-815	392	17	ap	ap	PROPN
ajpf-815	392	18	(	(	PUNCT
ajpf-815	392	19	1996	1996	NUM
ajpf-815	392	20	)	)	PUNCT
ajpf-815	392	21	.	.	PUNCT
ajpf-815	393	1	a	a	DET
ajpf-815	393	2	study	study	NOUN
ajpf-815	393	3	on	on	ADP
ajpf-815	393	4	the	the	DET
ajpf-815	393	5	antiviral	antiviral	ADJ
ajpf-815	393	6	caracteristics	caracteristic	NOUN
ajpf-815	393	7	of	of	ADP
ajpf-815	393	8	persea	persea	NOUN
ajpf-815	393	9	americana	americana	ADJ
ajpf-815	393	10	extracts	extract	NOUN
ajpf-815	393	11	against	against	ADP
ajpf-815	393	12	aujesky‟s	aujesky‟s	ADJ
ajpf-815	393	13	disease	disease	NOUN
ajpf-815	393	14	vírus	vírus	NOUN
ajpf-815	393	15	.	.	PROPN
ajpf-815	393	16	biomed	biome	VERB
ajpf-815	393	17	.	.	PUNCT
ajpf-815	394	1	let	let	VERB
ajpf-815	394	2	.	.	PUNCT
ajpf-815	395	1	54:173	54:173	NUM
ajpf-815	395	2	-	-	SYM
ajpf-815	395	3	181	181	NUM
ajpf-815	395	4	.	.	PUNCT
ajpf-815	396	1	simoni	simoni	PROPN
ajpf-815	396	2	ic	ic	PROPN
ajpf-815	396	3	,	,	PUNCT
ajpf-815	396	4	manha	manha	NOUN
ajpf-815	396	5	aps	aps	PROPN
ajpf-815	396	6	,	,	PUNCT
ajpf-815	396	7	sciessere	sciessere	ADJ
ajpf-815	396	8	l	l	NOUN
ajpf-815	396	9	,	,	PUNCT
ajpf-815	396	10	hoe	hoe	ADJ
ajpf-815	396	11	vmh	vmh	ADJ
ajpf-815	396	12	,	,	PUNCT
ajpf-815	396	13	takinami	takinami	PROPN
ajpf-815	396	14	vh	vh	PROPN
ajpf-815	396	15	,	,	PUNCT
ajpf-815	396	16	fernandes	fernandes	PROPN
ajpf-815	396	17	mjb	mjb	PROPN
ajpf-815	396	18	(	(	PUNCT
ajpf-815	396	19	2007	2007	NUM
ajpf-815	396	20	)	)	PUNCT
ajpf-815	396	21	.	.	PUNCT
ajpf-815	397	1	evaluation	evaluation	NOUN
ajpf-815	397	2	of	of	ADP
ajpf-815	397	3	the	the	DET
ajpf-815	397	4	antiviral	antiviral	ADJ
ajpf-815	397	5	activity	activity	NOUN
ajpf-815	397	6	of	of	ADP
ajpf-815	397	7	brazilian	brazilian	ADJ
ajpf-815	397	8	cerrado	cerrado	NOUN
ajpf-815	397	9	plants	plant	NOUN
ajpf-815	397	10	against	against	ADP
ajpf-815	397	11	animal	animal	NOUN
ajpf-815	397	12	viruses	virus	NOUN
ajpf-815	397	13	.	.	PUNCT
ajpf-815	398	1	virus	virus	NOUN
ajpf-815	398	2	rev	rev	VERB
ajpf-815	398	3	.	.	PUNCT
ajpf-815	399	1	res	re	NOUN
ajpf-815	399	2	.	.	PUNCT
ajpf-815	400	1	12(1/2):25	12(1/2):25	NUM
ajpf-815	400	2	-	-	SYM
ajpf-815	400	3	31	31	NUM
ajpf-815	400	4	.	.	PUNCT
ajpf-815	401	1	simoni	simoni	PROPN
ajpf-815	401	2	ic	ic	PROPN
ajpf-815	401	3	,	,	PUNCT
ajpf-815	401	4	fernandes	fernandes	PROPN
ajpf-815	401	5	mjb	mjb	PROPN
ajpf-815	401	6	,	,	PUNCT
ajpf-815	401	7	camargo	camargo	PROPN
ajpf-815	401	8	lmm	lmm	PROPN
ajpf-815	401	9	,	,	PUNCT
ajpf-815	401	10	biltoveni	biltoveni	PROPN
ajpf-815	401	11	lr	lr	PROPN
ajpf-815	401	12	,	,	PUNCT
ajpf-815	401	13	manha	manha	NOUN
ajpf-815	401	14	aps	aps	PROPN
ajpf-815	401	15	,	,	PUNCT
ajpf-815	401	16	tomitão	tomitão	PROPN
ajpf-815	401	17	mtp	mtp	PROPN
ajpf-815	401	18	,	,	PUNCT
ajpf-815	401	19	de	de	PROPN
ajpf-815	401	20	oliveira	oliveira	PROPN
ajpf-815	401	21	db	db	PROPN
ajpf-815	401	22	,	,	PUNCT
ajpf-815	401	23	negrelle	negrelle	PROPN
ajpf-815	401	24	r	r	PROPN
ajpf-815	401	25	,	,	PUNCT
ajpf-815	401	26	costa	costa	PROPN
ajpf-815	401	27	ss	ss	PROPN
ajpf-815	401	28	(	(	PUNCT
ajpf-815	401	29	2014	2014	NUM
ajpf-815	401	30	)	)	PUNCT
ajpf-815	401	31	.	.	PUNCT
ajpf-815	402	1	plants	plant	NOUN
ajpf-815	402	2	from	from	ADP
ajpf-815	402	3	deer	deer	NOUN
ajpf-815	402	4	diet	diet	NOUN
ajpf-815	402	5	in	in	ADP
ajpf-815	402	6	the	the	DET
ajpf-815	402	7	brazilian	brazilian	ADJ
ajpf-815	402	8	pantanal	pantanal	PROPN
ajpf-815	402	9	wetland	wetland	NOUN
ajpf-815	402	10	as	as	ADP
ajpf-815	402	11	potential	potential	ADJ
ajpf-815	402	12	source	source	NOUN
ajpf-815	402	13	of	of	ADP
ajpf-815	402	14	antiviral	antiviral	ADJ
ajpf-815	402	15	and	and	CCONJ
ajpf-815	402	16	antioxidant	antioxidant	ADJ
ajpf-815	402	17	compounds	compound	NOUN
ajpf-815	402	18	.	.	PUNCT
ajpf-815	403	1	virus	virus	PROPN
ajpf-815	403	2	rev	rev	VERB
ajpf-815	403	3	.	.	PUNCT
ajpf-815	404	1	res	re	NOUN
ajpf-815	404	2	.	.	PUNCT
ajpf-815	405	1	19:1	19:1	NUM
ajpf-815	405	2	-	-	SYM
ajpf-815	405	3	12	12	NUM
ajpf-815	405	4	.	.	PUNCT
ajpf-815	406	1	stashenko	stashenko	PROPN
ajpf-815	406	2	ee	ee	PROPN
ajpf-815	406	3	,	,	PUNCT
ajpf-815	406	4	jaramillo	jaramillo	PROPN
ajpf-815	406	5	be	be	VERB
ajpf-815	406	6	,	,	PUNCT
ajpf-815	406	7	martínez	martínez	PROPN
ajpf-815	406	8	jr	jr	PROPN
ajpf-815	406	9	(	(	PUNCT
ajpf-815	406	10	2004	2004	NUM
ajpf-815	406	11	)	)	PUNCT
ajpf-815	406	12	.	.	PUNCT
ajpf-815	407	1	analysis	analysis	NOUN
ajpf-815	407	2	of	of	ADP
ajpf-815	407	3	volatile	volatile	ADJ
ajpf-815	407	4	secondary	secondary	ADJ
ajpf-815	407	5	metabolites	metabolite	NOUN
ajpf-815	407	6	from	from	ADP
ajpf-815	407	7	colombian	colombian	ADJ
ajpf-815	407	8	xylopia	xylopia	PROPN
ajpf-815	407	9	aromatica	aromatica	PROPN
ajpf-815	407	10	(	(	PUNCT
ajpf-815	407	11	lamarck	lamarck	PROPN
ajpf-815	407	12	)	)	PUNCT
ajpf-815	407	13	by	by	ADP
ajpf-815	407	14	different	different	ADJ
ajpf-815	407	15	extraction	extraction	NOUN
ajpf-815	407	16	and	and	CCONJ
ajpf-815	407	17	headspace	headspace	NOUN
ajpf-815	407	18	methods	method	NOUN
ajpf-815	407	19	and	and	CCONJ
ajpf-815	407	20	gas	gas	NOUN
ajpf-815	407	21	chromatography	chromatography	NOUN
ajpf-815	407	22	.	.	PUNCT
ajpf-815	408	1	j.	j.	PROPN
ajpf-815	408	2	chromatogr	chromatogr	PROPN
ajpf-815	408	3	.	.	PUNCT
ajpf-815	409	1	a	a	DET
ajpf-815	409	2	1025(1):105	1025(1):105	NUM
ajpf-815	409	3	-	-	SYM
ajpf-815	409	4	113	113	NUM
ajpf-815	409	5	.	.	PUNCT
ajpf-815	410	1	takeuchi	takeuchi	PROPN
ajpf-815	410	2	h	h	PROPN
ajpf-815	410	3	,	,	PUNCT
ajpf-815	410	4	baba	baba	PROPN
ajpf-815	410	5	m	m	PROPN
ajpf-815	410	6	,	,	PUNCT
ajpf-815	410	7	shigeta	shigeta	PROPN
ajpf-815	410	8	s	s	X
ajpf-815	410	9	(	(	PUNCT
ajpf-815	410	10	1991	1991	NUM
ajpf-815	410	11	)	)	PUNCT
ajpf-815	410	12	.	.	PUNCT
ajpf-815	411	1	an	an	DET
ajpf-815	411	2	application	application	NOUN
ajpf-815	411	3	of	of	ADP
ajpf-815	411	4	tetrazolium	tetrazolium	NOUN
ajpf-815	411	5	(	(	PUNCT
ajpf-815	411	6	mtt	mtt	NOUN
ajpf-815	411	7	)	)	PUNCT
ajpf-815	411	8	colorimetric	colorimetric	ADJ
ajpf-815	411	9	assay	assay	NOUN
ajpf-815	411	10	for	for	ADP
ajpf-815	411	11	the	the	DET
ajpf-815	411	12	screening	screening	NOUN
ajpf-815	411	13	of	of	ADP
ajpf-815	411	14	anti	anti	ADJ
ajpf-815	411	15	-	-	ADJ
ajpf-815	411	16	herpes	herpes	ADJ
ajpf-815	411	17	simplex	simplex	NOUN
ajpf-815	411	18	virus	virus	NOUN
ajpf-815	411	19	compounds	compound	VERB
ajpf-815	411	20	.	.	PUNCT
ajpf-815	412	1	j.	j.	PROPN
ajpf-815	412	2	virol	virol	PROPN
ajpf-815	412	3	.	.	PUNCT
ajpf-815	413	1	methods	method	NOUN
ajpf-815	413	2	33(1	33(1	PROPN
ajpf-815	413	3	-	-	SYM
ajpf-815	413	4	2):61	2):61	NUM
ajpf-815	413	5	-	-	PUNCT
ajpf-815	413	6	71	71	NUM
ajpf-815	413	7	.	.	PUNCT
ajpf-815	414	1	vadlapudi	vadlapudi	ADJ
ajpf-815	414	2	ad	ad	NOUN
ajpf-815	414	3	,	,	PUNCT
ajpf-815	414	4	vadlapatla	vadlapatla	PROPN
ajpf-815	414	5	rk	rk	PROPN
ajpf-815	414	6	,	,	PUNCT
ajpf-815	414	7	mitra	mitra	PROPN
ajpf-815	414	8	ak	ak	PROPN
ajpf-815	414	9	(	(	PUNCT
ajpf-815	414	10	2013	2013	NUM
ajpf-815	414	11	)	)	PUNCT
ajpf-815	414	12	.	.	PUNCT
ajpf-815	415	1	update	update	NOUN
ajpf-815	415	2	on	on	ADP
ajpf-815	415	3	emerging	emerge	VERB
ajpf-815	415	4	antivirals	antiviral	NOUN
ajpf-815	415	5	for	for	ADP
ajpf-815	415	6	the	the	DET
ajpf-815	415	7	management	management	NOUN
ajpf-815	415	8	of	of	ADP
ajpf-815	415	9	herpes	herpe	NOUN
ajpf-815	415	10	simplex	simplex	NOUN
ajpf-815	415	11	virus	virus	NOUN
ajpf-815	415	12	infections	infection	NOUN
ajpf-815	415	13	:	:	PUNCT
ajpf-815	415	14	a	a	DET
ajpf-815	415	15	patenting	patenting	NOUN
ajpf-815	415	16	perspective	perspective	NOUN
ajpf-815	415	17	.	.	PUNCT
ajpf-815	416	1	recent	recent	ADJ
ajpf-815	416	2	pat	pat	PROPN
ajpf-815	416	3	antiinfect	antiinfect	PROPN
ajpf-815	416	4	.	.	PUNCT
ajpf-815	416	5	drug	drug	NOUN
ajpf-815	416	6	.	.	PUNCT
ajpf-815	417	1	discov	discov	NOUN
ajpf-815	417	2	.	.	PUNCT
ajpf-815	418	1	8(1):55	8(1):55	NUM
ajpf-815	418	2	-	-	SYM
ajpf-815	418	3	67	67	NUM
ajpf-815	418	4	.	.	PUNCT
ajpf-815	419	1	wyler	wyler	PROPN
ajpf-815	419	2	e	e	PROPN
ajpf-815	419	3	,	,	PUNCT
ajpf-815	419	4	menegatti	menegatti	PROPN
ajpf-815	419	5	j	j	PROPN
ajpf-815	419	6	,	,	PUNCT
ajpf-815	419	7	franke	franke	PROPN
ajpf-815	419	8	v	v	NOUN
ajpf-815	419	9	,	,	PUNCT
ajpf-815	419	10	kocks	kock	NOUN
ajpf-815	419	11	c	c	NOUN
ajpf-815	419	12	,	,	PUNCT
ajpf-815	419	13	boltengagen	boltengagen	PROPN
ajpf-815	419	14	a	a	PROPN
ajpf-815	419	15	,	,	PUNCT
ajpf-815	419	16	hennig	hennig	PROPN
ajpf-815	419	17	t	t	PROPN
ajpf-815	419	18	,	,	PUNCT
ajpf-815	419	19	theil	theil	PROPN
ajpf-815	419	20	k	k	PROPN
ajpf-815	419	21	,	,	PUNCT
ajpf-815	419	22	rutkowski	rutkowski	PROPN
ajpf-815	419	23	a	a	PROPN
ajpf-815	419	24	,	,	PUNCT
ajpf-815	419	25	ferrai	ferrai	ADJ
ajpf-815	419	26	c	c	PROPN
ajpf-815	419	27	,	,	PUNCT
ajpf-815	419	28	baer	baer	PROPN
ajpf-815	419	29	l	l	PROPN
ajpf-815	419	30	,	,	PUNCT
ajpf-815	419	31	kermas	kermas	PROPN
ajpf-815	419	32	l	l	PROPN
ajpf-815	419	33	,	,	PUNCT
ajpf-815	419	34	friedel	friedel	PROPN
ajpf-815	419	35	c	c	PROPN
ajpf-815	419	36	,	,	PUNCT
ajpf-815	419	37	rajewsky	rajewsky	PROPN
ajpf-815	419	38	n	n	CCONJ
ajpf-815	419	39	,	,	PUNCT
ajpf-815	419	40	akalin	akalin	PROPN
ajpf-815	419	41	a	a	PROPN
ajpf-815	419	42	,	,	PUNCT
ajpf-815	419	43	dölken	dölken	ADJ
ajpf-815	419	44	l	l	NOUN
ajpf-815	419	45	,	,	PUNCT
ajpf-815	419	46	grässer	grässer	NOUN
ajpf-815	419	47	f	f	PROPN
ajpf-815	419	48	,	,	PUNCT
ajpf-815	419	49	landthaler	landthaler	PROPN
ajpf-815	419	50	m	m	PROPN
ajpf-815	419	51	(	(	PUNCT
ajpf-815	419	52	2017	2017	NUM
ajpf-815	419	53	)	)	PUNCT
ajpf-815	419	54	.	.	PUNCT
ajpf-815	420	1	widespread	widespread	ADJ
ajpf-815	420	2	activation	activation	NOUN
ajpf-815	420	3	of	of	ADP
ajpf-815	420	4	antisense	antisense	NOUN
ajpf-815	420	5	transcription	transcription	NOUN
ajpf-815	420	6	of	of	ADP
ajpf-815	420	7	the	the	DET
ajpf-815	420	8	host	host	NOUN
ajpf-815	420	9	genome	genome	NOUN
ajpf-815	420	10	during	during	ADP
ajpf-815	420	11	herpes	herpe	NOUN
ajpf-815	420	12	simplex	simplex	NOUN
ajpf-815	420	13	virus	virus	NOUN
ajpf-815	420	14	1	1	NUM
ajpf-815	420	15	infection	infection	NOUN
ajpf-815	420	16	.	.	PUNCT
ajpf-815	421	1	genome	genome	NOUN
ajpf-815	421	2	biol	biol	NOUN
ajpf-815	421	3	.	.	PUNCT
ajpf-815	422	1	18:209	18:209	NOUN
ajpf-815	422	2	.	.	PUNCT
ajpf-815	423	1	wernike	wernike	PROPN
ajpf-815	424	1	k	k	PROPN
ajpf-815	424	2	,	,	PUNCT
ajpf-815	424	3	hoffmann	hoffmann	PROPN
ajpf-815	424	4	b	b	PROPN
ajpf-815	424	5	,	,	PUNCT
ajpf-815	424	6	beer	beer	NOUN
ajpf-815	424	7	m	m	PROPN
ajpf-815	424	8	(	(	PUNCT
ajpf-815	424	9	2013	2013	NUM
ajpf-815	424	10	)	)	PUNCT
ajpf-815	424	11	.	.	PUNCT
ajpf-815	425	1	single	single	ADJ
ajpf-815	425	2	-	-	PUNCT
ajpf-815	425	3	tube	tube	NOUN
ajpf-815	425	4	multiplexed	multiplexed	ADJ
ajpf-815	425	5	molecular	molecular	ADJ
ajpf-815	425	6	detection	detection	NOUN
ajpf-815	425	7	of	of	ADP
ajpf-815	425	8	endemic	endemic	ADJ
ajpf-815	425	9	porcine	porcine	NOUN
ajpf-815	425	10	viruses	virus	NOUN
ajpf-815	425	11	in	in	ADP
ajpf-815	425	12	combination	combination	NOUN
ajpf-815	425	13	with	with	ADP
ajpf-815	425	14	background	background	NOUN
ajpf-815	425	15	screening	screen	VERB
ajpf-815	425	16	for	for	ADP
ajpf-815	425	17	transboundary	transboundary	ADJ
ajpf-815	425	18	diseases	disease	NOUN
ajpf-815	425	19	.	.	PUNCT
ajpf-815	426	1	j.	j.	PROPN
ajpf-815	426	2	clin	clin	PROPN
ajpf-815	426	3	.	.	PUNCT
ajpf-815	427	1	microbiol	microbiol	PROPN
ajpf-815	427	2	.	.	PUNCT
ajpf-815	428	1	51(3):938	51(3):938	NUM
ajpf-815	428	2	-	-	SYM
ajpf-815	428	3	944	944	NUM
ajpf-815	428	4	.	.	PUNCT
ajpf-815	429	1	wachtel	wachtel	ADJ
ajpf-815	429	2	-	-	PUNCT
ajpf-815	429	3	galor	galor	NOUN
ajpf-815	429	4	s	s	PROPN
ajpf-815	429	5	,	,	PUNCT
ajpf-815	429	6	benzie	benzie	PROPN
ajpf-815	429	7	iff	iff	PROPN
ajpf-815	429	8	(	(	PUNCT
ajpf-815	429	9	2011	2011	NUM
ajpf-815	429	10	)	)	PUNCT
ajpf-815	429	11	.	.	PUNCT
ajpf-815	430	1	herbal	herbal	ADJ
ajpf-815	430	2	medicine	medicine	NOUN
ajpf-815	430	3	:	:	PUNCT
ajpf-815	430	4	an	an	DET
ajpf-815	430	5	introduction	introduction	NOUN
ajpf-815	430	6	to	to	ADP
ajpf-815	430	7	its	its	PRON
ajpf-815	430	8	history	history	NOUN
ajpf-815	430	9	,	,	PUNCT
ajpf-815	430	10	usage	usage	NOUN
ajpf-815	430	11	,	,	PUNCT
ajpf-815	430	12	regulation	regulation	NOUN
ajpf-815	430	13	,	,	PUNCT
ajpf-815	430	14	current	current	ADJ
ajpf-815	430	15	trends	trend	NOUN
ajpf-815	430	16	,	,	PUNCT
ajpf-815	430	17	and	and	CCONJ
ajpf-815	430	18	research	research	NOUN
ajpf-815	430	19	needs	need	NOUN
ajpf-815	430	20	.	.	PUNCT
ajpf-815	431	1	in	in	ADP
ajpf-815	431	2	:	:	PUNCT
ajpf-815	431	3	benzie	benzie	PROPN
ajpf-815	431	4	iff	iff	PROPN
ajpf-815	431	5	,	,	PUNCT
ajpf-815	431	6	wachtel	wachtel	ADJ
ajpf-815	431	7	-	-	PUNCT
ajpf-815	431	8	galor	galor	NOUN
ajpf-815	431	9	s	s	X
ajpf-815	431	10	(	(	PUNCT
ajpf-815	431	11	eds	ed	NOUN
ajpf-815	431	12	,	,	PUNCT
ajpf-815	431	13	)	)	PUNCT
ajpf-815	431	14	.	.	PUNCT
ajpf-815	432	1	herbal	herbal	ADJ
ajpf-815	432	2	medicine	medicine	NOUN
ajpf-815	432	3	:	:	PUNCT
ajpf-815	432	4	biomolecular	biomolecular	ADJ
ajpf-815	432	5	and	and	CCONJ
ajpf-815	432	6	clinical	clinical	ADJ
ajpf-815	432	7	aspects	aspect	NOUN
ajpf-815	432	8	.	.	PUNCT
ajpf-815	433	1	2nd	2nd	PROPN
ajpf-815	433	2	edition	edition	PROPN
ajpf-815	433	3	.	.	PUNCT
ajpf-815	434	1	boca	boca	PROPN
ajpf-815	434	2	raton	raton	PROPN
ajpf-815	434	3	(	(	PUNCT
ajpf-815	434	4	fl	fl	PROPN
ajpf-815	434	5	):	):	PUNCT
ajpf-815	434	6	crc	crc	PROPN
ajpf-815	434	7	press	press	PROPN
ajpf-815	434	8	/	/	SYM
ajpf-815	434	9	taylor	taylor	PROPN
ajpf-815	434	10	&	&	CCONJ
ajpf-815	434	11	francis	francis	PROPN
ajpf-815	434	12	;	;	PUNCT
ajpf-815	434	13	2011	2011	NUM
ajpf-815	434	14	.	.	PUNCT
ajpf-815	435	1	chapter	chapter	NOUN
ajpf-815	435	2	1	1	NUM
ajpf-815	435	3	.	.	PUNCT
ajpf-815	435	4	available	available	ADJ
ajpf-815	435	5	at	at	ADP
ajpf-815	435	6	:	:	PUNCT
ajpf-815	435	7	https://www.ncbi.nlm.nih.gov/books/nbk92773/	https://www.ncbi.nlm.nih.gov/books/nbk92773/	PROPN
ajpf-815	435	8	wang	wang	PROPN
ajpf-815	435	9	yh	yh	PROPN
ajpf-815	435	10	,	,	PUNCT
ajpf-815	435	11	samoylenko	samoylenko	PROPN
ajpf-815	435	12	v	v	PROPN
ajpf-815	435	13	,	,	PUNCT
ajpf-815	435	14	tekwani	tekwani	VERB
ajpf-815	435	15	bl	bl	PROPN
ajpf-815	435	16	,	,	PUNCT
ajpf-815	435	17	khana	khana	PROPN
ajpf-815	435	18	ia	ia	PROPN
ajpf-815	435	19	,	,	PUNCT
ajpf-815	435	20	millerls	millerl	NOUN
ajpf-815	435	21	,	,	PUNCT
ajpf-815	435	22	chaurasiya	chaurasiya	NOUN
ajpf-815	435	23	nd	nd	PRON
ajpf-815	435	24	,	,	PUNCT
ajpf-815	435	25	md	md	PROPN
ajpf-815	435	26	.	.	PUNCT
ajpf-815	436	1	rahman	rahman	PROPN
ajpf-815	436	2	m	m	PROPN
ajpf-815	436	3	,	,	PUNCT
ajpf-815	436	4	tripathi	tripathi	PROPN
ajpf-815	436	5	lm	lm	PROPN
ajpf-815	436	6	,	,	PUNCT
ajpf-815	436	7	khan	khan	PROPN
ajpf-815	436	8	si	si	PROPN
ajpf-815	436	9	,	,	PUNCT
ajpf-815	436	10	joshi	joshi	PROPN
ajpf-815	436	11	vc	vc	PROPN
ajpf-815	436	12	,	,	PUNCT
ajpf-815	436	13	wigger	wigger	NOUN
ajpf-815	436	14	ft	ft	PROPN
ajpf-815	436	15	,	,	PUNCT
ajpf-815	436	16	muhammada	muhammada	NOUN
ajpf-815	436	17	i	i	PRON
ajpf-815	436	18	(	(	PUNCT
ajpf-815	436	19	2010	2010	NUM
ajpf-815	436	20	)	)	PUNCT
ajpf-815	436	21	.	.	PUNCT
ajpf-815	437	1	composition	composition	NOUN
ajpf-815	437	2	,	,	PUNCT
ajpf-815	437	3	standardization	standardization	NOUN
ajpf-815	437	4	and	and	CCONJ
ajpf-815	437	5	chemical	chemical	NOUN
ajpf-815	437	6	profiling	profiling	NOUN
ajpf-815	437	7	of	of	ADP
ajpf-815	437	8	banisteriopsis	banisteriopsis	PROPN
ajpf-815	437	9	caapi	caapi	NOUN
ajpf-815	437	10	,	,	PUNCT
ajpf-815	437	11	a	a	DET
ajpf-815	437	12	plant	plant	NOUN
ajpf-815	437	13	for	for	ADP
ajpf-815	437	14	the	the	DET
ajpf-815	437	15	treatment	treatment	NOUN
ajpf-815	437	16	of	of	ADP
ajpf-815	437	17	neurodegenerative	neurodegenerative	ADJ
ajpf-815	437	18	disorders	disorder	NOUN
ajpf-815	437	19	relevant	relevant	ADJ
ajpf-815	437	20	to	to	ADP
ajpf-815	437	21	parkinson	parkinson	NOUN
ajpf-815	437	22	's	's	PART
ajpf-815	437	23	disease	disease	NOUN
ajpf-815	437	24	.	.	PUNCT
ajpf-815	438	1	j.	j.	PROPN
ajpf-815	438	2	ethnopharmacol	ethnopharmacol	PROPN
ajpf-815	438	3	.	.	PUNCT
ajpf-815	439	1	128(3):662	128(3):662	NUM
ajpf-815	439	2	-	-	SYM
ajpf-815	439	3	671	671	NUM
ajpf-815	439	4	.	.	PUNCT
ajpf-815	440	1	vissani	vissani	PROPN
ajpf-815	440	2	ma	ma	PROPN
ajpf-815	440	3	,	,	PUNCT
ajpf-815	440	4	thiry	thiry	NOUN
ajpf-815	440	5	e	e	NOUN
ajpf-815	440	6	,	,	PUNCT
ajpf-815	440	7	dal	dal	NOUN
ajpf-815	440	8	pozzo	pozzo	PROPN
ajpf-815	440	9	f	f	PROPN
ajpf-815	440	10	,	,	PUNCT
ajpf-815	440	11	barrandeguy	barrandeguy	PROPN
ajpf-815	440	12	m	m	PROPN
ajpf-815	440	13	(	(	PUNCT
ajpf-815	440	14	2016	2016	NUM
ajpf-815	440	15	)	)	PUNCT
ajpf-815	440	16	.	.	PUNCT
ajpf-815	441	1	antiviral	antiviral	ADJ
ajpf-815	441	2	agents	agent	NOUN
ajpf-815	441	3	against	against	ADP
ajpf-815	441	4	equid	equid	ADJ
ajpf-815	441	5	alpha	alpha	NOUN
ajpf-815	441	6	herpesviruses	herpesviruse	NOUN
ajpf-815	441	7	:	:	PUNCT
ajpf-815	441	8	current	current	ADJ
ajpf-815	441	9	status	status	NOUN
ajpf-815	441	10	and	and	CCONJ
ajpf-815	441	11	perspectives	perspective	NOUN
ajpf-815	441	12	.	.	PUNCT
ajpf-815	442	1	vet	vet	NOUN
ajpf-815	442	2	.	.	PUNCT
ajpf-815	443	1	j.	j.	PROPN
ajpf-815	443	2	207:38	207:38	PROPN
ajpf-815	443	3	-	-	PUNCT
ajpf-815	443	4	44	44	NUM
ajpf-815	443	5	.	.	PUNCT
ajpf-815	444	1	zouharova	zouharova	PROPN
ajpf-815	445	1	d	d	X
ajpf-815	445	2	,	,	PUNCT
ajpf-815	445	3	lipenska	lipenska	PROPN
ajpf-815	445	4	i	i	PRON
ajpf-815	445	5	,	,	PUNCT
ajpf-815	445	6	fojtikova	fojtikova	PROPN
ajpf-815	445	7	m	m	PROPN
ajpf-815	445	8	,	,	PUNCT
ajpf-815	445	9	kulicha	kulicha	PROPN
ajpf-815	445	10	p	p	NOUN
ajpf-815	445	11	,	,	PUNCT
ajpf-815	445	12	neca	neca	PROPN
ajpf-815	445	13	j	j	PROPN
ajpf-815	445	14	,	,	PUNCT
ajpf-815	445	15	slanya	slanya	PROPN
ajpf-815	445	16	m	m	PROPN
ajpf-815	445	17	,	,	PUNCT
ajpf-815	445	18	kovarcik	kovarcik	PROPN
ajpf-815	445	19	k	k	PROPN
ajpf-815	445	20	,	,	PUNCT
ajpf-815	445	21	turanek	turanek	ADV
ajpf-815	445	22	-	-	PUNCT
ajpf-815	445	23	knotigova	knotigova	VERB
ajpf-815	445	24	p	p	X
ajpf-815	445	25	,	,	PUNCT
ajpf-815	445	26	hubatka	hubatka	PROPN
ajpf-815	445	27	f	f	PROPN
ajpf-815	445	28	,	,	PUNCT
ajpf-815	445	29	celechovska	celechovska	ADJ
ajpf-815	445	30	h	h	NOUN
ajpf-815	445	31	,	,	PUNCT
ajpf-815	445	32	maseka	maseka	PROPN
ajpf-815	445	33	j	j	PROPN
ajpf-815	445	34	,	,	PUNCT
ajpf-815	445	35	koudelka	koudelka	PROPN
ajpf-815	445	36	s	s	PROPN
ajpf-815	445	37	,	,	PUNCT
ajpf-815	445	38	prochazka	prochazka	PROPN
ajpf-815	445	39	l	l	PROPN
ajpf-815	445	40	,	,	PUNCT
ajpf-815	445	41	eyer	eyer	PROPN
ajpf-815	445	42	l	l	PROPN
ajpf-815	445	43	,	,	PUNCT
ajpf-815	445	44	plockova	plockova	PROPN
ajpf-815	445	45	j	j	PROPN
ajpf-815	445	46	,	,	PUNCT
ajpf-815	445	47	10	10	NUM
ajpf-815	445	48	bartheldyova	bartheldyova	X
ajpf-815	445	49	e	e	NOUN
ajpf-815	445	50	,	,	PUNCT
ajpf-815	445	51	miller	miller	PROPN
ajpf-815	445	52	ad	ad	NOUN
ajpf-815	445	53	,	,	PUNCT
ajpf-815	445	54	ruzek	ruzek	NOUN
ajpf-815	445	55	d	d	NOUN
ajpf-815	445	56	,	,	PUNCT
ajpf-815	445	57	turaneka	turaneka	PROPN
ajpf-815	445	58	j	j	PROPN
ajpf-815	445	59	(	(	PUNCT
ajpf-815	445	60	2016	2016	NUM
ajpf-815	445	61	)	)	PUNCT
ajpf-815	445	62	.	.	PUNCT
ajpf-815	446	1	antiviral	antiviral	ADJ
ajpf-815	446	2	activities	activity	NOUN
ajpf-815	446	3	of	of	ADP
ajpf-815	446	4	2,6	2,6	NUM
ajpf-815	446	5	-	-	ADJ
ajpf-815	446	6	diaminopurine	diaminopurine	NOUN
ajpf-815	446	7	-	-	PUNCT
ajpf-815	446	8	based	base	VERB
ajpf-815	446	9	acyclic	acyclic	ADJ
ajpf-815	446	10	nucleoside	nucleoside	ADJ
ajpf-815	446	11	phosphonates	phosphonate	NOUN
ajpf-815	446	12	against	against	ADP
ajpf-815	446	13	herpesviruses	herpesviruse	NOUN
ajpf-815	446	14	:	:	PUNCT
ajpf-815	446	15	in	in	ADP
ajpf-815	446	16	vitro	vitro	X
ajpf-815	446	17	study	study	NOUN
ajpf-815	446	18	results	result	NOUN
ajpf-815	446	19	with	with	ADP
ajpf-815	446	20	pseudorabies	pseudorabie	NOUN
ajpf-815	446	21	virus	virus	NOUN
ajpf-815	446	22	(	(	PUNCT
ajpf-815	446	23	prv	prv	PROPN
ajpf-815	446	24	,	,	PUNCT
ajpf-815	446	25	suhv-1	suhv-1	NOUN
ajpf-815	446	26	)	)	PUNCT
ajpf-815	446	27	vet	vet	NOUN
ajpf-815	446	28	.	.	PUNCT
ajpf-815	447	1	microbiol	microbiol	PROPN
ajpf-815	447	2	.	.	PUNCT
ajpf-815	448	1	184(29):84	184(29):84	NUM
ajpf-815	448	2	-	-	SYM
ajpf-815	448	3	93	93	NUM
ajpf-815	448	4	.	.	PUNCT